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Abstract 
Stroke is a global health concern, with a significant impact on mortality and 
disability.  Motor impairment, including upper limb impairment is particularly 
common following stroke. Upper limb impairment impacts on an individual’s 
ability to complete activities of daily living and quality of life.   Effective 
interventions targeted at upper limb recovery are therefore important and 
further research, within this area, has been identified as necessary.  
However, challenges researching such complex interventions have been 
recognised.  To attempt to overcome such difficulties the Medical Research 
Council (MRC) proposed a framework for the development and evaluation of 
RCTs for complex interventions. 
In this thesis the MRC framework has been used, focusing on the processes 
of developing and feasibility/piloting, to provide information for a phase III 
randomised controlled trial (RCT) of a novel intervention targeted at upper 
limb recovery following stroke.   
A systematic review and meta-analysis was undertaken to investigate and 
clarify any possible association between predictive variables and upper limb 
recovery.  Observational studies of stroke patients investigating at least one 
predictive variable and its relationship with a defined measure of upper limb 
recovery at a future time point were included.  For this review data analysis 
combined several approaches.  Fifty eight studies were included and 41 
predictor variables identified.  Initial measures of upper limb function and 
impairment were found to be the most significant predictors of upper limb 
recovery; odds ratio (OR) 38.62 (95% confidence interval (CI) 8.40-177.55) 
and OR 14.84 (95% CI 9.08-24.25) respectively.  Neurophysiological factors 
(motor evoked potentials and somatosensory evoked potentials) were also 
consistently identified as strongly associated with upper limb recovery; OR 
11.76 (95% CI 2.73-69.05) and OR 13.73 (95% CI 2.73-69.05) respectively.  
Moderate evidence of association was found for global disability and lower 
limb impairment.  Interpretation of results is complicated by methodological 
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factors, particularly relating to the heterogeneous nature of the included 
studies.  
In order to identify interventions which show potential for reducing 
impairment and/or improving upper limb function after stroke, an overview of 
the available evidence was completed.  This systematic review and meta-
analysis included Cochrane systematic reviews, other reviews and, where 
necessary, additional RCTs of interventions to promote upper limb recovery.  
Thirteen relevant interventions were found, covered by nine Cochrane 
systematic reviews (bilateral training, constraint-induced movement therapy 
(CIMT), electromyograhphic (EMG) biofeedback, electrostimulation, hands-
on therapy interventions, mental practice, repetitive task training (RTT), 
electromechanical/robotic devices and virtual reality) and four other reviews 
(neurophysiological approaches, high-intensity therapy, mirror therapy and 
splinting).  A statistically significant result, in terms of arm recovery, was 
found in favour of eight of the interventions:  CIMT (standardised mean 
difference (SMD) 0.74 95% CI 0.44-1.03), EMG biofeedback (SMD 0.41 95% 
CI 0.05-0.77), electrostimulation (SMD 0.40 95% CI 0.02-0.77), mental 
practice (SMD 1.37 95% CI 0.60-2.15), mirror therapy (SMD 0.41 95%CI 
0.05-0.77), RTT (SMD 0.23 95% CI 0.06-0.41), electromechanical/robotic 
devices (SMD 0.30 95% CI 0.02-0.58) and virtual reality (SMD 0.52 95% CI 
0.25-0.78).  Two out of the eleven interventions, which investigated hand 
function outcomes found a positive result (CIMT SMD 0.39 95% CI 0.11-0.68 
and repetitive task training SMD 0.27 95% CI 0.06-0.47).  Analyses were 
limited by a relatively small number of RCTs, which were also generally small 
in size.  Heterogeneity of the available data and methodological limitations 
further impacts on the conclusions.  Despite these limitations this overview 
provided a concise and informative summary of the available evidence.  The 
interventions found to be beneficial, or showing promise tend to include 
elements of intensive, repetitive, task-specific practice.    
To build the evidence base for upper limb interventions, two Cochrane 
systematic reviews were undertaken.  These reviews investigated the effects 
of bilateral training and home therapy programmes on upper limb recovery.  
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Both included RCTs of stroke patients.  Eighteen trials were included in the 
bilateral review, of which 14 were included in the analyses.  Most of the 
included trials were considered to be at high risk of bias and the evidence 
was further limited by heterogeneity.  No statistically significant results were 
found for any of the primary outcomes.  One study found a statistically 
significant result in favour of another upper limb intervention for performance 
in extended ADL. No statistically significant differences were found for any of 
the other secondary outcomes.  Four RCTs were included in the home-
based therapy programmes review.  No statistically significant result was 
found for any of the outcomes.  There is currently insufficient good quality 
evidence to determine the effects of both the interventions studied.   
Following the evidence gained from the overview of interventions elements of 
intensive, repetitive and task-specific practice were to be included in a novel 
upper limb intervention.  Robotic interventions, which incorporate these 
principles, were also found to have a positive effect on upper limb outcomes.  
Therefore a pilot, feasibility and acceptability study of a novel device 
(Armeo®Spring) that included these elements was completed.  Medically 
stable adults with a clinical diagnosis of stroke and arm deficits admitted to 
an acute stroke unit were recruited.  Participants were randomly allocated to 
experimental intervention (high or low intensity training with the 
Armeo®Spring arm orthosis) or usual stroke unit care.  Primary outcomes 
were feasibility and acceptability of the experimental device recorded at post-
intervention.  Secondary outcomes were; safety and three efficacy outcomes 
recorded at post-intervention, and 3 month follow-up.  Patient recruitment 
was challenging; over eight months 393 consecutive stroke admissions were 
screened and 12 participants recruited.  This study demonstrated that per-
protocol levels of intensity were not feasible to provide in an acute stroke 
unit.  However, higher levels of intensity could be achieved and this novel 
intervention was found to be acceptable to patients.   This pilot trial also 
found higher change scores on the three efficacy outcomes within both 
intervention groups, compared to the control group.  Due to small sample 
size and other possible confounding factors, these findings must be 
interpreted with caution.   
  4 
Using the MRC complex intervention framework as a guide I completed 
development and feasibility/piloting work surrounding an upper limb 
intervention, following stroke.  Following the results of this research further 
development, feasibility/piloting work is suggested for the ArmeoSpring 
device prior to the undertaking of a phase III RCT.  The information gained 
from this research could be used to inform phase III RCTs of other upper 
limb interventions.   
 
  5 
Acknowledgements 
There are a number of people who I would like to take the opportunity to 
thank for assisting me in completing this thesis. 
Professor Peter Langhorne, Professor Philip Rowe and Dr Christopher Weir; 
my supervisors, for their guidance, advice and support.  Particular thanks 
must go to my principal supervisor, Professor Peter Langhorne, who enabled 
me to keep a sense of humour throughout the process and who I am 
privileged to have worked with. 
To all my colleagues and friends in the Academic Section of Geriatric 
Medicine and clinical section (past and present) who have provided practical 
support, assistance and guidance, as well as many good times and fond 
memories.  Lynn Legg and Gillian Kerr must be given a particular mention.  
The staff, notably Beverly Honderbrink and the therapists and patients of 
wards 17/31 and 36 at Glasgow Royal Infirmary who allowed me to conduct 
the pilot feasibility study.   
Katie Thomson for completing the outcome assessments for the trial and 
David Legg for transcribing the interviews for the feasibility study.   
The co-reviewers on the systematic reviews described in this thesis and the 
Cochrane Stroke group for all their assistance with the two Cochrane 
reviews. 
The Chief Scientist Office for funding my post, which allowed me to complete 
this research.   
Sandra and Mike for all the extra babysitting duties, support and continual 
encouragement. 
  6 
Mum and dad and my sisters, Susan and Aileen for their practical help, 
always believing in me and for their continued unconditional support, 
encouragement and love.   
Lastly, but most importantly to the two most important people in my life:  
Philip and Abby.  None of this could have been achieved without Philips’ 
encouragement to attempt it in the first place and dedication to the cause of 
“getting it done.”   He has loved and supported me through the process, and 
for this I am amazed and grateful!  Abby has to be thanked for her ability to 
continually amaze and terrify me in equal measures and for reminding me 
that there is something more important than this thesis.  It is to the two of 
them that this thesis is dedicated. 
 
  7 
Table of contents 
Abstract ........................................................................................................ 1 
Acknowledgements ..................................................................................... 5 
Table of contents ......................................................................................... 7 
List of tables............................................................................................... 12 
List of figures ............................................................................................. 14 
Authors declaration ................................................................................... 16 
List of abbreviations.................................................................................. 18 
List of publications .................................................................................... 20 
List of presentations.................................................................................. 21 
Chapter 1 Introduction........................................................................... 24 
1.1 Stroke ................................................................................................. 24 
1.1.1 Definition of stroke ....................................................................... 24 
1.1.2 The impact of stroke on public health .......................................... 25 
1.1.3 The impact of stroke on the individual ......................................... 26 
1.1.4 Current stroke treatments ............................................................ 28 
1.1.5 Stroke rehabilitation ..................................................................... 30 
1.2 Problems researching rehabilitation ................................................... 31 
1.2.2 Framework for researching complex interventions ...................... 35 
1.3 Conclusion.......................................................................................... 37 
1.4 Research aims ................................................................................... 37 
1.4.1 Research objectives .................................................................... 38 
Chapter 2 Predictors of upper limb recovery after stroke:  a 
systematic review and meta-analysis ...................................................... 40 
2.1 Introduction......................................................................................... 40 
2.1.1 Upper limb deficits ....................................................................... 40 
2.1.2 Variability of outcome of upper limb following stroke ................... 40 
2.1.3 Systematic reviews ...................................................................... 42 
2.2 Objectives........................................................................................... 44 
2.3 Methods.............................................................................................. 44 
2.3.1 Eligibility criteria ........................................................................... 45 
2.3.2 Search methods for identification of studies ................................ 47 
2.3.3 Identification of relevant studies................................................... 48 
2.3.4 Data extraction............................................................................. 48 
2.3.5 Documentation of methodological quality .................................... 49 
2.3.6 Data analysis ............................................................................... 50 
2.4 Results ............................................................................................... 51 
2.4.1 Results of the search ................................................................... 51 
  8 
2.4.2 Included studies........................................................................... 54 
2.4.3 Predictor variables ....................................................................... 66 
2.4.4 Outcome measures ..................................................................... 69 
2.4.5 Methodological quality of included studies................................... 71 
2.4.6 Primary analysis .......................................................................... 72 
2.4.7 Secondary analysis...................................................................... 85 
2.5 Discussion .......................................................................................... 90 
2.5.1 Summary of findings .................................................................... 90 
2.5.2 Limitations of the review and the included studies....................... 91 
2.5.3 Strengths of the review ................................................................ 95 
2.5.4 Implications for practice ............................................................... 95 
2.5.5 Implications for research.............................................................. 95 
2.5.6 Conclusions ................................................................................. 96 
Chapter 3 Effectiveness of interventions targeted at upper limb 
recovery after stroke:  an overview.......................................................... 98 
3.1 Introduction......................................................................................... 98 
3.1.1 Motor impairment ......................................................................... 98 
3.1.2 Upper limb rehabilitation .............................................................. 98 
3.1.3 Interventions for motor recovery of the upper limb....................... 99 
3.2 Objectives......................................................................................... 100 
3.3 Methods............................................................................................ 100 
3.3.1 Eligibility criteria ......................................................................... 100 
3.3.2 Search methods for identification of studies .............................. 102 
3.3.3 Identification of relevant trials .................................................... 102 
3.3.4 Data extraction........................................................................... 103 
3.3.5 Documentation of methodological quality .................................. 103 
3.3.6 Data analysis ............................................................................. 104 
3.4 Results ............................................................................................. 105 
3.4.1 Results of the search ................................................................. 105 
3.4.2 Included studies......................................................................... 106 
3.4.3 Methodological quality of the included studies........................... 109 
3.4.4 Evidence for effects of interventions: Arm function .................... 110 
3.4.5 Evidence for effects of interventions: Hand function .................. 114 
3.4.6 Evidence in context.................................................................... 120 
3.5 Discussion ........................................................................................ 120 
3.5.1 Summary of findings .................................................................. 120 
3.5.2 Limitations of the review ............................................................ 122 
3.5.3 Strengths of the review .............................................................. 124 
3.5.4 Implications for practice ............................................................. 124 
3.5.5 Implications for research............................................................ 125 
3.6 Conclusions...................................................................................... 125 
Chapter 4 Systematic review of simultaneous bilateral training for 
improving arm function after stroke ...................................................... 128 
4.1 Introduction....................................................................................... 128 
  9 
4.1.1 Cochrane reviews ...................................................................... 128 
4.1.2 Bilateral training ......................................................................... 129 
4.2 Objectives......................................................................................... 129 
4.3 Methods............................................................................................ 130 
4.3.1 Eligibility criteria ......................................................................... 130 
4.3.2 Search methods for identification of studies .............................. 134 
4.3.3 Identification of relevant trials .................................................... 136 
4.3.4 Data extraction........................................................................... 137 
4.3.5 Documentation of methodological quality .................................. 137 
4.3.6 Data analysis ............................................................................. 138 
4.4 Results ............................................................................................. 139 
4.4.1 Results of the search ................................................................. 139 
4.4.2 Included studies......................................................................... 141 
4.4.3 Excluded studies........................................................................ 147 
4.4.4 Risk of bias in included studies.................................................. 148 
4.4.5 Effects of interventions............................................................... 149 
4.4.6 Sensitivity and subgroup analyses............................................. 157 
4.5 Discussion ........................................................................................ 158 
4.5.1 Summary of findings .................................................................. 158 
4.5.2 Limitations of the review ............................................................ 161 
4.5.3 Strengths of the review .............................................................. 163 
4.5.4 Implications for practice ............................................................. 163 
4.5.5 Implications for research............................................................ 163 
4.6 Conclusions...................................................................................... 164 
Chapter 5 Home-based therapy programmes for upper limb 
functional recovery following stroke ..................................................... 167 
5.1 Introduction....................................................................................... 167 
5.2 Objectives......................................................................................... 168 
5.3 Methods............................................................................................ 168 
5.3.1 Eligibility criteria ......................................................................... 168 
5.3.2 Search methods for identification of studies .............................. 171 
5.3.3 Data extraction........................................................................... 173 
5.3.4 Assessment of risk of bias in included studies........................... 174 
5.3.5 Data analysis ............................................................................. 174 
5.4 Results ............................................................................................. 175 
5.4.1 Results of the search ................................................................. 175 
5.4.2 Included studies......................................................................... 177 
5.4.3 Excluded studies........................................................................ 181 
5.4.4 Risk of bias in included studies.................................................. 182 
5.4.5 Effects of interventions............................................................... 183 
5.4.6 Subgroup and sensitivity analyses............................................. 186 
5.5 Discussion ........................................................................................ 187 
5.5.1 Summary of findings .................................................................. 187 
5.5.2 Limitations of the review ............................................................ 189 
  10 
5.5.3 Strengths of the review .............................................................. 190 
5.5.4 Implications for practice ............................................................. 190 
5.5.5 Implications for research............................................................ 190 
5.6 Conclusions...................................................................................... 191 
Chapter 6 The feasibility and acceptability of a gravity-supported, 
computer-enhanced arm exerciser for acute stroke patients:  a pilot 
randomised controlled trial..................................................................... 193 
6.1 Introduction....................................................................................... 193 
6.1.1 Upper limb intervention .............................................................. 193 
6.2 Objectives......................................................................................... 195 
6.3 Methods............................................................................................ 196 
6.3.1 Study population ........................................................................ 196 
6.3.2 Study interventions .................................................................... 197 
6.3.3 Outcome measures ................................................................... 199 
6.3.4 Data analysis ............................................................................. 201 
6.4 Results ............................................................................................. 203 
6.4.1 Primary outcome: Feasibility...................................................... 206 
6.4.2 Primary outcome: Opinions of therapy – Acceptability............... 209 
6.4.3 Secondary outcomes: Safety ..................................................... 213 
6.4.4 Secondary outcome: Efficacy outcomes.................................... 215 
6.4.5 Secondary outcome: Exploratory outcome ................................ 217 
6.5 Discussion ........................................................................................ 217 
6.5.1 Summary of findings .................................................................. 217 
6.5.2 Limitations of the study .............................................................. 221 
6.5.3 Strengths of the study................................................................ 222 
6.5.4 Implications for practice ............................................................. 222 
6.5.5 Implications for research............................................................ 222 
6.6 Conclusions...................................................................................... 223 
Chapter 7 Conclusions........................................................................ 226 
7.1 Key Findings..................................................................................... 227 
7.1.1 Predictors of upper limb recovery .............................................. 227 
7.1.2 Interventions targeted at upper limb recovery............................ 227 
7.1.3 Effectiveness of two specific interventions................................. 228 
7.1.4 Identify and evaluate a novel, evidence-based intervention ...... 228 
7.2 Challenges encountered................................................................... 229 
7.3 Future directions............................................................................... 230 
Appendices............................................................................................... 233 
Appendix A – Upper limb functional outcomes ....................................... 234 
Appendix B – Upper limb impairment outcomes..................................... 239 
Appendix C – Details of included studies ............................................... 245 
Appendix D – Characteristics of included studies (bilateral training) ...... 254 
Appendix E – Characteristics of included studies (home-based therapy 
programmes) .......................................................................................... 265 
  11 
Appendix F – ArmeoSpring device ...................................................... 269 
Appendix G - Consent form.................................................................... 270 
Appendix H – Interview topic guide ........................................................ 271 
Appendix I – Safety Checklist: End of intervention period ...................... 273 
Appendix J – Action Research Arm Test ................................................ 275 
Appendix K – Fugl-Meyer Assessment................................................... 277 
Appendix L – Barthel Index .................................................................... 278 
Reference List ........................................................................................ 282 
 
  12 
List of tables 
Table 2-1 - Levels of evidence..................................................................... 50 
Table 2-2 - Characteristics of included studies ............................................ 55 
Table 2-3 - Methodological quality of included studies................................. 71 
Table 2-4 - Primary analysis:  Results of association of predictor variables 
and measure of upper limb recovery............................................................ 74 
Table 2-5 - Overall evidence conclusions for each of the three analyses .... 88 
Table 3-1 - Outline of intervention categories and sources of evidence..... 107 
Table 3-2 - Key design features of the included trials ................................ 110 
Table 3-3 - Summary of evidence for interventions aimed at promoting upper 
limb (arm and hand) recovery after stroke ................................................. 116 
Table 4-1 - Characteristics of included studies (abbreviated) .................... 142 
Table 4-2 - Risk of bias summary .............................................................. 148 
Table 5-1 - Characteristics of included studies (abbreviated) .................... 178 
Table 5-2 - Risk of bias summary .............................................................. 182 
Table 6-1 - Baseline characteristics of participants per allocated group .... 205 
Table 6-2 - Amount of actual intervention using experimental device received 
by participants in both intervention groups................................................. 206 
Table 6-3 - Amount of intervention completed; days, sessions and minutes, 
by intervention group ................................................................................. 207 
Table 6-4 - Total amount of standard care (SC) received (time in minutes) 
during intervention period by intervention group ........................................ 208 
Table 6-5 - Amount of standard care received (time in minutes per 
observable day during intervention period) by intervention group.............. 208 
Table 6-6 - Number of reported adverse events; number of participants 
experiencing an adverse event (number of participants available for analysis)
................................................................................................................... 214 
Table 6-7 -Borg Perceived Exertion Scale recorded at end of intervention 214 
Table 6-8 - Efficacy outcomes at baseline, end of intervention and change 
score between baseline and end of intervention........................................ 215 
  13 
Table 6-9 - Efficacy outcomes at baseline, 3 month follow-up and change 
score between baseline and 3 month follow-up (n=4 unless otherwise stated)
................................................................................................................... 215 
Table 6-10 - Change scores between baseline and end of intervention for 
control and low and high intervention groups combined ............................ 216 
Table 6-11 - Change scores between baseline and 3 month follow-up for 
control and low and high intervention groups combined ............................ 216 
 
Table A-1 - Secondary analysis – (ii) Results of association between 
predictor variables and functional outcomes of upper limb recovery.......... 234 
Table B-1 - Secondary analysis – (iii) Results of association between 
predictor variables and impairment outcomes of upper limb recovery ....... 239 
Table C-1 - Approaches to therapy (Bobath) ............................................. 245 
Table C-2 - Bilateral training ...................................................................... 245 
Table C-3 - Constraint-induced movement training (CIMT) ....................... 246 
Table C-4 - Electromyographic biofeedback (EMG-BFB) .......................... 247 
Table C-5 - Electrostimulation.................................................................... 248 
Table C-6 – Hands-on therapy interventions ............................................. 249 
Table C-7 - High-intensity therapy ............................................................. 249 
Table C-8 - Mental practice........................................................................ 250 
Table C-9 - Mirror therapy.......................................................................... 250 
Table C-10 - Repetitive task training.......................................................... 251 
Table C-11 – Electromechanical/Robotic devices...................................... 251 
Table C-12 - Splinting ................................................................................ 253 
Table C-13 - Virtual reality training............................................................. 253 
Table D-1 - Full characteristics of included studies for review of bilateral 
training ....................................................................................................... 254 
Table E-1 - Full characteristics of included studies for review of home-based 
therapy programmes.................................................................................. 265 
 
  14 
List of figures 
Figure 1-1 - Graphical representation of MRC framework of the key elements 
of the development and evaluation process................................................. 36 
Figure 2-1 - Study selection flow diagram.................................................... 53 
Figure 2-2 – Meta-analysis of primary analysis:  Predictor variables and 
association with upper limb recovery ........................................................... 82 
Figure 2-3 – Meta-analysis of secondary analysis (1):  Predictor variables 
and association with measures of upper limb functional recovery ............... 85 
Figure 2-4 - Meta-analysis of secondary analysis (2):  Predictor variables and 
association with measures of upper limb impairment................................... 86 
Figure 3-1 - Flow chart of searching process and evidence identified at each 
stage of searching...................................................................................... 106 
Figure 3-2 - Forest plot of 13 interventions targeted at arm recovery 
compared to control group ......................................................................... 112 
Figure 3-3 - Forest plot of 8 interventions targeted at hand recovery 
compared to control group ......................................................................... 115 
Figure 4-1 – Study selection flow diagram ................................................. 140 
Figure 4-2- Comparison:  Bilateral training versus usual care.  Outcome:  
Performance in ADL................................................................................... 150 
Figure 4-3 - Comparison:  Bilateral training versus usual care.  Outcome:  
Functional movement of the upper limb ..................................................... 150 
Figure 4-4 - Comparison:  Bilateral training versus usual care.  Outcome:  
Performance in extended ADL................................................................... 151 
Figure 4-5 - Comparison:  Bilateral training versus usual care.  Outcome:  
Motor impairment of the upper limb (Motor impairment scales random effects 
model analysis) .......................................................................................... 152 
Figure 4-6 - Comparison:  Bilateral training versus usual care.  Outcome:  
Motor impairment of the upper limb ........................................................... 152 
Figure 4-7 - Comparison:  Bilateral training versus other specific upper limb 
intervention or programme.  Outcome:  Performance in ADL .................... 153 
Figure 4-8 - Comparison:  Bilateral training versus other specific upper limb 
intervention or programme.  Outcome:  Functional movement of the upper 
limb ............................................................................................................ 154 
  15 
Figure 4-9 - Comparison:  Bilateral training versus other specific upper limb 
intervention or programme.  Outcome:  Performance in extended ADL..... 154 
Figure 4-10 - Comparison:  Bilateral training versus other specific upper limb 
intervention or programme.  Outcome:  Motor impairment of the upper limb
................................................................................................................... 156 
Figure 4-11- Comparison:  Bilateral training versus other specific upper limb 
intervention or programme.  Outcome:  Motor impairment of the upper limb 
(Strength outcomes random effects model analysis) ................................. 156 
Figure 5-1 - Study selection flow diagram.................................................. 177 
Figure 5-2 - Comparison:  Home therapy programme versus usual care.  
Outcome:  Performance in ADL ................................................................. 184 
Figure 5-3 - Comparison:  Home therapy programme versus usual care.  
Outcome:  Functional movement of the upper limb.................................... 184 
Figure 5-4 - Comparison:  Home therapy programme versus usual care.  
Outcome:  Performance in extended ADL ................................................. 185 
Figure 5-5 - Comparison:  Home therapy programme versus usual care.  
Outcome:  Motor impairment of the upper limb.......................................... 186 
Figure 5-6 - Comparison:  Home therapy programme versus same therapy 
programme in hospital.  Outcome:  Motor impairment of the upper limb.... 186 
Figure 6-1 - Flow of participants through the study .................................... 204 
 
  16 
Authors declaration 
The research described in this thesis was completed during my time as a 
Chief Scientist Office Research Training Fellow in the Academic Section of 
Geriatric Medicine, Division of Cardiovascular and Medical Sciences, Faculty 
of Medicine, University of Glasgow based at Glasgow Royal Infirmary. 
The protocols for the research described in this thesis were designed by me 
with the advice and guidance of my supervisors, principally Professor Peter 
Langhorne, University of Glasgow. 
Dr. Alex Pollock (Research Fellow, NMAHP Research Unit, Glasgow 
Caledonian University) and Professor Peter Langhorne were co-reviewers of 
the systematic reviews and meta-analyses described in Chapters 2 and 3.  
Alex Pollock, Dr. Frederike van Wijck (Senior Lecturer, Queen Margaret 
University), Dr. Jacqui Morris (Research Fellow, University of Dundee) and 
Professor Peter Langhorne (University of Glasgow) were co-reviewers of the 
systematic review and meta-analysis described in Chapter 4.  Professor 
Paulette van Vliet (Fellow, University of Newcastle, Australia), Dr. Alex 
Pollock, Professor Catherine Sackley (Professor of Rehabilitation, University 
of Birmingham) and Lynn Legg (Research Training Fellow, University of 
Glasgow) were co-reviewers of the systematic review and meta-analysis 
described in Chapter 5.  The screening of stroke patients into the stroke unit 
at Glasgow Royal Infirmary was completed by me, although I had assistance 
form the clinical staff and therapists within the unit and from Ruth Graham 
(Stroke Research Nurse, Glasgow Royal Infirmary).  Katie Thomson 
(Lecturer in Occupational Therapy, Glasgow Caledonian University) 
completed the end of intervention and 3-month follow-up assessments for 
the participants in the trial described in Chapter 6.  Assistance was received 
to transcribe the interviews undertaken during the pilot trial and Lynn Legg 
acted as a second reviewer when analysing qualitative data.  Statistical 
advice regarding sample size calculation was given by Dr Christopher Weir.   
All other work, including data analysis was completed by me. 
  17 
The idea, design, organisation, administration and writing up of this thesis 
were performed by me with the advice and guidance of my supervisors, 
particularly Professor Peter Langhorne.  
The original research completed for this thesis was performed in accordance 
with the principles stated in the Declaration of Helsinki, and the conduct of 
the research accorded to the principles of good clinical practice.  Consent 
was gained according to the requirements of the local research ethics 
committee.  Management of all data was in compliance with the Data 
Protections Act.   
  18 
List of abbreviations 
5MWT 5 Metre Walk Test 
ADL  Activities of daily living 
ADM  Abductor digiti minimi 
AMED  Allied and complementary medicine database 
APB  Abductor pollicis brevis 
ARAT  Action Research Arm Test 
BBT  Box and Block Test 
BI  Barthel Index 
CI  Confidence interval  
CINAHL  Cumulative index to nursing and allied health literature 
CNS  Canadian Neurological Scale 
CST  Corticospinal tract 
EDC  Extensor digitorum communis 
EMBASE  Excerpta medica database  
EMG  Electromyography 
F  Female 
FA  Fractional anisotropy 
FAT  Frenchay Arm Test 
FDI  First dorsal interosseus 
F-M  Fugl-Meyer Assessment 
GCS  Glasgow Coma Scale 
M  Male  
MAL  Motor Activity Log 
MAS  Motor Assessment Scale 
MEDLINE Medical literature analysis and retrieval system online 
MEPs  Motor Evoked Potentials 
MI  Motricity Index 
MMSE Mini Mental State Examination 
Mos  Months 
MRC  Medical Research Council 
NHPT  Nine Hole Peg Test 
  19 
NIHSS National Institute for Health Stroke Scale  
OCSP  Oxfordshire Community Stroke Project  
OR  Odds ratio 
QOM  Quality of movement 
RCT  Randomised controlled trial 
SD  Standard deviation 
SMD  Standardised mean difference 
SPD  Silent period duration 
SSEP  Somatosensory evoked potential 
STREAM Stroke Rehabilitation Assessment of Movement 
TMS  Transcranial Magnetic Stimulation 
UEFT  Upper Extremity Function Test 
UK  United Kingdom 
UL  Upper limb 
USA  United States of America 
WMFT Wolf Motor Function Test 
  20 
List of publications  
Chapter 2 
Coupar F, Pollock A, Rowe P, Weir C, Langhorne P.  Predictors of upper 
limb recovery after stroke:  a systematic review and meta-analysis.  Clinical 
Rehabilitation 2012 26(4): 291-313  
Chapter 3 
Langhorne P, Coupar F, Pollock A. Motor recovery after stroke:  a systematic 
review.  Lancet Neurology 2009 Aug;8(8):741-54. 
Chapter 4 
Coupar F, Pollock A, van Wijck F, Morris J, Langhorne P. Simultaneous 
bilateral training for improving arm function after stroke. Cochrane Database 
of Systematic Reviews 2010, Issue 4. Art. No.: CD006432. DOI: 
10.1002/14651858.CD006432.pub2.  
Pollock A, Morris J, Wijck F, Coupar F, Langhorne P.  Response to 
Cauruagh J. H et al Bilateral movement training and stroke motor recovery 
progress.  Human Movement Science 2011 Feb 30(1) 143-6; author reply 
147-9. 
Chapter 5 
Coupar F, Pollock A, Sackley C, Legg L, van Vliet P. Home-based therapy 
programmes for upper limb functional recovery following stroke Cochrane 
Database of Systematic Reviews 2012, Issue 5. Art No.: CD006755. DOI: 
10.1002/14651858.CD006755.pub2. 
 
  21 
List of presentations 
Chapter 2 
Coupar F, Pollock A, Rowe P, Weir C, Langhorne P.  Predictors of upper 
limb recovery following stroke:  A systematic review.  Oral presentation at UK 
Stroke Forum 2008.  Abstract published in International Journal of Stroke.   
Coupar F, Pollock A, Rowe P, Weir C, Langhorne P.  Predictors of upper 
limb recovery following stroke:  A systematic review.  Poster presentation at 
European Stroke Conference 2008.  Abstract published in Cerebrovascular 
Diseases.   
Chapter 3 
Coupar F, Pollock A, Rowe P, Weir C, Langhorne P.  Effectiveness of 
interventions for upper limb recovery after stroke.  Oral presentation at 
European Stroke Conference 2009.  Abstract published in Cerebrovascular 
Diseases.   
Coupar F, Pollock A, Rowe P, Weir C, Langhorne P.  Effectiveness of 
interventions for upper limb recovery after stroke.  Oral presentation at UK 
Stroke Forum 2009.  Abstract published in International Journal of Stroke.   
Chapter 4 
Coupar F, van Wijck F, Morris J, Pollock A, Langhorne P.  Simultaneous 
bilateral training for improving arm function after stroke:  A Cochrane 
Systematic Review.  Poster presentation at UK stroke forum 2007.  Abstract 
published in International Journal of Stroke. 
 
Chapter 5 
Coupar F, Pollock A, Sackley C, Legg L, van Vliet P.  Home-based therapy 
programmes for upper limb functional recovery following stroke:  A Cochrane 
Systematic Review.  Oral presentation at the UK Stroke Forum 2011.  
Abstract published in International Journal of Stroke.   
 
  22 
Chapter 6 
Coupar F, Thomson K, Weir C, Langhorne P. A randomised, feasibility study 
of an assistive technology intervention targeted at the upper limb.  Oral 
presentation at the Society of Rehabilitation Research July 2012 (winner of 
best oral presenation). 
 
 
  23 
Chapter 1 
Introduction
  24 
Chapter 1  Introduction   
This thesis investigates upper limb interventions following stroke.  This 
introductory chapter will define key terms and place this investigation in 
appropriate context.   
1.1 Stroke 
1.1.1 Definition of stroke 
Stroke is regularly defined as;  
“a syndrome of rapidly developing symptoms and signs of focal, 
and at times, global, loss of cerebral function lasting more than 24 
hours or leading to death, with no apparent cause other than that 
of vascular origin1”  
This definition encompasses three pathological types of stroke; ischaemic, 
primary intracerebral haemorrhage and subarachnoid haemorrhage (SAH)2.  
Two systematic reviews3;4 of population-based incidence studies reported on 
the prevalence of stroke type and found largely consistent results.  
Approximately, ischaemic stroke accounts for 80% of cases, intracerebral 
haemorrhage 10%, SAH 5% and uncertain cause 5%.  The studies in these 
reviews however were largely based on white people in more developed 
countries and therefore the findings are not generalisable to various ethnic 
groups and less developed countries.  A further limitation of these reviews is 
that not all the participants in the studies received computerised tomography 
(CT) or magnetic resonance imaging (MRI) scans and therefore rates of 
intracerebral haemorrhage may have been underestimated5. 
While the above definition has been broadly accepted for many years, a 
revised definition has recently been proposed.  This revised definition does 
not include subarachnoid haemorrhage, as it is argued that the clinical 
features, aetiology, prognosis and treatment of SAH are quite distinct.  The 
modified definition of stroke is therefore;   
  25 
“a clinical syndrome characterised by an acute loss of focal 
cerebral function with symptoms lasting more than 24 hours or 
leading to death, which is thought to be due to either spontaneous 
haemorrhage into the brain substance (haemorrhagic stroke) or 
inadequate cerebral blood supply to a part of the brain (ischaemic 
stroke) as a result of low blood flow, thrombosis or embolism 
associated with diseases of the blood vessels (arteries or veins), 
heart or blood”5.  
In addition, to account for advancing technologies and treatments, the new 
proposed definition adds the following section:  
 “Patients who are being assessed within 24 hours of symptom 
onset and who still have focal neurological symptoms are 
temporarily classified as having a 'brain attack' (or something 
similar, such as an 'acute stroke syndrome' or 'unstable brain 
ischemia')”5.  
1.1.2 The impact of stroke on public health 
Stroke is a major public health concern worldwide and places a huge burden 
on patients, families and wider society2.  Globally stroke is the third most 
common cause of death (after coronary heart disease (CHD) and cancers) 
and a leading cause of permanent disability6.  
Within the United Kingdom (UK) stroke affects between 174 and 216 people 
per 100,000 of the population7, with approximately 12,500 new stroke events 
annually8.  Of these individuals 20-30% would be expected to die within a 
month9 and nearly 50% to remain dependent after a year2. Therefore, it is 
evident that the main impact of stroke is in increased levels of chronic, 
permanent disability, rather than death (in contrast to CHD and cancers).  
Indeed in the UK stroke is reported as the most prevalent cause of severe 
adult disability10.  Additionally while stroke mortality in developed countries is 
falling, it is argued that a large proportion of this is related to a reduction in 
case-fatality and other factors, rather than a reduction in incidence5. Further 
there is little evidence that the burden of stroke-related disability has fallen, 
adding weight to this argument11. 
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Subsequently, stroke is a major source of health and social care expenditure.  
In the UK 6% of the National Health Service (NHS) and social service 
spending budget is attributable to stroke and its consequences11. 
Additionally, with an increasingly ageing population the incidence of stroke is 
likely to increase12, and medical advancements are likely to further reduce 
case-fatality.   Thus stroke-related disability and its associated costs are 
likely to escalate.  It is predicted that disability-adjusted life years (DALYs) 
lost to stroke will rise from 38 million in 1990 to 51 million in 20206.  For all of 
these reasons stroke has been identified as an NHS priority area13;14.   
 
1.1.3 The impact of stroke on the individual 
At an individual level the consequences of stroke can be devastating.  
Depending on the area of the brain affected and the extent of the damage, 
the effects can be wide-ranging15.  Residual neurological deficits can include 
loss or impairment of the use of a limb (paresis), difficulties with speech 
(aphasia/dyspharthia), decline in mental functions (cognitive/perceptual 
impairments) and impaired emotional functioning16.  These deficits can 
impact upon an individual’s ability to move (e.g. walking), complete activities 
of daily living (ADL) (e.g. feeding, dressing) and reduce quality of life.  
Additionally a number of secondary medical problems; particularly infections 
and falls are common after stroke17.  However each stroke will have a 
varying clinical presentation secondary to vascular anomalies and the size 
and extent of the lesion18. 
If the consequences of stroke are considered in terms of the World Health 
Organization (WHO) International Classification of Functioning, Disability and 
Health19 the full impact of stroke can be recognised.  Stroke can affect each 
aspect of an individual’s life, as represented by the model; it can impair 
bodily functions and structures, limit activity and restrict participation.   
One of the most common and obvious deficits following stroke is motor 
impairment4.  Upper limb motor impairment has been estimated to affect 
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between 50-80% of stroke patients20.  In the population-based Copenhagen 
stroke study 32% of patients were admitted with severe upper extremity 
paresis, and 37% with mild arm paresis21.   It has been further suggested 
that, despite rehabilitation efforts, 50-75% of patients with initial upper limb 
impairment report persisting problems 6 months later22.   
Upper limb impairment is therefore a considerable problem following stroke 
and a significant contributor to stroke-related disability23.  This is perhaps 
most highlighted when considering the range of activities that involve arm 
function in everyday life:  basic activities of daily living (e.g. dressing, eating 
and drinking, toileting) communication; sensory activities (touch, 
temperature, pain); manipulation; defence and aggression and sexual 
activity24.  Additionally upper limb impairment has been found to be 
associated with reduced quality of life and unhappiness25.   
Upper limb motor deficits can occur following damage to the motor cortex, 
pre-motor cortex, supplementary motor cortex or damage to the descending 
fibres of the corticospinal tract.  Upper limb problems can be present in any 
of the Oxfordshire Community Stroke Project (OCSP) classifications; lacunar 
syndrome (LACs), total anterior circulation syndrome (TACs), posterior 
circulation syndromes (POCs) and partial anterior circulation syndrome 
(PACs)5.   
The main characteristics of upper limb impairment following stroke include 
changes in muscle tone and strength, abnormal reflexes, impairment of 
volitional movements and sensory deficits5.  Related secondary 
complications e.g. shoulder subluxation, oedema, pain and shoulder hand 
syndrome are also common26. 
It is therefore evident that upper limb impairments are a frequent, persisting 
and disabling consequence of stroke27.  Upper limb motor deficits and 
interventions targeted at recovery of upper limb functional movement and 
reduction in motor impairment will form the focus of this thesis.  Before giving 
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further consideration to these aspects it is worth reviewing the current 
treatments available to stroke patients.  
 
1.1.4 Current stroke treatments 
It is beyond the scope of this thesis to discuss in any detail the range of 
therapies available for the treatment of stroke.  It is worth however 
mentioning that a number of treatments (e.g. drug regimes, surgical 
interventions and rehabilitation) are available for the prevention and 
management of stroke and evidence is continually emerging on the effects of 
such treatments.  It has been suggested that there are currently two main 
treatments for stroke that significantly improve outcomes – thrombolysis and 
stroke units15. 
Thrombolysis has been found to significantly reduce the proportion of 
individuals, with acute ischaemic stroke, dead or dependent at the end of 
follow-up (odds ratio (OR) 0.84, 95% confidence interval (CI) 0.75 to 0.95)28.  
Thrombolysis is however, restricted in use; it can only be delivered to those 
with ischemic stroke, admitted within four and a half hours of definite onset of 
symptoms and should be delivered within the context of an acute stroke 
unit29.  Due to these restrictions less than 10% of stroke patients are 
currently eligible for thrombolytic therapy30;31.  
Stroke unit care is now widely recommended as the most appropriate 
method for the organisation of hospital stroke services32-34.  The evidence for 
stroke units has been growing for over 10 years.  The stroke unit trialists 
collaboration (SUTC) provide systematic review evidence that, when 
compared to general wards, stroke unit care is associated with a reduction in 
death (OR 0.86, 95% CI 0.76 to 0.98), combined outcomes of death or 
dependency (OR 0.82, 95% CI 0.73 to 0.92) and death or institutionalisation 
(OR 0.82, 95% CI 0.73 to 0.92) at the end of follow-up35.   
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This review completed subgroup analyses based on patient and intervention 
characteristics and the conclusions (based on 31 trials) of this review are that 
acute stroke patients are more likely to survive, return home and regain 
independence if they receive organised inpatient (stroke unit) care when 
compared to alternative care.  The subgroup analysis results indicate that the 
benefits of organised stroke unit care are not limited to any particular 
subgroup of patients (male/female, over 75/under 75, mild/moderate/severe 
stroke) or model of stroke unit organisation (comprehensive units, mixed 
assessment/rehabilitation units, rehabilitation stroke units).  Therefore this 
treatment approach is more likely to have a beneficial effect on a greater 
number of individuals.  However the authors of this review urge caution in 
respect of interpretation of these findings due to low statistical power.   
Despite the evidence for the effectiveness of organised (stroke unit) care the 
precise mechanisms of what constitutes an effective service are difficult to 
define due to the complex and multi-faceted nature of this treatment.  The 
main features of stroke unit care however have been described as: (i) a 
discrete unit, (ii) organisation (coordinated multidisciplinary rehabilitation, 
nursing integration and involvement of carers in rehabilitation process), (iii) 
specialist staffing (medical, nursing and therapy staff with specialist interest 
in stroke/rehabilitation) and (iiii) programmes of education and training35.  
Additionally, it has been found that trials which demonstrated a beneficial 
effect each followed a similar approach to care that incorporated:  (i) 
assessment and monitoring procedures (medical, nursing and therapy), (ii) 
early management policies (e.g. avoidance of urinary catheterisation, early 
mobilisation, treatment of early infection and (iii) ongoing rehabilitation 
policies (e.g. goal-setting, early assessment for discharge)36.   
Interpretation of the stroke unit trials would therefore suggest that 
multidisciplinary rehabilitation is a central component of this effective 
treatment.   
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1.1.5 Stroke rehabilitation 
Multidisciplinary rehabilitation is a well established and accepted element of 
stroke care32-34.  While no single definition is available a clear consensus 
exists that rehabilitation aims to minimise the impact of stroke and prevent 
secondary complications.  These aims are achieved using goal-setting, and a 
variety of problem-solving and therapeutic approaches5;37.  The key elements 
of rehabilitation are; assessment, goal-setting and intervention5;37;38.  
Stroke rehabilitation tends to involve experts from a number of different 
disciplines.  It has been suggested that the core multidisciplinary team 
should consist of appropriate levels of nursing, medical, physiotherapy, 
occupational therapy, speech and language therapy and social work staff33.  
However, perhaps the most important person in the process is the stroke 
patient themselves as rehabilitation requires patience, perseverance and 
active involvement39.    
As stated previously this research will concentrate on the problem of upper 
limb motor deficits following stroke and the particular focus will be on the 
intervention element of rehabilitation, in relation to these deficits.   
In order to reduce upper limb motor impairment and subsequent disability, 
upper limb recovery has been identified as an important rehabilitation goal40.  
As with other rehabilitation interventions, therapy targeted at the upper limb, 
(provided primarily by physiotherapists and occupational therapists) focuses 
on reducing impairment and increasing function.  Due to the impact upper 
limb problems can have on an individual it is essential that related 
interventions are effective in order to; maximise outcomes, reduce 
dependency and ensure appropriate use of resources. Improving upper limb 
outcomes however continues to present a challenge41 due to the complexity 
of the area and a lack of definitive research evidence to guide practice.    
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1.2 Problems researching rehabilitation 
Historically, research into all aspects of rehabilitation has been limited and 
frequently of poor quality13.  Randomised controlled trials (RCTs) are widely 
accepted as the “gold-standard” for assessing the effects of interventions42.  
However, it has been acknowledged that very few well designed and reliable 
RCTs exist that assess the effectiveness of rehabilitation after stroke16.  This 
situation has improved, however a number of inherent problems in 
researching such “complex interventions” still exist.  Complex interventions 
are defined as those “built up from a number of components, which may act 
both independently and inter-dependently” and encompass the majority of 
healthcare interventions43.  The particular difficulties of researching such 
interventions are identified below44;45: 
• Small sample sizes 
• Interventions poorly described or difficult to compare  
• Blinding   
• Difficulty testing accepted practice against placebo 
• Difficulty accepting uncertainty and acknowledging requirement for 
RCTs  
• Lack of funding, education, infrastructure and experience of research 
• Learning “curve” for practices 
• Patients’ concerns/reluctance to participate in RCTs  
Each of these elements will now be given further consideration, relating to 
stroke or general rehabilitation research.    
Small sample sizes 
A frequent criticism of rehabilitation trials is that the sample size is too small.  
This leads to a lack of sufficient statistical power and thus does not allow for 
definitive conclusions to be made43.  Research should enable hypothesis to 
be answered and that this can only be achieved through appropriate trial 
design and adequate numbers of patients46.   
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Interventions poorly described or difficult to compare  
Within complex interventions it is often difficult to ascertain what the “active 
ingredient” actually is43.  Difficulties often arise in assessing complex 
interventions as researchers have not fully defined and developed the 
intervention47.  Unless the processes and mechanisms of the interventions 
are made clear then replication or generalisation is nearly impossible47;48.  
The expertise of the professionals involved, dosage, intensity and setting of 
the intervention are just some of the elements that need to be considered43.    
Blinding   
In order to reduce bias the trial participants, outcome assessors and 
therapists providing the intervention should be unaware of group 
assignment49.  Trials which do not report double-blinding have been found to 
yield larger estimates of effect50.  However, due to the nature of rehabilitation 
trials it is often impossible to blind participants and the therapists providing 
the intervention.  However it should almost always be possible to blind 
outcome assessors 
When therapists/other staff are not blinded to group assignment, there is a 
risk of ‘competitive therapy bias51, whereby patients in the control group 
receive additional ‘usual care’ as they are prioritised by ward therapists over 
those receiving the additional intervention.  This can inevitably impact upon 
the estimated study effects. 
Difficulty testing accepted practice against placebo  
Many aspects of rehabilitation e.g. physiotherapy and occupational therapy 
are an accepted and recommended part of stroke treatment.  While the 
evidence base is growing52;53 further RCTs are required to evaluate various 
aspects of stroke rehabilitation.  However, it is generally considered unethical 
to deny patients accepted treatments.  Therefore interventions are generally 
compared to other interventions (e.g. usual care) rather than placebo, limiting 
statistical power. 
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Difficulty accepting uncertainty and acknowledging requirement for RCTs  
Traditionally, rehabilitation interventions have been developed from an 
intuitive belief about what may be effective, rather than from research 
evidence43.  Additionally there is evidence that firmly held clinical beliefs can 
be unfounded; illuminating the importance of well-designed randomised 
controlled trials54.   
Lack of funding, education, infrastructure and experience of research 
Within the stroke arena significant progress is being made.  Nevertheless 
rehabilitation research still has a long way to go.  Indeed the potential of 
allied health professionals (AHPs) as researchers is not yet fully realised and 
continued support is needed to enable them to become fully research-aware, 
research-active and evidence-based professions55. 
Learning “curve” for practices 
Rehabilitation interventions are complex in nature and quality in delivery 
improves with repetition and over time.  Therefore randomising between a 
familiar and unfamiliar intervention could introduce bias against the latter44. 
In addition to the above difficulties there is also issues relating to economic 
evaluataion of rehabiltiaiton interventions.   To date very few rehabilitation 
trials have incorporated economic evaluation.  This is probably due to those 
undertaking rehabilitation research having limited knowledge and expertise in 
this area and researchers tending to focus on the efficacy of interventions.  
Economic evaluation requires specialist health economist input, and requires 
analysis of many elements; however economic evaluation should be 
considered as part of rehabilitation trials, particularly larger studies to 
investigate if interventions are economically feasible as well as effective.   
Additional difficulties are particular to stroke rehabilitation research; 
spontaneous improvement, variety of outcome measures and heterogeneity 
of patients.   
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Spontaneous improvement 
Most stroke patients have some degree of spontaneous recovery which 
compounds the difficulties in stroke rehabilitation research16.  By employing a 
randomised controlled trial methodology this should no longer be a factor. 
However if the sample size is not large enough disparity between groups 
may occur.  
Variety of outcome measures  
Difficulties with outcome measures in rehabilitation research include; lack of 
reliability, validity and/or sensitivity and difficulty ascertaining what particular 
aspect is being measured.  It has been argued that while rehabilitation 
studies have tended to assess the effectiveness of interventions using 
“higher level” outcome measures e.g. global ADL measures this approach 
should be re-considered and impairment outcome measures be considered, 
in the first instance, to assess if the intervention has an impact at the level at 
which it is aimed54.  The number of outcome measures available also causes 
difficulties as combining and comparing trials where different measures have 
been used, is problematic16.   
Heterogeneity of patients  
As outlined previously, stroke can affect people in a number of different 
ways.  Frequently stroke rehabilitation trials have relatively broad inclusion 
criteria, which may generate less useful information about the types of 
patients who may benefit (or not) from a specific intervention56.  In terms of 
upper limb rehabilitation, there are no clear guidelines on best practice and it 
has been argued that this is primarily due to uncertainty regarding who 
benefits from treatment and in what way57. 
Within stroke rehabilitation research there is also the question of ‘faster’ or 
‘better’ levels of recovery.  Often within stroke rehabilitation research, 
particularly trials completed in the acute stages, it is unclear if the 
intervention under investigation improves levels of recovery, or simply 
hastens the process of recovery.  For such reasons it is important to include 
a range of outcome measures, i.e. it is important to include outcomes 
  35 
covering a wide range of spectrums (ADL, motor impairment, functional 
movement) and it is also important to have outcomes measured over a 
period of time.  Stroke rehabilitation trials have tended to have short term 
follow-up (e.g. end of intervention, 3 month), probably principally due to 
practical issues such as funding and feasibility of completing longer term 
follow-up.  However this means it is often unclear if effects of interventions 
are maintained in the longer-term (6 months, 12 months and beyond).  
Therefore, when designing studies longer-term outcomes should be 
incorporated if at all possible.  If interventions are only effective in the short-
term and have no impact on outcomes in the longer-term the suitability of the 
intervention may be questioned, particularly in times of limited resources.     
1.2.2 Framework for researching complex interventions 
To overcome the difficulties posed by complex interventions, a framework for 
the development and evaluation of RCTs for complex interventions was 
initially proposed in 2000 by the Medical Research Council (MRC)43.  This 
framework consisted of 5 phases (pre-clinical, modelling, exploratory trial, 
definitive RCT and long term implementation) each with a separate purpose 
and set of suggested tasks43;47;58.  This guidance was updated and extended 
in 200859.  The updated framework places emphasis on the processes of 
development, feasibility/piloting, evaluation and implementation of complex 
interventions.  In contrast to the original guidance the updated framework is 
less linear and provides a more flexible approach.   The process of 
investigating complex interventions is represented in the figure below59;60.   
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Figure 1-1 - Graphical representation of MRC framework of the key elements of the 
development and evaluation process 
 
 
The key components of each part of the process are indicated in the above 
figure.  The components that are most relevant to this thesis are 
development and feasibility/piloting.    
Development 
This part of the process is essential as it is imperative to develop the 
intervention to the point where it can be reasonably expected to have a 
worthwhile effect59;60.   
Feasibility/Piloting  
There is evidence to suggest that the feasibility/piloting part of the process is 
often not completed, which can lead to problems of acceptability, 
compliance, delivery of the intervention, recruitment and retention and 
smaller than expected effect sizes at the evaluation stage59;60.  
The evaluation of complex interventions poses a number of challenges and 
requires a substantial investment of time.  However, only thorough 
consideration of the processes and mechanisms of the problem, the 
intervention and evaluation can an adequate and cost-effective proposal for 
a randomised controlled trial be developed47.   
Feasibility/piloting 
1 Testing procedures 
2 Estimating recruitment/retention 
3 Determining sample size 
Evaluation 
1 Assessing effectiveness 
2 Understanding change process 
3 Assessing cost-effectiveness 
Implementation 
1 Dissemination 
2 Surveillance and monitoring 
3 Long term follow-up 
Development 
1 Identifying the evidence base 
2 Identifying/developing theory 
3 Modelling process and outcomes 
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1.3 Conclusion  
From this introductory chapter it is clear that stroke is an important global 
health concern, and one that is likely to escalate with an increasing ageing 
population.  Thus, it is imperative that effective strategies for the prevention, 
treatment, and rehabilitation of this disease are investigated. 
Organised inpatient (stroke unit) care has been identified as the most 
effective intervention in the treatment of patients with stroke.  While the 
essential components of stroke unit care are still not clear, multidisciplinary 
rehabilitation is accepted as a core component.   
Multidisciplinary stroke rehabilitation involves a number of processes and 
interventions, which aim to reduce impairment and disability and improve 
function.  The evidence for some aspects of stroke rehabilitation is still 
relatively limited or unclear.  Therefore, in order to ensure improved 
outcomes for patients, further research is crucial.   
Difficulties with researching complex interventions, such as aspects of 
rehabilitation, have been identified; however, to overcome such complexities 
a framework has been suggested. 
My research will use this complex intervention framework as a guide to 
identify and evaluate a novel intervention for upper limb recovery following 
stroke.  Upper limb recovery has been identified as an area of concern and 
an important area for research due to its prevalence and impact on an 
individual’s ability to complete activities of daily living.   
1.4 Research aims  
This thesis will investigate a number of issues related to upper limb recovery 
following stroke in order to provide information for a phase III randomised 
controlled trial that is;  theoretically-defensible, reproducible and adequately 
controlled, with appropriate statistical power.   
  38 
1.4.1 Research objectives 
1. To identify predictive variables of upper limb recovery after stroke 
2. To identify interventions that show potential for reducing impairment 
and/or improving upper limb function after stroke 
3. To identify a novel, evidence-based intervention to reduce upper limb 
impairment/improve function 
4. To complete a pilot trial and provide information for a phase III 
randomised controlled trial of a novel upper limb intervention 
To meet these stated aims a programme of work will be completed and for 
each stage of the programme the appropriate research method to answer the 
research questions will be utilised.  
In Chapter 2 the background to investigating predictive variables will be 
discussed and the mechanisms and results of a systematic review of this 
area will be presented. 
In Chapter 3 the background to investigating upper limb interventions will be 
examined and the mechanisms and results of a systematic review and meta-
analysis of this area will be described. 
In Chapters 4 and 5 investigations into the effects of particular upper limb 
interventions will be presented. 
In Chapter 6 the design, methods and subsequent results of a pilot trial of a 
novel upper limb intervention will be described.  
In Chapter 7 conclusions will be drawn.   Limitations of the work will also be 
discussed and how the information gained could inform other phase III trials 
will be proposed.   
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Chapter 2 
Predictors of upper limb recovery 
after stroke:  a systematic review 
and meta-analysis 
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Chapter 2  Predictors of upper limb recovery 
after stroke:  a systematic review and meta-
analysis 
2.1 Introduction 
2.1.1 Upper limb deficits  
As reported in Chapter 1 upper limb deficits are one of the most common 
impairments to affect individuals following stroke.  In addition the upper limbs 
are of special concern because of the significant impact these impairments 
have on disability, health and quality of life61 and due to the relatively limited 
attention this area has received62.  
2.1.2 Variability of outcome of upper limb following stroke 
It is acknowledged in the literature that there is variability across individuals 
in the nature and extent of upper limb outcome63.  While several studies have 
been conducted to examine the recovery of the hemiplegic arm, 
discrepancies in terms of reported rates of recovery are evident.  Rates of no 
functional recovery have been reported as 13% (n=491)21 and 60% (n=92)64.  
Complete functional recovery has been reported as occurring in between 
12% (n=102)65 and 20% of patients (n=491)21.  The discrepancies between 
these studies could be attributable to differing choice of outcome measure, 
variations in the time to measurement of recovery and/or slight differences in 
case selection. Despite the variations it is clear that some patients will have 
little or no functional improvement, some partial recovery and others 
complete recovery. 
As a result of these differing levels of recovery individual patients will have 
different rehabilitation needs.  However the literature currently lacks methods 
for stratification and individualisation of rehabilitation programmes for the 
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upper limb57.  A systematic review of exercise therapy for arm function 
concluded that identification of patients who would be most likely to benefit 
from particular interventions was not possible66.  In addition it has been 
proposed that the lack of positive findings in the stroke rehabilitation 
literature could be attributed to the heterogeneity of study populations67. 
Therefore to optimise rehabilitation, clarify outcomes and effects of therapy, 
identify appropriate interventions, stratify patients within trials and accurately 
inform patients of likely outcomes, there is a need to identify variables, which 
may allow early and reliable prediction of upper limb outcome65;68;69.  This 
information would be useful to both clinicians and researchers70.  I wanted to 
gain a better understanding of upper limb problems and enable a better 
characterisation of clinical presentation54 and likelihood of recovery.  This 
was achieved through completion of a systematic review of predictor studies.  
The purposes of prognostic/predictive studies are identified below: 
• To guide clinical decision making, including treatment selection and 
patient counselling  
• To improve understanding of the disease process  
• To improve the design and analysis of clinical trials (for example, risk 
stratification)  
• To assist in comparing outcome between treatment groups in non-
randomised studies by allowing adjustment for case mix  
• To define risk groups based on prognosis  
• To predict disease outcome more accurately or parsimoniously  
For the reasons outlined above and to allow appropriate stratification and 
analysis in my planned trial, an investigation into variables which predict 
upper limb outcome was deemed appropriate.  Due to the potential 
difficulties of establishing and using complex prediction models71;72 and in 
order to highlight easily used and potentially clinically relevant variables I 
decided to focus on the identification of individual (univariate) predictor 
variables. 
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A brief review of the literature established that a number of variables have 
been investigated in terms of their predictive value for upper limb recovery, 
including presence of evoked potentials73, initial motor deficit of the arm74, 
age70, ability to shrug the shoulder75 and cognitive impairment76.  
Inconsistency was evident between studies regarding the usefulness of such 
individual predictive variables.  Therefore a formal investigation to clarify 
associations between predictive variables and upper limb recovery was 
deemed appropriate.  This was achieved through the completion of a 
systematic review. 
A similar analysis77, published during conduct of this review, reported that 
neurophysiological measures and initial sensoriomotor abilities were the best 
predictors of voluntary arm movement after stroke. This review focused on 
categorising the predictive variables and associated outcome measures in 
terms of the International Classification of Functioning, Disability and 
Health19.  In contrast, I intended to provide a more wide-ranging and 
comprehensive summary of reported predictive variables and their 
association with upper limb recovery.  A further review of prediction of motor 
recovery78 considered only the predictive value of motor impairment scores, 
neuroimaging and neurophysiological assessment.  The aim of the current 
review was to systematically review and summarise the current, available 
literature regarding prognostic variables relating to upper limb recovery 
following stroke.  
2.1.3 Systematic reviews  
Systematic reviews have become essential tools to allow individuals to keep 
up to date with ever-accumulating evidence, in their field of interest79.  A 
systematic review is defined as; 
 “an overview of primary studies which contains an explicit 
statement of objectives, materials and methods and has been 
conducted according to explicit and reproducible methodology80”  
  43 
Where appropriate and sensible to do so, systematic reviews may include a 
meta-analysis, which is a statistical technique used to synthesise the results 
from independent studies.  It is important to distinguish between systematic 
review and meta-analysis because whilst it is always desirable to 
systematically review a body of data on some occasions it may be 
inappropriate or even misleading, to pool results from separate studies79.  It 
is therefore crucial that the limitations of meta-analysis and the importance of 
exploring sources of heterogeneity (inconsistency of results across studies) 
and bias are understood.     
Systematic review and meta-analysis methodology are most commonly 
associated with reviews of randomised controlled trials, and this will be 
discussed further in subsequent chapters.  However, this methodology are 
applicable to all types of research design, including prognostic/predictive 
studies71.  Indeed as multiple studies investigating prediction of a particular 
outcome accumulate it becomes increasingly important to identify and 
evaluate all of the relevant studies to develop a more reliable overall 
assessment. 
For prognostic/predictive studies the process of systematic review is not 
straightforward and a number of particular difficulties have been identified, as 
follows71:  
• Difficulty identifying all studies  
• Negative (non-significant) results may not be reported (publication 
bias)  
• Inadequate reporting of methods  
• Variation in study design  
• Most studies are retrospective  
• Variation in inclusion criteria  
• Lack of recognised criteria for quality assessment  
• Variation in methods of analysis  
• Differing methods of handling of continuous variables (some 
dependent on data)  
  44 
• Different statistical methods of adjustment  
• Adjustment for different sets of variables  
• Inadequate reporting of quantitative information on outcome  
• Variation in presentation of results (e.g. survival at different time 
points) and inconsistency in terms of outcome measures used  
Due to the presence of serious methodological limitations, it is often difficult 
to carry out sensible meta-analysis.  However, application of the principals of 
systematic review is desirable and advocated for predictive studies.  I 
therefore carried out a systematic review that followed the standard process 
of; statement of objectives, identification of eligibility criteria, identification of 
appropriate literature, data extraction, assessment of methodological quality, 
and data-analysis.  The aim of the review was to systematically review and 
summarise the current literature regarding prognostic variables relating to 
upper limb recovery following stroke.   
2.2 Objectives  
• To review which variables have been studied in relation to upper limb 
recovery  
• To identify which, if any variables independently predict upper limb 
recovery  
2.3 Methods  
The MOOSE (Meta-analysis of observational studies in epidemiology) 
guidelines for Meta-Analyses and Systematic Reviews of Observational 
Studies were used, for guidance to complete and report this review81.   
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2.3.1 Eligibility criteria  
Types of studies 
Observational studies, regardless of specific study design.  A study must 
have investigated at least one variable (explanatory variable); measured at 
baseline or another pre-determined point and its relationship with a measure 
of upper limb recovery (response variable), measured at a future time point.  
Only studies with extractable data of independent predictors were included 
i.e. studies with only multivariate analysis were not included in this review.     
Studies were included regardless of the nature of rehabilitation undertaken, 
although where available this information was documented.     
Subgroup analyses, completed within randomised controlled trials (RCTs) of 
specific interventions were not included in this review.  Entire cohorts of 
patients participating in RCTs were included.   
Types of participants 
The study population of interest were individuals with upper limb impairment 
following a clinical diagnosis of stroke.  If studies included a small 
percentage of individuals without upper limb impairment, where possible 
these individuals were excluded from any analysis.   
Types of outcome measures 
The outcome of interest (response variable) was upper limb recovery.  For 
the purposes of this review any outcome measures related to upper limb 
recovery, which fell into one of three categories were included:   
1. Upper limb function (measures of upper limb functional ability).  
Measures include; upper limb subsections of Barthel Index (BI)82, 
Rankin Scale83 and Functional Independence Measure (FIM)84.  
Global measures of function (i.e. full measure not just upper limb 
subsections) were excluded. 
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2. Upper limb functional movement (measures of general functional 
movement, dexterity, manipulation, grasp/grip/pinch).  Measures 
include; Action Research Arm Test (ARAT)85, Motor Assessment 
Scale (MAS)86 and Box and Block Test (BBT)87. 
3. Upper limb motor impairment (measures of general upper limb 
impairment, muscle strength). Measures include; Fugl-Meyer (F-M) 
assessment scale (upper limb section)88 and muscle testing.  
Outcomes related to specific impairments e.g. pain, spasticity, 
contractures were excluded from this review.    
All end points in each study were recorded.  Where more than one measure 
of upper limb recovery was used within a study the three categories were 
used in a priority order hierarchy i.e. if a study reported a measure of upper 
limb function and a measure of upper limb impairment, the exploratory 
variable was assessed in relation to the measure of upper limb function, for 
use in the primary analysis.  Secondary analysis was undertaken to assess 
the association between predictive variables and measures of upper limb 
function/functional movement and measures of motor impairment. If more 
than one outcome measurement was available within a category, the 
decision about which outcome to include was made by consensus.   
Timing of measurement of outcomes was recorded, as reported in the 
studies. Where more than one measurement was taken i.e. 3, 6 and 12 
months the data from the 6 month outcome measurement was used in the 
analysis, as most motor recovery will be achieved by 6 months89.  If 
outcomes were not measured at 6 months or were not presented in a 
suitable format for use in the analysis, the data from the last outcome 
measurement or the data that was the most complete and suitable for 
inclusion was used.     
Where both change and outcome scores were available, outcome scores 
were used in the analysis.  If only change scores were available and could 
be incorporated, these were used.    
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2.3.2 Search methods for identification of studies 
To identify relevant studies the following databases, with associated time 
periods were searched:   
• MEDLINE (1950 - November 2010) 
• EMBASE (1980 - November 2010) 
• AMED (1985 –November 2010) 
• CINHAL (1982 – November 2010) 
• Cochrane CENTRAL (September 2007) 
• Follow-up references from relevant papers 
The search strategy (outlined below) was generated following consultation 
with a medical librarian, consideration of appropriate literature71, and using 
search terms developed by the Cochrane Stroke Group90.  The searches 
were not limited to English.  This review was restricted to published articles.  
Only published data was used.   No attempt was made to contact authors for 
clarification.   
Search Strategy 
1. exp cohort studies/ 
2. incidence.sh. 
3. exp mortality/ 
4. follow-up studies.sh. 
5. prognos$.tw. 
6. predict$.tw. 
7. course$.tw. 
8. predictor$.tw. 
9. exp models, statistical/ 
10. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 
11. cerebrovascular disorders/ or exp basal ganglia cerebrovascular 
disease/ or exp brain ischemia/ or exp carotid artery diseases/ or 
cerebrovascular accident/ or exp brain infarction/ or exp 
cerebrovascular trauma/ or exp hypoxia-ischemia, brain/ or exp 
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intracranial arterial diseases/ or intracranial arteriovenous 
malformations/ or exp "Intracranial Embolism and Thrombosis"/ or exp 
intracranial hemorrhages/ or vasospasm, intracranial/ or vertebral 
artery dissection/ 
12. (stroke or poststroke or post-stroke or cerebrovasc$ or brain vasc$ or 
cerebral vasc$ or cva$ or apoplex$ or SAH).tw. 
13. hemiplegia/ or exp paresis/ 
14. (hemipleg$ or hemipar$ or paresis or paretic).tw. 
15. 11 or 12 or 13 or 14 
16. exp Upper Extremity/ 
17. (upper adj3 (limb$ or extremity)).tw. 
18. (arm or shoulder or elbow or forearm or hand or wrist or finger or 
fingers).tw. 
19. 16 or 17 or 18 
20. 10 and 15 and 19 
This search strategy was modified to suit different databases. 
2.3.3 Identification of relevant studies 
Initially I reviewed all the titles identified by the searches, removed all the 
duplicate titles between the databases and then deleted any obviously 
irrelevant titles.  Two independent reviewers then ranked abstracts as 
“relevant, possibly relevant or definitely irrelevant.”  The full text of studies 
categorised by at least one reviewer as “relevant or possibly relevant” were 
retrieved and eligibility of the study was again assessed by two review 
authors.  Where disagreement existed, consensus was reached through 
discussion. 
2.3.4 Data extraction 
Two reviewers independently extracted data.  Any differences between 
reviewer’s results were resolved by returning to the relevant study and 
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through discussion.  Where possible the following information was 
documented:   
1. Study setting (e.g. hospital, community, out-patients) 
2. Participant details (age, gender, type of stroke, time since stroke, 
initial upper limb impairment) 
3. Inclusion and exclusion criteria  
4. Rehabilitation received 
5. Predictive variables investigated  
6. Duration of follow up  
7. Outcomes investigated 
8. Data on associations between exploratory and dependent variables 
(when possible, the odds ratio (OR) was used, or calculated). 
Otherwise, other measures of associations (hazard ratio, correlations) 
or values for statistical significance (P value) of the reported 
association were extracted). 
2.3.5 Documentation of methodological quality 
The variation of the methodological quality of observational studies may 
influence the results and conclusions of a systematic review.  Therefore, the 
quality of each individual study was assessed.   
Assessing the quality of observational studies is more difficult and 
problematic than assessing the quality of randomised controlled trials and 
other types of experimental studies.  For this reason quality assessment 
methods for observational studies have not been formalised and although 
several checklists are available, none have been fully validated.  One 
commonly used checklist for assessing the quality of observational studies is 
the Newcastle-Ottawa Scale91.  This checklist is quite comprehensive and 
has been partly validated.  This was considered by the review team as a 
method of assessing the quality of the included studies; however this scale 
was not felt to be compatible with the nature of the studies included in this 
review.  Previously proposed criteria79 for assessing the validity of studies 
  50 
related to prognosis was considered to be more relevant to the studies 
included in this review.  Therefore a checklist was developed, based on this 
criterion and following suggestions in previous reviews of predictor 
studies92;93  
Two reviewers independently rated the quality of the included studies.  Any 
disagreements were resolved through discussion.  The methodological 
criteria included questions relating to:  
1. Sample of patients 
2. Follow-up 
3. Prognostic variable 
4. Outcome measurement 
5. Treatment 
6. Analysis 
2.3.6 Data analysis 
Due to the exploratory nature of this review and the expected variations in 
the available evidence, data analysis was undertaken using a combination of 
approaches.   
Initially data were analysed using a vote counting methodology.  For this 
analysis the number of studies investigating a particular explanatory variable 
was identified and the number of these studies that reported a statistically 
significant association between the specific variable and upper limb recovery 
was recorded. 
Based on the information gained from the vote counting analysis a best 
evidence synthesis was used to summarise the data.  This was assessed by 
defining four levels of evidence,42;94 illustrated in Table 2-1. 
Table 2-1 - Levels of evidence 
Strong  Consistent findings (≥80%) in at least 2 high quality cohorts 
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Moderate One high quality cohort and consistent findings (≥80%) in one 
or  more low more low quality cohorts 
Limited Findings of one cohort or consistent findings in one or more 
low quality cohorts  
Inconclusive Inconsistent findings regardless of study quality   
 
To give an overview of the collected data and a graphical representation of 
the studies, statistical pooling was performed and forest plots generated.  
This was completed using, where available, odds ratios (ORs) presented in 
the original papers.  Where odds ratios were not presented but sufficient data 
was available, the association between each predictive variable(s) 
(explanatory variable) and measures of upper limb recovery (response 
variable) in terms of odds ratio with 95% confidence intervals was calculated.  
Cut-offs used to calculate the odds ratios were determined by those used in 
other studies and/or the data available.   Odds ratios were calculated in order 
to ascertain the strength of association with better upper limb outcomes.  
This also involved inverting some odds ratios which were presented in the 
reciprocal format in the original papers.  In order to combine presented and 
calculated odds ratio the inverse variance analysis was used.  Due to 
suspected heterogeneity between the studies, analyses were completed 
using a random effects model.  All analyses was undertaken using the 
Cochrane software package RevMan 4.295.  
As a final analysis a consensus approach to categorising the evidence, 
based on the strength and consistency of the evidence was undertaken.  
This took into account the outcomes of both the vote counting and statistical 
methodologies. 
2.4 Results  
2.4.1 Results of the search 
The initial and updated searches identified a total of 7599 non-duplicate 
titles.  After the first screening, 558 abstracts were selected and reviewed, 
following which 165 full papers were retrieved. One hundred papers were 
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excluded, reasons for which are summarised in Figure 2-1.  Three studies 
were in languages other than English, and I have been unable to access a 
further study. Therefore four studies were identified that have not been 
included as they could not be fully reviewed.  An additional six papers were 
included from reference lists from other reviews.  Sixty seven papers 
reporting on 58 studies were included in this review.  The flow chart of the 
study selection is shown in Figure 2-1.  To avoid duplication of counting of 
participants, where it was assessed that participants were included in more 
than one publication, such papers were counted as one study. However, 
pertinent information from as many publications as relevant was used. The 
most comprehensive publication was used to describe the study.   
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Figure 2-1 - Study selection flow diagram 
 
Titles reviewed 
n= 5022 
Abstracts reviewed  
n = 558 
Excluded 
n=4464  
Papers retrieved for detailed 
evaluation  
n = 165  
Papers excluded   n = 100 
 
Not appropriate study design (response to 
treatment; subgroups of RCTs; review 
papers; not assessing prediction): n=48 
 
Not two time points: n=17 
 
Not suitable outcomes (not UL specific 
outcomes; outcomes related to specific UL 
impairments): n=20 
 
No extractable data:  n=12 
 
Duplicate publication  n=2 
 
Not >75% stroke participants  n=1 
Included papers/No of 
studies 
n = 67; 58 
Excluded 
n = 393 
 
Titles obtained from databases 
n=7599 
Duplicates excluded 
n= 2577 
4 studies 
awaiting 
review 
6 papers included 
from reference 
lists from other 
reviews 
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2.4.2 Included studies 
A brief overview of the included studies is presented below.  Table 2-2 
outlines the pertinent information of the included studies; number of 
participants, predictor variables and outcomes used in the analysis of this 
review.  
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Table 2-2 - Characteristics of included studies 
Study Number of 
participants 
Explanatory variables investigated  Outcomes used (Cut-off used) 
Timing of outcome(s) used  
Alagona 
200196 
Delaux 200397 
 
N=25  
N=22 (6 mos) 
 
N=16 (12 mos) 
for UL 
impairment  
Age (≤55/>55), sex (M/F), global disability (NIH; <11/≥11), TMS variables (MEP; 
FDI muscle of the hand, present/absent), side of stroke (L/R), UL impairment (MRC 
scale 0-5; ≥2/<2)  
 
(1) Barthel Motor (≥20/<20) 
(2) MRC (FDI muscle) (≥4/<4) 
6 months (12 months for analysis of 
UL impairment) 
Al-Rawi 
200998 
N=22 UL impairment (MRC scale), SSEP MRC scale 
3 months 
Au-Yeung 
200999 
N=70 
N=57 (follow-
up) 
UL impairment (MI), side of stroke, stroke location (lacunar  or no obvious lesion, 
cortical, subcortical or combined subcortical and cortical lesions), overall disability 
(NIHSS), cognition and perceptual (neurobehavioural cognitive status examination), 
UL sensation (two point discrimination) 
ARAT (0-57) (≥35/<35) 
6 months 
Barreca  
199976 
N=16 UL functional movement (UEFT score), cognition and perception (Halstead 
Category test score), time post stroke,  UL impairment (Chedoke McMaster stroke 
assessment arm and hand subscore) 
UEFT (0-100)  
Last week of rehabilitation (average 
length of rehabilitation 77 days) 
Beebe 2009100 N=33 
N=28 (3 mos) 
UL impairment (NIHSS motor arm score; (≤2/>2) (1) ARAT (0-57) (≥40/<40) 
(2) Grip (kg) (≥14/<14) 
3 months post-stroke 
Binkofski 
2001101 
 
N=52 
N=15 (6 mos)  
Analyses 
based on n=52 
UL functional movement (arm and hand function score 0-32; ≤16/>16),  lesion size, 
lesion localisation (subcortical/ cortical) 
Multifactorial score for arm and hand 
function (0-32; inverted scale, 
≤16/>16) 
180 days after admission 
Canning 
2004102 
N=22 Upper limb functional movement  (MAS),  UL impairment (strength; torques)  MAS (item 6 – upper arm function; 0-
6) 
27 weeks post-stroke 
*Catano 
1995103 
N=40 TMS (MEP responses; FDI and ADM muscles; present/absent) MRC (FDI and ADM muscle) 
90 days post-stroke 
*Catano 
1997104 
N=49 TMS (EMG silence – silent period following MEP; SPD stable/ SPD reduced by 
increasing facilitation) 
MRC (FDI muscle) (≥4/<4) 
90 days post-stroke 
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Cho 2007105 N=55 Diffusion tensor tractography (integrity of corticospinal tract) Modified Brunnstrom classification 
6 months after onset 
Cruz-Martinez 
1999106 
N=15 (with UL 
deficit)  
TMS variables (MEPs; thenar muscles, present/absent), age (≤55/>55), sex, size of 
lesion (1-3cm/>3cm), side of lesion (L/R), UL impairment (CNS distal arm score; 
1.0/<1.0)  
CNS (distal arm score; 0-1.5) 
(≥1.0/<1.0) 
6 months post-stroke 
Dachy 2003107 N=56 
N=48 (76±17 
days) 
TMS variables; (MEPs; ADM muscle, present/absent), side of lesion  
 
MI (UL;  0-100) 
Late stage of rehabilitation mean 
76±17 days post-stroke 
De Souza 
1980108 
N=14 UL impairment (arm, trunk and hand movement; >50%/<50%) Assessment of arm, trunk and hand 
movement (>80%/<80%) 
32 weeks post-stroke 
De Weerdt 
1987109 
N=111 
N=58 (6 mos) 
 
Age, sex, pre-stroke ability, pre-stroke mental status, duration for stroke to develop, 
handedness, global impairment, speech disorders, side of lesion (side of 
hemiplegia), number of previous strokes, visual disorders (visual field loss), seventh 
cranial nerve, pain in arm (spontaneous arm pain), shoulder complications, UL 
impairments (F-M), UL functional movement (ARAT), sensation (light touch),  
cognition and perception (post-stroke mental status)  
(1) ARAT (0-57) 
(2) F-M (0-66) 
6 months  
Escudero 
1998110 
N=50 
N=39 (6 mos) 
Analyses 
based on n=50 
UL impairment (MRC abductor pollicis brevis), Global disability (Barthel Index), 
TMS variables (MEPs APB muscle present/absent) 
MRC scale (APB muscle) 
6 months 
Feys 200070 
Feys 2000111 
Feys 2000112 
 
 
N=100 
N=96 (6 mos) 
For stroke 
location 
analysis;  n=45  
For MEPs and 
SEPs analysis; 
n=48  
Global disability (BI), TMS variables (MEPs; APB muscle present/absent), SSEPs; 
median nerves at the wrist, present/absent, infarction location,  
age, sex, UL impairment (F-M UL section), side of hemiparesis, UL sensation 
(tactile), visual disorders (hemianopia; not occurring/occurring) cognition and 
perceptual (MMSE; no deficit ≥ 24/deficit <24), speech disorders (not 
occurring/occurring), mood (Hospital Anxiety and Depression Scale; no deficit >10/ 
deficit ≤10), shoulder complications (shoulder pain; absent/present) 
F-M (UL section; 0-66) 
6 months 
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Gowland 
1982113 
 
N=229 
N=223 
(discharge) 
Nos in 
analyses not 
always n=223 
due to missing 
or excluded 
data 
Age (≤55/>55), UL sensation (normal sensation/sensory involvement), perception 
(no deficit/deficit), global impairment (hemiparesis/hemiplegia), time since stroke 
(onset <12 weeks/ >12 weeks), side of stroke (side of hemiplegia R/L) 
Brunnstrom stages of arm motor 
recovery (1-6) (≥1/0 stages of 
improvement) 
Discharge from rehabilitation centre 
(median 7 (range 1-23) weeks) 
Hatakenaka 
2007114 
N=34 Sex, UL impairment (F-M UL section), distribution of upper extremity paresis 
(proximal /distal), TMS variables (MEPs; biceps brachii potentials 
presence/absence), size of lesion 
Functional category of upper 
extremity (A-D) (A-B/D) 
End of inpatient rehabilitation (108±17 
days) 
Heald 1993115 N=118 
N=76 (12 mos) 
TMS variables (central motor conduction time; normal, delayed or absent) (1) NHPT 
(2) MI  
12 months 
Hendricks 
1997116 
Hendricks 
1994117 
N=29  
N=20 (follow-
up 1-4 yrs)  
Analyses 
based on n=29 
MEPs (abductor digiti quinti muscle, present/absent), SEPs (median nerve 
stimulation; present/absent)  
Motor recovery (voluntary motor 
action) (Presence/absence of motor 
recovery)  
1-4 years post-stroke (mean 2.4 
years) 
Hendricks 
2003118 
N=43 
N=40 (26 
weeks) 
TMS variables (MEPs; biceps brachii muscle, present/absent)  F-M (arm score; 0-30; arm motor 
recovery yes/ no)  
26 weeks post-stroke 
Higgins 
2005119 
N=56  
N=55 (5 
weeks)  
Age, sex, UL functional movement (FAT), UL impairment (strength; Jamar), general 
motor impairment (STREAM), lower limb impairment (gait speed; 5MWT), number 
of co morbid conditions, type of stroke, side of lesion 
BBT (number of blocks in one minute) 
5 weeks post-stroke 
Jang 2010120 N=53 TMS variable (MEP; abductor pollics brevis, present/absent), Diffusion tenor 
tractography imaging (CST integrity, +/-) 
MI (>62/<62) 
6 months post-stroke 
 
Jorgensen 
199989 
Nakayama 
199421 
N=826 UL 
impariment 
N=619 (6 mos) 
Upper limb impairment (Scandinavian Stroke Scale sub-scores for arm and hand; 
mild or moderate/severe) 
BI (subscores for feeding and 
grooming; full or partial function/ no 
function) 
6 months 
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Katrak 199075 N=29 (initial 
UL deficits and 
followed-up) 
UL impairment (hand movement scale, 1-6; >2/≤2 and shoulder shrug; 
present/absent)   
(1)MAS; Hand movement section 
Discharge from hospital (mean 125 
days post-stroke) 
(2) Hand movement scale (0-6; 
≥4/<4) 
Final discharge (average 223 days 
post-stroke) 
Katrak 1998121 N=57  
N=46 (3 mos) 
Age, sex, UL impairment (hand movement scale, 1-6; 1/2 or 3),UL sensation 
(incorporating light touch, sensory inattention and proprioception), side of stroke 
(side of hemiparesis) 
(1)Hand function test (1-4) – “Good” 
hand function – able to complete one 
of the tasks. 
(2) Hand movement scale (1-6) (≥4 
“Good” hand movements/<4) 
3 months 
Keren 1993122 
Keren 1995123 
N=19 SEPs (median nerve, present/absent) (1) Rancho Los Amigos (17 UL 
activities) 
(2) MI (0-100) 
Approximately 10 weeks after first 
evaluation (71±14.6 days) 
Kwakkel 
200365 
N=102 
N=100 (6 mos) 
Age (<70/  ≥70), sex, UL impairment (MI (arm), 0-100; ≥11/<11), urinary 
incontinence (BI subsection; absent/present), type of stroke (OCSP), side of stroke 
(L/R), time since stroke, cognition and perception (MMSE; no deficit/deficit), 
consciousness during initial 24 hours (GCS), sitting balance (Trunk Control Test; no 
deficit/ deficit), global disability (Barthel), UL sensation (Thumb finding test), visual 
deficits (hemianopia; no/yes), social support (present/absent), lower limb 
impairment (F-M leg; ≥25/<25) 
ARAT (0-57) (≥10/≤9) 
6 months 
La Joie 
1982124 
N=68 SSEPs evoked potentials (median nerve; present/absent), UL function at admission 
(present/absent) 
UL functional return (self-care activity; 
functional return/no functional return) 
Discharge (mean 84 (range 44-205) 
days) 
Lin 2009125 N=57 Age, sex, side of stroke, time since stroke, global disability (NIHSS), UL impairment 
(F-M distal section) 
(1) MAL (QOM scale) 
(2) F-M (UL section) 
End of intervention period (3 weeks) 
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Loewen 
1990126 
N=57 
N=50 
(discharge) 
Age, sitting balance (Modified MAS component), sit to stand (Modified MAS 
component), UL functional movement (Modified MAS; combined arm score), bowel  
function (BI component), urinary incontinence/ bladder function (BI component) 
Modified MAS (combined arm score; 
sum of scores on upper arm function, 
hand movements and advanced hand 
movement sections)  
Discharge 
Loubinoux 
2003127 
N=9 Global disability (NIHSS, <11/ ≥11), UL impairment (MI; UL section, 0-100; 
≥11/<11), UL functional movement (NHPT; able to complete/ unable to complete), 
global impairment (MI; ≥66/<66)  
MI (UL section, 0-100; ≥66/<66) 
28 days after first assessment (11±6 
days) 
Meldrum 
200457 
Meldrum 
2000128 
N=114  
N=108 (6 mos) 
Age (<65/65-74/ ≥75), type of stroke (OCSP), UL sensation (normal/ 
impaired/absent or unable to assess), UL impairment (Rivermead arm score), 
global disability (Orpington Prognostic score) 
Rivermead arm score (0-15;  5-15/ 0-
4/death) 
6 months 
Nagao 1992129 N=13 Age(≤55 >55), sex, side of stroke (L/R), TMS variables (MEP; thenar muscles, 
present/absent), UL impairment (Manual Motor Test, 0-5; >2/≤2), time since stroke 
(Day 0/ ≥Day 1) 
Manual Motor Test  (0-5;  ≥2 (fair and 
good/<2 (poor) 
3 months after initial testing 
Nascimbeni 
200669 
N=19  TMS (MEP; first dorsal interosseous muscle, present/ absent), UL impairment 
(Motricity Index,  upper limb subscale; ≥11/<11), global disability (NIHSS, <11/≥11) 
MRC scale (hand, 0-5; ≥2/<2) 
4 months post stroke 
Nijland 2010130 N=188 
N=156 (6 mos) 
Age (<70/ ≥70), sex, side of stroke (L/R), type of stroke (OCSP), time since stroke, 
comorbidities (≥1/0), cognition and perception (present/absent), visual deficits 
(hemianopia; no/yes), sensation (absent/present), urinary incontinence (BI 
subsection; absent/present), lower limb impairment (MI leg; ≥25/<25), sitting 
balance (present/absent), UL impairment (F-M finger extension <1/≥1) 
ARAT (0-57) (≥10/≤9) 
6 months 
Olsen 1990131 N=66  UL impairment (MRC scale, 0-5; >2/≤2), global disability (BI, ≥60/<60) 
 
BI (UL sections; prepare tray and 
feed self and dress upper body; 0-11, 
≥9/<9)  
Discharge 
Paci 2007132 N=121  
N=107 
(completed) 
Age, sex, side of stroke, length of stay, time since onset of stroke, UL impairment 
(motricity sub-score of F-M; UL), UL sensation (F-M; UL sensory score), shoulder 
complications (shoulder pain; absence/presence) 
F-M (Upper limb score) 
Follow-up (30-40 days) after 
discharge from rehabilitation 
Park 2008133 N=222 UL motor impairment (F-M), age, sex, side of stroke, global disability (Functional 
level), sensation (F-M light touch), UL functional measures (WMFT functional ability 
scale), time after stroke, type of stroke, cognition and perception (impaired visual 
perception) 
MAL (QOM) scale(≥3/<3)  
12 months post-treatment 
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Parker 198627 N=266 initial 
Ul deficits  
N=152 (3 mos) 
UL impairment (MI, 0-100; ≥33 (mild or moderate)/<33 (severe) (1) FAT (0-5; ≥4/<4)  
(2) MI (0-100;  ≥66/<66) 
3 months 
Pennisi 
1999134 
N=15 Age(≤55/>55), sex, infarction location (subcortical or cortico-subcortical), lesion 
size, side of stroke, global disability (NIHSS, <11/ ≥11 ) 
Scale derived from MRC (0-5) (≥2/<2) 
Day 365 
Pizzi 2009135 N=52 
N=38 (follow-
up) 
TMS (MEP; EDC present/absent), UL impairment (MRC scale EDC  ≥2/<2) FAT (0-5; ≥2/<2) 
MRC scale (≥4/<4) 
12 months 
Prabhakaran 
2008136 
N=41  Age, sex, UL impairment (F-M UL), lesion location, lesion volume, time to 
reassessment 
F-M UL change score (0-66)  
3 months post-infarct 
Putman 
200763 
N=532  
N-419 
Socioeconomic status  Rivermead motor assessment (arm 
section; 0-5/6-10/11-15) 
Discharge 
Rapisarda 
1996137 
N=26 TMS (MEP; hand muscles, present/absent), global disability (NIH, <11/≥11) 
 
Scale derived from MRC scale (hand; 
0-5)  (≥2/<2)  
Day 14 
Renner 
2009138 
N=16 UL impairment (hand grip) (1) ARAT 
(2) Hand grip 
6 weeks after enrolment 
Roy 1995139  N=76 Shoulder complications (shoulder pain; absence/presence), cognition, UL sensation 
(touch sensation absent/present) and urinary incontinence (absent/present) 
(1) FAT 
(2) MI 
12 weeks 
Shelton 
2001a74 
Shelton 
2001b68 
N=171 
N=41 used for 
analysis of 
global 
disability 
Age, sex, UL impairment (F-M; UL motor section), cognition (MMSE), type/class of 
stroke (hemiparetic motor deficits, hemiparetic motor plus hemisensory deficit or 
hemianopic visual deficits, motor plus hemisensory plus hemianopic visual deficits 
or other combinations of deficits), lower limb impairment (F-M; lower limb motor 
section), global impairment (F-M),  lesion location (cortical/ subcortical/ mixed), 
handedness (right/left/ambidextrous), side of stroke, time since stroke (interval from 
stroke to admission; < 2 weeks/ 2-4 weeks/ >4 weeks),  global disability (FIM) 
F-M (UL 0-58)    
Recorded at discharge (38±17days) 
Smania 
2007140 
N=48 
N=37 (6 mos) 
UL impairment (hand movement scale, 1-6; >3/≤3) (1) NHPT 
(2) MI (UL section) 
180 days after stroke 
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Stinear 
2007141 
N=21  
N=17 (30 
days) 
Age (≤55/>55), sex,  side of stroke (hemisphere affected (L/ R)), time since stroke 
<29 mos/> 29 mos), hand grip asymmetry (force transducer), TMS variables 
(MEPs; extensor carpi radialis, present/ absent), global disability (NIHSS, ≤4/>4), 
UL impairment  (F-M UL movement section, 0-32; ≥11/<11), infarction location 
(motor cortex damage), UL sensation (cutaneous sensation; no sensation 
loss/sensation loss) 
F-M (UL movement section; 0-32) 
(≥2/<2 points of improvement) 
End of motor practice (30 days) 
 
Sunderland 
1989142 
N=38 
N=31 (6 mos) 
UL impairment (MI, 0-100; >18/<18), UL functional movement (FAT; >0/0) FAT (>0/0) 
6 months (193±16 days) post-stroke 
Trompetto 
2000143 
N=21 
N=14 (6 mos) 
TMS variables (MEPs; thenar muscles, present/ absent), age (<70/≥70), sex, side 
of stroke (L/R), global disability (Scandinavian stroke scale 0-58; >29/≤29), UL 
impairment (Scandinavian stroke scale hand motor score, 0-6; 0/ ≥1) 
Scandinavian Stroke Scale (subscore 
for hand motor function; 0-6) (≥4/<4) 
6 months after stroke 
Turton 1996144 N=21 UL impairment (Motricity Index upper limb section; >11/≤11), age (≤55/>55), sex 
(M/F), side of stroke (L/R), TMS (MEPs response/no response) 
(1) NHPT (able/unable to complete).  
Only available for TMS variable 
6 weeks 
(2) MI (UL section 0-100; ≥66/<66) 
6 months 
Tzvetanov 
2005145 
Tzvetanov 
2004146 
 
N=102 
N=94 (6 mos) 
N=22 for 
analyses of 
age, sex and 
side of stroke 
SSEPs (median nerve, normal/absent/amplitude ratio <0.5 but >0), age, UL 
impairment (MRC scale), sex, side of stroke. 
 
MRC scale (0-5) 
6 months after stroke 
Van Kuijk 
2009147 
N=39 
N=35 (follow-
up)  
UL impairment (F-M ; presence/absence of any motor recovery of the UL), TMS 
(MEPs; present/absent), lower limb impairment (F-M lower limb section; 
presence/absence of motor recovery) 
F-M; hand section  (0-14; (>3/≤3) 
6 months after stroke 
Wagner 
2007148 
N=39 UL impairments (composite active range of motion), shoulder complications 
(shoulder pain), UL sensation (composite light touch sensation) 
Accuracy of  reaching 
108.7±16.6 days 
Yagura 
2003149 
N=947  Time since stroke, upper limb functional movement (category B-D) Upper extremity functional category 
(A-D, reaching  independence 
(category A)) 
Discharge (length of stay 
101.18±27.3 days) 
Yoshioka 
2008150 
N=17  
 
Diffusion-tensor tractography imaging data (FA ratio,  ((>0.75/≤0.75), age 
(≤55/>55), gender, stroke location, stroke volume (<15/>15ml), UL impairment 
(MMT >2/≤2), lower limb impairment (>2/≤2) 
Manual Motor Test (0-5) (≥3/<3)   
3 months after stroke onset 
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Footnotes  
Those in bold represent the main study (if more than one publication) 
Unless otherwise stated (mean±SD) 
* - These studies were considered unique studies but at least some overlap of participants is possible 
 
Abbreviations used in Table:  
 
ADM – Abductor digiti minimi 
APB – Abductor pollicis brevis 
ARAT - Action Research Arm Test 
BI – Barthel Index 
BBT – Box and Block Test 
CNS – Canadian Neurological Scale 
CST – Corticospinal tract 
EMG – Electromyography 
EDC - Extensor digitorum communis 
FAT – Frenchay Arm Test 
F – Female 
FDI – First dorsal interosseus 
FA - Fractional anisotropy 
 
F-M – Fugl-Meyer 
GCS – Glasgow Coma Scale 
M – Male  
MMSE – Mini Mental State Examination 
MAL – Motor Activity Log 
MAS – Motor Assessment Scale 
MEPs – Motor Evoked Potentials 
MI – Motricity Index 
MRC – Medical Research Council 
Mos - Months 
NIHSS – National Institute for Health Stroke Scale  
NHPT – Nine Hole Peg Test 
OCSP – Oxfordshire Community Stroke Project  
 
QOM – Quality of movement 
SPD – Silent period duration 
SSEP – Somatosensory evoked potential 
STREAM – Stroke Rehabilitation Assessment of 
Movement 
TMS – Transcranial Magnetic Stimulation 
WMFT – Wolf Motor Function Test 
UEFT – Upper Extremity Function Test 
UL – Upper limb 
5MWT – 5 Metre Walk Test 
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Study design 
The type of study design was often not reported.  All studies were 
categorised as some form of cohort study, with the exception of 
eight98;102;104;105;132;138;139;150.  These studies were reported as a longitudinal 
descriptive study102, case-control132, multiple baseline experiment138, 
prospective observational study139 and case series150 respectively.  Three 
studies were clearly convenience sample studies98;104;105.  Six studies were 
reported as cohorts embedded within randomised controlled 
trials65;70;119;133;142;148. Twenty nine studies27;57;63;65;70;74-
76;89;100;101;103;109;110;113;116;118-121;126;131;135;136;139;140;142;143;147
 explicitly reported 
or were assessed to have screened consecutive admissions.   
Setting  
Of the 58 studies, six were each carried out in Netherlands65;100;116;118;130;147; 
United Kingdom (UK)27;108;109;115;142;144 and USA74;124;131;133;136;148.  Five were 
carried out in Italy69;132;135;140;143; four were completed in Canada76;113;119;126, 
Belgium96;103;104;107 and Japan114;129;149;150; three were completed in 
Australia75;102;121; two in New Zealand139;141, Germany101;138,  Spain106;110 and 
Republic of Korea105;120 and one in China99, France127, Israel122, Denmark89, 
Ireland57, Iraq98 and Bulgaria145 respectively.  One study63 was completed 
between four countries (UK, Belgium, Switzerland and Germany) and one 
study70 was completed between two countries (Belgium and Switzerland).  It 
was unclear if two studies were completed in Italy or Belgium134;137 and if one 
study125 was undertaken in Taiwan or USA.  
All studies explicitly stated or were assessed to have recruited hospital 
inpatients (either from acute general wards, stroke units or rehabilitation 
units), with the exception of four studies.  Three studies108;125;133 recruited 
outpatients; another study141 was assumed to be a mixed inpatient and 
outpatient population.  
Sample size 
The sample sizes reported within the included studies ranged from 9127 to 
119789 Twenty nine studies69;75;76;96;98;100;102-104;106;108;114;116;118;122;127;129;134;136-
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138;140-144;147;148;150
 included 50 participants or less and only 15 
studies27;57;63;65;70;74;89;109;113;115;130;132;133;145;149 had an initial sample size of 
100 or more participants.  Therefore the remaining 14 
studies99;101;105;107;110;119-121;124-126;131;135;139 had an initial sample size of 
between 51 and 99 participants.   
Participants  
The 58 studies initially recruited a total of 6404 participants, of which 5443 
demographic details were reported and 5741 were considered to have some 
form of initial upper limb impairment.  Where it was clear from the 
publication, only participants with initial upper limb impairment were included 
in the analyses.  In the analyses 5051 participants were included.   
Of the studies that reported loss to follow-up (n=31), the percentage of 
participants lost to follow up varied between 2%65 and 48%109.  
All except two studies63;109 reported information on gender of included 
participants.  The remaining 56 studies included both genders, with 54% of 
participants being male.    
All of the included studies, with one exception109 reported information relating 
to the age of the included participants.  The mean (or median) ranged from 
53101 to 74.39140 years.  In 12 studies96;100;101;105;106;120;122;127;129;136;141;147 
participants had a mean (or median) age of less than 60 and in ten 
studies27;63;89;110;115;132;139-141;143 the mean age was 70 or over.   
Time since stroke   
The mean time since stroke was reported in a variety of ways across the 58 
studies.  The mean (or median) time since stroke ranged from within 24 
hours (or admission to acute hospital)89;101;119;134;137;140 to 29 months141.  
Thirty-six studies27;57;65;69;89;96;98;99;101;103;104;106;109;110;115;116;118-
121;126;127;129;130;134;136;137;139;140;142-145;147;148;150
 reported, or were assumed to 
have recruited the majority of participants within 14 days of stroke onset.  
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Twelve studies63;70;74;100;102;105;107;108;122;131;132;138 reported mean time of stroke 
of participants to be within one month.  A further five studies75;113;114;124;135 
recruited within 3 months of stroke and two studies recruited patients 
between 3 months and 6 months76;149.  One study133 recruited patients 
between 3 and 9 months poststroke (mean 182.5 days) and in another 
study125 participants were a mean of 12 months post-stroke (0.7-88 months). 
Type of stroke 
The type of stroke of participants in the studies was recorded; however this 
was reported inconsistently across the included studies.  Twenty-three 
studies57;65;69;74;96;99;101;103-107;110;116;122;127;130;134;136-138;140;147 reported that 
participants only had ischaemic stroke, three studies haemorrhagic stroke 
only120;129;150, 15 studies70;89;98;100;114;119;126;131;133;135;143-145;148;149 reported 
participants with both types of stroke and within 17 
studies27;63;75;76;102;108;109;113;115;118;121;124;125;132;139;141;142 it was not reported or 
was unclear.  Further stroke classifications were either not reported or 
reported inconsistently. 
Initial upper limb impairment  
A wide variety of measures were used to assess initial upper limb impairment 
and therefore close comparability of the studies, in terms of initial upper limb 
impairment was difficult to obtain.  Thirty-six studies63;65;69;70;75;96;99-
106;108;110;113;116;118;120;121;125;127;130;131;133-137;141-144;147;148
 explicitly reported some 
form of upper limb impairment at onset as an inclusion criterion; however, the 
definitions of such ranged considerably e.g. hemiplegia or hemiparesis or 
below a score on a certain clinical test (e.g. Fugl-Meyer upper limb section).  
Fifty-two studies27;57;63;65;69;70;75;76;89;96;98-108;110;113;115;116;118-121;124;125;127;129-
131;133-145;147-150
 provided details on initial upper limb impairment in terms of a 
mean score on a clinical measure e.g. Motricity Index (arm), Rivermead 
Motor Assessment (arm section) or by using general descriptions such as 
hemiplegia or paresis.  Six studies74;109;114;122;126;132 did not report any details 
on initial upper limb impairment.   
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2.4.3 Predictor variables 
The variables assessed for prognostic ability of upper limb outcomes, varied 
between the studies.  Details of the variables used in the data analyses 
(including cut-offs used, where appropriate) are presented in Table 2-2.  
Some studies reported using additional variables, however then did not 
report the association of these variables with a measure of upper limb 
recovery, therefore only those variables available for use in this review are 
presented.     
To allow for increased statistical pooling and ease of reporting, predictor 
variables of similar constructs were linked together e.g. measures of 
cognition and perception.  This process identified 41 groups of variables, 
which are listed below in order of the number of studies reporting each and 
where appropriate, with a brief description of what were included in the 
categories.    
1. upper limb impairment measures (n=39).  Measures of upper limb 
impairment, muscle strength, muscle tone, individual movements.   
2. age (n=23).  Various cut-offs used for defining younger/older 
participants.  
3. side of stroke (n=21).  Incorporating hemisphere affected and side of 
hemiparesis – left or right sided stroke. 
4. sex (n=21).  Male/Female.   
5. motor evoked potentials (n=20).  Presence/absence of a motor 
evoked potential in an upper limb muscle following transcranial 
magnetic stimulation (TMS).   
6. global disability (n=16).  Measures of functional ability.   
7. upper limb sensation (n=11).  Different measures of upper limb 
sensation.  
8. upper limb functional measures (n=10).  Any measures/scales of 
upper limb functional movement i.e. scales that look at arm movement 
in a functional manner. 
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9. time since stroke (n=11).  Different cut-offs were used for defining 
less/more time since stroke. 
10. cognition and perception (n=10).  Measures of cognitive and 
perceptual abilities.   
11. stroke location (n=8).  Different locations of stroke e.g. cortical vs. 
subcortical. 
12. type/class of stroke (n=7).  Measures indicating global severity of 
stroke or particular stroke classifications e.g. OSCP classification.   
13. lower limb motor impairment (n=6).   Measures of lower limb 
impairment.   
14. somatosensory evoked potentials (SSEPs) (n=6).  Presence/absence 
of SSEPs in upper limb nerve following stimulation. 
15. global motor impairment (n=5).  Measures of complete motor 
impairment e.g. measuring arm and leg impairment (e.g. Fugl-Meyer).   
16. shoulder complications (n=5).  Measures of shoulder pain or 
subluxation.   
17. infarction volume/size of lesion (n=5). Different cut-offs used to assess 
size/volume of lesion.  
18. visual disorders (n=4).  Presence/absence of homonymous 
hemianopia or other type of visual disorder. 
19. urinary incontinence/bladder function (n=4).  Presence/absence of 
urinary incontinence. 
20. sitting balance (n=3).  No deficit/deficit on a measure of sitting 
balance.   
21. diffusion tensor tractography (n=3).  Integrity of cerebrospinal tract. 
22. speech disorders (n=2).  Absence/presence of any speech disorders.   
23. handedness (n=2).  Right or left handed. 
24. sensation (n=2).  No deficit/deficit of sensation.   
25. no. of comorbid conditions (n=2).  Less/more comorbid conditions.     
26. pre-stroke ability (n=1) 
27. pre-stroke mental status (n=1) 
28. bowel function (n=1) 
29. distribution of paresis (n=1).  Proximal or distal paresis. 
30. no of previous strokes (n=1)  
  68 
31. sit to stand ability (n=1) 
32. pain in arm (n=1) 
33. 7th cranial nerve lesion (n=1)  
34. duration for stroke to develop (n=1) 
35. mood (n=1) 
36. social support (n=1) 
37. length of stay (n=1) 
38. socioeconomic status (n=1) 
39. level of consciousness at onset (n=1) 
40. hand grip asymmetry (n=1)  
41. recombinant tissue plasminogen activator (Rt-PA) (n=1) 
Of these 41 predictor groups, 25 were reported by more than one study.   
As it was impossible to anticipate the full range of predictor variables that 
had been studied, the process of categorising the predictor variables into the 
above groups was undertaken by consensus, following data extraction but 
prior to analysis.   
Some studies reported more than one predictor variable, within a categorised 
group.  The decision on which variable to include was agreed by consensus 
between reviewers. This decision took into account the following factors; 
availability of information for inclusion in data analysis, consistency between 
the studies and the most comprehensive measure (e.g. Fugl-Meyer upper 
limb scores chosen as a predictor of upper limb impairment over a measure 
of muscle strength).  The predictor variable chosen (where more than one 
variable available in a grouping) is presented in the table of included studies 
(Table 2-2).  Where more than one predictor was available within a category 
and a different association (e.g. non-significant instead of a significant result 
was found) with the measure of upper limb recovery, this is highlighted as 
footnotes in Appendix A and Appendix B.  Some predictor variables identified 
in the studies were not available for inclusion in the analysis due to lack of 
extractable data or lack of information within the papers.   
  69 
To allow for ease of presentation of results predictor variables were further 
categorised into headings of comparable variables.  These headings were 
agreed between two reviewers and reflected the nature of the variables.  The 
headings are (i) Demographic variables (ii) Severity of stroke – global factors 
(iii) Severity of stroke – focal factors (iv) Co-factors (associated with severity) 
(v) Neurophysiological factors and (vi) Pre-morbid function. 
2.4.4 Outcome measures 
The 58 included studies used a wide range of different outcome measures, 
time intervals for follow-up and statistical analysis.  The outcome measures 
and the timing of these measures used in the analyses are presented in 
Table 2-2.  Within the included studies 28 different outcome measures were 
reported and included in the analyses.   
Upper limb function 
Three studies89;96;131 reported an upper limb function outcome.  Measures in 
this category were: Barthel feeding, personal toilet and dressing, Barthel 
feeding and grooming and Barthel feeding and dressing upper limb 
subsections respectively.   
Upper limb functional movement  
Twenty six studies27;65;75;76;99-102;109;114;115;119;121;122;124-126;130;133;135;138-
140;142;144;149reported an upper limb functional movement outcome.  Measures 
in this category were: ARAT (6 studies), Frenchay Arm Test (4 studies), Nine 
Hole Peg Test (3 studies), Motor Assessment scale (of some form; 3 
studies), Functional category of upper extremity (2 studies), Motor Activity 
Log (Quality of movement) scale (2 studies), a multifactorial score designed 
for examining hand and arm function, Upper Extremity Function Test, 
Rancho Los Amigos, Box and Block Test, Hand function grade and ability to 
use upper extremity for some aspect of self-care. 
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Upper limb impairment   
Forty-three studies27;57;63;69;70;74;75;96;98;100;103-110;113;115;116;118;120-
122;125;127;129;132;134-141;143-145;147;148;150
 reported an outcome, classified as an 
impairment outcome.  Measures in this category were: Motricity Index (upper 
limb section) (9 studies), Fugl-Meyer (upper limb section) (8 studies), 
Rivermead Motor Assessment (arm score) (2 studies), MRC scale (8 
studies), scale derived from MRC scale (2 studies), Grip strength (2 studies),  
hand movement scale (2 studies), Brunnstrom classification (2 studies), 
Manual Motor Test (2 studies), Canadian neurological scale (distal arm 
score), arm, trunk and hand movement score, any voluntary motor action, 
accuracy of reaching, Scandinavian Stroke Scale (hand motor power), and 
Fugl-Meyer hand subset were all reported by one study.   
Fourteen studies27;75;96;100;109;115;121;122;125;135;136;139;140;144 reported more than 
one category of outcome measure. All except one study96 reported a 
functional movement and an impairment measure.  This study96 reported an 
upper limb function and an upper limb impairment outcome.   
Seven studies27;100;105;120;126;140;148 reported more than one outcome measure 
within a category, the outcome measure used in this review is indicated in 
Table 2-2 (Characteristics of included studies). 
Within the included studies a variety of different statistical analyses were 
used to determine association between a certain variable and a measure of 
upper limb recovery.  From the data presented in 26 
studies27;69;75;89;96;100;101;104;106;108;113;118;120;124;127;129;131;134;135;137;141-144;147;150 
odds ratios with 95% confidence intervals were calculated for at least one of 
the variables and its association with a measure of upper limb recovery.  A 
further six studies65;99;114;116;121;130 presented odds ratios which were used in 
the analysis.   
The shortest follow-up period was 2 weeks137 and the longest between 1-4 
years (mean 2.4 years)116.   
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2.4.5 Methodological quality of included studies 
The methodological quality of the included studies varied considerably.   The 
results of the quality assessment are presented in Table 2-3. 
Table 2-3 - Methodological quality of included studies 
Potential bias Studies 
adequately 
assessing 
bias 
Domains addressed Studies 
assessing 
domain 
The study sample 
represents the 
population of interest 
on key characteristics, 
sufficient to limit 
potential bias to the 
results  (study 
participation) 
13/58    22% 1.  Sampling frame and recruitment 
adequately described? 
2.  Inclusion/exclusion adequately 
described? 
3.  Clinical and demographic 
characteristics described? 
4.  Were participants recruited at 
within 2 weeks of stroke onset? 
5.  Was sample size adequate in 
relation to number of variable(K 
exceeds 10:1)? 
21/58  36% 
 
43/58  74% 
 
42/58  72% 
 
32/58  55% 
 
44/58  76% 
Loss to follow-up 
(from sample to study 
population) is not 
associated with key 
characteristics, 
sufficient to limit 
potential bias (i.e. the 
study data adequately 
represent the sample 
(study attrition) 
31/58    53% 1.  Was follow-up ≥3 months? 
2.  Was the data collected 
prospectively? 
3.  Was the response rate (i.e. 
proportion of study sample 
completing the study and providing 
outcome data) adequate (>80%)? 
4.  Were reasons for loss to follow-
up provided? 
41/58   71% 
50/58   86% 
 
46/58  79% 
 
 
 
51/58  88% 
The prognostic factor 
of interest is 
adequately measured 
in study participants to 
sufficiently limit 
potential bias 
(prognostic factor 
measurement) 
54/58    93% 1.  Was a clear definition or 
description of the predictive variable 
provided, including method of 
measurement, if relevant? 
2.  Were the variables measured in 
a valid and reliable way? 
3.  Was there adequate proportion 
of the study sample with complete 
data for variables? 
56/58  97% 
 
 
 
47/58  81% 
 
56/58  97% 
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The outcomes of 
interest are 
adequately measured 
in study participants to 
sufficiently limit 
potential bias 
(outcome 
measurement) 
15/58    26% 1.  Was a clear definition of the 
outcome of interest provided? 
2.  Was the outcome of interest 
appropriate/clinically relevant? 
3.  Were the outcomes used 
standardised or tested for reliability 
and validity (or references made to 
other studies) 
4.  Was the outcome assessor 
blinded? 
5.  Was the data presented for most 
important outcome measures? 
53/58  91% 
 
56/58  97% 
 
41/58  71% 
 
 
 
14/58   24% 
 
55/58   95% 
Treatment given to 
cohort (possible 
confounding) 
27/58    47% 1.  Is the treatment given to the 
cohort described? 
2.  Is the treatment provided to the 
cohort standardised/randomised? 
29/58   50% 
 
28/58   45% 
The statistical analysis 
is appropriate for the 
design of the study, 
limiting potential for 
presentation of results 
(analysis) 
26/58    45% 1.  Were continuous variables 
analysed appropriately? 
2.  Is there sufficient presentation of 
the data to assess the adequacy of 
the analysis? 
3.  Is the relationship between 
dependent and independent 
variables tested for statistical 
significance? 
31/58   53% 
 
34/58   59% 
 
 
44/58   76% 
 
As is evident from Table 2-3 only measurement and reporting of the 
prognostic variable was consistently reported.   
Due to poor reporting within the studies some assumptions and/or a number 
of subjective decisions had to be made.  Where disagreement between 
authors occurred, this was resolved by discussion.   
2.4.6 Primary analysis 
Each identified predictive variable and its relationship with a measure of 
upper limb recovery (as defined in the outcomes section above) was 
analysed.  The results for the primary analysis (any outcome of the upper 
limb recovery) are outlined in Table 2-4 and Figure 2-2.  For subsequent 
secondary analyses (ii) functional measures (incorporating UL function and 
functional measures) and (iii) impairment measures the results are displayed 
graphically in Figure 2-3 and Figure 2-4 respectively and the main points of 
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the results are discussed.  Full details of these analyses are tabulated in 
Appendix A and B.  The data is presented according to the headings of; (i) 
Demographics (ii) Severity of stroke – global factors (iii) Severity of stroke – 
focal factors (iv) Co-factors (relating to stroke impairment) (v) 
Neurophysiological factors and (vi) Pre-morbid function, as discussed 
previously.   
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Table 2-4 - Primary analysis:  Results of association of predictor variables and measure of upper limb recovery 
Variable Total no. of 
studies 
(participants) 
Vote 
counting 
(significant 
association) 
Strength of 
evidence analysis  
Statistical analysis.   No. of 
studies (participants) 
Pooled odds ratio  
(95% CI) 
Statistical 
conclusion 
Combined 
assessment of 
evidence.   
Demographic factors  
Age  
(younger vs. 
older) 
2357;65;70;74;96;106;109
;113;119;121;125;126;129;
130;132-
134;136;141;143;144;146;1
50
 (n=1695) 
257;125 (n=265) Strong evidence of 
no association 
1165;96;106;113;129;130;134;141;143;144;
150
 (n=590) 
1.54 (1.06 - 2.25) 
Significant 
association 
Inconclusive 
evidence.  
Suggestion that 
younger people are 
more likely to have 
better upper limb 
recovery. 
Sex  
(male vs. female) 
2165;70;74;96;106;109;11
4;119;121;125;129;130;132
-
134;136;141;143;144;146;1
50 (n=1371) 
0 Strong evidence of 
no association 
1165;96;106;114;129;130;134;141;143;144;
150
 (n=424) 
1.61 (1.11 – 2.33) 
Significant 
association 
Inconclusive 
evidence.  
Suggestion that 
males are more likely 
to have better upper 
limb recovery. 
Time since 
stroke (less vs. 
more time) 
1165;74;76;113;125;129;1
30;132;133;141;149
 
(n=2006) 
565;125;133;141;149 
(n=1343) 
Inconclusive  
evidence 
565;113;129;130;141  (n=486) 
1.13 (0.90 – 1.40) 
No significant 
association 
Inconclusive 
evidence.   
Socioeconomic 
status 
163 (n=419) 1 Limited evidence of 
assosication 
0 NA Limited evidence of 
association between 
socioeconomic status 
and upper limb 
recovery.   
Social support 
(yes/no) 
165 (n=100) 0 Limited evidence of 
no association 
165 (n=100) 
1.41 (0.84 – 2.38) 
NA Limited evidence of 
no association 
between level of 
social support and 
upper limb recovery.  
Severity of stroke – global factors 
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Global disability 
(less vs. more 
disability) 
1657;65;68-
70;96;99;110;125;127;131;
133;134;137;141;143 
(n=919) 
957;65;70;99;110;125
;131;133;134 
 (n=771) 
Inconclusive 
evidence 
965;69;96;127;131;134;137;141;143 
(n=288) 
3.64 (1.63 - 8.10) 
I2=52% 
 
Significant 
association 
Moderate evidence 
of association.  
Those with less initial 
disability more likely 
to have better upper 
limb recovery.   
Type/Class of 
stroke (less vs. 
more severe) 
757;65;74;110;119;130;13
3
 (n=862) 
 
457;65;74;130 
(n=535) 
 
Inconclusive 
evidence 
265;130 (n=256) 
3.54 (0.46 – 27.34) 
I2=95% 
No significant 
association 
Inconclusive 
evidence of 
association between 
severity of stroke and 
upper limb recovery.    
Global 
impairment (less 
vs. more 
impairment) 
574;109;113;119;127   
(n=493) 
374;109;119 
(n=284) 
Inconclusive 
evidence  
2113;127   (n=209) 
2.19 (0.35 - 13.90) 
No significant 
association 
Inconclusive 
evidence of 
association between 
global impairment 
and upper limb 
recovery.   
Lesion 
size/volume 
(smaller vs. 
larger) 
5101;106;114;134;150 
(n=132) 
 
0 Limited evidence of 
no association 
3106;114;150 (n=65) 
1.32 (0.74 - 2.38) 
 
No significant 
association 
Limited evidence of 
no association 
between infarction 
size/volume and 
upper limb recovery.   
Urinary 
incontinence 
(absent vs. 
present) 
465;126;130;139  
(n=382) 
265;130 
(n=256) 
Inconclusive 
evidence 
265;130 (n=256) 
4.12 (1.82 – 9.32) 
I2=55.2% 
Significant 
association 
Inconclusive 
evidence relating to 
the association 
between urinary 
incontinence and 
upper limb recovery.   
Level of 
consciousness at 
onset (GCS) 
165 (n=100) 165 (n=100) Limited evidence of 
association 
1 (n=100) 
1.03 (1.01 – 1.06) 
Significant 
association 
Limited evidence of 
association between 
level of 
consciousness at 
onset and upper limb 
recovery.   
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7th Cranial nerve 1109 (n=58) 1 (n=58) Limited evidence of 
association 
0 NA Limited evidence of 
association between 
7th cranial nerve 
involvement and 
upper limb recovery.  
Bowel function 1126 (n=50) 0 Limited evidence of 
no association 
0 NA Limited evidence of 
no association 
between bowel 
function and upper 
limb recovery.   
Severity of stroke – focal factors 
UL baseline  
impairment 
measures (less 
vs. more 
impairment)* 
3927;57;65;69;70;74-
76;89;97-100;102;106;108-
110;114;119;121;125;127;1
29-133;135;138;140-
145;147;148;150 
(n=2715) 
2527;57;65;70;74-
76;89;98;99;109;114;1
25;127;129-
133;135;142;144;145;
147;148 
  
(n=2349) 
Strong evidence of 
association 
2027;65;69;89;97;100;106;108;121;127;129
-131;135;141-144;147;150 (n=1425)  
14.84 (9.08 – 24.25) 
Significant 
association 
Strong evidence of 
association.  Those 
with less initial UL 
impairment are more 
likely to have better 
upper limb recovery. 
UL baseline 
functional 
measures (more 
vs. less function) 
10101;102;109;119;124;1
26;127;133;142;149  
(n=1512) 
9101;102;109;119;12
4;126;133;142;149 
(n=1503) 
Strong  evidence of 
association  
4101;124;127;142 (n=158) 
38.62 (8.40 – 177.53) 
Significant 
association 
Strong evidence of 
association.   Those 
with more initial 
upper limb function 
are more likely to 
have better upper 
limb recovery. 
Lower limb 
impairment (less 
vs. more 
impairment) 
665;74;119;130;147;150 
(n=534) 
565;74;119;130;147 
(n=517) 
Moderate evidence 
of association 
465;130;147;150 (n=308) 
11.83 (6.53 – 21.42) 
Significant 
association 
Moderate evidence 
of association.  
Those with less leg 
impairment more 
likely to have better 
upper limb recovery. 
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Hand grip 
asymmetry 
1141 (n=17) 0 Limited evidence of 
no association 
0 NA Limited evidence of 
no association 
between hand grip 
asymmetry and upper 
limb recovery. 
Co-factors (associated with stroke severity) 
Side of stroke  
(left vs. right) 
2165;70;74;96;99;106;107
;109;113;119;121;125;129;
130;132-
134;141;143;144;146
 
(n=1506) 
265;130  
(n=256) 
Strong evidence of 
no association 
1165;96;99;106;113;129;130;134;141;143;1
44 (n=624) 
1.47 (1.07 – 2.01) 
Significant 
association 
Inconclusive 
evidence.  
Suggestion that left 
hemisphere stroke 
may be associated 
with better upper limb 
recovery.   
UL sensation  
(no deficit vs. 
deficit) 
1157;65;70;99;109;113;12
1;132;139;141;148  
(n=859) 
657;65;99;109;113;13
2 (n=584) 
Inconclusive 
evidence 
3 65;113;141  (n=271) 
1.92 (1.41 – 2.61) 
Significant 
association  
Inconclusive 
evidence.  
Suggestion that 
absence of sensory 
deficit is associated 
with better upper limb 
recovery. 
Cognition and 
perception (no 
deficit vs. deficit) 
1065;70;74;76;99;109;113
;130;133;139 
(n=1101)  
474;76;109;130 
 (n=401) 
Inconclusive 
evidence 
465;99;113;130 (n=462) 
1.86 (0.91 – 3.78) 
I2=89.4% 
No significant 
association 
Inconclusive 
evidence relating to 
the association 
between cognition 
and perception and 
upper limb recovery.   
Stroke location 874;99;101;111;134;136;1
41;150
 (n=415) 
374;99;101 
(n=280)  
Inconclusive 
evidence  
Unable to pool data together 
in statistical analysis 
Unable to pool data Inconclusive 
evidence.  Unable to 
combine data.   
Shoulder 
complications  
(absent vs. 
present) 
570;109;132;139;148 
(n=376) 
2109;139 
(n=134) 
Inconclusive 
evidence 
0 NA Inconclusive 
evidence regarding 
association between 
shoulder 
complications and 
upper limb recovery.   
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Visual disorders 
(absent vs. 
present) 
465;70;109;130 
 (n=410) 
365;109;130 
(n=314) 
Moderate evidence 
of association 
265;130 (n=256) 
5.22 (2.40 – 11.36) 
Significant 
association 
Moderate evidence 
of association.  
Those with absence 
of a visual disorder 
more likely to have 
better upper limb 
recovery.   
Sitting balance  
(no deficit vs. 
deficit) 
365;126;130 
 (n=306) 
1130 
(n=156) 
Inconclusive 
evidence  
265;130 (n=256) 
4.75 (0.28 – 80.53) 
I2=96.8% 
No significant 
association 
Inconclusive 
evidence.  
Suggestion of no 
association between 
sitting balance and 
upper limb recovery.   
Speech 
disorders (absent 
vs. present)  
270;109  
(n=154) 
1109 
(n=58) 
Inconclusive 
evidence   
0 NA Inconclusive 
evidence relating to 
association between 
speech disorders and 
upper limb recovery.   
Handedness 
(right vs. left vs. 
ambidextrous) 
274;109 (n=229) 0 Limited evidence of 
no association 
0 NA Limited evidence of 
no association 
between handedness 
and upper limb 
recovery. 
Sensation (no 
deficit vs. deficit) 
2130;133 (n=378) 1130 (n=156) Inconclusive 
evidence 
1130 (n=156) 
9.15 (3.36 – 24.89) 
Significant 
association 
Inconclusive 
evidence relating to 
association between 
sensation and upper 
limb functional 
recovery. 
No. of comorbid 
conditions (less 
vs. more) 
2119;130 (n=211) 0 Limited evidence of 
no association 
1130 (n=156) 
1.96 (0.96 – 3.98) 
No significant 
association 
Limited evidence of 
no association 
between no. of 
comorbid conditions 
and upper limb 
functional recovery.   
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Rt-PA (yes/no) 1130 (n=156) 0 Limited evidence of 
no association 
1130 (n=156) 
1.73 (0.81 – 3.73) 
No significant 
association 
Limited evidence of 
no association 
between Rt-PA and 
upper limb functional 
recovery. 
Length of stay 1132 (n=107) 0 Limited evidence of 
no association 
0 NA Limited evidence of 
no association 
between length of 
stay and upper limb 
recovery.   
Mood  170 (n=96) 0 Limited evidence of 
no association 
0 NA Limited evidence of 
no association 
between mood and 
upper limb recovery. 
No. of previous 
strokes 
1109 (n=58) 1109 (n=58) Limited evidence of 
association 
0 NA Limited evidence of 
association between 
number of previous 
strokes and upper 
limb recovery.   
 
Duration for 
stroke to develop 
1109 (n=58) 1109 (n=58) Limited evidence of 
association 
0 NA Limited evidence of 
association between 
duration for stroke to 
develop and upper 
limb recovery.   
Pain in arm  1109  (n=58) 1109  (n=58) Limited evidence of 
association 
0 NA Limited evidence of 
association between 
pain in arm and 
upper limb recovery.  
Sit to stand 1126 (n=50) 0 Limited evidence of 
no association 
0 NA Limited evidence of 
no association 
between sit to stand 
and upper limb 
recovery.   
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Proximal/Distal 
paresis 
1114 (n=34) 0 Limited evidence of 
no association 
1 (n=34) 
9.09 (0.26 – 333.33) 
No significant 
association 
Limited evidence of 
no association 
between distribution 
of paresis and upper 
limb recovery. 
Neurophysiological factors 
Motor evoked 
potentials  
(present vs. 
absent) 
2069;96;103;104;106;107;
110;112;114-
116;118;120;129;135;137;1
41;143;144;147
 
(n=687) 
1569;96;103;107;110
;112;115-
117;120;129;135;137;
143;147  
(n=551) 
Strong evidence of 
association 
1569;96;104;106;114;116;118;120;129;135;
137;141;143;144;147 (n=425) 
11.76 (5.19 – 26.65) 
Significant 
association 
Strong evidence of 
association.  Those 
with present MEPs 
are more likely to 
have better upper 
limb recovery. 
Somatosensory 
evoked 
potentials  
(present vs. 
absent) 
698;112;116;122;124;145  
(n=280) 
698;112;116;122;124;
145  
(n=280) 
Strong evidence of  
association  
2116;124 (n=97) 
13.73 (2.73 – 69.10) 
Significant 
association 
Strong evidence of 
association.  Those 
with present SSEPs 
are more likely to 
have better upper 
limb recovery. 
Diffusion tensor 
tractography 
(DTT) (preserved 
corticospinal 
tract or not) 
3105;120;150 
(n=125) 
3105;120;150 
(n=125) 
Limited evidence of 
association 
2120;150 (n=70) 
35.46 (8.97 – 140.10) 
Significant 
association 
Limited evidence of 
association.  Those 
with preserved 
corticospinal tract 
(determined by DTT) 
more likely to have 
better upper limb 
recovery. 
Pre-morbid function 
Pre-stroke ability 1109  (n=58) 0 Limited evidence of 
no association   
0 NA Limited evidence of 
no association 
between pre-stroke 
ability and upper limb 
recovery. 
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Pre-stroke 
mental status 
1109  (n=58) 0 Limited evidence of 
no association   
0 NA Limited evidence of 
no association 
between pre-stroke 
mental status and 
upper limb recovery.   
Footnotes:   
0 – no studies able to be included in statistical analysis 
NA – no conclusions could be drawn from statistical analysis as no studies were available for inclusion in meta-analysis 
Unable to pool data – due to differences in way data presented unable to sensibly combine in a meta-analysis 
I2 data only given if I2>50% 
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Figure 2-2 – Meta-analysis of primary analysis:  Predictor variables and association 
with upper limb recovery  
 
 
Demographic factors  
Within the main analysis (better upper limb recovery in terms of functional or 
impairment measures), combined evidence conclusions for the variables of 
age and sex were inconclusive due to inconsistencies between data analysis 
methods.  Vote counting analysis did not identify any association with either 
of these variables and upper limb recovery, however a statistically significant 
result was found in both cases (OR 1.54 (95% CI 1.06 -2.25) and OR 1.61 
(95% CI (1.11 – 2.33) respectively).   These statistical analyses suggested 
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younger people and males respectively are more likely to have better upper 
limb recovery.      
Severity of stroke – global factors 
Inconclusive evidence was identified in the vote counting analysis for the 
variable of global disability.  However, a statistically significant result was 
found in the statistical analysis of nine studies (n=288) suggesting that those 
with less disability are more likely to have better upper limb recovery. 
Inconclusive evidence was found for global motor impairment, urinary 
incontinence and type/class of stroke and limited evidence of no association 
for lesion size/volume and bowel function; in terms of upper limb recovery.    
Severity of stroke – focal factors 
The most commonly investigated variable was a baseline measure of upper 
limb impairment.  The overall qualitative conclusion was that there was 
strong evidence that a lesser degree of impairment is associated with better 
upper limb recovery.  Although this was due to only 25 of the 39 studies 
reporting a significant association, this did encompass 87% of the included 
participants.  Strong evidence of association was found for baseline upper 
limb functional measures and moderate evidence for baseline lower limb 
impairment.   
Co-factors (related to stroke impairment) 
In terms of side of stroke only two of 21 studies reported an association; 
however, statistical analysis suggests that left hemisphere stroke is 
significantly associated with better upper limb recovery. The evidence was 
inconclusive for cognition and perception, stroke location, shoulder 
complications, sitting balance, speech disorders and sensation.  Evidence 
was also inconclusive for an association between upper limb sensory deficits 
and upper limb recovery.  
Neurophysiological factors 
Consistent results were found between studies indicating strong evidence for 
the association between the presence of evoked potentials (both motor and 
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somatosensory) and better upper limb recovery.   Limited evidence was 
found for an association between preserved corticospinal tract (determined 
by diffusion tensor tractography) and better upper limb recovery.   
Pre-morbid function 
Limited evidence of no association was found for the pre-morbid function 
variables of pre-stroke ability and pre-stroke mental status.   
Therefore in this main analysis strong evidence was found for an association 
between initial upper limb impairment and functional measures, presence of 
motor and somatosensory evoked potentials and better upper limb recovery.   
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2.4.7 Secondary analysis 
Figure 2-3 – Meta-analysis of secondary analysis (1):  Predictor variables and 
association with measures of upper limb functional recovery 
 
Consistent with the main analysis, initial measures of upper limb impairment 
and upper limb function were found to be strongly associated with better 
upper limb functional outcomes.  However, some inconsistencies in the 
considered judgements between this secondary and the main analysis were 
identified.  Inconclusive evidence of association for the variable of age was 
found in the main analysis.  However, in this secondary analysis there was 
strong evidence of no association.  This is likely to be related to the fact that 
11 studies were included in the main statistical analysis and only three 
studies were included in this secondary analysis.  A further discrepancy was 
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identified for the variables of motor evoked potentials and somatosensory 
evoked potentials.  Strong evidence of association was found for these 
variables in the main analysis, however in this analysis inconclusive and 
limited evidence of association respectively was found.  This again is 
probably related to a greater number of studies being included in the main 
analysis.   
Figure 2-4 - Meta-analysis of secondary analysis (2):  Predictor variables and 
association with measures of upper limb impairment 
 
Consistent with the main analysis, initial measures of upper limb impairment 
and evoked potentials (motor and somatosensory) were found to be strongly 
associated with upper limb recovery, in terms of impairment.  Discrepancies 
however were again evident.  In the main analysis inconclusive evidence 
was found for the variable of sex, however in this analysis there was strong 
evidence of no association.  For side of stroke the evidence in the main 
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analysis was inconclusive, and yet in this analysis the evidence strongly 
suggested no association.   
For ease of presentation Table 2-5 indicates the combined assessment of 
evidence conclusions for each of the analysis.  Only those variables 
investigated by more than one study have been included.   
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Table 2-5 - Overall evidence conclusions for each of the three analyses  
Variable Main analysis conclusion Functional outcome analysis 
conclusion 
Impairment outcome analysis conclusion 
Age Inconclusive evidence Strong evidence of no association Inconclusive evidence 
Sex Inconclusive evidence Inconclusive evidence Strong evidence of no association 
Time Inconclusive evidence Moderate evidence of association Inconclusive evidence 
Global disability Moderate evidence of association Inconclusive evidence Moderate evidence of association 
Type/class of stroke Inconclusive evidence Inconclusive evidence Limited evidence of association 
Global impairment Inconclusive evidence Limited evidence of association Inconclusive evidence 
Lesion size/volume Limited evidence of no association Limited evidence of no association Limited evidence of no association 
Urinary incontinence Inconclusive evidence Inconclusive evidence Limited evidence of no association 
UL baseline impairment 
measures 
Strong evidence of association Strong evidence of association Strong evidence of association 
UL baseline functional 
measures 
Strong evidence of association Strong evidence of association Limited evidence of no association 
Lower limb impairment Moderate evidence of association Moderate evidence of association Limited evidence of association 
Side of stroke Inconclusive evidence Moderate evidence of no association Strong evidence of no association 
UL sensation Inconclusive evidence Inconclusive evidence Inconclusive evidence 
Cognition and perception Inconclusive evidence Inconclusive evidence Inconclusive evidence 
Stroke location Inconclusive evidence Limited evidence of association Moderate evidence of no association 
Shoulder complications Inconclusive evidence Limited evidence of association Inconclusive evidence 
Visual disorders Moderate evidence of association Moderate evidence of association Inconclusive evidence 
Sitting balance  Inconclusive evidence Inconclusive evidence NA 
Speech disorders Inconclusive evidence Limited evidence of association Inconclusive evidence 
Handedness Limited evidence of no association Limited evidence of no association Limited evidence of no association 
Sensation Inconclusive evidence Inconclusive evidence NA 
Motor evoked potentials Strong evidence of association Inconclusive evidence Strong evidence of association 
Somatosensory evoked 
potentials 
Strong evidence of association Limited evidence of association Strong evidence of association 
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Diffusion-tensor 
tractography (DTT) 
(preserved corticospinal 
tract or not) 
Limited evidence of association NA Limited evidence of association 
Footnote: 
NA – no studies identified to include in this analysis i.e. no studies investigated that variable in association with any relevant outcomes in that category.  
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2.5 Discussion  
2.5.1 Summary of findings 
This review identified and summarised the results of 58 studies that reported 
on the predictive value of a number of variables for upper limb recovery 
following stroke.  A wide range of variables and outcome measures have 
been considered within the literature.  However, despite a number of 
variables being investigated, only baseline upper limb functional and 
impairment measures and neurophysiological factors (motor evoked 
potentials and somatosensory evoked potentials) were consistently identified 
as being strongly associated with upper limb recovery following stroke.  
Motor evoked potentials and somatosensory evoked potentials 
(neurophysiological factors) provide assessment of the integrity of cortico-
spinal and somatosensory pathways.  Therefore it is perhaps unsurprising 
that they provide an objective and useful insight into prediction of recovery 
following stroke.   
Moderate evidence that less disability and lower limb impairment were 
associated with better upper limb recovery was also identified.  No predictive 
value was found for lesion size.  The findings of this review are largely 
consistent with the other previous reviews in this area77;78, despite these 
other reviews having different objectives and using different methods of data 
analysis.  The first of these reviews77 also used a systematic approach to 
reviewing the evidence, however, in contrast, a best evidence synthesis was 
used and therefore only evidence from studies considered to be of higher 
methodological quality was reported.  No meta-analysis was undertaken in 
this review.  The other review78 was a narrative type of review with no clear 
systematic methodology, and focused on the predictive value of motor 
impairment scores and neuroimaging, rather than the range of predictor 
variables.   
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For this review the decision was taken to have the broad concept of upper 
limb recovery as the main outcome.  It could be argued that a more focused 
approach to outcomes would have been better.  However, secondary 
analysis by functional and impairment outcomes was also undertaken and it 
is evident that the findings were largely consistent across the analyses.  Any 
discrepancies can be related to the differences in the quantity of evidence 
available.  The consistency of results adds weight to the findings of this 
review.    
2.5.2 Limitations of the review and the included studies 
Many of the limitations of this review relate to the problems of systematic 
reviews of prognostic studies71, referred to in the introduction of this chapter.  
Those most relevant to this review will now be considered.  
Difficulty identifying all studies 
Despite a rigorous and thorough search strategy, it is acknowledged that 
relevant studies may have been missed.   
Negative (non-significant) results may not be reported (publication bias)  
Publication bias is a concern with this type of review.  Studies with significant 
results are more likely to be published, have more than one associated 
publication and also are more likely to be identified through the searching 
process151.  This was addressed through a rigorous searching process. It is 
reassuring that the completed search for this review identified a very similar 
group of studies to the other recent reviews of this area77;78.  
Inadequate reporting of methods  
Limitations in reporting of methods were evident throughout a number of 
studies.  Therefore a number of subjective decisions and assumptions had to 
be made throughout the review process, which could have potentially 
introduced bias.   
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Variation in study design  
The included studies were heterogeneous in many aspects, and this was the 
main limitation of this review.  Some included studies were clearly 
prospective cohorts set up to investigate predictors of upper limb recovery, 
whereas other studies were randomised controlled trials which also 
investigated predictive variables.  The variation in length of follow-up (2 
weeks to 1-4 years) will have had a substantial impact on the interpretation 
of the results, and is evidence of one of the main variations between the 
studies.     
Variation in inclusion criteria  
This was evident throughout the studies; some studies had very clear and 
explicitly stated inclusion and exclusion criteria, whereas others had only 
limited reporting of inclusion criteria.  Also variations between participants 
included and excluded were evident, adding to the heterogeneous nature of 
the included studies.   
Lack of recognised criteria for quality assessment  
The quality assessment criteria used within this review were based on sound 
theoretical considerations.  The decision was taken not to use an established 
quality criteria checklist, such as the Newcastle-Ottawa scale91 but rather to 
consider the studies in terms of quality criteria71. However, consensus 
between the reviewers was difficult to obtain as a number of subjective 
decisions had to be made due to frequent poor reporting of methodological 
aspects.  For this reason the methodological quality of the studies was not 
used to exclude studies.  It should be recognised that conclusions with 
moderate evidence of association could potentially be overturned by more 
methodologically robust studies. 
Variation in methods of analysis  
This was encountered within this review.  Some studies used correlation 
coefficients to assess association, others odds ratios and others just reported 
if significant or not.  This made combining studies difficult.   
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Differing methods of handling of continuous variables (some dependent on 
data)  
In order to analyse continuous variables some studies did dichotomise 
predictor and outcome variables.  From examination of these studies it was 
clear that most did try and make a decision on the cut-off based on clinical 
significance or following further analysis, however, it is acknowledged that 
some cut-offs may have been data dependent.  This problem was further 
compounded by the fact that in order to include as many relevant studies as 
possible within the statistical analysis a decision was taken to ascribe cut-
offs to predictor variables and outcomes of interest, to calculate odds ratios,  
where data allowed.  The cut-offs to be used were not stipulated prior to data 
extraction.  However, instead of being data driven, attempts were made to 
use cut-offs used within other studies.   
Adjustment for different sets of variables  
This particular issue was avoided in this review as only univariate analyses 
were considered.   
As stated above the main limitation of this review relates to the heterogeneity 
of the studies.  This includes the varying definitions of initial upper limb 
problems, differing predictive variables and measurements, outcome 
measures, length of follow up and data presentation.  Statistical 
heterogeneity (I2) was seen in a number of the studies, reflecting the differing 
nature of many of the studies.  Ascribing arbitrary cut-offs to variables, 
including continuous measures, which were not consistent across the studies 
further adds to the potential heterogeneity.   
The main focus of this review was to answer the question:  Is there any 
evidence of association between individual variables and upper limb 
recovery?  The approach to data analysis was suitable for answering the 
question.  Despite this ascertain, limitations with these approaches to data 
analysis must be acknowledged.  Vote counting is recognised as having 
limitations152.  The main weaknesses of vote counting relate to the fact that 
no account is taken of the differential weights of each study and usually 
  94 
subjective decisions have to be taken.  However, as the research question 
was limited to looking for evidence of effect this approach was considered to 
be appropriate and allowed for the inclusion of the greatest number of 
studies.  Additionally, as this approach was supplemented by quantitative 
analyses complete emphasis was not placed on this method of data analysis.  
Statistical analysis of predictive studies is also recognised as raising 
significant challenges71.   The poor quality of predictive studies, variable 
methodological quality and often poor reporting of methodology79 are 
identified as reasons for not completing meta-analysis of such studies.  
Differences between studies (as highlighted above) further raise questions 
about the suitability of undertaking meta-analysis.  Despite these concerns, it 
was considered that statistical analysis of the studies added another 
dimension and reduced the subjectivity in interpreting the evidence.  
Therefore, while the individual approaches to data analysis used within this 
review have their limitations, this review was strengthened by having both 
types of analysis and also considered judgements about the state of the 
evidence, which considered not only the results of the vote counting and 
statistical results but also the quality of each study.  Despite a few 
discrepancies, particularly relating to age and sex, there was a good level of 
consistency between the conclusions of the statistical and other analytical 
approaches. This adds confidence to the findings of this review.   
Within this review the findings were based on information from univariate 
analyses.  These univariate results are not adjusted for potential 
confounders; which is considered to be good practice in studies of predictive 
variables79.  However, this review was intended to identify which predictor 
variables were available and their individual ability to predict upper limb 
recovery. 
The exclusion of studies that did not report univariate results may have 
introduced a degree of bias into this review as some useful information may 
have been omitted.  However only a small number of studies were excluded 
for this reason, as most studies that did go onto complete multi-variate 
analyses initially reported univariate results. 
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The way that individual predictor variables were grouped and the outcome 
measures that were chosen for inclusion in the analysis may have influenced 
the results of this review.  However, there is no suggestion that the main 
conclusions would have changed had alternative groupings or outcomes 
been chosen.   
2.5.3 Strengths of the review 
The main strength of this review was that a rigorous systematic review 
methodology was used and that a large number of studies were included.  
Furthermore, a rigorous, explicit and prospective approach to identify, 
appraise, combine and synthesise a lot of complex data into a clear and 
concise format was used.  The included studies showed a reasonable 
consistency of results, which adds to the confidence in the conclusions of the 
review.  
2.5.4 Implications for practice 
This review found evidence for variables that suggest an association with 
upper limb outcome.  Upper limb level of impairment and function at baseline 
and intact motor evoked potentials or somatosensory potentials appear to be 
the most powerful predictors of upper limb recovery.  Evoked potentials are 
usually only collected in the context of research trials and therefore clinical 
measures will be far more useful to clinicians.  This information may be 
useful to clinicians when planning treatment programmes and discussing 
likely prognosis with patients.   
2.5.5 Implications for research  
For stratification in clinical trials researchers should consider using those 
measures which have been found to be strongly associated with recovery 
(for example, baseline Fugl-Meyer, MRC scale, Action Research Arm Test). 
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This review has highlighted the need for improved quality of reporting of 
predictive studies in this area.  In addition, large high quality cohort studies 
would be useful to validate the strength of evidence of this systematic review.  
Further studies could also investigate multivariate models and their 
usefulness for predicting upper limb recovery.  For future studies to be 
relevant to clinical practice and research it would be useful to establish an 
international consensus on a core set of relevant predictive variables and 
standardised outcome criteria for upper limb recovery. The COMET153 core 
outcomes project is currently looking into producing datasets of core 
outcome measures for use in clinical trials, however, have not yet produced 
details of outcomes relating to stroke rehabilitation trials.  These findings will 
be passed onto the COMET working group, and a stroke rehabilitation 
outcomes work stream will be proposed.  The distinction between outcomes 
appropriate for stroke rehabilitation trials and acute stroke trials will be 
highlighted to the group.   
2.5.6 Conclusions 
This systematic review found a large number of studies which investigated 
the predictive value of at least one variable and its association with a 
measure of upper limb recovery at a future time point.  This information was 
synthesised and combined, in order to highlight those variables which have 
been found to show evidence of association with upper limb recovery. 
Strong evidence was found that indicated that initial measures of upper limb 
function and impairment and neurophysiological measures can predict upper 
limb recovery.  Moderate evidence of association was found for the variables 
of global disability and lower limb impairment.  Limited evidence of 
association or no association or inconclusive evidence was concluded for the 
other variables.  
The results of this review must be taken in context of the limitations of this 
review, which particularly relate to the heterogeneous nature of the included 
studies.   
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Chapter 3  Effectiveness of interventions 
targeted at upper limb recovery after stroke:  an 
overview  
3.1 Introduction 
In order to plan a randomised controlled trial of an evidence-based 
intervention for improving upper limb recovery after stroke, examination of 
the current literature on the subject was considered appropriate.  This 
chapter will focus on the current, available evidence for the treatment of 
upper limb motor impairment and restoration of motor function after stroke 
and identify which interventions have been studied and which, if any show 
promise of efficacy.   
3.1.1 Motor impairment 
As outlined previously the most common and recognisable deficit following 
stroke is motor impairment. Motor impairment, of some description, will affect 
approximately 80% of stroke patients and will present as a loss or limitation 
of function in muscle control or movement154 of the face, arm and/or leg of 
one side of the body.  For the purposes of this thesis the focus is on motor 
impairment of the upper limb.   
3.1.2 Upper limb rehabilitation 
Within stroke rehabilitation interventions targeted at reducing impairment and 
improving the function of the upper limb are common, and forms much of the 
focus of occupational therapy and physiotherapy interventions within stroke 
rehabilitation.  Two studies illustrate this155;156.   
A small pilot study155 of occupational therapists and physiotherapists (n=13), 
found that upper limb interventions were one of the most frequently recorded 
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aspects of physiotherapy.  The other study, investigating the content of 
physiotherapy (PT) and occupational therapy (OT) sessions, across four 
European stroke centres, found that in a one hour PT session, selective 
movements (which included upper limb interventions)  were the most 
frequently completed activities (median 16.03 minutes).   
The ultimate goal of therapy targeted at upper limb motor impairment is to 
improve the function of the upper limb, as well as recovery of movement.  
For the purposes of this review motor impairment and its associated 
functional activities have been considered as part of a continuum. 
Despite being a common element of stroke rehabilitation, rehabilitation of the 
upper limb is acknowledged as posing a particular challenge to the 
multidisciplinary team157 due to poor levels of upper limb recovery and a lack 
of conclusive evidence to guide practice.   
3.1.3 Interventions for motor recovery of the upper limb  
It is clear from the rehabilitation literature over the past decade that to 
attempt to improve upper limb outcomes a number of interventions have 
been designed, many of which have been evaluated using systematic review 
and/or randomised controlled trial (RCT) methodology90.  However, this area 
is confusing as most of these developed interventions do not explicitly target 
a specific pathophysiological process and have been tested using a variety 
of patient groups and outcome measures.    
In order to identify which interventions appear to show promise I undertook a 
broad based systematic review of previously tested interventions.   The 
purpose of this review was to provide a standardised summary of the 
available evidence for the treatment of upper limb motor impairment and 
restoration of motor function after stroke. 
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3.2 Objectives 
• To summarise the available evidence of interventions which target 
upper limb recovery following stroke 
• To identify interventions which show promise of efficacy 
• To identify characteristics of interventions that show promise of 
efficacy 
• To relate the information gained to the current guideline advice on 
clinical management 
• To use the information gained to identify a suitable intervention to be 
investigated in the planned randomised controlled trial   
3.3 Methods 
Due to the summary nature of this review and the known variations in the 
available evidence base a pragmatic, empirical approach was taken to 
describing and reviewing the evidence.   
3.3.1 Eligibility criteria  
Types of studies 
In order to identify relevant upper limb interventions a number of approaches 
had previously been completed, which included expert opinion158, gauging 
the views of multidisciplinary focus groups and systematic searching of 
relevant texts and guidelines159.  This was supplemented by searching the 
Cochrane Stroke Group list of systematic reviews and protocols90 and the 
Cochrane library for additional systematic reviews. 
Systematic reviews of randomised trials of interventions to promote upper 
limb motor recovery (recovery of impairment or related function) after stroke 
were considered and included in the first instance.  It was decided to initially 
concentrate on reviewing the available systematic review evidence, as a 
number of such reviews have already been carried out within (or overlap) 
  101 
with this area and systematic reviews are considered to be the highest level 
of evidence160.  Therefore, where available, systematic reviews were sought 
and used, and then supplemented (where necessary) with additional 
information from recent RCTs.   
Types of participants 
The population of interest was adults with a clinical diagnosis of stroke.   
Types of interventions 
Any intervention aimed specifically at improving upper limb motor recovery 
was considered.  Pharmacological and surgical interventions were excluded.  
Any duration or intensity of programme was included.   
Types of comparisons 
Comparisons of interventions against no treatment, placebo intervention or 
standard/usual care were included.  Randomised controlled trials comparing 
one specific upper limb intervention to another specific upper limb 
intervention (for example constraint-induced movement therapy vs. robotic 
intervention) were excluded, wherever possible (see results for exceptions).   
Types of outcome measures 
The focus of this review was on the effects of interventions on recovery of 
upper limb movement and function.  For analysis this was separated into arm 
and hand function.  A wide range of outcome measures related to upper limb 
recovery were included.  Priority was given to functional tests (e.g. Action 
Research Arm Test (ARAT)85, Motor Assessment Scale (MAS)86, Frenchay 
Arm Test (FAT)161, Nine Hole Peg Test (NHPT)162 before impairment scales 
(Fugl-Meyer (F-M) scale88, Motricity Index (MI)163).  However, in the first 
instance the outcome measures reported in the relevant systematic reviews 
were used.  As the primary focus of this review was motor recovery of the 
upper limb (impairment and associated functions) outcomes relating to the 
recovery of impairment of specific muscles or muscle groups (such as 
muscle tone or muscle length), or related impairments (such as pain, 
spasticity or contractures) were not included. 
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For analysis, data recorded at the end of the intervention period was used, 
where possible.  Otherwise data recorded at different time points (e.g. end of 
scheduled follow-up), as reported in the relevant systematic review was 
used.  
3.3.2 Search methods for identification of studies 
Initially the list of all systematic reviews (full reviews, protocols and titles) 
registered with the Cochrane Stroke Group90 by March 2009 and then 
updated to September 2011 was searched to identify all relevant Cochrane 
systematic reviews .   
If a Cochrane systematic review was identified fully covering the intervention 
of interest, searching for additional RCTs was only carried out past the 
search date of the identified review.  If a Cochrane review was not available 
the Cochrane Library (using the terms “stroke” and intervention specific 
terms, such as “approaches to therapy”, “neurophysiological”, “bobath”, 
“bilateral training”, “constraint-induced movement therapy”, “biofeedback”, 
“electrostimulation” “intensity”, “mental practice” “imagery”, “mirror”, 
“repetitive task training”, “robotics” “splinting”, “orthosis” and “virtual reality”) 
was searched for “other” systematic reviews and/or RCTs relevant to the 
topic.  This was supplemented by a MEDLINE search of key terms.  Only full, 
published studies were considered for inclusion.   
3.3.3 Identification of relevant trials 
Initially I read all the identified titles and excluded any obviously irrelevant 
studies.  Obviously relevant studies were included within the relevant 
intervention categories.  If I was uncertain about including a study or about 
allocation to a particular intervention the opinion of a second reviewer was 
sought.   
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3.3.4 Data extraction 
The purpose of this review was to provide an overview of the available 
evidence and therefore only a limited amount of information was extracted.   
The following information was extracted from the systematic reviews: 
1. Number of RCTs (as relevant to this review) 
2. Number of participants (as relevant to this review) 
3. Intervention characteristics 
4. Comparison intervention(s) 
5. Outcome(s)  
Where additional trials were identified the following information was 
extracted: 
1. Number of participants (as relevant to this review) 
2. Intervention characteristics 
3. Comparison intervention(s) 
4. Outcome(s)  
3.3.5 Documentation of methodological quality 
The three key methodological characteristics164 likely to influence the 
reliability of study conclusions were considered:   
1. Allocation concealment – did the trial report describe adequate 
concealment of treatment allocation? 
2. Blinding of outcome assessor – did the trials report that the outcome 
assessor was unaware of treatment allocation? 
3. Intention-to-treat analysis – did the trial report the use of an intention-
to-treat analysis? 
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Where available the assessment undertaken within the Cochrane systematic 
review was used, otherwise each trial was critically appraised considering 
the three outlined criteria. 
3.3.6 Data analysis 
Where possible, means and standard deviations (SD) for outcomes relating 
to upper limb recovery, from each group, were extracted either directly from 
the relevant systematic reviews or from individual trials and combined within 
a meta-analysis to derive a standardised mean difference (SMD) and 95% 
confidence intervals (CI).  This expresses the difference between 
intervention and control groups in terms of standard deviation units.   
Where additional trials to those already included within a systematic review 
were identified, data from these trials were added into the analysis, where 
possible, and new estimates of effect obtained.  A number of the identified 
reviews presented analyses of outcomes in a different way from the global 
outcome of interest of this review. Where this occurred the data from the 
individual trials included in the review were re-analysed.  In some cases trials 
with different comparators (e.g. placebo, control and usual care) were also 
grouped together to gain one estimate of intervention effect.  For these 
reasons the summary estimates of treatment effect and conclusions of this 
review may vary from the previously published, identified reviews of 
individual interventions.  Where means and standard deviations were not 
presented within a trial, these trials were either excluded from data analysis 
or, in a few cases; imputations were made for the missing data and/or 
calculations made to derive the required data.  Where more than one 
subgroup was presented in a trial both were included in the analysis.  If the 
same control group was used for both subgroups i.e. in trials which had two 
appropriate interventions (e.g. high and low intensity of a robotic intervention) 
compared to one control group, the number of participants within the control 
group was split between the two subgroups and the standard deviation was 
doubled to reduce the weight given to the two halves of the control groups.  
RevMan 5 software165 was used for all analyses. Results were analysed 
  105 
using the standardised mean difference with a fixed effects model.  
Heterogeneity was determined using the I-squared (I2) statistic (I2 > 50% 
considered substantial heterogeneity). If I2 >50% meta-analysis was 
performed using both fixed-effect and random-effects modelling to assess 
sensitivity to the choice of modelling approach. 
Classification of the effects of an intervention 
For understanding SMD in terms of clinical difference it is generally 
considered that a SMD of 0.2 suggests a small effect, 0.5 a moderate effect 
and 0.8 and over indicates a large effect166.  To attempt to provide further 
clarification of the effect of each intervention a semi-quantitative Clinical 
Evidence classification of effectiveness167 was also used, where each 
intervention was classified as ‘beneficial’, ‘likely to be beneficial’, ‘trade-off 
between benefits and harm’, ‘unlikely to be beneficial’, ‘likely to be ineffectual 
or harmful’ or ‘unknown effectiveness’.  These classification decisions were 
based on the results of the statistical analysis, combined with a considered 
judgement relating to the power of the RCTs and their heterogeneity and 
consistency of effect.  
The most recently published Scottish Intercollegiate Guidelines Network 
(SIGN)33 were searched and guidance on the use of identified interventions 
for upper limb recovery was also reported. 
3.4 Results 
3.4.1 Results of the search 
Thirteen intervention categories relevant to upper limb motor recovery after 
stroke were identified.   
Of the 13 interventions, nine had associated Cochrane systematic reviews 
and four were covered by another review (Figure 3-1).   
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The sum of the included RCTs is 118, however seven trials were included in 
more than one intervention category, therefore 111 RCTs were included in 
this overview of interventions to improve upper limb recovery.   
Figure 3-1 - Flow chart of searching process and evidence identified at each stage of 
searching 
 
 
3.4.2 Included studies 
Table 3-1 outlines the thirteen intervention categories (with an accompanying 
description of each intervention) and the associated sources of evidence 
which were identified and used in this review.  Sources included the relevant 
Cochrane systematic review or similar high quality systematic review, the 
relevant trials included within that review and any additional trials identified.  
13 intervention categories relevant to upper limb 
recovery identified 
Search of Cochrane Stroke Group list of systematic 
reviews  
9 Cochrane Systematic reviews identified  
Search of Cochrane library and MEDLINE using 
stroke and intervention specific terms 
5 Cochrane systematic 
reviews covering whole 
intervention topic:  
• Bilateral training 
• Electromygraphic 
(EMG)biofeedback 
• Hands on therapy 
• Mental Practice 
• Virtual Reality 
4 Cochrane systematic 
reviews partially 
covering intervention 
topic, supplemented with 
additional RCTs: 
• Constraint-induced 
movement therapy 
• Electrostimulation 
• Repetitive task 
training 
• Robotics 
No Cochrane systematic 
review, 4 other reviews, 
possibly supplemented 
with additional RCTs: 
• Neurophysiological 
approaches 
• High-intensity 
therapy  
• Mirror therapy 
• Splinting 
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For all of the included interventions a systematic review was identified (nine 
Cochrane reviews and four other reviews) and, in seven cases this 
information was supplemented with data from additional RCTs.  Most of the 
analyses of the effects of an intervention were informed by a relatively small 
number of randomised trials (average of 8 trials per intervention category for 
outcome of arm function and 3 for outcome of hand function). 
Table 3-1 - Outline of intervention categories and sources of evidence 
Intervention Description Cochrane or 
other review 
(relevant 
RCTs 
included) 
Additional 
RCTs 
identified 
Total 
RCTs 
included 
Approaches to 
therapy - 
Neurophysiological 
(Bobath) 
Various therapeutic 
approaches based on 
neurophysiological 
knowledge and 
theories, most 
commonly the Bobath 
approach 
Other  
review168 (2 
RCTs)169;170 
3171-173 
 
5 
 
Bilateral training Using both upper limbs 
to perform identical 
activities 
simultaneously but 
independently 
CR174 (10 
RCTs)175-184 
 
0 10 
Constraint induced 
movement therapy 
(CIMT) 
Restraint of the intact 
limb, in combination 
with a large number of 
repetitions of task-
specific training 
CR185 (19  
RCTs)186-204  
4178;205-207  
 
23 
EMG biofeedback 
  
Using instrumentation 
applied to muscles with 
external electrodes to 
capture motor unit 
electrical potentials.  
The instrumentation 
converts the potentials 
into audio or visual 
information 
CR208 (4 
RCTs)209-212 
 
0  
 
4  
 
Electrostimulation  
  
Electrostimulation 
delivered to the 
peripheral 
neuromuscular system 
by external or internal 
electrodes, at a range 
of frequencies, 
intensities and patterns 
of delivery 
CR213 (10 
RCTs)175;214-222 
 
1141;223-232 
 
21 
 
Hands-on therapy 
interventions 
Hands-on physical 
interventions (manual 
therapy techniques) 
CR233 (3 
RCTs)234-236 
0 3 
High-intensity 
therapy 
Increased amount of 
focused 
Other review237 
(4 RCTs)51;238-
0  
 
4  
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therapy/interventions 240 
Mental 
practice/Imagery  
Cognitive rehearsal of a 
physical action.   
CR241 (6 
RCTs)242-247 
0 6 
Mirror therapy  Mirror is placed in the 
patient’s midsagittal 
plane, presenting the 
patient the mirror image 
of their non-affected 
arm  
Other review248 
(4 RCTs)249-252 
1253 5 
Repetitive task 
training 
Active motor sequence 
performed repetitively 
within a single training 
session, aimed towards 
a clear functional goal. 
CR 254 
 (8 
RCTs)62;170;173;2
38;255-258  
 
1259 
 
9 
 
Electromechanical/
Robotics  
Devices which allow for 
high-intensity, 
repetitive, task-specific 
and interactive 
treatment of the upper 
limb   
CR260 (10 
RCTs)181;261-269 
6270-275 16 
Splinting/orthosis 
  
External, removable 
devices that are used to 
meet a number of 
clinical aims  
Other review276 
(2 RCTs)277;278 
1279 
 
3  
 
Virtual reality An advanced form of 
human-computer 
interface that allows the 
user to ’interact’ with 
and become ’immersed’ 
in a computer-
generated environment 
in a naturalistic fashion. 
CR280 (9 
RCTs)272;281-288 
0 9  
 
Additional details extracted from all of the included trials, taken from 
Cochrane systematic reviews where possible, or from the individual trials 
(numbers of participants, intervention undertaken, comparison group and 
outcome measure(s) used in this review) are outlined in (Appendix C) and 
briefly reported below.   
Participants 
Only basic information i.e. number of participants within each study at 
recruitment (as relevant to this review) and then at outcome was recorded.  If 
a trial reported more than one control group only one control group was 
chosen for inclusion and only these participants were included.  Despite only 
basic information being extracted and presented it was clear from the 
literature that a heterogeneous group of patients’ i.e. differing populations 
across and within the different intervention categories had been studied.  In 
terms of numbers it was clear that most of the included trials only recruited 
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relatively small numbers of participants, as relevant to this review (average of 
36 participants; median 27 per trial).  Only seven51;173;182;201;239;240;259 of the 
included trials recruited more than 100 participants, which were relevant to 
this review.   
Interventions 
It was clear that even within the intervention categories there were variations 
in the interventions delivered.  This was evident in terms of intensity, duration 
and types of intervention delivered (e.g. type of constraint-induced 
movement therapy, electromechanical/robotic device used).   
Comparators 
Differences in the comparator interventions were also evident.  As far as 
possible I aimed to only include RCTs which compared the intervention of 
interest to usual care, placebo or no treatment.  However this was not always 
possible (as evident in Appendix C).  In some cases increased intensity of 
usual care was also evident.   
Outcome measures 
A range of measures of upper limb motor recovery (arm and hand 
function/impairment) were reported.  The outcome measures reported by the 
included Cochrane systematic reviews were used in this analysis.  Therefore 
on occasions an outcome relating to motor impairment (e.g. Fugl-Meyer 
Scale) was included over a measure of motor function (e.g. Action Research 
Arm Test).  For trials that were identified, in addition to those included in the 
Cochrane reviews, functional measures were chosen over motor impairment 
measures.  The most commonly used outcome measures in this review were 
the ARAT, MAS, F-M scale and BBT.  For hand function the most common 
measures of hand function were various peg tests, particularly the NHPT.  
3.4.3 Methodological quality of the included studies 
Table 3-2 outlines the key design features of the included trials within each 
intervention category, in relation to the three main features that are likely to 
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affect the reliability of the trials conclusions; whether there was adequate 
allocation concealment; whether the outcome assessor was blinded to 
treatment allocation; and whether an intention-to-treat analysis was used.  
Table 3-2 - Key design features of the included trials 
Intervention category Number of 
included 
RCTs  
Allocation 
concealment 
Adequate/Unclear 
/Not adequate 
Blinded 
assessor 
Intention-
to-treat 
analysis 
Approaches to therapy – 
Neurophysiological 
(Bobath) 
5 2 / 3 / 0 
 
3 
 
1 
 
Bilateral training 10 3 / 4 / 3  8 
 
0  
Constraint-induced 
movement therapy 
23 4 / 19  / 0  20 2 
EMG biofeedback 4 1 / 1 / 2 
 
2  
 
0  
 
Electrostimulation 21 3  / 16  / 2 
 
11 
 
4 
 
Hands-on therapy 
interventions 
3 1 / 2 / 0 0 0 
High-intensity therapy 4 3 / 1 / 0 
 
4  
 
1  
 
Mental practice/imagery 6 0 / 6 / 0 5 0  
Mirror therapy 5 3 / 2 / 0 5 1 
Repetitive task training 9 6 / 2 / 1  6  2  
Electromechanical/Robotic 
devices  
16 3 / 10 / 3 12 2 
Splinting/orthotics 3 2 / 1 / 0 
 
3 
 
2  
 
Virtual reality 9 5 / 3 / 1 6 3  
 
Quality of the included trials was variable.  Adequate allocation concealment 
was reported in only 30% of trials (although only 10% had clearly inadequate 
allocation concealment), blinding of outcome assessment was reported in 
72%, and an intention-to-treat analysis was only clearly reported as 
completed in 15% of trials; although this may, in part be attributable to poor 
reporting.  Additionally many of the trials did not report any dropouts. 
3.4.4 Evidence for effects of interventions: Arm function 
Figure 3-2 and Table 3-3 summarise the results of the meta-analysis for the 
effect of the identified upper-limb interventions on measures of motor 
recovery (impairment/function) of the arm.  Figure 3-2 is presented over two 
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pages.  A range of measures of arm function were reported and included in 
this analysis.  The most common were the ARAT, MAS and F-M scale.  
The results indicate that several interventions have a potential effect on arm 
function.  Eight interventions were found to have a statistically significant 
result:  constraint-induced movement therapy (SMD 0.71 95% CI 0.54-0.87), 
EMG biofeedback (SMD 0.41 95% CI 0.05-0.77), electrostimulation (SMD 
0.30 95% CI 0.11-0.50), mental practice (SMD 1.16 95% CI 0.71-1.60), 
mirror therapy (SMD 0.41 95% CI 0.05-0.77), repetitive task training (SMD 
0.23 95% CI 0.06-0.41), electromechanical/robotics (SMD 0.34 95% CI 0.16-
0.52) and virtual reality (SMD 0.52 95% CI 0.25-0.78).  One intervention 
category; hands-on therapy interventions only included three trials and was 
not included in any meta-analyses, as the authors of this included systematic 
review deemed the interventions too heterogeneous.  The four other 
interventions (approaches to therapy, bilateral training, high-intensity therapy 
and splinting) had a non significant result for arm recovery.    
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Figure 3-2 - Forest plot of 13 interventions targeted at arm recovery compared to 
control group 
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3.4.5 Evidence for effects of interventions: Hand function 
Eleven of the thirteen interventions (see Figure 3-3) were suitable for 
including in the hand function analyses.  The most common measures of 
hand function were various peg tests.   The intervention categories of 
constraint-induced movement therapy and repetitive task training showed 
statistically significant results for improvement of hand function (SMD 0.39 
95% CI 0.11-0.68) and (SMD 0.27 95% CI 0.06-0.47) respectively.  The 
analysis for hand function is limited due to the small number of trials 
reporting hand function outcomes. 
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Figure 3-3 - Forest plot of 8 interventions targeted at hand recovery compared to 
control group 
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Table 3-3 - Summary of evidence for interventions aimed at promoting upper limb (arm and hand) recovery after stroke 
Intervention Evidence and considered 
judgement (n=recruited; 
n=analysed) 
SMD (95% CI) SIGN guideline 
recommendation 
Comments 
Approaches to therapy 
(Bobath) 
Arm function:  unknown 
effectiveness; 5 trials169-173 (n=292; 
n=241) 
Hand function:  unknown 
effectiveness; 3 trials169;170;173 (n=208; 
n=157) 
0.11 (-0.14-0.36) 
 
 
0.13 (-0.19-0.44) 
 
 
There is insufficient evidence 
to suggest that any one 
approach to therapy is more 
effective for improving upper 
limb function in stroke 
patients 
Five RCTs identified.  One trial171 
had two subgroups, which were 
analysed as different trials (thus the 
number of trials within forest plot for 
arm function is six) 
Bilateral training Arm function:  unknown 
effectiveness; 10 trials175-184 (n=327); 9 
trials176-184 in analysis (n=307; n=290) 
Hand function:  unknown 
effectiveness;  6 trials177;178;181-184 
(n=237; n=220) 
-0.12 (-0.35-0.12) 
 
 
-0.14 (-0.41-0.13) 
There is insufficient evidence 
to recommend or refute 
bilateral training for 
improving arm function after 
stroke 
Four RCTs289-292 included in 
Cochrane review not included in this 
analysis as unsuitable outcomes.  A 
further four studies293-296 included in 
the Cochrane review not included in 
this review as unsuitable study 
design 
Constraint-induced 
movement therapy 
Arm function:  likely to be beneficial; 
23 trials178;186-207  (n=719); 21 
trials178;187-193;195-207 in analysis (n=700; 
n=658) 
 
Hand function:  likely to be beneficial; 
7 trials178;188;190;192;198;204;205 (n=217; 
n=196) 
0.71 (0.54-0.87) 
(I2=58.5%) 
0.74 (0.44-1.03) 
(random effects 
model) 
0.39 (0.11-0.68) 
CIMT may be considered for 
carefully selected individuals 
with at least 10 degrees of 
finger extension, intact 
balance and cognition 
Restrictive inclusion criteria for this 
intervention 
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EMG biofeedback Arm function:  likely to be beneficial; 
4 trials209-212 (n=126; n=126). 
0.41 (0.05-0.77) There is currently insufficient 
high quality evidence to 
support or refute the use of 
EMG biofeedback for 
improving upper limb 
function after stroke. 
Data from review used – all 
identified as being measures of arm 
function and not split into arm and 
hand function 
Electrostimulation Arm function:  likely to be beneficial; 
19 
 trials41;175;214-226;229-232 (n=532); 17 
trials175;214-225;229-232 in analysis (n=498; 
n=456)  
Hand function:  unknown 
effectiveness 9 trials41;218;221;224;225;227-
230
 (n=283); 6 trials218;221;224;225;229;230 in 
analysis (n=223; n=188) 
0.30 (0.11-0.50) 
(I2=70%) 
0.40 (0.02-0.77) 
(random effects 
model) 
0.10 (-0.19-0.40) 
 
There is currently insufficient 
high quality evidence to 
support or refute the use of 
electrostimulation for 
improving upper limb 
function after stroke. 
17 RCTs identified.  One trial229 had 
two subgroups, which were   
analysed as different trials (thus the 
number of trials within forest plot is 
18 for arm function and seven for 
hand function) 
Hands-on therapy 
interventions 
Arm function:  unknown 
effectiveness; 3 trials234-236 (n=86). No 
trials included in a meta-analysis 
Not applicable Not reviewed in guideline. The authors of the Cochrane review 
concluded that the limited evidence 
of benefit of stretching, passive 
exercises and mobilisation, merits 
further research 
High-intensity therapy  Arm function:  unknown 
effectiveness; 4 trials51;238-240 (n=612; 
n=571) 
 
 
Hand function: unknown 
effectiveness; 2 trials239;240  (n=419; 
n=403) 
-0.09 (-0.26-0.08) 
(I2=59.5%) 
-0.09 (-0.36-0.18) 
(random effects 
model) 
0.09 (-0.11-0.30) 
Increased intensity of 
therapy for improving upper 
limb function in stroke 
patients is not 
recommended. 
Four RCTs identified.  Two 
trials239;240 had two subgroups each, 
which were analysed as different 
trials (thus the number of trials 
within forest-plot is six for arm 
function and four for hand function)  
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Mental practice with motor 
imagery 
Arm function:  likely to be beneficial; 
5 trials243-247 (n=102; n=102) 
 
 
 
Hand function: unknown 
effectiveness; 1 trial242 (n=12; n=12) 
1.16 (0.71-1.60) 
(I2=59.5%)  
1.37 (0.60-2.15) 
(random effects 
model) 
-0.67 (-1.85-0.51)  
Mental practice may be 
considered as an adjunct to 
normal practice to improve 
upper limb function after 
stroke. 
 
Mirror therapy Arm function: likely to be beneficial; 5 
trials249-253 (n=153); 4 trials249;250;252;253 
in analysis (n=137; n=121) 
Hand function: unknown 
effectiveness 2 trials252;253 (n=80; 
n=76) 
0.41 (0.05-0.77) 
 
 
0.43 (-0.03-0.88) 
Not reviewed in guideline.  
Repetitive task training Arm function:  likely to be beneficial; 
9 trials62;170;173;238;255-259 (n=570; n=515) 
Hand function:  likely to be beneficial; 
6 trials170;173;255-257;259 (n=427; n=384) 
0.23 (0.06-0.41) 
 
0.27 (0.06-0.47) 
 
Repetitive task training is not 
routinely recommended for 
improving upper limb 
function. 
 
Electromechanical/Robotic 
devices 
Arm function: likely to be beneficial; 
16 trials181;261-272;274;275 (n=553); 15 
trials181;262-275 in analysis (n=522; 
n=510)  
 
 
Hand function:  unknown 
effectiveness 11 trials181;262;264;266-
269;271;272;274;275
 (n=366); 10  trials in 
analysis181;262;264;266;267;269;271;272;274;275; 
n=310; n=278) 
 
0.34 (0.16-0.52) 
(I2=59%) 
0.30 (0.02-0.58) 
(random effects 
model) 
 
0.19 (-0.30-0.68) 
(I2=74%) 
0.24 (-0.01-0.49) 
(random effects 
model) 
Electromechanical/robotic 
devices may be considered 
to improve arm motor 
function and motor strength 
in selected patients where 
the necessary equipment is 
already available and 
healthcare professionals are 
competent in the use of the 
equipment. 
15 RCTs identified.  Two trials270;271 
had 2 subgroups each, which were 
analysed as different trials (thus the 
number of trials within forest plot is 
17 for arm function and 11 for hand 
function). 
One RCT273 was a much larger 
study (n=127) than reported here.  
However only the comparison of 
robot-assisted therapy vs. usual 
care was used in this review 
One RCT297 included in Cochrane 
review was excluded from this 
review as not suitable comparator.    
Two RCTs265;266 not included in 
Cochrane review analysis 
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Splinting Arm function:  unknown 
effectiveness; 3 trials277-279 (n=109); 2 
trials278;279 in analysis (n=81; n=80) 
Hand function:  unknown 
effectiveness; 2 trials277;278 (n=46); 1 
trial278 included in analysis (n=18; 
n=18) 
0.05 (-0.41-0.51) 
 
 
-0.01 (-0.94-0.91) 
 
Splinting is not 
recommended for improving 
upper limb function. 
One trial279 had two subgroups, 
which were analysed as different 
trials (thus the number of trials 
within forest plot is three for arm 
function)  
Virtual reality Arm function: likely to be beneficial; 9 
trials272;281-288 (n=250; n=235) 
Hand function: unknown 
effectiveness; 3 trials272;286;288 (n=76; 
n=64) 
0.52 (0.25-0.78) 
 
0.34 (-0.16-0.84) 
 
Due to the limited amount of 
high quality evidence and 
heterogeneity between the 
studies conclusions about 
the effects of virtual reality 
cannot be made. 
Two trials282;288 not included in 
Cochrane review analysis 
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3.4.6 Evidence in context 
In addition to the meta-analyses outlined above in Figure 3-2 and Figure 3-3, 
a semi-quantitative classification of effectiveness (Table 3-3) was also 
carried out.  This process involved classifying the effect of each intervention 
on the basis of published criteria167.  These conclusions were also compared 
with the findings of the most recently published SIGN guidelines33.  
Generally, the considered judgement categories match those of the meta-
analyses.  With regard to consistency between the findings of this review and 
the clinical practice guidelines, discrepancies exist with regard to the 
interventions of EMG biofeedback, electrostimulation and repetitive task 
training; the guidelines suggest that these interventions should not be used 
on a routine basis.  Additionally, no comment was made about the 
intervention of mirror therapy within the SIGN guidelines.  These 
discrepancies could be related to differences in the way in which trial 
evidence was combined and analysed, the amount of evidence available at 
the time of publication of the guidelines or because of the process of 
considered judgement undertaken by clinical guideline review panels, which 
takes into account a number of factors including perceived applicability and 
availability of a particular intervention.   
3.5 Discussion 
3.5.1 Summary of findings 
This systematic review and meta-analysis identified a broad range of 
interventions which have been developed to assist motor recovery 
(movement and related functions) of the upper limb (arm and hand function).  
In addition to the thirteen interventions reported in this review other 
interventions have been investigated in the literature, such as transcranial 
direct current stimulation298, however those not included did not meet the 
original criteria for the review and/or were felt to be interventions still very 
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much in their infancy or not easily translated into routine physiotherapy or 
occupational therapy clinical practice.  
Eight of thirteen interventions suggest potential benefit in improving arm 
function.  However, when considering only outcomes relating to hand 
function only constraint-induced movement therapy and repetitive task 
training were found to suggest a beneficial effect.  Very limited evidence was 
available relating specifically to hand function.  The effect sizes were, in 
general, similar to that of arm function; however fewer trails were available 
for hand function outcomes, limiting statistical power.   
Despite a number of interventions suggesting a potential beneficial effect on 
arm function, a number of issues limit the validity of these conclusions.  In 
general, the results for constraint-induced movement therapy seem the most 
robust for the following reasons; the effect size (SMD) was large, the quality 
of the trials was high (Table 3-2) and a relatively large number of trials and 
participants were included, including one multi-centre study201.  However 
applicability conclusions for this intervention are limited due to the variety of 
the CIMT approaches studied between the included trials and the fact that all 
trials focused on very selected populations (e.g. those with limited arm 
impairment and/or cognitively intact).  Additionally constraint-induced 
movement therapy is a resource and time intensive intervention, which 
presents a challenge to compliance and applicability to routine clinical 
practice.  Modifications to the original CIMT protocol are now being 
investigated with the aim of developing a more widely applicable intervention.   
Trials of EMG biofeedback and mirror therapy are particularly limited by their 
small size.  In addition, the EMG biofeedback trials reported low levels of use 
of a blinded outcome assessor and inadequate allocation concealment.  
Trials of mental practice and virtual reality have relatively high and moderate 
effect sizes respectively, but are again limited by small numbers of 
participants.  Owing to these limitations, the results from the analyses of 
EMG biofeedback, mirror therapy, mental practice and virtual reality could be 
overturned by new, larger trials.  The effect size for electromechanical 
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/robotic devices was relatively low, however a relatively large number of trials 
and participants were included in the analysis of this intervention category.  
However, general applicable conclusions are again limited due to the 
different devices and patient groups studied.  Additionally, there is a lack of 
available evidence for most of the identified interventions, with regard to their 
effectiveness in a routine clinical setting.  The intervention of repetitive task 
training, which also suggested a beneficial effect is limited due to the 
differing interventions studied within this intervention category; however, 
there is evidence to suggest such interventions could be more generally 
applied to routine clinical settings.   
Of the interventions that have been identified which suggest a beneficial 
effect on upper limb (arm) motor recovery, most appear to include the 
characteristics of intensive, repetitive, task-specific practice (CIMT, mental 
practice, repetitive task training, robotics and virtual reality).  Therefore, it is 
suggested that the elements of intensive, repetitive task-specific practice 
might be the most effective principles to include in interventions when trying 
to promote upper limb motor recovery following stroke.     
It has also been found that despite a number of systematic reviews and 
randomised controlled trials relating to interventions targeting upper limb 
motor recovery following stroke being available, much further evaluation of 
these interventions is required.  At present the only conclusions that can be 
drawn from the available evidence are that some interventions show a 
suggestion of beneficial outcome and that many of these interventions share 
similar characteristics.  Further evaluation would allow for conclusions to be 
drawn regarding interventions for specific problems in specific patients and 
allow for translation of the evidence into broad, practical recommendations 
for the wider stroke population.   
3.5.2 Limitations of the review 
The main weaknesses of this review relate to the heterogeneity of the 
available data.  For this reason the evidence from this review could not 
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provide guidance on which intervention should be given to a particular 
patient in a particular situation.   
Within and between the thirteen identified interventions there were 
substantial differences in terms of the populations studied, the type, amount 
and duration of intervention delivered and control comparators and outcome 
measures used.  Differences were also apparent in the methodological 
quality of the RCTs and several had methodological limitations.  The quality 
of reporting in the trials was often identified to be poor.  This limits 
confidence in the findings and makes interpretation of the findings 
problematic.   
A range of outcome measures were used and combined in the analyses of 
this review to lead to a standardised effect measure in terms of the broad 
outcome of recovery of upper limb motor function, for each intervention 
category.  Due to the heterogeneity of the available evidence some 
intervention categories were considered more in terms of motor impairment 
and others in terms of outcomes more relating to motor function.  Therefore, 
direct comparisons between intervention categories may be problematic.  
However, due to the continuum which has been shown to exist between 
outcomes of motor impairment and motor function299 the suggestion of effect 
for each intervention in this review is valid. 
Lastly, even the trials which were found to have better methodological rigour 
(i.e. have good internal validity) were generally small in size, recruited 
selected populations and used outcome measures at the level of impairment 
or limb function.  There are still only a few multicentre randomised trials that 
have tested interventions in routine clinical settings on relatively large 
numbers of patients and that have used outcome measures targeted at 
functional ability.   
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3.5.3 Strengths of the review 
The main strengths of this review, which took a broad overview approach, 
relate to the comprehensive methods which were used to attempt to identify 
and synthesise all relevant, high-quality evidence relating to interventions 
targeting upper limb motor recovery.   
Only systematic reviews of randomised controlled trials or individual RCTs 
were included in this review; such types of methodologies are the least likely 
to provide biased estimates of effect, increasing confidence in the 
conclusions gained.  Thorough searching was used to identify all relevant 
systematic reviews and trials to ensure a comprehensive overview, which is 
an additional strength of this review.   
As far as possible, an explicit and unbiased approach to data analysis was 
undertaken, and any conclusions were considered with reference to the key 
methodological features of the identified evidence.  In an attempt to provide a 
contextual overview of the evidence, the conclusions of the meta-analyses 
were considered alongside a semi-quantitative assessment (considered 
judgement) and further cross-referencing to the most recent clinical 
guidelines.  This also limited the amount of emphasis placed on the meta-
analyses alone, as data from such could be limited due to the heterogeneity 
of the available evidence.   
3.5.4 Implications for practice 
The evidence from this review can only provide broad, indicative guidance 
due to the gaps that still exist in the evidence base of interventions to 
improve upper limb motor recovery and function after stroke.  To a large 
extent, individual clinical decisions will continue to rely on the clinical 
reasoning of individual therapists. The general conclusion of this review is 
that interventions to improve upper limb motor recovery should (as much as 
possible) include elements of high-intensity, repetitive task-specific practice.  
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3.5.5 Implications for research 
Research within this area is required to further define the interventions that 
carry benefit, to quantify that benefit within a routine clinical setting and to 
define the target populations for these interventions.  Additional research is 
also required about how the complex interventions, identified in this review 
can be implemented into routine clinical settings.   
Future research should focus on randomised controlled trials with key 
methodological elements (i.e. randomisation, allocation concealment, 
blinding of outcome assessor, intention-to-treat analysis) present and 
reported to reduce the risk of bias and increase confidence in the findings.   
A wide range of outcome measures, used in the included trials were 
identified in this review.  In order to enable comparison between 
interventions there is a real need for RCTs in this area to focus on a smaller 
number of robust, standardised and relevant outcome measures.  
3.6 Conclusions 
This systematic review provides a relatively concise and informative 
overview of the current available evidence relating to interventions for 
improving upper limb motor recovery following stroke.   
There is evidence that several interventions might be beneficial or at least 
show promise for improving upper limb motor recovery following stroke.   The 
most promising intervention for upper limb (arm) function appears to be 
constraint-induced movement therapy.  Seven other interventions also 
suggest a promising effect.   Among these seven promising interventions are 
electromechanical/robotic devices which, in contrast to some of the other 
interventions, potentially offer a less resource intensive approach to 
providing more intensive, repetitive therapy.  Electromechanical/robotic 
devices are of particular interest at present and it is an area with many 
opportunities, and one which is constantly developing.  
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The limitations of this review, which particularly relate to heterogeneity of the 
available data, limit the conclusions that can be drawn.  However, this review 
does appear to suggest that interventions with elements of intensive, 
repetitive, task-specific practice are beneficial for improving upper limb 
recovery after stroke.  
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Chapter 4  
Systematic review of simultaneous 
bilateral training for improving arm 
function after stroke 
  128 
Chapter 4  Systematic review of simultaneous 
bilateral training for improving arm function 
after stroke 
4.1 Introduction 
In Chapter 3 a number of interventions, targeted at upper limb recovery were 
investigated.  A number of these interventions had been or were in the 
process of being systematically reviewed by Cochrane systematic reviews.  
Prior to the update (September 2011) of the review reported in Chapter 3 , 
bilateral training was identified as one intervention which still required 
rigorous systematic evaluation.  The results gained from Chapter 4 (this 
chapter) were subsequently used in the update of Chapter 3 .   
The process of systematic reviews was introduced in Chapter 2 .  Systematic 
reviews of interventions are considered to be the highest level of evidence160.  
Therefore, subjecting interventions to the rigours of systematic evaluation will 
give the most explicit information about the specific effects of that 
intervention.   
4.1.1 Cochrane reviews 
Cochrane reviews are systematic reviews of primary research, through which 
effects of intervention are reviewed using predefined, rigorous and explicit 
methodology.  Cochrane reviews are generally accepted as the highest 
standard in evidence-based health care and therefore to add to the evidence 
base of upper limb interventions I decided to complete a Cochrane 
systematic review of a specific intervention.  Therefore, a Cochrane 
systematic review of bilateral training was completed.  
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4.1.2 Bilateral training 
Simultaneous bilateral training involves the execution of identical activities 
with both arms simultaneously but independently300.  Beneficial effects of 
bilateral training are assumed to arise from an interlimb coupling effect, in 
which the non-paretic arm facilitates movements in the impaired 
limb182;301;302.  It has been further suggested176;303 that bilateral practice of 
synchronous movements with the paretic and non-paretic limbs allows 
activation of the intact hemisphere to facilitate activation of the damaged 
hemisphere through enhanced interhemispheric inhibition.  Bilateral training 
is often combined with other interventions, such as electrostimulation or 
assistive technology, to assist the affected arm to undertake the 
simultaneous movements. 
Two reviews304;305 have reported favourable effects of bilateral training.  
These reviews however, included studies other than randomised controlled 
trials (RCTs) and both acknowledged that there are inconsistencies across 
bilateral training studies.  A further, more recent narrative review of bilateral 
training306 suggested that bilateral studies have not shown improvements in 
all patients and that bilateral training has not been found to be more 
beneficial than other training approaches.  However, this review was not 
systematic and included a range of study designs, including single case 
studies.   
This current review sought to undertake a complete, up to date, systematic 
review of randomised controlled trials to determine the effects of bilateral 
training.  
4.2 Objectives  
To determine the effects of simultaneous bilateral training for improving arm 
function after stroke compared with: 
• Placebo or no intervention 
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• Usual care 
• Other specific upper limb interventions or programmes. 
4.3 Methods 
Cochrane guidelines for systematic reviews of interventions were used to 
complete and report this review307. 
4.3.1 Eligibility criteria  
Types of studies  
Only RCTs (that is, each participant is allocated to one of the available 
treatment groups at random (like the toss of a coin), where one of the groups 
was a control (comparator) group, for example ‘usual care’) were included.  
Only the first phases of cross-over studies were included to exclude any 
carry-over or learning effects.  
One of the intervention groups must have included simultaneous bilateral 
training (see definition in Types of interventions), compared to another group, 
consisting of either:  no-treatment, placebo, usual ('conventional' or 
'traditional') care, or another specific upper limb intervention or programme. 
Types of participants  
Trials of participants with a clinical diagnosis of stroke, regardless of time 
since onset, initial upper limb impairment, ability to follow instructions, co-
morbidities, previous strokes or location of stroke were included. 
Randomised controlled trials with participants with other neurological 
conditions were included if more than 75% of participants were stroke 
patients. 
Types of interventions  
Only trials which included simultaneous bilateral training were considered. 
The definition of simultaneous bilateral training used, was; 'when a motor 
activity is completed at the same time by both upper limbs independently'300. 
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Trials that investigated simultaneous bilateral training in conjunction with 
another intervention (e.g. assistive technology such as machine, a robot or 
electrical stimulation) and compared to a control group, for example, 
simultaneous bilateral training and electrical stimulation compared to a 
control group were excluded. This was to ensure that the treatment effect 
under investigation was bilateral training.  However, studies where assistive 
technology was given to both an intervention (bilateral training) and control 
(unilateral training) group were included, as in these cases it is the bilateral 
component of the training which is the active treatment under investigation, 
and not the assistive technology.  Similarly, trials which investigated bilateral 
training completed using assistive technology which was compared with a 
control intervention, also completed using assistive technology were also 
included.  Any duration or intensity of programme was included.   
For studies comparing simultaneous bilateral training with 'usual care', any 
control intervention considered by the original trial authors to be a normal or 
usual component of stroke rehabilitation was accepted. The description of 
'usual care', where this was provided by the authors, was documented. 
Types of comparisons to be made 
Three comparisons were investigated: 
1. Simultaneous bilateral training versus placebo or no intervention 
2. Simultaneous bilateral training versus usual care 
3. Simultaneous bilateral training versus other specific upper limb 
interventions or programmes 
Where trials included another intervention as an adjunct to bilateral training, 
which was also delivered to the control group, these studies were included in 
the appropriate comparison groups as listed above, regardless of the adjunct 
intervention.  For example, comparisons of (i) robot-assisted simultaneous 
bilateral training versus robot-assisted unilateral training or (ii) simultaneous 
bilateral training plus electrical stimulation versus unilateral training plus 
electrical stimulation would both be included in comparison 3 (simultaneous 
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bilateral training versus other specific upper limb interventions).  A sensitivity 
analysis was completed to explore the effect of including studies where the 
simultaneous bilateral training was combined with another intervention. 
Types of outcome measures  
The primary or initial aim of upper limb interventions is usually to improve 
functional movement and reduce impairment.  However, arguably the most 
important goal for patients is to improve their ability to participate in and 
achieve independence with activities of daily living.  Additionally, this is the 
over-arching aim of all rehabilitation interventions.  Therefore, two primary 
outcomes of interest were identified for this review: performance in activities 
of daily living and functional movement of the upper limb.  The primary 
outcomes of interest were (1) Performance in activities of daily living (ADL) 
and (2) Functional movement of the upper limb. 
It was anticipated that the studies would use and report a large variety of 
different outcome measures relevant to the primary and secondary outcomes 
of this review.  Therefore, for each outcome of interest (primary and 
secondary) an attempt was made to identify and list all the common, specific 
measurement tools or scales that could be included.  If a study was identified 
which reported more than one measurement tool or scale, addressing the 
same outcome, the scale listed earliest in the hierarchical lists was used.  If a 
study did not use any of the measures in the list, but measured the outcome 
using a different measurement tool or scale this was included and 
documented.  The hierarchical lists are given below under each outcome.     
Primary outcomes 
Performance in activities of daily living (including feeding, dressing, 
bathing, toileting, simple mobility and transfers).  Common outcome 
measures of global measures of activities of daily living include: Barthel 
Index (BI)82, Rivermead ADL assessment308, Rankin Scale83, Functional 
Independence Measure (FIM)84. 
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Functional movement of the upper limb (such as measures of active 
movement, co-ordination, dexterity, manipulation, grasp/grip/pinch).  
Common outcome measures include: Action Research Arm Test (ARAT)85, 
Motor Assessment Scale (MAS) - upper arm function or combined arm 
score86, Frenchay Arm Test (FAT)161, Wolf Motor Function Test (WMFT)309, 
Functional Test of the Hemiparetic Upper Extremity310, Box and Block Test 
(BBT)87, Upper extremity performance test for the elderly (TEMPA)311, 
Chedoke arm and hand activity inventory312, Sodring Motor Evaluation of 
stroke patients - arm section313, Motor Activity Log (MAL)199, Motor 
Assessment hand movement or advanced hand movement scales86, Jebsen 
Hand Function Test314, Nine Hole Peg Test (NHPT)162 and Purdue Peg 
Test315. 
Secondary outcomes 
Performance in extended activities of daily living (including shopping, 
household tasks). Common outcome measures: Nottingham Extended 
Activities of Daily Living316, Rivermead Extended Activities of Daily Living317, 
Frenchay Activities Index318. 
Motor impairment of the upper limb (measures/scales of upper limb 
impairment, muscle strength, muscle tone). Common outcome measures 
include: Fugl-Meyer (F-M) Assessment of Sensorimotor Recovery after 
Stroke (upper limb section)88, Motricity Index (MI)163, Rivermead motor 
assessment (arm section)319, Motor Club Assessment320, Ashworth 
Scale321/Modified Ashworth Scale322, MRC scale323, Dynamometer scores 
(including Jamar)324, kinematic measures (e.g. movement time, movement 
efficiency, movement speed, spatial accuracy, velocity). 
Additional outcomes 
Adverse events (e.g. death, shoulder pain/subluxation). 
Outcomes from the end of the intervention period were used for analysis as 
the primary aim of this review was to determine whether bilateral training had 
any immediate beneficial treatment effect.    
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4.3.2 Search methods for identification of studies   
To identify appropriate studies the following resources were searched: 
• The Cochrane Stroke Group Trials Register was searched by the 
Managing Editor (August 2009)  
• Cochrane Central Register of Controlled Trials (CENTRAL) (The 
Cochrane Library Issue 3, 2009) 
• MEDLINE (1966 to August 2009) 
• EMBASE (1980 to August 2009) 
• CINAHL (1982 to August 2009)  
• AMED (1985 to August 2009) 
The following occupational therapy and physiotherapy databases were 
searched:  OTseeker (http://www.otseeker.com/) (August 2009), 
Physiotherapy Evidence database (PEDro, 
http://www.pedro.fhs.usyd.edu.au/index.html), Chartered Society of 
Physiotherapy Research Database (August 2009) and REHABDATA 
(http://www.naric.com/research/rehab/default.cfm) (August 2009).   
Search strategies were developed in consultation with the Cochrane Stroke 
Group’s Trials Search coordinator. 
Search strategy (MEDLINE) 
1. cerebrovascular disorders/ or exp basal ganglia cerebrovascular 
disease/ or exp brain ischemia/ or exp carotid artery diseases/ or 
cerebrovascular accident/ or exp brain infarction/ or exp 
cerebrovascular trauma/ or exp hypoxia-ischemia, brain/ or exp 
intracranial arterial diseases/ or intracranial arteriovenous 
malformations/ or exp "Intracranial Embolism and Thrombosis"/ or exp 
intracranial hemorrhages/ or vasospasm, intracranial/ or vertebral 
artery dissection/ 
2. (stroke or poststroke or post-stroke or cerebrovasc$ or brain vasc$ or 
cerebral vasc$ or cva$ or apoplex$ or SAH).tw. 
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3. ((brain$ or cerebr$ or cerebell$ or intracran$ or intracerebral) adj5 
(isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$)).tw. 
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracranial or 
subarachnoid) adj5 (haemorrhage$ or hemorrhage$ or haematoma$ 
or hematoma$ or bleed$)).tw. 
5.  hemiplegia/ or exp paresis/ 
6.  (hemipleg$ or hemipar$ or paresis or paretic).tw. 
7.  1 or 2 or 3 or 4 or 5 or 6 
8.  *cerebrovascular disorders/rh or exp *basal ganglia cerebrovascular 
disease/rh or exp *brain ischemia/rh or exp *carotid artery diseases/rh 
or *cerebrovascular accident/rh or exp *brain infarction/rh or exp 
*cerebrovascular trauma/rh or exp *hypoxia-ischemia, brain/rh or exp 
*intracranial arterial diseases/rh or *intracranial arteriovenous 
malformations/rh or exp *"Intracranial Embolism and Thrombosis"/rh 
or exp *intracranial hemorrhages/rh or *vasospasm, intracranial/rh or 
*vertebral artery dissection/rh 
9.  *hemiplegia/rh or exp *paresis/rh 
10.  8 or 9 
11.  exp Upper Extremity/ 
12.  (upper adj3 (limb$ or extremity)).tw. 
13.  (arm or shoulder or elbow or forearm or hand or wrist or finger or 
fingers).tw. 
14.  11 or 12 or 13 
15.  rehabilitation/ or "recovery of function"/ 
16.  physical therapy modalities/ or "Physical Therapy (Specialty)"/ 
17.  exercise movement techniques/ or exercise/ or exercise therapy/ 
18.  range of motion, articular/ or movement/ or motor activity/ or 
kinesiology, applied/ 
19.  "task performance and analysis"/ 
20.  occupational therapy/ or activities of daily living/ 
21.  "Physical Education and Training"/ or motor skills/ 
22.  (rehabilitation or recovery of function or physiotherap$ or physical 
therap$ or exercise$ or movement$ or motor activit$ or occupational 
therap$ or activities of daily living or adl).tw. 
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23.  ((bilateral or bimanual) adj5 (train$ or retrain$ or facilitat$ or function$ 
or activit$)).tw. 
24.  ((mirror$ or coupled) adj5 movement$).tw 
25.  or/15-24 
26.  10 and 14 
27.  7 and 14 and 25 
28.  26 or 27 
29.  limit 28 to humans 
This search strategy was adapted for other databases.   
In an effort to identify further published, unpublished and ongoing trials the 
following were also searched: 
• Reference lists of all included studies and review papers 
• ClinicalTrials.gov (http://www.clinicaltrials.gov/) and the National 
Research Register Archive 
(http://portal.niht.ac.uk/Pages/NNRArchive.aspx) (last searched 
February 2009) 
• Science Citation Index Reference Search to track relevant papers 
(last searched February 2009) 
• ProQuest Dissertations and Theses (PQDT) dissertation abstracts (lat 
searched February 2009)  
• Index to Theses – dissertation abstracts (last searched September 
2009) 
4.3.3 Identification of relevant trials 
Initially I read all identified titles and excluded any obviously irrelevant 
studies.  The abstracts for the remaining studies were then obtained and, 
based on the inclusion criteria, two reviewers independently ranked these as 
'possibly relevant' or 'definitely irrelevant'.  If both reviewers identified a trial 
as 'definitely irrelevant’ the study was excluded but all other trials were 
included at this stage.  Consensus discussions were then held, with 
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assistance of additional reviewers, where appropriate and further studies 
were excluded.  The full text of the remaining trials were then retrieved and 
reviewed by two independent reviewers. Where disagreement occurred 
between review authors, or a decision could not be reached, consensus was 
reached through discussion and/or the opinion of a third reviewer was 
sought. 
4.3.4 Data extraction 
Two reviewers independently performed data extraction.  Where the 
information was provided the following information was extracted: 
1. Trial setting 
2. Participant details (age, gender, type of stroke, time since stroke) 
3. Inclusion and exclusion criteria 
4. Duration or intensity of the intervention 
5. Description of the bilateral training intervention (including movement 
activities completed, number of repetitions, feedback provided, goals), 
as reported;  
6. Comparison intervention 
7. Outcomes 
4.3.5 Documentation of methodological quality 
Two reviewers independently assessed the methodological quality of the 
trials.  Assessment of the quality of studies focused on potential areas of bias 
within the studies, as this has been shown to affect the estimation of 
effectiveness of interventions164.  The following areas were considered and 
documented, where the information was available:   
1. Methods, including method of randomisation 
2. Allocation concealment 
3. Blinding of outcome assessor 
4. Intention-to-treat 
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5. Baseline similarity 
6. Number of patients lost to follow-up 
7. Other possible sources of bias 
Consideration of blinding of participants and therapists led to the conclusion 
that blinding would not be possible in these types of trials; consequently this 
information was not documented. 
Any disagreements between reviewers were resolved through discussion, 
involving a third reviewer, if necessary. 
4.3.6 Data analysis 
For each comparison the study results for performance in activities of daily 
living (ADL), measures of functional movement, measures of motor 
impairment, and adverse effects were used, if documented.  The Cochrane 
Collaboration's Review Manager software, RevMan 5, was used for all 
analyses165. 
All outcome measures were analysed as continuous data.  The standardised 
mean differences (SMD) and 95% confidence intervals were calculated. 
Heterogeneity was determined using the I-squared (I2) statistic (I2 > 50% 
considered substantial heterogeneity)307.  If I2 ≦50% a fixed-effect meta-
analysis approach was used325.  If I2 >50% individual trial characteristics 
were explored to identify potential sources of heterogeneity.  Meta-analysis 
was then performed using both fixed-effect and random-effects326 modelling 
to assess sensitivity to the choice of modelling approach. 
Subgroup analyses, following Deeks method327(a simple approach for a 
significance test to investigate differences between two or more subgroups 
and is the standard method in Revman), on differences between acute (time 
at entry to trials less than three months post-stroke) and chronic (time at 
entry to trials equal to or more than three months) patients, duration 
(intervention for less than four weeks and intervention equal to or more than 
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five days per week) and number of repetitions of the programme were 
planned. These subgroup analyses were to be undertaken where data 
permitted (sufficient data considered to be more than five trials reporting the 
information) and undertaken on the primary outcome only.  A sensitivity 
analysis based on methodological quality of studies was also planned, where 
data allowed. 
4.4 Results  
4.4.1 Results of the search  
A flow diagram of study selection is presented (Figure 4-1).  Searching 
identified 6809 titles.  After elimination of duplicates and obviously irrelevant 
studies 296 possibly relevant abstracts were identified.  These 296 abstracts 
were independently assessed for inclusion by two reviewers.  Eighty two 
abstracts were assessed as ‘include’ and the full papers of these studies 
were obtained.  Of these 82 full papers, 61 were excluded; there was 
insufficient information to determine inclusion eligibility for five papers 
(referring to four studies); leaving 16 studies for inclusion.  In addition, four 
ongoing trials were identified from searching additional databases.  Contact 
with the principal investigator led to the identification of a relevant publication 
from one of these trials183.  Published data relating to a further ongoing 
study179 was identified from a journal online (ahead of print).  These trials 
were assessed as relevant for inclusion.  Thus, a total of 18 trials were 
included.   
Contact with authors identified that two of the included trials178;179 are still 
recruiting patients.  However, as published data was available for both of 
these ongoing trials it was decided that it was appropriate to include these 
preliminary data within this review. 
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Figure 4-1 – Study selection flow diagram 
 
Titles reviewed 
n=6809 
Excluded 
n=6513 
Abstracts reviewed 
n=296 
Excluded 
n=214 
Full paper reviewed 
n=82 
Studies excluded  n=61 
 
Not simultaneous bilateral training: n=25 
 
Not RCT: n=17 
 
Bilateral training completed with               
assistive technology: n=7                                        
 
Bilateral training received by  
both groups: n=6 
 
Review papers: n=3 
 
Not stroke population: n=2                                                                             
 
No relevant outcomes: n=1 
 
 
Insufficient information to determine inclusion 
eligibility n= 5 (relating to 4 studies) 
Additional searching 
n=4 
Included trials 
n=18 
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4.4.2 Included studies  
Eighteen trials (549 randomised stroke participants, of which 528 were 
relevant to this review (21 participants were randomised to additional groups 
not relevant to this review)) met the inclusion criteria for this review175-184;289-
296
.  One study291 reported data divided into two groups - acute and chronic. 
A brief description of the studies is presented below.  Descriptions of the 
included studies can be found in Table 4-1 which provides a brief overview of 
characteristics of included studies and Appendix D which gives a full 
description of the studies.   
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Table 4-1 - Characteristics of included studies (abbreviated) 
Study Methods Participants Interventions  Relevant Outcomes  
Cauraugh 
2002175 
RCT N=25 (20 
relevant to 
this review)  
 
Group 1 (n=10) – unilateral training + EMG 
triggered stimulation  
Group 2 (n=10) - bilateral training + EMG 
triggered stimulation  
BBT 
Premotor reaction time  
Muscle activity (EMG activity of wrist/fingers 
extensor muscles) 
Cauraugh 
2003a289 
RCT N=20 
 
Group 1(n=10) - unilateral training + EMG 
triggered stimulation 
Group 2 (n=10) – bilateral training + EMG 
triggered stimulation 
EMG activity level (wrist and finger extensor 
muscles) 
Cauraugh 
2005290 
RCT N=21 
 
Group 1 (n=10) – unilateral training + EMG 
triggered stimulation  
Group 2 (n=11) - bilateral training + EMG 
triggered stimulation  
Movement time for single aiming test recorded by 
EMG 
Cauraugh 
2008176 
Randomly 
assigned to 
one of two 
treatment 
orders 
N=16 
 
Group 1(n=8) – unilateral training + EMG 
triggered neuromuscular stimulation 
Group 2(n=8) - bilateral training + EMG triggered 
neuromuscular stimulation 
BBT 
Motor reaction time 
Maximal isometric contraction of wrist/finger 
extensors 
Chang 
2006293 
Randomised 
cross-over 
design 
N=20 
 
Three movement tasks (i) reaching forward with 
affected limb (unilateral) (ii) reaching forward with 
both limbs simultaneously (bilateral) (iii) reaching 
forward with both limbs simultaneously + load 
applied to non -affected upper limb (bilateral + 
load).  
Movement time of elbow flexion 
Elbow flexion-extension range 
 
Desrosiers 
2005177 
RCT N=41 
 
Group 1 (n= 21) - usual care  
Group 2 (n= 20) – bilateral training  
 
Measure de l'independence fonctionelle (FIM) 
BBT 
Purdue Pegboard Test 
F-M (upper limb section) 
Finger to nose (Number of movements) 
Grip strength 
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Dickstein 
1993294 
Randomised 
cross-over 
design 
N=25 
 
One familiarisation set of unilateral movements 
with unaffected arm, then 3 sets of movements 
presented in a random order (unilateral 
(unaffected), unilateral (affected) or bilateral) + 
auditory signal 
Movement time of elbow flexion 
Harris-Love 
2005295 
Randomised 
cross-over 
design 
N=32 
  
Four trials each of unilateral paretic, unilateral 
nonparetic and bilateral reaching, then 4 trials of 6 
reaching tasks (unilateral paretic, unilateral 
nonparetic, bilateral reaching and 3 bilateral 
reaching tasks involving different loads added to 
the nonparetic hand) 
Movement time of reaching task 
Kilbreath 
2006296 
Randomised 
cross-over 
design 
N=13 
 
Two bimanual and one unimanual task  Movement time for specified reaching task 
 
Lin 2009a178 RCT using 
stratified block 
allocation 
scheme 
N=60 
 
Group 1 (n= 20) - usual care.  
Group 2 (n= 20) – other upper limb intervention; 
Constraint–induced therapy (CIT) 
Group 3 (n=20) bilateral training  
FIM 
MAL (amount of use) 
Stroke Impact Scale – hand function section 
Stroke Impact Scale (ADL/IADL section) 
F-M Meyer Scale (UL section) 
Lin 2009b179 RCT N=33 
 
Group 1 (n= 17) - usual care.   
Group 2 (n= 16) – bilateral training 
FIM 
MAL (amount of use) 
F-M Scale (UL section) 
Movement time for unilateral task 
Normalised total distance 
Luft 2004180 RCT N=21 
 
Group 1 (n=12) - usual care 
Group 2 (n=9) - bilateral training with auditory 
cueing (BATRAC) 
Wolf Motor Arm Test 
F-M (UL section) 
Wolf Motor Arm Test (strength) 
Lum 2006181 Restricted 
RCT 
N=30 (14 
relevant to 
this review) 
 
Group 1 (n=9) - robot-unilateral group 
Group 2 (n=5) - robot-bilateral group 
 
FIM 
F-M (proximal UL section) 
Motor power examination  
Morris 
2008182 
RCT N=106  
 
Group 1 (n=50) – unilateral training 
Group 2 (n=56) – bilateral training  
BI  
ARAT 
NHPT  
Rivermead Motor Assessment (UL section)  
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Mudie 
2001291 
(acute and 
chronic) 
RCT with 
blocked 
randomisation 
according to 
side of stroke 
N=36 
 
Group 1 (n=18) – unilateral isometric contractions 
Group 2 (n=18) – bilateral isometric contractions 
 
Muscle activity (EMG) for wrist extension 
Platz 
2001292 
RCT N=14 
 
Group 1 (n=18) - unilateral training 
Group 2 (n=18) - bilateral training 
Total movement time (ms) 
Spatial error (mm) 
Stoykov 
2009183 
RCT stratified 
into 2 
impairment 
levels 
N=24 
 
Group 1 (n=12):  unilateral training 
Group 2 (n=12) – bilateral training 
MAS (Upper arm scores) 
MAS (Hand movements) 
Motor Status Score (Total scale) 
Arm strength outcome 
Summers 
2007184 
RCT N=12 
   
Group 1 (n=6) – unilateral training 
Group 2 (n=6) – bilateral training 
 
Modified MAS (upper arm function)  
Modified MAS (hand movement scores)  
Movement time of dowel placement 
Elbow angle 
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Study Design 
Fourteen175;176;178-184;289-292;311 of the 18 included studies were randomised 
controlled trials.  Four studies293-296 were randomised cross-over design 
studies with random allocation to the order of treatment sequence. These 
studies are not traditional RCTs in the sense that participants are randomly 
allocated to one (or more) groups.  Within these studies the participants were 
randomised to different treatment orders.  No data were available for the first 
phases only, within the published studies; therefore these four studies are 
not incorporated in any of the analyses.  Despite not being appropriate for 
incorporation in the data analysis these studies met the inclusion criteria for 
this review.  Details of these four crossover studies are included within the 
characteristics of included studies tables, and Table 4-2 (Methodological 
quality summary).  However, in order to avoid any confusion, these four 
cross-over studies are not discussed within the following text.  All following 
text descriptions therefore only apply to the 14 included RCTs for which data 
was extracted and analysed.   
Setting  
Of the 14 included studies, seven175;176;180;181;183;289;290 were carried out in the 
USA, three were carried out in Australia177;184;291, two in Taiwan178;179 and 
one in  Germany292 and the UK182 respectively.   
Sample sizes 
On average, included studies randomised 30 stroke patients into their trial 
prior to attrition. This ranged from just 12 participants184 to 106182.  All except 
two studies178;182 included less than 50 participants. 
Participants 
The 14 included trials randomised a total of 459 stroke participants; of which 
438 were relevant to this review.  Full demographic details of included 
participants are provided in Appendix D.  Of the included participants 39% 
were female.  Age ranged from 52.14 years178 to 74.9 years291.  Across the 
studies time since stroke varied from a mean of 22.9 days182 to a mean of 
9.85 years183. One study did not report time since stroke292.  Seven of the 
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included studies did not provide any information on type of stroke.  Side of 
stroke was reported in all studies except one 183; 257 participants had a left 
hemisphere stroke and 267 participants had a right hemisphere stroke.  
Information relating to initial upper limb impairment could not be extracted 
due to the limited information provided by some of the studies.   
Interventions 
The interventions investigated in the included studies varied in terms of types 
of bilateral tasks completed, duration of interventions and use of 
combinations of interventions.  Full details of the interventions, including 
types of tasks and durations are provided in the Characteristics of included 
studies table (Appendix D).  Some of the key differences are summarised 
below.   
The interventions of eight175;176;180;181;184;289-291 of the 14 included studies 
each concentrated on one specific upper limb movement or task.  In four 
studies175;176;289;290 bilateral interventions were aimed at wrist/finger 
extension.  In the other studies the intervention involved; isometric 
contractions of wrist extension291, bilateral reaching181, bilateral pushing and 
pulling180 and a bilateral dowel placement task184.   
The interventions of six177-179;182;183;292 of the 14 included studies involved 
more than one upper limb movement or task.  Three studies182;183;292 
completed four, three and six separate bilateral tasks respectively, and one 
study177 assessed a package of interventions, which included bilateral tasks 
in addition to unilateral and bimanually different tasks.  The other two 
studies178;179 investigated simultaneous movements during a number of 
functional tasks in symmetric or alternating patterns and simultaneous 
bilateral completion of functional tasks with symmetric patterns. 
Thirteen175-184;289;290;292 of the 14 included studies investigated the effect of 
training over a training period (rather than single training and evaluation 
sessions); the training period varied from four days176 to eight weeks183.  The 
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remaining RCT291 did not have a training period, rather a single training and 
evaluation session was completed. 
Five175;176;181;289;290  of the 14 studies provided another intervention as an 
adjunct to treatment in both the bilateral training and control groups.  Four 
studies175;176;289;290 included EMG-triggered neuromuscular stimulation, 
delivered to both the bilateral training and control group.  One study181 used 
a robot to assist movement of the affected limb in both the bilateral training 
and control (unilateral) groups.   
One study180 evaluated bilateral training in conjunction with auditory cueing; 
auditory cueing was not provided to the control group.  This study was 
included as auditory cueing was not assessed by the reviewers to be an 
'assistive technology', but to be a mode of delivery of the bilateral training 
intervention. 
Outcome measures  
As anticipated, a variety of outcome measures were used by the included 
studies.  All of the studies included a measure of motor impairment.  Due to 
differences in the measures, it was considered inappropriate to combine 
some of the outcomes together within analyses.  Therefore, following data 
extraction functional movement of the upper limb was further categorised 
into: (a) arm functional movement and (b) hand functional movement and 
motor impairment of the upper limb was categorised into the following 
subgroups: (a) motor impairment scales (b) temporal outcomes (c) spatial 
outcomes (d) strength outcomes.  The outcomes selected from each 
individual study are listed in both characteristic of included studies tables 
(Table 4-1 and Appendix D). 
4.4.3 Excluded studies  
A total of 61 studies were excluded following consideration of full papers.  
Reasons for exclusion were: not a simultaneous bilateral training intervention 
(n=25), not stroke population (n=2), review papers (n=3), bilateral training 
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intervention but not a randomised controlled trial (n=17), bilateral training 
intervention completed with assistive technology (n=7), no relevant outcomes 
(n=1) and bilateral training intervention received by both groups (n=6).  
4.4.4 Risk of bias in included studies  
For full details of methodology see Table 4-2 and Appendix D.  Generally, 
the included studied were judged to be of poor or uncertain methodological 
quality and therefore at high risk of bias.  Assessment of risk of bias was 
difficult due to lack of adequate reporting of methods: for 11 of the 14 
included studies at least one of the assessed components was judged to be 
unclear (or was not stated).  Only three trials177;178;182 reported adequate 
allocation concealment.  Eight studies177-184 reported blinding of outcome 
assessors.  No trials reported use of an intention-to-treat analysis. 
Table 4-2 - Risk of bias summary 
+ Adequate 
- Not adequate 
? Not clear 
Allocation 
concealment? 
Binding of 
outcome 
assessor? 
Intention-to-
treat 
analysis? 
Baseline 
similarity 
Cauraugh 2002 ? ? ? ? 
Cauraugh 2005 ? ? ? + 
Cauraugh 2008 ? ? ? - 
Cauraugh and Kim 2003 ? ? ? ? 
Chang 2006 ? ? ? ? 
Desrosiers 2005 + + - + 
Dickstein 1993 ? ? ? ? 
Harris-Love 2005 ? ? ? ? 
Kilbreath 2006 ? ? ? ? 
Lin 2009 + + ? + 
Lin 2009b ? + ? + 
Luft 2004 - + - - 
Lum 2006 - + ? + 
Morris 2008 + + - + 
Mudie 2001 ? ? ? + 
Platz 2001 ? ? ? + 
Stoykov 2009 - + ? + 
Summers 2007 ? + ? - 
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4.4.5 Effects of interventions  
Comparison interventions 
Fourteen RCTs175-184;289-292 were included in the meta-analyses.  One RCT178 
is included in two of the comparisons and another study291 had two 
subgroups (acute and chronic).  Within these 14 trials 459 stroke participants 
were randomised and 421 participants' data was available for analysis.  The 
missing data (n=38) relates to four studies175;177;181;182;  one study175 
randomised participants to a control group (5 participants) which were not 
included in the analyses and another study181 randomised participants to two 
other groups (n=16) which were not relevant to this review.  Two 
studies177;182 had eight and nine dropouts respectively.   
Numbers of participants given below relate to the number of participants 
whose data were available for inclusion in each of the analyses and not the 
number of randomised participants.   
Simultaneous bilateral training versus placebo or no intervention. 
No RCTs compared simultaneous bilateral training with placebo or no 
intervention. 
Simultaneous bilateral training versus usual care. 
Four RCTs177-180 (n=127) compared the effects of a bilateral training with 
usual care.    
Performance in ADL:  Three RCTs177-179 (n=106) reported performance of 
ADL (Functional Independence Measure); SMD 0.25 (95% CI -0.14 to 0.63) 
(Figure 4-2). 
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Figure 4-2- Comparison:  Bilateral training versus usual care.  Outcome:  Performance 
in ADL 
 
Functional movement of the upper limb:  All four RCTs177-180 (n=127) 
reported outcomes relevant to functional movement of the upper limb. 
All four RCTs reported arm functional movement outcomes; Box and Block 
Test177, Motor Activity Log (amount of use scale)178;179 and Wolf Motor 
Function Test (time to complete)180.   The pooled result was SMD -0.07 (95% 
CI -0.42 to 0.28) (Figure 4-3). 
Two RCTs177;178 (n=73) reported a hand functional movement outcome; 
Purdue Pegboard Test and Stroke Impact Scale (hand function subscale) 
respectively; SMD -0.04 (95% CI -0.50 to 0.42) (Figure 4-3). 
Figure 4-3 - Comparison:  Bilateral training versus usual care.  Outcome:  Functional 
movement of the upper limb 
 
Performance in extended ADL:  One RCT178 (n=40) reported the effects of 
bilateral training on performance of extended ADL (Stroke Impact Scale; 
ADL/IADL section); SMD 0.15 (95% CI -0.47 to 0.77) (Figure 4-4). 
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Figure 4-4 - Comparison:  Bilateral training versus usual care.  Outcome:  
Performance in extended ADL 
 
Motor impairment of the upper limb:  Four RCTs177-180 reported outcomes 
of motor impairment. 
All four RCTs reported motor impairment scale outcome; Fugl-Meyer (upper 
limb section).  The pooled result was SMD 0.67 (95% CI -0.43 to 1.77). A 
random-effects model was utilised due to I2 = 88% (Figure 4-5) (Fixed effect 
result: SMD 0.43 (0.06 to 0.81) (Figure 4-6). 
Two RCTs177;179 (n=66) reported a temporal outcome; finger to nose 
coordination (number of movements completed) and movement time for 
unilateral reaching task respectively.  The pooled result was SMD 0.04 (95% 
CI -0.45 to 0.52) (Figure 4-6). 
One RCT179 (n=33) reported a spatial outcome; normalised total distance for 
a unilateral reaching task; SMD 0.25 (95%CI -0.43 to 0.94) (Figure 4-6). 
Two RCTs 177;180 (n=54) reported strength outcomes; grip strength and Wolf 
Motor Function Test (strength of hemiparetic limb) respectively.   Pooled 
result was SMD -0.18 (95% CI -0.72 to 0.36) (Figure 4-6). 
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Figure 4-5 - Comparison:  Bilateral training versus usual care.  Outcome:  Motor 
impairment of the upper limb (Motor impairment scales random effects model 
analysis) 
 
Figure 4-6 - Comparison:  Bilateral training versus usual care.  Outcome:  Motor 
impairment of the upper limb 
 
 
Simultaneous bilateral training versus other specific upper limb interventions 
or programmes. 
Eleven RCTs 175;176;178;181-184;289-292 (n=314) compared the effects of a 
bilateral intervention with an unilateral intervention. 
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Performance in ADL:  Three RCTs178;181;182 (n=151) reported performance 
of ADL; Functional Independence Measure178;181 and Barthel Index182;  SMD 
-0.25 (95% CI -0.57 to 0.08) (Figure 4-7).  
Figure 4-7 - Comparison:  Bilateral training versus other specific upper limb 
intervention or programme.  Outcome:  Performance in ADL 
 
Functional movement of the upper limb:  Six RCTs175;176;178;182-184 (n=145) 
reported functional movement of the upper limb outcomes. 
All six RCTs reported arm functional movement outcomes; Box and Block 
Test175;176, Motor Activity Log (amount of use scale)178, Action Research Arm 
Test182, Motor Assessment Scale (upper arm section)183 and Modified Motor 
Assessment Scale (upper arm section)184.  Published data from one of the 
trials175 (n=20) were unsuitable for pooling; a graphical display was 
presented of means with no standard deviations (results: bilateral training 27 
blocks moved at post-test, unilateral training 22 blocks, as estimated from 
graph).  The pooled result for the remaining five RCTs (n=189) was SMD -
0.20 (95% CI -0.49 to 0.09) (Figure 4.8). 
Four RCTs178;182-184 (n=173) reported hand functional movement outcomes.  
The pooled result was SMD -0.21 (95% CI -0.51 to 0.09) (Figure 4-8). 
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Figure 4-8 - Comparison:  Bilateral training versus other specific upper limb 
intervention or programme.  Outcome:  Functional movement of the upper limb 
 
Performance in extended ADL:  One RCT178 (n=40) reported the effects of 
bilateral training on performance in extended ADL (Stroke Impact Scale 
ADL/IADL section); SMD -0.65 (95 % CI -1.29 to -0.01) (Figure 4-9). 
Figure 4-9 - Comparison:  Bilateral training versus other specific upper limb 
intervention or programme.  Outcome:  Performance in extended ADL 
 
Motor impairment of the upper limb:  Eleven RCTs175;176;178;181-184;289-292 
(n=310) reported motor impairment outcomes. 
Four RCTs178;181-183 (n=175) reported an upper limb motor impairment scale 
(Fugl-Meyer, Rivermead Motor Assessment and Motor Status Score); SMD -
0.25 (95% CI -0.55 to 0.05) (Figure 4-10). 
Five RCTs175;176;184;290;292 (n=79) reported temporal outcomes.  Data from 
one RCT184 (n=10) were unsuitable for pooling: median movement time 
  155 
values were reported without any standard deviations (bilateral training 
1.89sec at post-test, unilateral training 2.74sec).  The pooled result for the 
remaining four RCTs (n=69) was SMD 0.46 (95% CI -0.03 to 0.95) (Figure 
4-10). 
Two RCTs184;292 (n= 24) reported spatial outcomes. Data from one RCT184 
(n=10) were unsuitable for pooling.  This RCT reported an increase in mean 
elbow angle for both groups; however no standard deviations were reported.   
The result for the remaining RCT (n=14) SMD 0.00 (95 % CI -1.05 to 1.05) 
(Figure 4-10). 
Six RCTs175;176;181;183;289;291 (n=130) reported strength-related outcomes.  
Data from one RCT175 (n=20) was unsuitable for pooling; data for sustained 
muscle contraction and force modulation were presented in a bar graph of 
median root mean square error with no standard deviations (bilateral training 
median root mean square error 0.42 at post-test, unilateral training 0.42; 
estimated from graph).  Data from another RCT176 (n=16) was also 
unsuitable for pooling; no means or standard deviations were presented (the 
authors of this study stated that analysis did not reveal any significant 
effects).  Another RCT183 (n=24) did not present means and standard 
deviations for the two groups and therefore data from this study could not be 
included in the data analysis either.  The pooled result of the remaining three 
RCTs (n=70) was SMD 0.04 (-1.34 to 1.43).  A random effect model was 
utilised due to I2=85% (Figure 4-11) (Fixed effect result: SMD -0.07 (95% CI -
0.59 to 0.46) (Figure 4-10). 
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Figure 4-10 - Comparison:  Bilateral training versus other specific upper limb 
intervention or programme.  Outcome:  Motor impairment of the upper limb 
 
Figure 4-11- Comparison:  Bilateral training versus other specific upper limb 
intervention or programme.  Outcome:  Motor impairment of the upper limb (Strength 
outcomes random effects model analysis) 
 
Other outcomes:  No studies reported adverse events. 
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4.4.6 Sensitivity and subgroup analyses 
Sensitivity analyses that were carried out are discussed below. 
A sensitivity analysis was completed to investigate the effect of trials that had 
a single treatment and evaluation session.  One RCT291 (with 2 subgroups) 
was removed, the result following removal for motor impairment; strength 
outcomes was SMD 0.64 (95% CI -2.72 to 4.00).  A random effects model 
was used as I2 = 94% (fixed effect: SMD 0.63 (95% CI -0.21 to 1.48)). 
A further sensitivity analysis was undertaken, with regard to the effect of 
including trials that investigated the effect of an adjunct therapy / assistive 
technology in addition to the bilateral training and control interventions.  Six 
RCTs were removed from analyses175;176;180;181;289;290.  In the comparison 
bilateral training versus usual care, removing one RCT180 did not affect the 
significance of the results (arm functional outcomes: SMD -0.03 (95% CI -
0.42 to 0.35); motor impairment scales: SMD 0.73 (95% CI -0.76 to 2.23); 
motor impairment, strength outcomes: SMD -0.17 (95% CI -0.85 to 0.51)). 
For the comparison bilateral training versus other upper limb intervention, six 
RCTs were removed175;176;181;183;289;290 from the analysis.  With these studies 
removed the results were: performance in activities of daily living SMD -0.18 
(95% CI -0.52 to 0.16); arm functional outcomes SMD -0.30 (95% CI -0.62 to 
0.03 motor impairment scales SMD -0.31 (95% CI -0.65 to -0.03); motor 
impairment, temporal outcomes SMD -0.11 (-1.16 to 0.93) and motor 
impairment, strength outcomes SMD -0.51 (95% CI -1.18 to 0.16).  Following 
sensitivity analysis a change of significance for motor impairment scales for 
the comparison bilateral training versus other upper limb intervention was 
found, however, this significant result in favour of other upper limb 
intervention was based on only two RCTs.   
The lack of information provided by the majority of trials relating to 
methodological quality meant that sensitivity analyses to investigate the 
effect of including trials with low methodological quality could not be 
completed.   
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There was insufficient data to carry out planned subgroup analysis on 
differences between acute and chronic patients and duration of intervention 
programme. 
4.5 Discussion  
4.5.1 Summary of findings 
This systematic review found no RCTs that compared simultaneous bilateral 
training with placebo or no intervention. 
Four of 14 included RCTs compared simultaneous bilateral training with 
usual care and found no statistically significant effect of bilateral training on 
any analysed outcomes (performance activities of daily living (ADL), arm and 
hand functional movement, performance in extended ADL or motor 
impairment measures (motor impairment scales, temporal, spatial and 
strength outcomes)).  As stated in the methods section a random-effects 
model was used where heterogeneity was greater than 50%, therefore these 
conclusions are based on random-effects analyses where appropriate.  For 
motor impairment scales a significant result was found for the fixed effect 
analysis; however due to the heterogeneity (I2=88%) a random-effects model 
was more appropriate and this result was non-significant.   
Eleven of the 14 included RCTs compared the effects of a bilateral 
intervention with a unilateral intervention.  No statistically significant effects 
were found in favour of bilateral training for any of the specified outcomes. 
Data from one trial found a statistically significant result in favour of another 
upper limb intervention (constraint-induced movement therapy) for a 
measure of performance in extended ADL.  This result cannot be generalised 
to other outcomes and further research would be required to confirm this 
finding.   
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It must be noted that only six of the fourteen RCTs included in the analysis 
used a single bilateral training protocol.  The other eight RCTs included other 
intervention protocols in combination with bilateral training. 
In addition to the 14 RCTs included in the analyses, four relevant cross-over 
studies were indentified.  These studies were not included in any of the 
analyses. 
The evidence is currently insufficient to answer the review questions; the 
effects of bilateral training compared to placebo, usual care or other upper 
limb intervention in terms of performance in ADL, functional movement of the 
upper limb, performance in extended ADL, motor impairment of the upper 
limb and adverse events.  The included studies, with the exception of one, 
had small numbers of participants and reported a diverse range of outcome 
measures, of which many were unique to single studies and/or specific to 
certain impairments.  Both these factors limit the completeness of the 
evidence relevant to this review. 
Due to limited data, subgroup analysis for different participant subgroups or 
duration of training was unable to be completed.  The characteristics of the 
included studies indicate that participants varied in terms of time post stroke. 
Additionally the type, duration and intensity of training varied between the 
studies. 
All of the included studies had inclusion criteria specifying either minimum or 
maximum levels of upper limb ability, and preservation of at least some 
cognitive abilities (including ability to comprehend simple instructions).  
Therefore the results of this review may not be generalisable to the wider 
population of stroke patients. 
The lack of sufficient high quality evidence makes it inappropriate to draw 
conclusions from the results regarding the applicability of bilateral training 
within the context of current practice.   
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The quality of most of the evidence was poor, with incomplete reporting of 
methodological details.  The number of participants within the included 
studies was generally small, only two studies had more than 50 participants 
and seven of the studies had 20 or fewer participants.  Additionally few trials 
reported adequate allocation concealment and no studies reported using an 
intention-to-treat analysis.  The overall quality of the trials limits confidence in 
the results. 
The results of this review vary from the results presented in a previous 
review305, which reported a significant overall effect in favour of bilateral 
movement training alone or in combination with auxiliary sensory feedback 
for improving motor recovery post-stroke (Fugl-Meyer, Box and Block or 
kinematic variables).  While systematic methods were reported, this review305  
had a more limited search strategy and included trials that were not 
randomised controlled trials.  The reviewers did assess trials for 
randomisation, which was defined as either randomly placed in a treatment 
or control group or if the treatment was randomly assigned to the 
participants.  Eleven studies were included in this previous meta-analysis, 
seven of which were not included in this current review215;300;328-332.  Five of 
these studies215;300;328;330;331 did not meet the criteria for randomisation for 
this review.  Many of these studies were considered not to have an 
appropriate control group, and these types of studies will give an inflated 
effect of the intervention.  Two studies291;294 were included in this current 
review which were identified by the previously highlighted review but not 
included in the meta-analysis.  These studies were not included in the 
previous meta-analysis due to not having a functional outcome measure294 
and not involving bilateral movements as a treatment291.  In contrast, these 
studies were included in this current review as other outcomes relevant to 
this review criterion were included294 and for the other study it was assessed, 
for this review, to involve some element of bilateral intervention291.  Ten 
studies included in this current review were published after the searching for 
the previous review was completed.  Therefore, this review presents more 
up-to-date data.  Additionally, a further two studies289;292 were included in this 
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current review which were not acknowledged by the previous review, which 
may suggest a more comprehensive search strategy in this current review.   
A narrative review304 reported the findings from a number of studies, 
including non-randomised studies and concluded that favourable effects of 
bilateral training protocols have been found.  However this review makes no 
attempt to discuss the quality of the reviewed studies and the potential 
impact this could have on the individual study results.  Furthermore this 
review was not systematic and did not attempt to combine studies. 
4.5.2 Limitations of the review 
Through a thorough searching process it is assumed that all relevant 
published trials were identified, however, it must be acknowledged that there 
is a small possibility that there are additional trials (published and 
unpublished), that were not identified. 
Four RCTs were categorised as comparing bilateral training with usual care.  
It should be noted that the intervention (categorised as usual care) in these 
studies was dose matched with the bilateral intervention.  Therefore it is 
likely that these interventions were more intensive than the typical duration of 
usual care.  Furthermore, the interventions which were classified as usual 
care differ between the four studies.  However, it was felt that it was more 
appropriate to categorise these interventions within the usual care 
comparison than the other upper limb intervention comparison, as the 
interventions completed in these four studies were not specific other upper 
limb interventions or programmes.  Within the other upper limb interventions 
comparison, all except one study investigated bilateral training compared to 
unilateral training (i.e. completing the same activities or activity with both 
arms compared to completing with affected arm only).  One RCT compared 
the effects of bilateral training with constraint-induced movement therapy 
which, in addition to undertaking of functional tasks with the affected upper 
limb (which was dose matched to the bilateral training), involved restraint of 
the unaffected limb for six hours per day.  Combining these studies within 
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these stated comparison groups further increases the heterogeneity between 
the included studies, limiting the conclusions that can be drawn.   
The diversity of the bilateral training paradigms and the variations in 
reporting between trials led to some subjective decisions being made by the 
review team, and this may have introduced bias.  The studies within this area 
are heterogeneous in terms of what is defined as bilateral training and there 
were a number of complex strands which required discussions among the 
reviewers and consensus decisions being made.  This could be perceived as 
a limitation of this review. 
Hierarchical lists were used to select which outcome measure should be 
included if a study reported a number of different relevant outcome 
measures.  There could potentially be biases in the hierarchical order 
developed for each outcome. However, the order of the hierarchy was 
carefully considered and debated, and consensus reached.  Despite the 
potential limitations and biases of this approach the pre-stating of a 
hierarchical list provides substantial advantages in comparison to the 
alternative option of having to make subjective decisions about the selection 
of outcome measures after data collection has been completed. 
The included trials used a wide range of outcome measures, methodologies 
and time intervals for follow up making statistical pooling difficult.  To 
overcome the variations in outcome measures and to maximise statistical 
pooling the outcomes of functional movement and motor impairment of the 
upper limb were categorised into subgroups.  For four trials, mean values 
were not available (for at least some of the outcomes) and therefore median 
values (where these were provided instead of mean values) were imputed as 
mean values and standard deviations were calculated from reported 
standard error (SD= SE √n). Where data was presented in graphical form 
two reviewers independently estimated values from the graphs.  This may 
have introduced some bias.  However, it was felt that including imputed and 
estimated data from these studies was preferable to the exclusion of the 
data. 
  163 
4.5.3 Strengths of the review 
The main strengths of this review, relate to the following of rigorous 
Cochrane systematic review methodology to plan, undertake and write this 
review.  This involved a comprehensive peer-review process to ensure 
quality and accuracy.   
Thorough searching was undertaken to attempt to identify all appropriate 
trials relating to bilateral training and therefore this review is considered to be 
a comprehensive assessment of the effects of this intervention.   
Only randomised controlled trials were included in this review, increasing 
confidence in the results.   
4.5.4 Implications for practice   
This review identified that there is currently insufficient evidence to make any 
recommendations about the relative effect of bilateral training compared to 
placebo, no intervention or usual care. 
This review also identified evidence from trials of varied methodological 
quality, which suggests that bilateral training may be no more (or less) 
effective than unilateral training for performance in ADL, functional 
movement of the upper limb, performance in extended ADL or motor 
impairment outcomes. 
4.5.5 Implications for research   
Specific implications for research, based on the findings of this review, are 
outlined below. 
Randomised controlled trials are required to determine the effect of 
simultaneous bilateral training compared to no treatment, placebo or usual 
care and simultaneous bilateral training compared to unilateral training. 
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Such randomised controlled trials must: have adequate power (i.e. with an 
appropriate power calculation undertaken based on existing trial evidence); 
have adequate allocation concealment, blinding of outcome assessor and 
intention-to-treat analysis; clearly define trial participants (e.g. time since 
stroke, initial upper limb deficits); clearly define types, frequency, durations 
and intensities of bilateral training; include global measures of functioning 
(i.e. performance of ADL measures) and upper limb function (e.g. MAS, 
ARAT) and report clear and usable data. 
It is recommended that future RCTs concentrate on answering the specific 
question relating to the effectiveness of bilateral training and do not confound 
the answer to this question by introducing adjunct interventions such as 
robotics or electrical stimulation.  
Future RCTs should also have a defined training period, and should not have 
a single treatment and intervention session.  Further standard RCT 
methodology should be followed i.e. random allocation of participants to one 
of two (or more) groups and not random allocation to treatment order. 
There is also a need for further research to identify optimal outcome 
measures for use within future RCTs in this area.   
4.6 Conclusions 
This systematic review included 18 trials.  Methodological quality of these 
trials was generally poor, providing insufficient high quality evidence on 
which to reach generalisable conclusions.   
Limited evidence suggests that bilateral training is no more or less effective 
than usual care or unilateral training for functional outcomes.  Very limited 
evidence shows that bilateral training is no more or less effective than 
unilateral training for upper limb motor impairment outcomes.  Therefore 
there is not enough evidence to recommend bilateral training as a clinical 
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intervention.  High quality randomised controlled trials are needed to 
compare bilateral and unilateral training. 
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Chapter 5  Home-based therapy programmes 
for upper limb functional recovery following 
stroke 
Through completion of the review of interventions (Chapter 3 ) it was evident 
that a number of interventions had been investigated using systematic review 
methodology.  However, one intervention which was not identified through 
this process was home-based therapy programmes.  Such interventions are 
important, as increasingly stroke services are being moved into the 
community and form an important part of the patient’s journey.  Therefore I 
felt it was appropriate to complete a systematic review of home-based 
therapy interventions targeted at the upper limb.  For the same reasons 
outlined in the previous chapter this review was undertaken using Cochrane 
review methodology. 
5.1 Introduction 
Increasingly the trend within health service delivery (including stroke care) is 
toward decreasing length of inpatient stay and moving care into the 
community, which has led to the development of home-based stroke 
services333. A Cochrane review of therapy-based rehabilitation services for 
stroke patients at home334 found such services reduce the odds of a poor 
outcome in ability to perform activities of daily living (ADL) and have a 
beneficial effect on a patient's ability to perform personal ADL and extended 
ADL compared to conventional or no care. This review specifically 
investigated therapy service interventions primarily aiming to improve task-
orientated behaviour (not upper limb interventions or outcomes) and was 
based on a review of heterogeneous interventions. In contrast, this review 
will exclusively investigate the effects of home-based therapy programmes 
targeted at upper limb recovery. 
  168 
As highlighted previously within this thesis the effectiveness of specific upper 
limb interventions have been reviewed within other Cochrane systematic 
reviews174;185;208;213;233;241;254;260;280.  This review did not intend to replicate or 
overlap with these other reviews, as the focus was on programmes of 
interventions completed at home rather than on a specific intervention. 
With an increased focus on home-based stroke services and the undertaking 
of programmes of interventions targeted at upper limb recovery within clinical 
practice, a systematic review of home-based therapy programmes for 
individuals with upper limb impairment following stroke was deemed 
appropriate. 
5.2 Objectives   
To determine the effects of home-based therapy programmes for upper limb 
recovery in patients with upper limb impairment following stroke, compared 
with:  
1. Placebo or no intervention  
2. Usual care  
5.3 Methods   
As with the previous chapter Cochrane guidelines for systematic reviews of 
interventions were used to complete and report this review307.  The 
description of the methods for this chapter therefore only highlights the 
difference between this and the previous review, rather than repeating the 
same methods undertaken.   
5.3.1 Eligibility criteria 
Types of studies   
Only randomised controlled trials (RCTs) were included.  One of the 
intervention groups must have included an intervention group of a home-
  169 
based therapy programme and a comparison group of placebo or usual care 
('conventional' or 'traditional').  Studies that included a home-based therapy 
programme in addition to usual care, compared with usual care alone were 
also included. Usual care was determined, as defined by the original trial 
authors when it is considered to be a normal or usual component of stroke 
rehabilitation. Where appropriate, the description of usual care was 
documented. 
Only studies where the therapist had visited the patient in their own home (at 
least once) to prescribe treatment were included. 
Types of participants   
As with the previous chapter, trials of participants with a clinical diagnosis of 
stroke were included.  Only participants living in their own homes (that is, at 
their permanent address) were included. This included care homes and other 
forms of supported or sheltered accommodation. 
Types of interventions   
The included studies had to include one group which received a home-based 
therapy programme, targeted at upper limb recovery following stroke. For the 
purposes of this review home-based therapy programmes were defined as 
those including all of the following elements:  
1. Carried out in the patient's home (that is, at their permanent address; 
this may include care homes and other forms of supported or 
sheltered accommodation)  
2. Prescribed by healthcare professionals or individuals under the 
supervision of healthcare professionals  
3. Including more than one specific intervention targeted at upper limb 
recovery 
The rationale for including only these trials with more than one specific 
intervention was to avoid studies of single upper limb interventions.  The 
focus of this review was a 'programme' of therapy.  A programme of therapy 
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will always include several different treatment interventions.  The 
effectiveness of single interventions for the upper limb has been assessed in 
other reviews.  Excluding trials that assess only one specific intervention 
effectively limited this review to trials of 'programmes' of interventions to 
reduce or avoid overlap with other reviews, and reflect clinical reality. 
Studies of complex packages of rehabilitation were included if the 
administered package included interventions targeted at upper limb recovery 
and included the three elements outlined above. 
Any duration or intensity of programme was included and subgroup analysis 
completed as appropriate.  Where possible the professional background, 
training and experience of the person(s) delivering the intervention were 
documented. 
Types of comparisons to be made 
Two comparisons were investigated: 
1. Home-based upper limb programme versus placebo or usual care  
2. Home-based upper limb programme versus usual care 
Types of outcome measures   
The primary and secondary outcomes were the same as the previous review, 
and are outlined below.  The same hierarchical lists used in the previous 
chapter were again used for this review.   
Primary outcomes 
Performance in activities of daily living (including feeding, toileting, 
dressing, bathing, simple mobility and transfers).  
Functional movement of the upper limb (such as measures of active 
movement, co-ordination, dexterity, manipulation, grasp/grip/pinch).  
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Secondary outcomes 
Performance in extended activities of daily living (including shopping, 
household tasks).  
Motor impairment of the upper limb (measures/scales of upper limb 
impairment, muscle strength, muscle tone).  
Additional outcomes 
Adverse events (such as death, pain). 
Analysis was planned using data from the end of the intervention period and 
the end of scheduled follow up. 
5.3.2 Search methods for identification of studies  
To identify appropriate studies the following resources were searched:  
• The Cochrane Stroke Group Trials Register, last searched by the 
Managing Editor in May 2011 
• Cochrane Central Register of Controlled Trials (CENTRAL) (The 
Cochrane Library 2011 Issue 2, searched May 2011) 
• MEDLINE (1950 to May 2011) 
• EMBASE (1980 to May 2011)  
• AMED (1985 to May 2011)  
• CINAHL (1982 to May 2010)  
The following occupational therapy and physiotherapy databases were 
searched: OTseeker (http://www.otseeker.com/) (May 2010), Physiotherapy 
Evidence database (PEDro, http://www.pedro.org.au) (May 2010), Chartered 
Society of Physiotherapy Research Database (May 2010) and REHABDATA 
(http://www.naric.com/research/rehab/default.cfm) (May 2010).  In an effort 
to identify further published, unpublished and ongoing trials the following 
were also searched: reference lists of all included studies; ClinicalTrials.gov 
(http://www.clinicaltrials.gov/) and the National Research Register 
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(http://www.nihr.ac.uk/Pages/NRRArchiveSearch.aspx); (May 2010) and 
dissertation abstracts (http://www.lib.umi.com/dissertations/search) (May 
2010). 
The search strategies were developed, using a combination of controlled 
vocabulary and free text terms, in consultation with the Cochrane Stroke 
Group's Trials Search Co-ordinator. 
Search strategy (MEDLINE) 
1. cerebrovascular disorders/ or exp basal ganglia cerebrovascular 
disease/ or exp brain ischemia/ or exp carotid artery diseases/ or 
cerebrovascular accident/ or exp brain infarction/ or exp 
cerebrovascular trauma/ or exp hypoxia-ischemia, brain/ or exp 
intracranial arterial diseases/ or intracranial arteriovenous 
malformations/ or exp "Intracranial Embolism and Thrombosis"/ or exp 
intracranial hemorrhages/ or vasospasm, intracranial/ or vertebral 
artery dissection/ 
2. (stroke or poststroke or post-stroke or cerebrovasc$ or brain vasc$ or 
cerebral vasc$ or cva$ or apoplex$ or SAH).tw. 
3. ((brain$ or cerebr$ or cerebell$ or intracran$ or intracerebral) adj5 
(isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$)).tw. 
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracranial or 
subarachnoid) adj5 (haemorrhage$ or hemorrhage$ or haematoma$ 
or hematoma$ or bleed$)).tw. 
5. hemiplegia/ or exp paresis/ 
6. (hemipleg$ or hemipar$ or paresis or paretic).tw. 
7. 1 or 2 or 3 or 4 or 5 or 6 
8. exp Upper Extremity/ 
9. (upper adj3 (limb$ or extremity)).tw. 
10. (arm or shoulder or elbow or forearm or hand or wrist or finger or 
fingers).tw. 
11. 8 or 9 or 10 
12. 7 and 11 
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13. community health services/ or community health nursing/ or 
community networks/ or home care services/ or home care services, 
hospital-based/ or home nursing/ 
14. homebound persons/ or home health aides/ or home care agencies/ 
or house calls/ or primary health care/ or aftercare/ 
15. residential facilities/ or assisted living facilities/ or group homes/ or 
halfway houses/ or homes for the aged/ or exp nursing homes/ 
16. housing for the elderly/ or long-term care/ or institutionalization/ 
17. (home$ or house$ or domicile or domiciliary or community or 
institution$ or outreach or sheltered accomm$).tw. 
18. ((resident$ or long-term) adj5 (care or facilit$)).tw. 
19. or/13-18 
20. 12 and 19 
Identification of relevant trials 
To identify relevant trials a similar process to that outlined in the previous 
chapter was utilised.  Initially, either I or one of the other reviewers read the 
titles of the identified references and eliminated any obviously irrelevant 
studies.  The abstracts for the remaining studies were obtained, and then, 
based on the inclusion criteria, two reviewers independently ranked these as 
'possibly relevant' or 'definitely irrelevant.  Following this process the full text 
of those trials still categorised as 'possibly relevant' were retrieved.  The full 
text of the remaining studies were then retrieved and reviewed by two 
independent reviewers. 
5.3.3 Data extraction  
Where possible, the following was documented by two independent 
reviewers: 
1. Participant details (including age, gender, place of residence, type of 
stroke, time since stroke, initial upper limb impairment) 
2. Inclusion and exclusion criteria 
3. Duration/intensity/frequency of intervention 
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4. Brief description of the home-based therapy programme (including 
details of administered therapy programme (including if part of early 
supported discharge or standard discharge protocol), involvement of 
treating therapist and qualifications and experience of treating 
therapist(s)) 
5. Comparison intervention 
6. Outcomes 
5.3.4 Assessment of risk of bias in included studies  
Two reviewers independently assessed the methodology of the included 
studies.  Assessment of the quality of studies focused on potential areas of 
bias within the studies as this has been shown to affect the estimation of 
effectiveness of interventions164.  For each included trial two reviewers 
independently extracted information about the method of randomisation and 
allocation concealment (selection bias), blinding of outcome assessment 
(detection bias), whether all the randomised patients were accounted for in 
the analysis (attrition bias) and the presence of selective outcome reporting 
(selective reporting bias). 
Consideration of blinding of participants and therapists (performance bias) 
led to the conclusion that blinding would not be possible in these types of 
trials; consequently this information was not documented. 
Any disagreements between the two reviewers were resolved through 
discussion, involving a third reviewer, if necessary. 
5.3.5 Data analysis 
For each comparison the study results for performance in activities of daily 
living (ADL), measures of upper limb functional movement, measures of 
motor impairment, and adverse effects were used, if available.  All outcome 
measures analysed were presented as continuous data and thus means and 
standard deviations (SDs) were used, where available.  If the studies used 
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the same outcome measures a pooled estimate of the mean differences 
(MD) was calculated with 95% confidence intervals (CI).  If different outcome 
measures were used, within the same outcome category (for example one 
study used Action Research Arm Test and another study used Frenchay Arm 
Test to measure functional movement of the upper limb) analysis was 
completed using standardised mean difference (SMD) instead of MD.  The 
Cochrane Collaboration's Review Manager software, RevMan 5335 was used 
for all analyses. 
Heterogeneity was assessed using the I-squared (I2) statistic and dealt with 
in the same way as reported in the preceding chapter.   
Subgroup analysis was planned using the Deeks method327 on the following: 
1. Initial upper limb severity 
2. Place of residence (own home, residential or nursing care) 
3. Self practice versus no self practice  
4. Duration and frequency of intervention (intervention less than four 
weeks and intervention more than four weeks, intervention less than 
three times a week and intervention more than three times a week) 
These planned subgroup analyses were to be undertaken where data 
permitted (sufficient data were considered to be >5 trials reporting the 
information) and undertaken on the primary outcome only.  A sensitivity 
analyses based on the risk of bias criteria was planned (selection bias, 
detection bias, attrition bias and selective reporting).  
5.4 Results   
5.4.1 Results of the search   
Searches of the electronic bibliographic databases identified 1773 records 
after removal of duplicates (107 from Cochrane Trials Register, 1247 from 
MEDLINE, EMBASE, AMED and CINAHL, 52 from CENTRAL, 121 from OT 
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seeker, 78 from Physiotherapy Evidence Database and 168 from 
REHABDATA database).  After elimination of obviously irrelevant studies 
and further duplicates, 446 potential papers were identified.  The abstracts 
for these papers were obtained and assessed for inclusion by two 
independent reviewers.  Papers with abstracts classified as ‘possibly 
relevant’ were then further reviewed as full papers. Where disagreement 
arose consensus was reached through discussion and/or opinion of a third 
reviewer was sought.  From this process 56 studies were obtained.  Of these 
57 full papers (relating to 56 studies), 49 papers were excluded (see Figure 
5-1). A further two studies were not included as a decision could not be 
made about their classification (based on published information) and one 
ongoing study was identified.  This left four studies for inclusion (five papers 
included; one study with two associated papers).   
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Figure 5-1 - Study selection flow diagram 
 
5.4.2 Included studies   
Four trials284;336-338 (166 randomised participants) were included in this 
review. A summary of the included trials is outlined below.  An overview of 
the studies can be found in  
Titles reviewed 
n=1773 
Excluded 
n=1327 
Abstracts reviewed 
n=446 
Excluded 
n=389 
Full paper reviewed 
n=57 (56 studies) 
Studies excluded  n=49 
 
Intervention not specifically targeted at UL:n=18 
 
Intervention not completed at home:   n=17 
 
Single intervention (not programme):   n=6 
 
Not RCT:                                               n=5 
 
No appropriate comparison:                  n=2 
 
Therapist did not visit home:                  n=1 
Studies requiring classification             n=2 
Ongoing studies                                    n=1 
Included studies 
5 papers relating to 4 
RCTs 
  178 
Table 5-1 and a full description of the studies can be found in Appendix E. 
Table 5-1 - Characteristics of included studies (abbreviated) 
Study Methods Participants Interventions  Relevant 
Outcomes  
Duncan 
1998336 
RCT N= 20  
 
Group 1 (n=10) – usual care 
Group 2 (n=10) – home 
therapy programme (exercises 
to improve strength, balance 
and endurance and to improve 
use of affected UL) 
Barthel Index 
Jebsen Test of 
Hand function 
Lawton 
Instrumental ADL 
scale 
Fugl-Meyer UL 
scale 
Duncan 
2003337 
Studenski 
2005339  
RCT N=100 
 
Group 1(n=50) – usual care 
Group 2 (n=10) – home 
therapy programme (exercises 
to improve strength, balance 
and endurance and to improve 
use of affected UL) 
Barthel Index 
Wolf Motor 
Function Test 
Lawton 
Instrumental ADL 
scale 
Fugl-Meyer UL 
scale 
Piron 
2008338 
RCT N=10 
 
Group 1 (n=5) – virtual training 
with therapist 
Group 2 (n=5) – virtual reality 
with telerehabilitation at home 
Fugl-Meyer UL 
scale 
Piron 
2009284 
RCT N=36 
 
Group 1(n=18) – usual care 
Group 2 (n=18) – 
telerehabilitation system at 
home 
ABILHAND scale 
Fugl-Meyer UL 
scare 
 
The four trials were completed by two different research groups.  Two of the 
studies336;337 were completed by one research group.  Both of these studies 
were RCTs, which compared a home therapy programme to usual care and 
recruited individuals from the Kansas City Stroke Study registry.  It is 
assumed that the first study336 (20 participants) was a pilot study, undertaken 
prior to the larger study (100 participants)337.  Both studies included an 
exercise program that was designed to improve strength, balance and 
endurance and to encourage more use of the affected extremity.  This 
intervention met the inclusion criteria as it was explicitly stated that the 
program was targeted at upper limb recovery after stroke, the intervention 
was carried out in the patient’s home, was prescribed and supervised by a 
physiotherapist or occupational therapist and clearly involved more than one 
specific intervention targeted at upper limb recovery. 
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The other two studies284;338 were completed by another research group.  
Both were RCTs, which compared virtual reality plus telerehabilitation at 
home to either virtual reality training in hospital with a therapist present338 or 
conventional therapy in the local health district284.  Both studies aimed to 
improve motor impairment in the upper limb. 
Disagreement occurred between reviewers as to whether virtual reality 
telerehabilitation training should be considered as a single intervention or a 
therapy program.  The intervention described in the studies of virtual reality 
and telerehabilitation training consisted of different virtual tasks, comprising a 
number of arm movements, plus knowledge of results feedback and therapist 
instructions via teleconferencing284.  The intervention combined virtual reality 
training and tele-medicine. In one of the studies338 the intervention designed 
to be tested within the RCT was the teleconferencing itself; however the 
consequence of this design was a study which compared virtual reality arm 
training at home versus virtual reality arm training in hospital.  In the other 
study284 virtual reality arm training delivered at home using teleconferencing 
was compared with conventional or 'standard' care.  As the reviewers could 
not reach consensus on whether the virtual reality intervention was single 
intervention or therapy program, a majority decision was taken and virtual 
reality training was included as a therapy program.  
Study Design 
All four of the included studies were RCTs284;336-338. 
Comparison groups 
Three of the studies compared the effects of home therapy programmes for 
the upper limb with usual care284;336;337.  One study338compared a home 
therapy programme with the same therapy programme in hospital (which 
was not considered usual care).  This was considered to be a relevant study 
to include, despite not fitting into one of the pre-determined comparison 
groups.  Therefore a further comparison group was added: upper limb home 
therapy versus same upper limb therapy in hospital. 
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Follow up  
All four included studies completed outcomes at the end of the intervention 
period.  One study284 also completed outcomes after 1 month (follow-up) and 
another study337 reported follow-up data at 6 months post-treatment. 
Sample sizes 
Sample sizes were 10338, 20336, 36284 and 100337. 
Setting 
All four studies were carried out in two settings - one group at home; and the 
other either at hospital or in the local health district.  Two of the studies336;337 
were completed in the USA and the other two284;338 in Italy. 
Participants 
Demographics of included participants are outlined in Appendix E. Of the 
randomised participants 64 were female and 82 were male. One study did 
not report gender336.  The lowest reported mean age was 53 years (SD=15) 
and the highest mean age was 70.2 years (SD=11.4).  Across the studies 
time since stroke varied from a mean of 56 to a mean of 412 days. 
Interventions 
Two of the included studies336;337 delivered an exercise programme designed 
to increase strength, endurance and encourage use of the affected arm, 
which included functional exercises, assistive/resistive exercise with 
proprioceptive neuromuscular facilitation, and resistive exercise with 
theraband.  This exercise programme was compared to usual care, as 
prescribed by their physicians.  The remaining two studies284;338 delivered a 
virtual reality intervention with telerehabilitation.  This was compared with 
usual care284 or the same therapy delivered with a therapist present338.  
Therapists delivered or supervised interventions in all four studies.   
Outcome measures 
Performance in ADL was measured using the Barthel Index336;337. Functional 
movements of the upper limb were measured using the Jebsen Test of Hand 
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Function336 and the Wolf Motor Function test337.  Extended activities of daily 
living were measured using the Lawton Instrumental Activities of Daily 
Living336;337.  Upper limb motor impairment was measured using the Fugl-
Meyer upper extremity scale in all four studies. 
5.4.3 Excluded studies   
A total of 49 papers were excluded following consideration of full papers. 
The principal reasons for exclusion were: intervention not specifically 
targeted at the upper limb (18 papers), intervention not completed at home 
(17 papers), single intervention (not a programme of interventions) (6 
papers), non randomised controlled trial (5 papers), no appropriate 
comparison (2 papers) and participants not visited by health professional at 
home (1 paper).  
Several studies aimed to compare modes of service delivery, such as 
domiciliary versus hospital-based care.  These studies delivered general 
rehabilitation rather than being specifically targeted to the upper limb.  If a 
specific aim to target upper limb could not be found, these studies were 
excluded. 
One paper340 in particular was considered in detail.  There was initially 
disagreement between reviewers regarding whether or not the intervention in 
this study met the inclusion criteria.  This study investigated a home-based 
programme of individually prescribed exercises and activities.  No response 
was gained from attempts to contact the authors of this study.  Discussion 
between three reviewers led to consensus that there was insufficient 
information available within the published paper to definitively conclude that 
the programme did meet the criteria of including "more than one specific 
intervention targeted at upper limb recovery".  However, all reviewers did 
acknowledge that this assessment was based on a lack of information, rather 
than on definitive information.  This study was therefore excluded.   
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Where the comparison intervention was also conducted at home, these 
studies did not meet the criteria of the home intervention being compared to 
placebo, no treatment or usual care.  These studies help to determine 
whether home-based intervention of one type improved upper limb function 
and impairment compared to home intervention of another type.  This was 
not the purpose of this particular review and therefore this type of study was 
excluded.  
5.4.4 Risk of bias in included studies   
Full details of the included studies’ methodology are presented in Table 5-2 
and Appendix E.  The inclusion criteria for this review required a study to be 
randomised.  Three of the studies284;336;337 reported an adequately generated 
allocation sequence and adequately concealed allocation.  Blinding of 
outcome assessor was reported in three of the studies284;337;338.  Three of the 
studies284;336;338 did not report any drop-outs and therefore were considered 
to be at low risk of attrition bias.  The other study337 was also considered to 
be of low risk as the reasons for the drop-outs were provided and were 
similar across both groups.  Additionally an intention-to–treat analysis was 
used to account for missing data.  For performance in ADL and extended 
ADL outcomes, for this study337, an associated paper339 was used as this 
paper reported additional on-treatment data analysis; n=93 post-treatment 
and n=80 at 6 month follow-up that were available for inclusion in analysis 
(7% and 20% loss to follow-up respectively). 
Table 5-2 - Risk of bias summary 
+ Adequate 
- Not adequate 
? Not clear 
Random 
sequence 
generation 
(selection 
bias) 
Allocation 
concealment 
(selection 
bias) 
Binding of 
outcome 
assessment 
(detection 
bias) 
Incomplete 
outcome 
data 
(attrition 
bias) 
Selective 
reporting 
(reporting 
bias) 
Duncan 1998 + + ? ? + 
Duncan 2003 + + + + + 
Piron 2008 ? ? + ? + 
Piron 2009 + + + ? + 
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5.4.5 Effects of interventions   
Within the four included trials 166 stroke participants were randomised. 
One study338 did not include SDs in the paper. In order to include this study 
in the meta-analysis, the SDs reported by another study284 were used.  This 
study included participants with similar levels of initial upper limb motor 
impairment.  The largest SD reported by this study was used in order to be 
conservative. 
Home-based therapy programmes versus placebo or no intervention 
No studies compared the effects of a programme of home therapy (targeted 
at the upper limb) with placebo or no intervention. 
Home-based therapy programmes versus usual care 
Three studies (n=156) compared the effects of a home therapy programme 
for upper limb with usual care 284;336;337. 
Performance in ADL:  Two studies336;337 (n=113) reported performance of 
ADL (Barthel Index): MD 2.85 (95% CI -1.43 to 7.14) (Figure 5-2).  A random 
effects model was used for analysis as I2>50% (55%).  Fixed effects analysis 
produced a statistically significant result: MD 3.16 Barthel points (95% CI 
0.37 to 5.95), in favour of home therapy programme.  Follow-up data at 6 
months post-treatment was reported by one study337 (n=80): MD -1.70 (95% 
CI -5.51 to 2.11).  
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Figure 5-2 - Comparison:  Home therapy programme versus usual care.  Outcome:  
Performance in ADL 
 
 
Functional movement of the upper limb:  Two studies336;337 reported 
outcomes relevant to functional movement of the upper limb (Jebsen Test of 
Hand Function and Wolf Motor Function Test respectively).  The data from 
one study336 were not available for inclusion in the analysis as total scores 
and SDs were not reported.  The authors of this study reported no trends in 
changes in speed of upper extremity movements, as measured by the 
Jebsen Test of Hand Function, between the groups.  One study337 (n=100) 
reported data according to initial scores (above and below medians).  
Therefore this study has been entered as two subgroups (above median 
group presented first in forest plot).  There was no significant difference 
between intervention and control groups: MD 2.24 (95% CI -0.24 to 4.73) 
(Figure 5-3). 
Figure 5-3 - Comparison:  Home therapy programme versus usual care.  Outcome:  
Functional movement of the upper limb 
 
Performance in extended ADL:  Two studies336;337 (n=113) reported the 
effects of home-based therapy programmes (targeted at the upper limb) on 
performance of extended ADL (Lawton Instrumental ADL scale).  No 
significant difference was found between groups: MD 0.83 Lawton 
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Instrumental ADL scale points (95% CI -0.51 to 2.17) (Figure 5-4).  One 
study337 reported follow-up data (n=80) at 6 months post-treatment; MD 0.80 
(95% CI -0.96 to 2.56).  A fixed effects model was used as no substantial 
heterogeneity was found. 
Figure 5-4 - Comparison:  Home therapy programme versus usual care.  Outcome:  
Performance in extended ADL 
 
 
Motor impairment of the upper limb:  Three studies284;336;337 (n=156) 
reported outcomes of motor impairment. 
All three studies reported a motor impairment score (Fugl-Meyer upper 
extremity scale).  Two studies284;336 presented mean final outcome scores. 
One study337 presented mean change scores.  There was no significant 
difference between groups: MD 1.46 Fugl-Meyer upper extremity scale 
points (95% CI -0.58 to 3.51) (Figure 5-5).  A fixed effects model was used 
as no substantial heterogeneity found.  One study284 reported follow-up data 
(1 month after treatment ceased).  A statistically significant difference was 
found: MD 4.30 (95%CI 0.19 to 8.41) (Figure 5-5). 
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Figure 5-5 - Comparison:  Home therapy programme versus usual care.  Outcome:  
Motor impairment of the upper limb 
 
 
Home-based therapy programmes versus same therapy programme in 
hospital. 
One study338 (n=10) compared the effects of a home therapy programme for 
upper limb with the same therapy programme in hospital. 
Motor impairment of the upper limb:  The one study included in this 
comparison (n=10) reported a motor impairment score (Fugl-Meyer upper 
extremity scale).  There was no significant difference between groups: MD 
0.60 (95% CI -8.94 to10.14) (Figure 5-6). 
Figure 5-6 - Comparison:  Home therapy programme versus same therapy programme 
in hospital.  Outcome:  Motor impairment of the upper limb 
 
 
Other outcomes:  None of the studies reported any adverse events. 
5.4.6 Subgroup and sensitivity analyses 
As only four studies were included in this review none of the planned 
subgroup or sensitivity analysis could be undertaken.   
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5.5 Discussion   
5.5.1 Summary of findings 
This systematic review found no studies that compared home therapy 
programmes to placebo or no intervention. 
Three studies were included which compared home therapy programmes to 
usual care and a further study was included which compared home-based 
therapy to same therapy completed in hospital.  Two of the included studies 
had a small number of participants.  
Therefore, this systematic review has identified that there is insufficient 
evidence to determine if home therapy programmes are more or less 
effective than usual care (visits to hospital or local health centre or hospital 
inpatient care), no intervention or a placebo intervention for any of the pre-
determined outcomes.  Within the notable limits of this review, the wide 
confidence intervals for the primary outcomes include the possibility that the 
intervention of home-based therapy programmes could plausibly be effective 
(as indicated by several points of improvement on the Barthel and Wolf 
Motor Function Test respectively).  
Within all four of the included studies the initial level of impairment of 
participants was mild to moderate as measured by the Fugl-Meyer upper 
extremity scale.  Other inclusion criteria relating to exclusion of other serious 
medical conditions or cognitive impairment which interfered with 
comprehension were also specified.  These aspects further limit 
generalisability of the findings of this review to the wider population of stroke 
patients. 
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Additionally, only four studies were included and within these four studies 
essentially only two different programmes of therapy were investigated, 
which are not representative of all the therapies available. 
All four studies used the Fugl-Meyer as a measure of upper limb motor 
impairment, however, only two studies reported outcomes relating to 
measures of activities of daily living, functional movement of the upper limb 
and extended activities of daily living.  Therefore, overall, there was a lack of 
evidence concerning primary outcomes. 
The lack of sufficient high quality evidence makes it inappropriate to draw 
conclusions from the results regarding the applicability of home therapy 
programmes within the context of current practice. 
All of the included studies were randomised controlled trials and three of the 
studies reported adequate allocation concealment.  Additionally, three 
studies reported using a blinded outcome assessor and one study reported 
an intention-to-treat analysis. 
Within this review the reviewers encountered a number of difficulties in 
reaching consensus over the inclusion or exclusion of specific studies, 
despite attempts to create a clear and unambiguous definition of the 
intervention.  Within the literature there were a limited number of studies 
reporting on specific home-based therapy programmes targeted at the upper 
limb.  Many of the studies were service evaluations, which may have 
included elements of upper limb interventions; however it was unclear what, 
if any interventions were targeted at the upper limb.  General lack of 
information about interventions made it difficult to decide on whether to 
include some studies.  Considerations of home-based therapy versus other 
forms of service delivery have been covered in other reviews334 and 
therefore were not included in this review.  In addition, the aim of this review 
was to review studies that clearly had a programme of interventions targeted 
at the upper limb. 
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Particular difficulties were experienced in reaching a decision about the 
inclusion of two studies284;338.  Consensus could not be reached between 
reviewers, and the majority decision was taken.  This difficulty related to 
disagreement over whether virtual reality training comprised of more than 
one treatment component or not.  Difficulties were also experienced in 
reaching consensus on the exclusion of studies in which part of the 
intervention had been delivered at home. These difficulties suggest that the 
definition was not sufficiently clear.  
Whilst the research question posed had clear clinical relevance and focus, it 
is possible that in an attempt to apply rigorous and clearly defined criteria to 
the interventions may have inadvertently restricted the selection of relevant 
studies.  Consequently it may be that the focus of this review was too 
narrow.   
5.5.2 Limitations of the review 
Despite rigorous searching it is possible that some relevant studies may not 
have been identified.  By missing relevant studies, this potentially could have 
introduced bias into the review. 
The diversity of the training carried out at home and the variations in 
reporting between studies led to the review team making some subjective 
decisions, particularly about the trials to include (see sections above) which 
may have introduced bias.  The studies within this area are heterogeneous in 
terms of what can be classified as home therapy programmes targeted at the 
upper limb and there were a number of complex strands which required 
discussion among the review authors and consensus decisions being made.  
It is acknowledged that this is a clear limitation of this review.   
For one study SDs were not reported and the SD from another paper (by the 
same research group which included similar patients) was imputed.  
Furthermore, standard deviations were calculated from reported standard 
error (SD = SE √n), with regard to another study.  This may have introduced 
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some bias into the review process.  However, it was considered that 
including imputed and estimated data from these studies was preferable to 
excluding the data. 
5.5.3 Strengths of the review 
As with the previous review the main strength of this review, relate to the 
rigors of the Cochrane review process. 
Another strength relates to the perceived clinical relevance of this review as 
more and more stroke services are moved out into the community. 
5.5.4 Implications for practice   
There was insufficient evidence in this review to provide implications for 
practice.  As no negative effect was demonstrated, it is reasonable to 
suggest that, given the lack of evidence, there is no reason to currently 
change clinical practice if home-based therapy programmes for the upper 
limb are being provided.  
5.5.5 Implications for research   
In order to be able to achieve the objective of this review: to determine the 
effects of home-based therapy programmes for upper limb recovery in 
patients with upper limb impairment following stroke, compared with:  
placebo or no intervention, usual care, same treatment in hospital, further 
research is required.  Further research would provide evidence to ascertain if 
these interventions are effective, as proposed is possible, given the 
confidence intervals for the primary outcomes.  High quality randomised 
controlled trials are needed which aim to test a therapy programme 
specifically targeted at the upper limb, in the home, and where participants 
are visited by health professionals at home.  It is also desirable that future 
studies are explicit about the types of home therapy programmes provided 
and that an increased number of types of home therapy programmes are 
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investigated.  Trials of adequate size and quality are required, not only to 
assess the clinical effectiveness of home-based therapy programmes for 
upper limb recovery but also to assess the cost effectiveness of undertaking 
such interventions. 
5.6 Conclusions 
Four studies were included in this systematic review.  Due to the small 
number of included trials and small numbers of participants within these trials 
no conclusions can be drawn regarding the effects of home-based therapy 
programmes, targeted at the upper limb compared with placebo or no 
intervention, usual care or the same therapy completed in hospital. 
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Chapter 6  
The feasibility and acceptability of 
a gravity-supported, computer-
enhanced arm exerciser for acute 
stroke patients:  a pilot randomised 
controlled trial 
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Chapter 6  The feasibility and acceptability of 
a gravity-supported, computer-enhanced arm 
exerciser for acute stroke patients:  a pilot 
randomised controlled trial 
6.1 Introduction 
As identified in previous chapters’ stroke is a major public health concern 
and upper limb rehabilitation continues to pose a particular challenge to 
rehabilitation professionals. 
In Chapter 2 it was identified that the most predictive factor of upper limb 
outcome is initial level of motor impairment and function.  A systematic 
review of interventions targeted at arm recovery (Chapter 3 ) identified a 
number of interventions which may be beneficial (or at least show promise) 
for improving upper limb recovery.  These identified interventions were found 
to mainly incorporate elements of intensive, repetitive, task-specific practice.  
Therefore, these principles may be the most effective to incorporate into 
interventions, which are targeted at improving upper limb outcomes. 
6.1.1 Upper limb intervention  
Following the principles outlined above I wanted to pilot an intervention which 
could be easily integrated into clinical practice and incorporated the elements 
of intensive, repetitive, task-specific practice.  Electromechanical/Robotic 
devices were one of the interventions which were shown to potentially have a 
positive effect on arm function outcomes. In contrast to some of the other 
interventions identified these devices offer an opportunity to provide high 
intensity, repetitive and task-specific practice without being labour-intensive.   
Therefore, a randomised controlled trial of a device that could provide high-
intensity, repetitive, task-specific practice was proposed.  The chosen device; 
  194 
the Armeo®Spring is an arm orthosis which combines an adjustable, arm 
gravity support with augmented feedback and a large 3-D workspace.  This 
allows functional therapy exercises to be completed in a virtual reality 
environment341.  Although this device has been licensed for the rehabilitation 
of a number of conditions, including stroke, limited research evidence exists 
regarding the efficacy of this device.   
Furthermore the recent Cochrane review260 (used in the analysis in Chapter 
3 ) concluded that further research should focus on well-designed large-scale 
multicentre studies.  It also suggested that further research should address 
questions relating to type, timing, frequency and duration of 
electromechanical and robot-assisted training as it is still unclear if such 
devices should be applied in routine rehabilitation, or when and how often 
they should be used.  These uncertainties still exist as the current trials are 
small in size, include a number of different devices, focus on patients in the 
chronic phase and tend to use impairment rather than functional 
measures342.  Additionally none of the current trials have been completed in 
the UK.   
In addition, while the Armeo®Spring is licensed for use with stroke patients, 
only one randomised controlled trial has been published272.  This trial was 
completed with chronic stroke patients in an outpatient setting in the United 
States.  This trial of 28 participants found no significant difference between 
those who undertook the experimental intervention and those who received 
the control intervention (dose-matched table top exercises) on any outcome 
measures at end of intervention period.  A significant difference in favour of 
the experimental intervention was found, in terms of the Fugl-Meyer at 6 
month follow-up.  Following consideration of this trial, in conjunction with a 
review of the other relevant literature it was felt a feasibility study for acute 
stroke inpatients, in the UK was required prior to a proposal for a large-scale 
trial.   
The Medical Research Council (MRC)59 framework for the design and 
evaluation of RCTs for complex interventions states that data concerning the 
  195 
feasibility, acceptability and safety of any intervention should be acquired 
prior to undertaking a phase III randomised controlled trial.   
For all of the outlined reasons a pilot, randomised phase II trial to assess the 
feasibility and acceptability of the ArmeoSpring was deemed appropriate to 
provide information relating to the suitability of a phase III trial and inform the 
design of such a trial.  Following the update of the intervention review 
(September 2011) evidence relating to virtual reality was also available, 
which is relevant as the ArmeoSpring incorporates elements of virtual 
reality training.  The intervention category of virtual reality was deemed as 
likely to be beneficial, reflecting evidence gained from a Cochrane systematic 
review280.  This Cochrane review concluded that caution must be exercised 
when drawing conclusions from the evidence, as the studies of virtual reality 
are still too few and too small, and it is unclear what characteristics of the 
intervention are the most important.  As with the evidence relating to 
electromechanical/robotic devices the applicability of the intervention to 
stroke survivors still requires to be clarified in terms of which type of patient 
is most likely to benefit, at which point such interventions should be delivered 
and how acceptable such interventions are to stroke patients.   
The hypothesis of this pilot trial was that arm rehabilitation provided by the 
Armeo®Spring would be a feasible and acceptable intervention to implement 
with acute stroke patients with arm deficits.   
6.2 Objectives 
This phase II study had 3 main objectives:  
• To determine the feasibility and acceptability of the Armeo®Spring 
arm orthosis for arm rehabilitation in acute stroke patients compared 
with standard therapy 
• To assess the safety of the Armeo®Spring arm orthosis for acute 
stroke patients compared with standard therapy 
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• To assess the efficacy of the Armeo®Spring arm orthosis at two 
different intensities for acute stroke patients compared with standard 
therapy 
6.3 Methods  
This study was a phase II pilot prospective, randomised controlled trial with 
blinded outcome assessment, conducted within a single-centre (Glasgow 
Royal Infirmary stroke unit).  Ethical approval was given by the health 
authority involved (NHS Greater Glasgow and Clyde). 
6.3.1 Study population 
Patients with a clinical diagnosis of stroke admitted to Glasgow Royal 
Infirmary stroke unit between August 2009 - November 2009 and January 
2011 - June 2011 were considered for inclusion.  An attempt was made to 
screen all consecutive admissions.  Inclusion criteria for the study were:  ≥18 
years; clinical diagnosis of stroke; grade 1-4 on MRC scale of arm 
impairment; medically stable; ≤10 days post-stroke; able to give informed 
consent; able to understand and follow simple instructions and sitting 
balance sufficient to use the device safely.  The exclusion criteria were:  
orthosis could not be fitted to the affected limb; bone instability of affected 
upper limb; no prior functional use of affected upper limb due to previous 
stroke or other condition; pronounced, fixed contractures of affected upper 
limb; open skin lesions on affected upper limb; major sensory deficit of 
affected upper limb; shoulder instability or excessive pain; severe spasticity; 
severe spontaneous movements; confused or non-cooperative; isolation due 
to infection; visual, perceptual or cognitive problems precluding participation 
in study protocol or involvement in any other intervention study.  Initially it 
was estimated that 18 patients would be suitable for inclusion into the study, 
however due to feasibility nature of this trial no specific recruitment target 
was set.   
  197 
Participants who met the inclusion criteria and who consented (Appendix F) 
were randomly assigned to one of three groups.  A computer generated 
random number sequence in blocks of 6 was used to generate sequentially 
numbered opaque sealed envelopes, containing the participant allocation 
(1:1:1 for control: low intensity intervention: high intensity intervention).  
Group allocation for each participant was concealed in a sealed envelope 
and opened sequentially by a third party who was not otherwise involved in 
the study.  
From information gained from the systematic review of predictor variables 
(Chapter 2 ) stratification of participants according to severity of arm 
impairment (MRC motor power scale323); ‘severe’ impairment (MRC 1 or 2) 
or ‘mild/moderate’ (MRC 3 or 4) was planned.  The aim was to recruit equal 
numbers of participants with mild/moderate and severe upper limb deficits.  
However, due to limited numbers of appropriate patients with an initial 
‘severe’ MRC score this planned stratification was not possible.   
6.3.2 Study interventions 
Participants were randomised to one of three groups (i) standard care (SC) 
(control group) or standard care plus one of two intensities of the 
experimental intervention (ii) Armeo®Spring arm orthosis 40 minutes per 
day, 3 days per week (low intensity intervention group) (iii) Armeo®Spring 
arm orthosis 60 minutes per day, 5 days per week (high intensity intervention 
group).  The intervention period lasted for 2 weeks or until discharge from the 
acute stroke unit (whichever was sooner).   
The interventions in the two experimental groups (groups 2 and 3) were, on 
occasions completed in more than one session e.g. 40 minutes per day in 
group 2 was completed over 2 sessions of 20 minute duration.  This decision 
was based on the participants’ tolerance and other commitments.   
The experimental intervention was the Armeo®Spring arm orthosis.  This 
device is a commercially available product which facilitates intensive task-
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oriented arm rehabilitation.  This arm orthosis provides support for the arm 
against gravity, which enables individuals with moderate to severe arm 
impairment to achieve an increased range of movement.  The Armeo®Spring 
offers variable levels of support against gravity, provides a large 3D 
workspace and incorporates sensors of arm movement and hand grip which 
allows users to interact with therapeutic computer games and receive 
feedback about performance272;341.  Visual representation of the device is 
provided in 7.3Appendix F.        
Participants within the intervention groups were taken off the ward to a 
research office where the Armeo®Spring arm orthosis was located.  Patients 
sat in a wheelchair (with armrest on affected side removed) or were 
transferred onto a standard chair with no armrests.  At the beginning of each 
session the principal investigator adjusted the device to the individual, in 
terms of size adjustment and gravity support.  Gravity balance compensation 
was gradually decreased, as deemed appropriate by the principal 
investigator.  The principal investigator provided direct training/supervision 
throughout all the sessions.   
The games played during the session were decided by the principal 
investigator and were dependent on each participant’s abilities.  Each game 
had different levels of difficulty.  Games such as catching rain drops, picking 
apples and placing into a basket, cleaning a cooker top and revealing a 
picture were frequently used.  The games principally focused on shoulder 
and elbow movements (flexion/extension, adduction/abduction, 
internal/external rotation).  For participants with some wrist/hand movement 
games incorporating wrist flexion/extension, pronation/supination and 
grasp/release were also used.  Throughout all the games auditory and visual 
feedback is provided to maintain attention and motivation.  Additionally the 
end of each game feedback on performance was provided.   
Standard therapy was provided by the usual therapists on the ward and the 
experimental intervention was provided by the principal investigator.  Time 
spent in standard care and the activities completed were recorded.   
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Standard therapy interventions were chosen as the control intervention as it 
would be unethical to deny stroke patients usual care and this is the standard 
against which any new interventions would be compared.  An attention 
control was not chosen as this is not representative of routine clinical 
practice and the purpose of the study was to assess the feasibility of the 
experimental intervention, in relation to usual clinical practice.  Two different 
intensities of the experimental intervention were chosen as there is good 
evidence to suggest that increased intensity of practice leads to better 
outcomes, however, it is unclear what the optimum level of intensity actually 
is and it is also apparent that high intensity intervention can be difficult to 
achieve51.   
6.3.3 Outcome measures 
Several characteristics of the participants (e.g. age, initial MRC classification) 
were recorded for descriptive and comparative purposes.  Measures were 
completed at baseline, completion of intervention (2 weeks or discharge from 
stroke unit) and at 3 month follow-up.  At baseline the measures were 
completed by the principal investigator and at the end of intervention and at 3 
month follow-up the measures were completed by an external individual who 
was blinded to group allocation and had no contact with the study 
participants during the intervention period.     
Primary outcomes 
The primary outcomes of this trial were the feasibility and acceptability of the 
Armeo®Spring arm orthosis for arm rehabilitation in acute stroke patients.  
To assess feasibility, the number of sessions completed per-protocol and 
reasons for non-compliance with protocol at end of intervention period were 
documented.  
To gauge opinions, particularly relating to acceptability of the arm 
interventions that were received, informal, semi-structured interviews, guided 
by a topic guide (Appendix H) were completed at the end of the intervention 
period.  At the beginning of each interview the interviewer (PI) provided an 
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explanation of the purpose of the interview and highlighted that all 
information gained was confidential.  The purpose of audio-recording was 
outlined, in addition to information regarding how the gained data would be 
used.  To encourage open and honest feedback an explicit statement was 
made that all thoughts and opinions were valued and appreciated.  A number 
of background questions were initially asked and then questions relating to 
arm interventions were focused on.   
Interviews were chosen as the method of data collection to allow closed and 
open questions to be posed to participants.  Closed questions were used to 
enable particular opinions to be gained e.g. did you find the intervention 
acceptable? Through the process of the interview probing questions were 
asked to explore opinions, feelings and experiences relating to the arm 
interventions.  Due to the knowledge, skills and abilities of the participants 
involved, a flexible approach to undertaking the interviews was required and 
on occasions limited probing was relevant and/or possible.  A topic guide 
was used as a prompt to ensure that all topics of interest were covered and 
to ensure a degree of standardisation between the interviews.  Interviews 
were conducted by the principal investigator, who was not blinded to group 
assignment.   
Secondary outcomes 
Safety outcomes were assessed using a checklist (Appendix I).  Arm pain 
was recorded by patient report and rated on a likert scale.  The Borg 
Perceived Exertion Scale343 (scale 6-13) was used to assess perceived level 
of exertion at the end of the intervention assessment.  Other factors, 
assessed by patient report were:  subluxation, spasticity, skin breakdown (at 
end of intervention period), falls, chest infection, urinary tract infection and 
recurrent stroke (at end of intervention period and at 3 month follow-up).  
Upper limb function was assessed using the Action Research Arm Test 
(ARAT)85 (Appendix J).  This is a 19 item scale divided into 4 subscales 
(grasp, grip, pinch and gross movement) with a maximum score of 57.  The 
Fugl-Meyer upper limb section (F-M)88 (scale 0-66) was used to assess the 
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level of upper limb impairment (Appendix K) and the Barthel index (BI)82 
(scale 0-20) (Appendix L) was used to assess the level of disability in 
activities of daily living.  The reliability and validity of these measures have 
been established344-347.   
Exploratory Outcome 
To provide data to allow for a sample size calculation to determine the 
number of subjects required for a phase III randomised controlled trial.  This 
was determined from data at end of 3 month follow up.  
6.3.4 Data analysis 
The feasibility of the intervention of interest was assessed by analysing the 
number and percentage of participants completing all of the assigned 
intervention sessions.  Additionally, descriptive statistics (mean±standard 
deviation (SD) and median (range)) were used to summarise the number of 
days, sessions and minutes of intervention received by the participants in 
both of the intervention groups.  Reasons for non-compliance with the 
protocol were explored.  Time spent in standard care was analysed using 
descriptive statistics (as above) according to individual therapies 
(occupational therapy and physiotherapy) and by allocated group.  Analysis 
was also completed related to time spent in therapies, according to number 
of days participating in the trial.   
To assess acceptability of the arm interventions that were received, 
interviews were audio-taped and transcribed.  Initially the transcripts were 
read and re-read to allow for increased understanding of the raw data.  In the 
first instance frequency counts were used to provide a summary of the data, 
in relation to the closed questions that were posed using the topic guide 
(Appendix G).  Constant comparative analysis348 was then used to further  
explore the data.  The themes were principally generated from the questions 
asked and the data within the codes from each of the interviews were then 
compared with those in the other interviews, to create broader categories; 
linking the codes from different interviews together.  This process was initially 
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completed by myself, following the reading and re-reading of all the 
transcripts and then grouping similar aspects together using colour coding in 
the first instance and then within an excel spreadsheet. Another individual 
assisted in the coding process to attempt to increase validity of the findings.    
Participant validation of the findings was not completed.  Quotes from 
participants were used to highlight the main themes.   
The number of adverse events was analysed using descriptive statistics, by 
the overall group and each individual group. The scales used to assess 
particular safety outcomes i.e. arm pain scale and fatigue scale were 
analysed using mean±SD and median (range), with regard to allocated 
group. 
An intention-to-treat analysis was planned as the means of data analysis for 
efficacy outcomes.  However, two participants’ data were missing at 3 month 
follow-up and analysis was completed only on those participants with 
available data.  It was originally planned that any differences between groups 
would be investigated using analysis of covariance (ANCOVA), adjusting for 
baseline MRC score.  However, due to the small number of included 
participants this form of analysis was considered inappropriate and the data 
was analysed using descriptive statistics only.   
Change scores were used for the analysis of all three efficacy outcomes. The 
mean±SD and median (range) were calculated for the three efficacy 
outcomes.  SPSS software (version19.0)349 was used to conduct all 
statistical analysis.   
To estimate the required sample size for a phase III trial SPSS was initially 
used to apply a one-way analysis of variance (ANOVA) to the data of change 
in ARAT at 3 months (10 participant’s data available) to gain the residual 
standard deviation (variability in the data after taking account of any mean 
differences in 3-month ARAT change between groups).  This standard 
deviation was then used as a basis for the sample size calculation.  The 
statistical package nQuery350 was used to make the calculation, and the 
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following assumptions were made; that a two-group t-test would be used, at 
a significance level of 0.05, the test would be 2 sided, the difference in 
means to be detected was set at 6 points, power set at 90% and the 
standard deviation in both groups (estimated from the ANOVA analysis of 
residuals) was 15.76.  The difference of means was set at 6 points based on 
previous literature351 and knowledge of the ARAT measure.   
6.4 Results 
A total of 393 stroke patients were admitted and screened within the eight 
month recruitment period.  Three hundred and eighty one individuals were 
excluded.  The reasons for exclusion were:   no upper limb deficit (n=231), 
not medically stable (n=44), >10 days post-stroke (n=29), discharge 
scheduled (n=12), no UL return (n=12), non compliant/cooperative (n=9), 
unable to follow commands (n=6), pre-existing upper limb issues (n=6), 
cognitive issues (n=5), poor vision (n=5), declined to participate (n=5), other 
upper limb issues (n=4), ataxia (n=4), poor sitting balance (n=3), neglect 
(n=3), participation in another intervention trial (n=1), unable to give consent 
(n=1) and infection (n=1).  Twelve participants met the inclusion criteria, 
agreed to participate and were randomly allocated to control group (n=4), low 
intensity intervention group (n=4) or high intensity intervention group (n=4).  
All participants completed end of intervention assessments.  Two participants 
did not complete 3-month follow-up assessments.  One participant from the 
control group refused to complete ARAT and F-M assessments and one 
participant (from high intervention group) suffered a recurrent stroke.  The 
flow of participants through the study is illustrated in Figure 6-1.   
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Figure 6-1 - Flow of participants through the study 
 
Stroke patients assessed for eligibility 
n=393 
 
Individuals excluded 
n=381 
Individuals randomised  
n=12 
Control group 
n=4 
Low intervention group 
n=4 
High intervention group 
n=4 
Completed end of 
intervention 
assessments  
n=4 
Completed end of 
intervention 
assessment  
n=4 
Completed end of 
intervention 
assessment  
n=4 
Completed 3 month 
follow-up 
assessments  
n=3 
(1 refused to 
complete ARAT and 
FM) 
Completed 3 month 
follow-up 
assessments 
n=4 
Completed 3 month 
follow-up 
assessments 
n=3 
(1 unable to 
complete due to 
recurrent stroke) 
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For descriptive characteristics of the included participants see Table 6-1.  
The median age of participants was 70.50 (range 36-80) years and 67% of 
the participants’ were male.  
The baseline characteristics of the groups were similar, except for a few 
variables.  A difference in age was evident between the control group 
(median 64, range 36-72) and the low intervention group (median 74.5, 
range 58-80).  All participants in the low intervention group had a left sided 
paresis compared to one and two participants in the control and high 
intervention groups respectively.  The most notable difference was on 
baseline ARAT scores.  Participants in the control group had a mean of 
36.50±23.22, compared to means of 16±22.04 and 18.75±12.18 in the low 
and high intervention groups. 
Table 6-1 - Baseline characteristics of participants per allocated group 
 Control  
(n=4) 
Low 
intervention 
(n=4) 
High 
intervention 
(n=4) 
Age, mean±SD;  
median (range), yrs  
59±16.31;   
64 (36-72) 
71.75±9.53;  
74.5 (58-80) 
65±13.56;  
66 (49-79) 
Sex, n 2M/2F 3M/1F 3M/1F 
Side of paresis, n 3R/1L 0R/4L 2R/2L 
Type of stroke 3 Infarct/ 1 
Haemorrhage 
2 Infarct/ 2 
Haemorrhage 
2 Infarct/ 1 
Haemorrhage/1 
SVD 
Stroke classification (OCSP) 2 PACs/ 2 LACs 2 PACs/ 2 LACs 1 PACs/ 3 LACs 
Symptom onset to 
randomisation, mean±SD; 
median (range), days 
7.75±3.20;  
7.50 (5-11) 
9.25±1.71;  
9.50 (7-11) 
7.50±0.58; 
7.50 (7-8) 
Randomisation to end of 
intervention assessment, 
mean±SD; 
median (range), days 
8±3.92;  
8.50 (3-12) 
9.25±6.18;  
9 (2-17) 
11.50±7.05; 8.50 
(7-22) 
Randomisation to 3 month follow 
up assessment, mean±SD;  
median (range), days 
92.25±3.59; 
91.50 (89-97) 
91.75±4.27;  
91.50 (87-97) 
91.33±3.12;  
92 (90-92) 
MRC classification (0-5), 
mean±SD; median (range) 
3±1.08;  
3.50 (1-4) 
3±1.41; 
3.50 (1-4)  
3.25±0.5; 
3 (3-4) 
ARAT (0-57), mean ±SD; 
median (range)  
36.50±23.22; 
44.50 (3-54) 
16±22.04; 
 20.50 (0-48) 
18.75±12.18; 
20.50 (3-31) 
Fugl-Meyer (UL section, 0-66), 
mean±SD, median (range) 
37.25±21.72; 
45.50 (6-52) 
30.75±16.09;  
33 (10-47) 
36.25±10.34; 
40 (21-44) 
Barthel Index (0-20), mean±SD; 
median (range) 
9.50±5.32;  
9.50 (4-15) 
6.50±2.38;  
5.50 (5-10) 
9±3.92; 
8.50 (5-14) 
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6.4.1 Primary outcome: Feasibility 
Details of the intervention completed by the two experimental groups (low 
and high intervention groups) are detailed in Table 6-2 and summarised in 
Table 6-3. 
The median amount of time spent completing intervention using the 
experimental device was 140 (range 30-237) minutes in the low experimental 
group and 165.50 (range 35-445) minutes in the high experimental group.  
This was compared to the target of 240 minutes and 600 minutes 
respectively.  Only one individual (low intervention group) achieved the target 
number of days of intervention (6/6) and came very close to achieving the 
target number of minutes (237/240). 
The reasons for not achieving the target amounts of intervention were fairly 
consistent between participants and between the two groups.  The most 
common reason for not achieving the target amount of intervention was 
transfer to a rehabilitation facility.  Other common reasons mainly related to 
ward routines e.g. other therapies being delivered, patients not dressed and 
meal times. 
Table 6-2 - Amount of actual intervention using experimental device received by 
participants in both intervention groups 
Number of:  days, 
sessions, minutes per 
participant 
Percentage 
achieved  
Reasons protocol target not achieved 
Low intervention (n=4; Target 6 days, 240 minutes)  
6 days 
11 sessions 
237 minutes  
100% 
- 
98.75% 
Set-up of machine; pt tired; ward routines 
(meals, visiting, therapy), availability of 
patient (dialysis))                                                                                                                                                    
4 days 
6 sessions 
163 minutes 
66.67% 
- 
67.91% 
Transfer to rehab facility                                  
2 days 
2 sessions 
30 minutes 
33.33% 
- 
12.50% 
Transfer to rehab facility; pt issues 
(needing toilet; tired); limitation in what 
could be achieved due to poor movement     
3 days 
3 sessions 
117 minutes 
50% 
- 
48.75% 
Transfer to rehab facility; pt tired 
High Intervention (n=4; Target 10 days, 600 minutes) 
5 days 
7 sessions 
202 minutes 
50% 
- 
33.67% 
Transfer to rehab facility; pt tired; ward 
routines (not up till late, meals, therapy, 
visiting); IV antibiotics in affected arm; 
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Machine set-up                                                                                                                                                                   
1 day 
1 session 
35 minutes 
10% 
- 
5.83% 
Transfer to rehab facility                                                                                                  
8 days 
10 sessions 
445 minutes 
80% 
- 
74.17% 
Machine not working; machine 
adjustments required; ward routines 
(visitors, meals); pt attending 
investigations; pt cramp in hand                                                             
4 days 
5 sessions 
129 minutes 
40% 
- 
21.5% 
Transfer to rehab facility; pt waiting to see 
Dr; other pt in trial therefore time limited; 
ward routines (lunch, therapies, not 
dressed on arrival) 
 
Table 6-3 - Amount of intervention completed; days, sessions and minutes, by 
intervention group 
 Low intervention 
group 
High intervention 
group 
Mean±SD;  
median (range), days 
3.75 ±1.71;  
3.50 (2-6) 
4.50±2.89;  
4.50 (1-8) 
Mean± SD;  
median (range), sessions 
5.50±4.04;  
4.50 (2-11) 
5.75±3.77;  
6 (1-10) 
Mean±SD;  
median (range), minutes 
136.75±86.65;  
140 (30-237) 
202.75±175.37; 
165.50 (35-445)  
 
The amount of standard care received by the three groups was also 
recorded and is presented in Table 6-4 and Table 6-5.  The low and high 
intervention groups received more minutes of standard care than the control 
group.  The low intervention group received the most amount of standard 
care but also had the largest range of observable days (i.e. the length of time 
spent in the trial).    
Activities completed within standard care varied between patients.  The 
recorded direct interventions (number of sessions) were:  upper limb 
activities (n=40), dressing (n=26), gait (n=13), transfers (n=16), standing 
balance (n=14), lower limb activities (n=13), assessment (n=7), sitting 
balance (n=2), kitchen tasks (n=2), cognitive tasks (n=1) and chest 
physiotherapy (n=1).  
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Table 6-4 - Total amount of standard care (SC) received (time in minutes) during intervention period by intervention group 
 Control group  (n=4) Low intervention group (n=4) High intervention group (n=4) 
Occupational Therapy  
Physiotherapy 
Total amount of SC 
71.25±51.21; 55 (30-145) 
68.75±57.50; 60 (15-140) 
140±107.24; 115 (45-185) 
96.25±61.42; 77.50 (45-185)  
156.25±105.62; 135 (60-295) 
252.50±155.59; 192.50 (145-480) 
85±44.91; 92.50 (25-130) 
100±86.51; 100 (0-200) 
185±126.16; 192.50 (25-330) 
Data presented as Mean±SD; Median (range)  
 
Table 6-5 - Amount of standard care received (time in minutes per observable day during intervention period) by intervention group 
 Control group  (n=4) Low intervention group (n=4) High intervention group (n=4) 
No. of observable days 
Occupational therapy 
Physiotherapy 
Total amount of SC 
4.25 (1.26); 4 (3-6) 
15.73 (6.82); 15.62 (7.50-24.17) 
14.89 (9.61); 16.25 (3.75-23.33) 
30.62 (15.89); 31.87 (11.25-47.50) 
5.25 (3.95); 4 (2-11) 
22.01 (13.94); 17.15 (11.25-42.50) 
31.08 (9.77); 28.41 (22.50-45) 
53.09 (14.69); 49.94 (40-72.50) 
4.75 (3.30); 4.50 (1-9) 
21.29 (9.31); 20.50 (11.67-32.50) 
20.80 (22.34); 16.61 (0-50) 
42.10 (28.65); 33.50 (18.89-82.50) 
Data presented as Mean±SD; Median (range)  
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6.4.2 Primary outcome: Opinions of therapy – Acceptability 
Data gained from the qualitative interviews is reported below, in terms of the 
main themes generated from the questions that were posed.  
Hopes  
All participants had hopes for arm recovery.  From the data gained it was 
clear that three participants had particular hopes for recovery, had a target 
and were able to assess own progress; 
“….well I hoped to get back to, initially to get back to normal, 
the way it was originally but it still isn't back to what it was prior to 
the stroke…but it's a lot better, I must say it's a lot better.” 
(Participant number 12 – Low intervention group) 
Another theme to emerge was an acknowledgement that full recovery may 
not be possible, but targets were still set; 
"the hopes is… I'd be happy with 90% better, not the 100% 
because I'm not expecting that, if I get 90% of my fitness back, 
yes I'd be happy, body, arm, leg…" (Participant number 9 – High 
intervention group) 
Alongside hopes for recovery, one participant raised concerns;  
“I was hoping that my arm to progress as much as my leg… 
because I'm no getting any feeling yet and that's what I'm worried 
about…” (Participant number 11 – Control group) 
Importance  
All twelve participants reported that it was important to have therapy which 
was targeted at their arm.  One participant perceived targeted intervention to 
be important as it provided them with a gauge of their recovery.  They also 
used this as a source of influence and motivation for engaging in therapy.   
"…everyday I look forward to getting that (physiotherapy usual 
care) because I know that way I would know if I was getting better 
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or worse... I was grateful for that because I did try really, really 
hard. I had to try hard." (Participant number 3 – Control group) 
Frequently participants recognised the perceived value of therapy targeted 
towards the arm, and this particularly related to the recovery of movement 
and ability to complete activities;  
“I think it was very important…I don't know if it would ever 
recover without therapy. I can't see it (arm) recovering on it's 
own…” (Participant number 7 – High intervention group) 
“It was very important; because obviously I need my hands… 
obviously you need your hands for a lot of things…” (Participant 
number 3) 
Acceptability  
All twelve participants reported that the arm interventions received had been 
acceptable.  One participant outlined particular components of acceptability, 
which included; level of difficulty, level of pain involved and necessary output 
required (tiredness);  
“Well there was nothing hard about it, you weren’t told to do 
anything hard…likes of your one you said if you’re getting tired tell 
me and I’d say no we’ll just keep going , I’m alright…One time, I 
had to say I’m getting a wee bit tired but that was because it 
wasn’t working right that day.” (Participant number 5 – Low robot 
group) 
Another participant outlined that the intervention was acceptable as it was 
perceived to be beneficial; 
“Yes, I certainly did find it acceptable, aye, more than 
acceptable, once I realised what it was doing…”  (Participant 
number 6 – High intervention group) 
Satisfaction  
All participants reported being satisfied with the therapy they had received.  
The most frequently given reason for satisfaction was that outcomes were 
being achieved that were personally important;  
211 
“Yes, very much so…because I can see improvements going 
on in my arm, my arm is moving. I can pick up things with my 
fingers now which I wasn't doing before, so obviously I'm 
satisfied.” (Participant number 9 – High intervention group) 
Expectations  
Some participants did not have any preconceived ideas about therapy; 
“I didn't know what to expect to be honest… it was all new to 
me but I enjoyed it actually…I'm getting there.” (Participant 
number 3 – Control group) 
Other participants had preconceived ideas; however these were either 
challenged or surpassed by the therapy that was received;  
“…well I did have expectations but did it, yes it did, it 
outweighed my expectations… well I expected that it would help 
me…but it did more than help me, it would give me confidence as 
well because it was getting better and that do you know what I 
mean?” (Participant number 12 – Low intervention group) 
Likes and Dislikes 
The main theme to emerge throughout the interviews was that the 
participants perceived that there were benefits from the received therapy.  All 
participants reported that they felt that the intervention they received made a 
difference to their arm.   
“Just being able to do it myself again… being able to do it 
myself again and it was good cause you knew like, oh I'm getting 
better at that, you’re getting better and that gives you a wee sort of 
praise sort of thing. You know at least I'm going to have the use of 
them back soon, do you know what I mean rather than not having 
the use of them at all, so aye I enjoyed it because it was helping 
me to get better and you've got to do what they tell you and it does 
help, it really, really does help.”  (Participant number 3 – Control 
group) 
“You know I think it helped…” (Participant number 2 – High 
intervention group) 
“…well I've got wee tiny bits of movement now with probably 
the therapy I've been having…” (Participant number 7 – Low 
intervention group) 
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“…Well I think that it has helped…if it hadn’t have been done, it 
may not have came to being used so much and as well…as well 
as what I’m doing now” (Participant number 2 – high intervention 
group)  
Specific reasons for liking the ArmeoSpring intervention related to the 
therapy characteristics (full range of movement possible, feedback, 
motivating, support against gravity, diversity of therapy, challenging, and 
regular intervention); 
“That machine that you had that's good, because you're not 
going one way with your arm, you're going everyway, up, down 
and across, 45 degrees, 90 degrees and all this, chasing stuff. At 
the end of the day, after a wee while you start to catch it so once 
you get a plan and it starts to work and you say oh I can do this, 
and you try harder and harder get ahead and get more.” 
(Participant number 5 – Low intervention group) 
Negative comments were made infrequently.  Generally all twelve 
participants were positive about their experiences and there was a clear 
sense from the data that the participants were grateful for the assistance that 
had been received.   
However some downsides of participating in the ArmeoSpring therapy were 
reported, which included; post therapy tiredness, pain (on one occasion), 
boring at times, frustrating when desired movements could not be achieved 
and device breakdowns;  
“…sometimes after I was a bit tired.” (Participant number 1 – 
Low intervention group) 
 “…the fact there was a couple of break downs…” (Participant 
number 8 – High intervention group)  
One participant in the control group (participant number 10) reported having 
to deal with numerous activities “…sometimes it was just one thing after 
another.” 
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A number of participants explicitly stated that they would have liked longer 
intervention time (four from intervention groups and one from control group) 
and one participant reported that they would have liked to have been pushed 
harder; 
 “I couldn’t tell you if there’s anything better…..push me harder” 
(Participant number 5 – Low intervention group).  
Another participant reported that they were unable to comment on possible 
improvements to the ArmeoSpring intervention due to short term nature of 
the intervention and several participants reported that they felt unable to 
comment on possible improvements to therapy due to a lack of knowledge or 
experience of alternatives.   
One participant in the control group reported that he would have liked to 
have used the ArmeoSpring; 
 “... nah the only thing was maybe that machine you were 
talking about I want to try that, never got the chance at that…” 
(Participant number 11 – Control group) 
While every participant stated that they would recommend the intervention 
that they had received, only one participant stated that; 
 "the therapy that I got, I thought it helped and that I think that 
should be continued with anyone else with the same problems." 
(Participant number 2 – Low intervention group). 
6.4.3 Secondary outcomes: Safety  
There were no treatment-related serious adverse events.  During the 
intervention phase only one participant reported any adverse events (pain in 
hand).  At end of intervention three participants were not asked the specific 
questions relating to safety outcomes due to an administrative oversight.  
However no specific complaints were volunteered.  Therefore the following 
reporting of safety outcomes is based on nine participants.   
214 
At the end of the intervention period three adverse events were reported 
(Table 6-6).  Two participants reported some form of arm pain (one each 
from the control and low intervention group).  Pain analogue scale scores 
were reported as 3 (mild) and 5 (moderate). A further participant (control 
group) reported increased spasticity in upper limb.   
In relation to the therapy received, reports of fatigue (Borg Scale) (recorded 
at the end of the intervention period) ranged from 9 (very light) to 13 
(moderately hard) (Table 6-7). 
At the three month follow up assessment (n=12) ten adverse events were 
reported (Table 6-6).  Five adverse events were reported in the control 
group.  One participant reported falls and another participant reported arm 
pain (reported as 8 on pain analogue scale).  One participant reported three 
adverse events; arm pain (5 on pain analogue scale), chest infection and 
recurrent stroke.  The three adverse events reported by three participants in 
the low intervention group all related to arm pain (scores of 5, 8 and 6 
reported on pain analogue scale).  Within the high intervention group one 
participant reported falls and another patient had suffered a recurrent stroke 
(reported by wife).   
Table 6-6 - Number of reported adverse events; number of participants experiencing 
an adverse event (number of participants available for analysis) 
 Control group Low 
intervention 
group 
High 
intervention 
group 
End of intervention  2; 2 (n=4) 1; 1 (n=2) None (n=3) 
3 month follow-up  5; 3 (n=4) 3; 3 (n=4) 2 (n=4) 
 
Table 6-7 -Borg Perceived Exertion Scale recorded at end of intervention 
 Control group 
(n=4) 
Low 
intervention 
group (n=2) 
High 
intervention 
group (n=3) 
Borg Perceived 
Exertion Scale (6-13) 
11.50 ±1;  
11 (11-13) 
12±1.41;  
12 (11-13) 
11±2;  
11 (9-13) 
Data presented as Mean±SD; Median (range) 
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6.4.4 Secondary outcome: Efficacy outcomes 
Mean time between randomisation and the end of intervention assessment 
was 9.58 (±SD 5.52) days (median 8.50, range 2-22) and the 3 month follow-
up assessment was 91.82 (± SD 3.12) days (median 92, range 87-97).   
Results for the three efficacy outcomes are presented in Table 6-8 and Table 
6-9.  Change scores between baseline and the end of intervention 
assessments (Table 6-8) were higher for both intervention groups than the 
control group for all three efficacy outcomes (ARAT, F-M and BI).  This trend 
of higher change scores in the intervention groups was also evident between 
baseline and the 3 month follow-up assessments (Table 6-9). 
Table 6-8 - Efficacy outcomes at baseline, end of intervention and change score 
between baseline and end of intervention  
 Control group Low intervention 
group 
High intervention 
group 
Action Research Arm Test 
 Baseline  36.50±23.22;  
44.50 (3-54) 
16±22.04;  
8 (0-48)  
18.75±12.18;  
20.50 (3-31) 
 End of intervention  
 
42.50±28.34;  
56.50 (0-57) 
26.50±23.39; 
24.50 (0-57) 
32.75±24.13;  
37 (0-57) 
 Change 6.00±8.83;  
4.50 (-3-18) 
10.50±8.66;  
10.50 (0-21) 
14.00±18.94;  
9 (-3-41) 
Fugl-Meyer  
 Baseline 37.25±21.72; 
45.50 (6-52) 
30.75±16.09;  
33 (10-47)  
36.25±10.34;  
40 (21-44) 
 End of intervention 44.25±24.96;  
55 (7-60)  
40.75±17.23; 
45.50 (16-56) 
44±15.98;  
47 (22-60)  
 Change 7±6.05;  
6 (1-15) 
10±5.48;  
8 (6-18) 
7.75±6.40  
7 (1-16) 
Barthel Index 
 Baseline 9.50±5.32;  
9.50 (4-15) 
6.50±2.38;  
5.50 (5-10) 
9±3.92;  
8 (5-14) 
 End of intervention 12.50±5.26;  
12 (8-18) 
12.75±4.79);  
14 (6-17)  
13.25±5.85;  
13.50 (6-20)  
 Change 3±1.83;  
3 (1-5) 
6.25±3.77;  
7 (1-10) 
4.25±2.22;  
5 (1-6) 
Data presented as Mean±SD; median (range) 
 
 
Table 6-9 - Efficacy outcomes at baseline, 3 month follow-up and change score 
between baseline and 3 month follow-up (n=4 unless otherwise stated) 
 Control group Low 
intervention 
group  
High intervention 
group 
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Action Research Arm Test 
 Baseline 36.50±23.22;  
44.50 (3-54) 
16±22.04;  
8 (0-48)  
18.75±12.18;  
20.50 (3-31) 
 3 month follow-up 38±32.91;  
57 (0-57) (n=3) 
41.25±14.52;  
43 (22-57) 
36.67±31.82;  
53 (0-57)(n=3) 
 Change 6±10.82;  
3 (-3-18) (n=3) 
25.25±12.68;  
27 (9-38) 
22±22.60;  
28 (-3-41) (n=3) 
Fugl-Meyer 
 Baseline 37.25±21.72;  
45.50 (6-52) 
30.75±16.09;  
33 (10-47)  
36.25±10.34;  
40 (21-44) 
 3 month follow-up 43.67±22.59;  
46 (20-65) (n=3) 
54±9.63;  
54.50 (42-65) 
49 ±24.27;  
62 (21-64) (n=3) 
 Change 7±11.27;  
13 (-6-14) (n=3) 
23.25±6.70; 
21.50 (18-32) 
14±12.49;  
18 (0-24) (n=3) 
Barthel Index 
 Baseline 9.50±5.32;  
9.50 (4-15) 
6.50±2.38;  
5.50 (5-10) 
9±3.92;  
8 (5-14) 
 3 month follow-up 17.50±1.00;  
18 (16-18) 
18.75±1.26;  
19 (17-20) 
19.33±1.15;  
20 (18-20) (n=3) 
 Change 8±4.69;  
8.50 (3-12) 
12.25±1.71; 
12.50 (10-14) 
12±2.64;  
11 (10-15) (n=3) 
Data presented as Mean±SD; Median (range) 
 
As fewer participants were recruited than had originally been anticipated, the 
intervention groups were combined to assess the effects of any dosage of 
intervention compared to the control group (Table 6-10 and Table 6-11).  The 
trend for higher change scores between baseline and the end of intervention 
assessments and baseline and 3 month follow-up assessments was again 
evident.   
Table 6-10 - Change scores between baseline and end of intervention for control and 
low and high intervention groups combined 
 Control (n=4) Intervention groups combined 
(n=8) 
Action Research Arm Test  6 (8.83); 4.50 (-3-18) 12.25 (13.76); 10 (-3-41) 
Fugl-Meyer 7 (6.05); 6 (1-15) 8.87 (5.64); 8 (1-18) 
Barthel Index 3 (1.83); 3 (1-5) 5.25 (3.06); 5.50 (1-10) 
Data presented as Mean±SD; Median (range) 
 
Table 6-11 - Change scores between baseline and 3 month follow-up for control and 
low and high intervention groups combined 
 Control (n=4) Intervention groups combined 
(n=7) 
Action Research Arm Test  6 (10.82); 3 (-3-18) (n=3) 23.86 (15.93); 28 (-3-41)  
Fugl-Meyer 7 (11.27); 13 (-6-14) 
(n=3) 
19.28 (9.94); 18 (0-32)  
Barthel Index 8 (4.69); 8.50 (3-12)  12.14 (1.95); 12 (10-15) 
Data presented as Mean±SD; Median (range) 
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Blinding of outcome assessor was not achieved in seven cases due to 
participants discussing the interventions that they had received, despite 
being advised not to reveal group assignment to the outcome assessor. 
6.4.5 Secondary outcome: Exploratory outcome  
Following the assumptions outlined in the data analysis section it was 
estimated that 146 participants per group would be required.  As this 
calculation was based on a relatively small number of participants further 
calculations were completed varying the standard deviation by 30% to 
assess the impact on the sample size required.  For a 30% increase in the 
standard deviation (20.49) the sample size requirement is increased to 247 
participants per group and for a 30% reduction in standard deviation (11.03) 
a sample size of 72 per group would be required.  For a larger variability in 
data (using 30% increase in residual standard deviation) 190 participants per 
group would be required for the study still to achieve 80% power. 
6.5 Discussion 
6.5.1 Summary of findings 
This pilot study primarily examined the feasibility and acceptability of a novel 
device within an acute setting for individuals with arm deficits following 
stroke.  In addition to the primary aims the safety and efficacy of this device, 
compared to standard care was also investigated.   
Difficulty recruiting patients into this pilot trial was evident as only 3% 
(12/393) of those admitted to the acute stroke unit were recruited.  Including 
only those with upper limb deficits (n=162) the recruitment rate rises to 7%.  
The limited amount of people eligible to participate in the study was the 
biggest draw back to the feasibility of this intervention within the acute stroke 
setting.  Comparisons between the level of recruitment achieved in this study 
and other studies of upper limb interventions are difficult as few other studies 
have been completed with patients <10 days post-stroke.  Eligibility of 
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individuals recruited to stroke rehabilitation units for constraint-induced 
movement therapy has been reported as 10%352.  For a self-administered 
graded repetitive upper limb supplementary program (GRASP)259 40% of 
patients admitted to a rehabilitation facility with upper limb deficits were 
eligible.  The problems encountered with recruitment to this study may have 
been compounded by the nature of the acute and comprehensive ward on 
which this trial was completed; the full spectrum of stroke patients were 
admitted to this ward, which is different to a rehabilitation setting.   
Per-protocol levels of intensity, using the ArmeoSpring were not found to 
be feasible within the acute setting.  However, increased intensity of direct 
therapeutic intervention, using the novel device was achieved (means of 2 
hours 16 minutes and 3 hours 22 minutes for low and high intervention 
groups respectively).  If transfer to the rehabilitation facility had not occurred 
(as was the case for 6 out of the 8 participants in the intervention groups) 
and if the device was used outwith the context of a trial (less time required to 
commence intervention) it is surmised that more therapy using the 
ArmeoSpring could be achieved.    
The ArmeoSpring was found to be an acceptable intervention and positive 
feedback was received regarding the experience of using the device. 
However, participants also reported that standard care was acceptable.  
Therefore it would be inappropriate to surmise if the intervention under 
investigation was more acceptable to participants than standard care.  These 
findings are only applicable to the participants included in this study.  The 
only other reported trial of a similar device272 also found users were satisfied 
with the device and reported that 90% of subjects preferred this type of 
therapy over conventional training.   
The intervention was found to be safe with no participants suffering any 
serious adverse events during the intervention period.   
Higher change scores for the intervention groups were found between the 
baseline and the end of intervention assessments and baseline and the 3 
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month follow-up assessments on the outcomes relating to (1) upper limb 
functional movement (ARAT) (2) upper limb impairment (F-M) and (3) level of 
disability (BI), when compared to the control group.  On two of the three 
efficacy outcomes (F-M and BI) at the end of the intervention period and on 
all three measures at the 3 month follow-up assessment the mean change 
score was highest in the low intervention group. Statistical analysis was not 
appropriate due to the small number of participants, and therefore limited 
conclusions can be drawn. Nevertheless, this suggestion of a positive effect 
of the intervention concurs with other studies of interventions which have 
included aspects of intensive, task-specific repetitive practice.  Also the 
previous study272 of therapy delivered using a similar device found that 
intervention was associated with modest sustained gains at 6 month follow-
up when compared to conventional training.  However, comparisons between 
studies is difficult as this current study recruited patients much earlier than 
most studies (most robotic studies have recruited patients in the chronic 
phase)181;268;269;272;273 and involved a less intensive protocol.  
Group differences on the ARAT in favour of both intervention groups (4.5 
points for the low intervention group and 8 points for the high intervention 
group) were found at the end of intervention.  A group difference of 3 points 
on the ARAT has been reported as meaningful353.  Minimal clinically 
important change on the ARAT has been reported in different ways.  In acute 
population (as in this study) a minimal clinically important change was found 
to be 12 for affected dominant side and 17 for non-dominant affected side354.  
Within this current study change scores at end of intervention were 6, 10.5 
and 14 (control, low intervention and high intervention groups respectively).  
A change of 6 points on the ARAT has also been suggested as clinically 
significant for individuals with chronic hemiparesis as it represents 10% of 
the total scale351.   
Due to a small sample size and other possible confounding factors the 
findings of this study must be interpreted with caution.  Firstly, imbalance 
between the groups must be considered as weakening the validity of the 
between group comparisons.  The participants in the control group scored 
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considerably higher on the ARAT at baseline than the two intervention 
groups, therefore it must be considered that these subjects had less potential 
for improvement than the subjects in the intervention groups.  This issue was 
compounded by the ceiling effects of the chosen outcome measures.  A 
ceiling effect occurs when a measure possesses a distinct upper limit for 
potential responses and a large concentration of participants score at or near 
this limit (as evident in this study).  Thus further improvement may have 
occurred; however the outcome measures used did not reflect this 
improvement.   
Additionally, the participants in both the intervention groups received more 
standard care, and this may have been a confounding factor.   
The higher change scores at end of intervention assessment and retained at 
3 month follow-up would suggest that there is some beneficial effect of the 
intervention of interest.  However as stated above these findings are 
tentative.   
Within this trial the intervention delivered using the ArmeoSpring was 
conducted on a one-to-one basis with the principal investigator.  Therefore 
the way the intervention was delivered in this trial was no less labour 
intensive than standard therapy.   
With regard to the sample size calculations, caution must be exercised due 
to the number of assumptions made and the fact that the estimation of 
variability of the data was based on only 10 participants.  This note of caution 
is referred to within the MRC complex intervention framework as it is 
acknowledged that when evaluations are scaled up effects may be smaller or 
more variable and response rates lower when the intervention is carried out 
within a wider range of settings and participants59.   
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6.5.2 Limitations of the study  
Several potential limitations of this present study must be considered.  
Primarily the study enrolled only a small number of subjects and therefore 
generalising the results beyond this study population is problematic.  
Secondly it is impossible to determine which components of the therapy; the 
actual ArmeoSpring intervention, the increased therapy time or both 
contributed to the suggestion of positive effect.  A further source of potential 
bias could have been the failure to blind patients and members of the clinical 
team e.g. nursing and therapy to the allocation of treatment group.   
However, it is generally considered difficult to achieve blinding on this level 
within rehabilitation studies.  Blinding of outcome assessor was also 
compromised as seven participants indicated to the outcome assessor which 
group they belonged to.  The intervention groups received intervention from 
the same therapist.  A multi-therapist study is needed to clarify any 
independent effects of the ArmeoSpring, as opposed to the possibility of 
therapist effects.   
The interviews to gain the opinions of the participants were conducted by the 
principal investigator, who was not blinded to treatment group allocation.  
This could have biased the results as participants may not have been truly 
honest and open about their experiences and feelings, and may have been 
overly positive.  However, honest feedback about experiences of therapy 
was encouraged.   
While the outcome measures used in this study reflected a range of abilities, 
no measures relating to real world use of the upper limb or participants 
perceptions of use of the upper limb were utilised.  Additionally, within the 
current study, patient report of ability was generally used to achieve a Barthel 
score.  This could have led to under or over estimating of ability and 
inaccurate scores being gained.  The imbalances between the groups, as 
discussed above and the ceiling effects of the included outcome measures, 
further mean that the findings of this study can only be cautiously explored.    
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6.5.3 Strengths of the study 
This pilot study had many elements of a well-designed trial.  Attempts were 
made to screen all consecutive admissions into an acute stroke unit.  This is 
one of few studies investigating the use of a novel device within an acute 
setting and therefore a feasibility and acceptability design was appropriate. 
Allocation to treatment groups was completed through a randomisation 
procedure, with adequate allocation concealment.  Furthermore, a blinded 
outcome assessor was used for the efficacy outcomes and analysis was 
completed on an intention-to-treat basis at the end of intervention.   
6.5.4 Implications for practice 
This pilot study has limited implications for practice.  The findings of this 
study suggest that a small number of patients are eligible to receive this 
intervention in the acute phase post-stroke and that per-protocol levels of 
intensity are difficult to achieve.  Further research is required before definitive 
conclusions can be made regarding the efficacy of this novel device for 
improving upper limb outcomes.  If such a device is already in place in an 
acute setting it is reasonable to suggest that this should be used as an 
adjunct to standard therapy as it was found to be a safe and acceptable 
intervention in this small-scale study.   
6.5.5 Implications for research 
Randomised controlled trials with larger numbers of participants should be 
considered.  Larger studies with an additional group matched for therapist 
attention would be appropriate.  However, this again raises the question of 
the feasibility of increasing direct therapeutic interventions within the current 
health-care setting.  It is therefore suggested that in order for feasibility to be 
established the intervention should be delivered by ward therapists instead of 
a researcher in future studies.   In order for per-protocol levels of intensity to 
be achieved alternative health-care settings should be considered i.e. a 
combined acute and rehabilitation facility.  Any replication of this study 
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should also consider assessing outcomes at 6 months and 12 months post-
stroke to assess if differences exist between groups within the chronic stage.  
Additionally mechanical data, extracted from the ArmeoSpring is advised 
for future studies to provide objective measures of outcomes.  Included in the 
ArmeoSpring software are tools which allow for accurate, objective 
monitoring of progress, which in addition to an easily understandable 
summary of performance after each game and session, include precise 
assessment of participants ability to move in terms:  of active reaching 
distance, reaction time and movement velocity (A-MOVE), precise, goal 
orientated movements (A-GOAL), inter-limb coordination during active 
movements (A-COORD) and range of motion during active and passive 
movements (A-ROM).  All participants (control and intervention participants) 
should have an assessment using the device at baseline and then at follow-
up assessment points.   
6.6 Conclusions  
This small-scale randomised feasibility study found that implementation of a 
novel device (ArmeoSpring) within an acute stroke setting was challenging.  
Only a limited number of patients were eligible for participation in the study 
and per-protocol levels of intensity of the intervention could not be achieved.  
However, the intervention was found to be safe with positive findings 
reported by participants with regard to acceptability of and satisfaction with 
the intervention.  There was a suggestion that those receiving increased 
intensity of therapy, delivered by the ArmeoSpring achieved greater 
change scores on measures of upper limb recovery and level of disability 
between baseline and end of intervention and 3 month follow-up.  However, 
due to the small number of participants and limitations of the study these 
results must be interpreted with caution.  Further larger studies should be 
conducted to assess the feasibility of use of the ArmeoSpring within 
additional settings and to determine if any significant effects exist between 
groups.  Since completion of this feasibility study, the experiences 
encountered have been used to inform the design of two larger scale studies, 
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which are designed to investigate the use of devices in arm rehabilitation 
(personal communication).    
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Chapter 7  Conclusions 
This thesis set out to investigate issues and accumulate information relating 
to upper limb interventions following stroke.  This has been achieved using a 
number of methods. 
Throughout my research I used the Medical Research Council (MRC) 
complex intervention framework as a guide in order to provide information for 
a phase III randomised controlled trial (evaluation stage of the framework) 
that was theoretically-defensible, reproducible and adequately controlled, 
with adequate statistical power.  This thesis focused on the developmental 
and feasibility/piloting phases of the framework.   
In order to identify the relevant evidence base a number of systematic 
reviews were undertaken to establish what is already known about 
interventions targeted at the upper limb.  Additionally, a systematic review of 
predictive variables was completed to allow for better understanding of 
likelihood of recovery and identify potential predictive variables to stratify 
patients in a planned trial.  These reviews contributed to the development of 
relevant theory within this area.  Additionally completion of these reviews, 
and the other two reviews gave me the opportunity to; further consider upper 
limb problems and possible aspects associated with recovery, identify an 
appropriate intervention, understand the characteristics of beneficial 
interventions and consider important factors such as appropriate outcomes 
and control intervention.  The Cochrane systematic reviews that were 
undertaken were relevant to the undertaking of a feasilibty study of an 
electromechanical device as some such devices have a bilateral element 
and therefore when considering which device to study it was worth 
investigating if a device with such an element would have added benefit.   
With a push toward community rehabilitation, instead of prolonged 
rehabilitation within a hospital setting, devices which can be easily used with 
outpatients or within the home setting require to be investigated.  Currently 
there are limited devices which can be used at home.  
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Electromechanical/robotic devices also provide the possibility of providing an 
adjunct to other types of interventions, as it is unlikely that patients would 
only receive rehabiltiaiton with a device (patients would usually receive a 
programme of therapy).     
The feasibility trial that was undertaken assessed recruitment rates and 
feasibility of delivering per-protocol intensity of interventions, acceptability of 
the intervention and allowed for cautious estimation of sample size to be 
provided.   
Within this conclusions chapter I will outline the main results from each 
section of this thesis, in relation to the original research objectives.  In 
addition, challenges encountered and areas for future development will be 
discussed. 
7.1 Key Findings 
7.1.1 Predictors of upper limb recovery 
The first research objective was to identify predictive variables of upper limb 
recovery after stroke.  This was completed using systematic review 
methodology, with included meta-analysis. 
A large number of studies met the inclusion criteria for this review.  The most 
consistent and robust evidence indicated that initial measures of upper limb 
function and impairment and neurophysiological measures can predict upper 
limb recovery. Moderate evidence of association was found for the variables 
of global disability and lower limb impairment.   
7.1.2 Interventions targeted at upper limb recovery 
This systematic review and accompanying meta-analysis provided a 
summary of the existing evidence for interventions targeted at upper limb 
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recovery following stroke.  In total thirteen interventions were identified, eight 
of which suggested beneficial or promise of beneficial effects.   
Despite the heterogeneous nature of the evidence available there was 
consistent evidence to suggest that interventions with elements of intensive, 
repetitive, task-specific practice are likely to have favourable outcomes in 
terms of upper limb recovery after stroke.   
7.1.3 Effectiveness of two specific interventions 
Two Cochrane systematic reviews were completed to contribute high quality 
evidence to the existing evidence base of upper limb interventions.   
The first review investigated bilateral training.  Although eighteen trials were 
included in this review, firm conclusions could not be drawn due to 
insufficient high quality evidence.  The available evidence indicates that 
bilateral training is no more (or less) effective than usual care or unilateral 
training for functional or motor impairment outcomes.   
The second Cochrane review focused on home-based therapy interventions.  
This review was completed as increasingly stroke services are being 
provided in the community.  Only four small randomised controlled trials met 
the inclusion criteria for this review and therefore no conclusions could be 
drawn regarding the effects of such interventions.  
7.1.4 Identify and evaluate a novel, evidence-based 
intervention 
Following completion of a thorough examination of the existing evidence-
base I wanted to identify and then evaluate a novel, evidence-based 
intervention as per my research objectives.  From the research evidence I 
chose a repetitive, task-specific, intensive intervention (ArmeoSpring).  
Electromechanical/robotic devices had suggested a potential positive effect 
for upper limb recovery.   
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A pilot feasibility study of stroke patients with upper limb deficits within an 
acute stroke unit was undertaken with the primary aim of establishing the 
feasibility and acceptability of the ArmeoSpring device as a way of 
providing repetitive, task-specific, intensive practice.  Secondary outcomes of 
safety and efficacy were also considered.  This feasibility study 
demonstrated that recruiting into such a trial, in an acute setting is 
challenging and that per-protocol levels of intensity of intervention were not 
feasible to provide.  However, increased levels of therapeutic intervention 
were achieved and this novel intervention was found to be acceptable to 
participants.  This pilot trial also demonstrated a higher change in efficacy 
outcomes within both intervention groups than in the control group; although 
this is an indicative finding rather than a statistically significant result.  
Furthermore, due to small sample size and other confounding factors these 
findings must be interpreted with caution.   
7.2 Challenges encountered  
The systematic reviews were all primarily limited by the heterogeneity of the 
available studies.   
In particular, the predictive variable review proved to be complex and 
challenging, and took longer than originally anticipated.   Interpretation of the 
results was complicated by methodological factors including variations in 
study populations, upper limb motor outcome scales, timing of baseline and 
outcome assessments and predictors selected.  
The systematic review and meta-analysis of interventions was limited by 
small numbers of participants and trials and heterogeneous outcome 
measures and interventions.  A larger number of participants, within a larger 
number of more homogenous trials would obviously have been preferable.   
The two Cochrane reviews were mainly limited by the lack of high quality 
evidence, particularly within the home-based therapy review.  Further 
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limitations of the home-based therapy review, in terms of definition of the 
intervention are also acknowledged.   
Within the feasibility trial the recruitment rate was lower than expected and 
hoped for.  To overcome this, recruitment could have been extended.  
However, within the constraints of time and funding this would not have been 
practical, unless recruitment had been started earlier.  Unfortunately, due to 
only having access to one ArmeoSpring device involvement of more than 
one site was also not practical.  Despite these limitations the information 
gained from this study provides important information for future studies and it 
served the purpose of a feasibility study, as proposed by the MRC complex 
intervention framework.   
7.3 Future directions 
The rehabilitation research community need to consider a number of factors 
which have been highlighted throughout this thesis. 
Adequate reporting of methods undertaken in trials is essential.  This thesis 
has identified that poor reporting is often evident and this makes reviewing 
and summarising the available evidence problematic.   
A consensus on a core set of relevant outcome criteria for upper limb 
recovery would be useful to allow for more accurate comparison of trials.  It 
is suggested that such a dataset should include outcome measures, which 
are relevant to all domains of the International Classification of Functioning, 
Disability and Health (ICF)19. 
With regard to the particular findings of this thesis, trials of upper limb 
interventions should consider stratifying participants according to appropriate 
variables and interventions targeted at the upper limb should incorporate 
elements of intensive, task-specific and repetitive practice.   
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Interventions targeted at upper limb recovery is an area which is continually 
growing and it is clear from the work undertaken in this thesis that further 
research is required for evidence to be applicable and relevant in all clinical 
settings.   
Further developmental, feasibility/piloting work is suggested as this thesis 
gave limited consideration to the implementation of the ArmeoSpring 
device, in terms of clinicians’ perceptions and likelihood of funding being 
available for such a device.  Such considerations form an important part of 
the development process (modelling process and outcomes) of the MRC 
complex intervention.  
This thesis used the MRC complex intervention framework as a guide to 
identify and evaluate a novel intervention for upper limb recovery following 
stroke.  The information gained; appropriate variables to stratify patients, 
characteristics of beneficial interventions, feasibility of recruiting and 
providing intensive levels of per-protocol interventions within an acute stroke 
unit and sample size estimation, would not only be useful to plan a further 
study of the ArmeoSpring device but also for randomised controlled trials of 
other upper limb interventions.   
Therefore in conclusion a future large scale study of the ArmeoSpring is 
recommended, once further work (outlined above) is completed.  It is 
recommended that such a study be completed in a setting where patients are 
not transferred to another location within a short time frame.   Furthermore 
stratification on the basis of clinical baseline measures is suggested.  For a 
future study I would propose only a two group study with the intervention 
group receiving more toward the low-intensity amount of ArmeoSpring 
intervention (40 minutes a day 3 times a week) and the control group 
receiving standard care.  In terms of outcome measure I would advocate the 
use of the Action Research Arm Test as the primary outcome measure, with 
additional measures incorporating motor impairment of the upper limb, ability 
in ADL and perceived usage of the upper limb.  It is also my suggestion that 
mechanical data, incorporated within the software of the device be included 
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as an objective outcome measure.  Longer-term follow-up (6-12 months) is 
also proposed to assess effects of the intervention in the longer term.   
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Appendix A – Upper limb functional outcomes 
Table A-1 - Secondary analysis – (ii) Results of association between predictor variables and functional outcomes of upper limb recovery 
Variable Total no. of 
studies 
(participants) 
Vote counting 
(significant 
association) 
Strength of 
evidence analysis  
Statistical analysis 
No. of studies 
(participants) 
Odds ratio (95% CI) 
Statistical 
conclusion 
Combined assessment of 
evidence.   
Demographic factors  
Age  
(younger vs. older) 
965;96;109;119;121;125;12
6;130;133
 (n=766) 
1125 (n=57) Strong evidence of 
no association 
365;96;130 (n=278) 
1.31 (0.75 - 2.29) 
 No significant 
association 
Strong evidence of no 
association between age and 
upper limb functional recovery.  
Sex  
(male vs. female) 
965;96;109;114;119;121;12
5;130;133 (n=750) 
0 Strong evidence of 
no association 
465;96;114;130 (n=312) 
1.53 (1.02 – 2.32) 
Significant 
association 
Inconclusive evidence.  
Suggestion that males are more 
likely to have better upper limb 
functional recovery. 
Time since stroke 
(less vs. more 
time) 
665;76;125;130;133;149  
(n=1498) 
565;125;133;141;149 
(n=1343) 
Moderate evidence 
of association 
265;130 (n=256) 
1.06 (1.02 – 1.10) 
Significant 
association 
Moderate evidence of 
association.  Those less time 
since stroke more likely to have 
better upper limb functional 
recovery. 
Social support 
(yes/no) 
165 (n=100) 0 Limited evidence of 
no association 
165 (n=100) 
1.41 (0.84 – 2.38) 
No significant 
association 
Limited evidence of no 
association between level of 
social support and upper limb 
recovery.  
Severity of stroke – global factors 
Global disability 
(less vs. more 
disability) 
665;96;99;125;131;133 
(n=524) 
565;99;125;131;133 
(n=502) 
Moderate evidence 
of association 
365;96;131 (n=188) 
2.47 (0.87 – 7.04) 
 
No significant 
association 
Inconclusive evidence of 
association between global 
disability and upper limb 
functional recovery. 
Type/Class of 
stroke (less vs. 
more severe) 
465;119;130;133  
(n=533) 
 
265;130 (n=256) 
 
Inconclusive 
evidence 
265;130 (n=256) 
3.54 (0.46 – 27.34) 
I2=95% 
No significant 
association 
Inconclusive evidence of 
association between severity of 
stroke and upper limb functional 
recovery.    
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Urinary 
incontinence 
(absent vs. 
present) 
465;126;130;139  
(n=382) 
265;130 (n=256) Inconclusive 
evidence 
265;130 (n=256) 
4.12 (1.82 – 9.32) 
I2=55.2% 
Significant 
association 
Inconclusive evidence relating to 
the association between urinary 
incontinence and upper limb 
functional recovery.   
Global impairment 
(less vs. more 
impairment) 
2109;119 (n=113) 2109;119 (n=113) Limited evidence of 
association 
0 NA Limited evidence of association 
between global impairment and 
upper limb functional recovery. 
Lesion size/volume 
(smaller vs. larger) 
2101;114 (n=86) 
 
0 Limited evidence of 
no association 
1114 (n=34) 
1.20 (0.70 - 2.05) 
 
No significant 
association 
Limited evidence of no 
association between infarction 
size/volume and upper limb 
functional recovery.   
Level of 
consciousness at 
onset (GCS) 
165 (n=100) 165 (n=100) Limited evidence of 
association 
1 (n=100) 
1.03 (1.01 – 1.06) 
Significant 
association 
Limited evidence of association 
between level of consciousness 
at onset and upper limb 
functional recovery.   
7th Cranial nerve 1109 (n=58) 1109 (n=58) Limited evidence of 
association 
0 NA Limited evidence of association 
between 7th cranial nerve 
involvement and upper limb 
functional recovery.  
Bowel function 1126 (n=50) 0 Limited evidence of 
no association 
0 NA Limited evidence of no 
association between bowel 
function and upper limb 
functional recovery.   
Severity of stroke –focal factors 
UL baseline  
impairment 
measures (less vs. 
more impairment)* 
20 (n=1838) 
27;65;75;76;89;99;100;102;1
09;114;119;121;125;130;131
;133;135;138;140;142
 
1427;65;75;76;89;99;10
9;114;125;130;131;133;1
35;142
 (n=1634) 
Strong evidence of 
association 
927;65;89;100;121;130;131;135;142  
(n=1235)  
18.66 (9.80 – 35.53) 
Significant 
association 
Strong evidence of association.  
Those with less initial UL 
impairment are more likely to 
have better upper limb functional 
recovery. 
UL baseline 
functional 
measures (more 
vs. less function)** 
9101;102;109;119;124;126;
133;142;149
 (n=1503) 
9101;102;109;119;124;1
26;133;142;149
 
(n=1503) 
Strong  evidence of 
association  
3101;124;142 (n=149) 
51.97 (9.34 – 289.03) 
Significant 
association 
Strong evidence of association.   
Those with more initial upper 
limb function are more likely to 
have better upper limb functional 
recovery. 
Lower limb 
impairment (less 
vs. more 
impairment) 
365;119;130 (n=311) 365;119;130 
(n=311) 
Moderate evidence 
of association 
265;130 (n=256) 
10.65 (4.94 – 22.94) 
Significant 
association 
Moderate evidence of 
association.  Those with less leg 
impairment more likely to have 
better upper limb functional 
recovery. 
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Co-factors (associated with stroke severity) 
Side of stroke  
(left vs. right) 
965;96;99;109;119;121;125;
130;133
 (n=773) 
265;130 (n=256) Moderate evidence 
of no association 
465;96;99;130  (n=335) 
1.49 (0.82 – 2.71) 
No significant 
association 
Moderate evidence of no 
association between side of 
stroke and upper limb functional 
outcomes.   
Cognition and 
perception (no 
deficit vs. deficit)*** 
765;76;99;109;130;133;139 
(n=685)  
376;109;130 
(n=230) 
Inconclusive 
evidence 
365;99;130 (n=313) 
2.01 (0.79 – 5.15) 
I2=92.6% 
No significant 
association 
Inconclusive evidence relating to 
the association between 
cognition and perception and 
functional upper limb recovery.   
UL sensation  
(no deficit vs. 
deficit) 
565;99;109;121;139 
(n=337) 
365;99;109 (n=215) Inconclusive 
evidence 
165 (n=100) 
1.89 (1.33 – 2.69) 
Significant 
association  
Inconclusive evidence.  
Suggestion that absence of 
sensory deficit is associated with 
better upper limb functional 
recovery. 
Visual disorders 
(absent vs. 
present) 
365;109;130 (n=314) 365;109;130 
(n=314) 
Moderate evidence 
of association 
265;130 (n=256) 
5.22 (2.40 – 11.36) 
Significant 
association 
Moderate evidence of 
association.  Those with absence 
of a visual disorder more likely to 
have better upper limb functional 
recovery.   
Sitting balance  
(no deficit vs. 
deficit) 
365;126;130 (n=306) 1130 (n=156) Inconclusive 
evidence  
265;130 (n=256) 
4.75 (0.28 – 80.53) 
I2=96.8% 
No significant 
association 
Inconclusive evidence.  
Suggestion of no association 
between sitting balance and 
upper limb functional recovery.   
Stroke location 299;101  (n=109) 299;101 (n=109) Limited evidence of 
association 
Unable to pool data 
 
Unable to pool data Limited evidence of association 
between stroke location and 
upper limb functional recovery.  
Shoulder 
complications  
(absent vs. 
present) 
2109;139 
 (n=134) 
2109;139 (n=134) Limited evidence of 
association   
0 NA Limited evidence of association.  
Those with absent shoulder 
complications more likely to have 
better upper limb functional 
recovery. 
Speech disorders 
(absent vs. 
present)  
1109  (n=58) 1109 (n=58) Limited evidence of 
association 
0 NA Limited evidence of association.  
Those with no speech disorders 
more likely to have better upper 
limb functional recovery. 
Handedness (right 
vs. left vs. 
ambidextrous) 
1109 (n=58) 0 Limited evidence of 
no association 
0 NA Limited evidence of no 
association between handedness 
and upper limb functional 
recovery. 
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Sensation (no 
deficit vs. 
deficit)**** 
2130;133 (n=378) 1130 (n=156) Inconclusive 
evidence 
1130 (n=156) 
9.15 (3.36 – 24.89) 
Significant 
association 
Inconclusive evidence relating to 
association between sensation 
and upper limb functional 
recovery. 
No. of comorbid 
conditions (less vs. 
more) 
2119;130 (n=211) 0 Limited evidence of 
no association 
1130 (n=156) 
1.96 (0.96 – 3.98) 
No significant 
association 
Limited evidence of no 
association between no. of 
comorbid conditions and upper 
limb functional recovery.   
Rt-PA (yes/no) 1130 (n=156) 0 Limited evidence of 
no association 
1130 (n=156) 
1.73 (0.81 – 3.73) 
No significant 
association 
Limited evidence of no 
association between Rt-PA and 
upper limb recovery. 
No. of previous 
strokes 
1109 (n=58) 1109 (n=58) Limited evidence of 
association 
0 NA Limited evidence of association 
between number of previous 
strokes and upper limb functional 
recovery.   
 
Duration for stroke 
to develop 
1109 (n=58) 1109 (n=58) Limited evidence of 
association 
0 NA Limited evidence of association 
between duration for stroke to 
develop and upper limb 
functional recovery.   
Pain in arm  1109 (n=58) 1109 (n=58) Limited evidence of 
association 
0 NA Limited evidence of association 
between pain in arm and upper 
limb functional recovery.  
Sit to stand 1126 (n=50) 0 Limited evidence of 
no association 
0 NA Limited evidence of no 
association between sit to stand 
and upper limb functional 
recovery.   
Proximal/Distal 
paresis 
1114 (n=34) 0 Limited evidence of 
no association 
1 (n=34) 
9.09 (0.26 – 333.33) 
No significant 
association 
Limited evidence of no 
association between distribution 
of paresis and upper limb 
functional recovery. 
Neurophysiological factors 
Motor evoked 
potentials  
(present vs. 
absent) 
596;114;115;135;144 
(n=191) 
396;115;135  
(n=136) 
Inconclusive 
evidence 
496;114;135;144  (n=115) 
8.75 (0.94 – 81.80) 
No significant 
association 
Inconclusive evidence of 
association between presence of 
MEPs and better upper limb 
recovery.   
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Somatosensory 
evoked potentials  
(present vs. 
absent)***** 
2122;124  
 (n=87) 
2122;124 (n=87) Limited evidence of 
association.   
1124 (n=68) 
35.14 (4.18 – 295.19) 
Significant 
association 
Limited evidence of association.  
Those with present SSEPs are 
more likely to have better upper 
limb functional recovery. 
Pre-morbid function 
Pre-stroke ability 1109 (n=58) 0 Limited evidence of 
no association   
0 NA Limited evidence of no 
association between pre-stroke 
ability and upper limb functional 
recovery. 
Pre-stroke mental 
status 
1109 (n=58) 0 Limited evidence of 
no association   
0 NA Limited evidence of no 
association between pre-stroke 
mental status and upper limb 
functional recovery.   
Footnotes:   
0 – no studies able to be included in statistical analysis 
NA – no conclusions could be drawn from statistical analysis as no studies were available for inclusion in meta-analysis 
Unable to pool data – due to differences in way data presented unable to sensibly combine in a meta-analysis 
I2 data only given if I2>50% 
 
*Au-Yeung 200999 - 2 variables; Motricity Index (MI) and Composite Spasticity Scale.  MI (chosen for analysis) significant; Composite Spasticity Scale non-significant association.  
*Beebe 2009100 - 10 variables; NIHSS motor arm and Active range of movement at 9 segments of upper extremity. NIHSS motor arm (chosen for analysis as odds ratios could be calculated for 
association with ARAT at 3 months) non-significant.  All 9 segments of AROM significant association with upper extremity function score.  
*Katrak 1998121 - 3 variables; hand movement scale, shoulder shrug and shoulder abduction.  Hand motor scale (chosen for analysis) and shoulder abduction non-significant association.  Shoulder 
shrug had a significant association.   
*Park 2008133 - 4 variables of upper limb impairment; Fugl-Meyer (F-M) UL (chosen for analysis) and spasticity of elbow, flexors and wrist flexors.  F-M significant.  Other variables non-significant.   
*Renner 2009138 - 5 variables; hand grip, rise of rate of tension of hand grip, wrist extension, rate of rise of tension of wrist extension and isotonic wrist extension acceleration.  Hand grip (chosen for 
analysis) and wrist extension non-significant association.  Other variables had a significant association.   
 
**Canning 2004102 - 2 variables; Motor Assessment Scale (MAS) and dexterity.  MAS (chosen for analysis) significant association; dexterity non-significant association.  
**Loewen 1990126 – 2 variables; Modified MAS combined arm score and upper arm function scales.  Combined arm score (chosen for analysis) significant; upper arm function non-significant.   
 
***Kwakkel 200365 – 2 variables; MMSE and visual inattention (letter cancellation test).  MMSE (chosen for analysis) no significant association; visual inattention found to have a significant 
association.   
***De Weerdt 1987109 – 3 variables; Post stroke mental status, tactile hemi-inattention and stereognosis.  Post stroke mental status (chosen for analysis) and tactile hemi-inattention significant 
association.  Stereognosis non-significant association.   
 
****Park 2008133 - 2 variables;  light touch and proprioception.  Light touch (chosen for analysis) non-significant association; proprioception significant association.   
 
******Al-Rawi 200998 – 3 variables; N20 latency, peak to peak amplitude and amplitude ratio.  N20 latency (chosen for analysis) and peak to peak amplitude positively correlated.  No relationship 
reported for amplitude ratio.    
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Appendix B  – Upper limb impairment outcomes 
Table B-1 - Secondary analysis – (iii) Results of association between predictor variables and impairment outcomes of upper limb recovery 
Variable Total no. of 
studies 
(participants) 
Vote counting 
(significant 
association) 
Strength of 
evidence analysis  
Statistical analysis 
No. of studies 
(participants) 
Odds ratio (95% CI) 
Statistical 
conclusion 
Combined assessment of 
evidence.   
Demographic factors  
Age  
(younger vs. older) 
1857;70;74;96;106;109;113
;121;125;129;132;134;136;1
41;143;144;146;150
  
(n=1120) 
157 (n=108) Strong evidence of 
no association 
996;106;113;129;134;141;143;144;150 
(n=334) 
1.92 (1.16 – 3.17) 
Significant 
association 
Inconclusive evidence.  
Suggestion that younger 
people are more likely to have 
better upper limb recovery in 
terms of impairment.   
Sex  
(male vs. female) 
1670;74;96;106;109;121;12
5;129;132;134;136;141;143;
144;146;150
 (n=804) 
0 Strong evidence of 
no association 
896;106;129;134;141;143;144;150 
(n=134) 
1.80 (0.85 – 3.82) 
No significant 
association 
Strong evidence of no 
association between sex and 
upper limb recovery in terms of 
impairment.   
Time since stroke 
(less vs. more 
time) 
674;113;125;129;132;141  
(n=565) 
1125 (n=57) Moderate evidence 
of no association 
3113;129;141 (n=230)  
2.14 (1.12 – 4.07) 
Significant 
association 
Inconclusive evidence of 
association between time 
since stroke and upper limb 
recovery in terms of 
impairment.   
Socioeconomic 
status 
163 (n=419) 163 Limited evidence of 
association 
NA NA Limited evidence of 
association between 
socioeconomic status and 
upper limb recovery.   
Severity of stroke – global factors 
Global disability 
(less vs. more 
disability) 
1257;68-
70;96;110;125;127;134;137;
141;143
 (n=474) 
657;70;96;110;125;134 
(n=348) 
Inconclusive 
evidence 
769;96;127;134;137;141;143 
(n=122) 
6.11 (2.45 – 15.23) 
 
Significant 
association 
Moderate evidence of 
association.  Those with less 
initial disability more likely to 
have better upper limb 
recovery in terms of 
impairment.   
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Global impairment 
(less vs. more 
impairment) 
474;109;113;127 
(n=435) 
274;109 (n=229) Inconclusive 
evidence  
2113;127 (n=209) 
2.19 (0.35 - 13.90) 
No significant 
association 
Inconclusive evidence of 
association between global 
impairment and upper limb 
recovery in terms of 
impairment.     
Type/Class of 
stroke (less vs. 
more severe) 
357;74;110 (n=329) 
 
257;74  (n=279) 
 
Limited evidence of 
association 
0 NA Limited evidence of 
association.  Those with less 
severe strokes more likely to 
have better upper limb 
recovery in terms of 
impairment.   
Lesion size/volume 
(smaller vs. 
larger)* 
3106;134;150 (n=46) 0 Limited evidence of 
no association 
2106;150 (n=31) 
2.65 (0.41 – 17.18) 
 
No significant 
association 
Limited evidence of no 
association between infarction 
size/volume and upper limb 
recovery.   
Urinary 
incontinence 
(absent vs. 
present) 
1139  (n=76) 0 Limited evidence of 
no association 
0 NA Limited evidence of no 
association. 
7th Cranial nerve 1109 (n=58) 1109 (n=58) Limited evidence of 
association 
0 NA Limited evidence of 
association between 7th cranial 
nerve involvement and upper 
limb recovery.  
Severity of stroke –focal factors 
UL baseline  
impairment 
measures (less vs. 
more impairment)** 
2827;57;69;70;74;75;97;98;
100;106;108-
110;121;125;127;129;132;13
5;138;140;141;143-
145;147;148;150
 
(n=1338) 
1727;57;70;74;75;98;10
9;125;127;129;132;135;1
38;144;145;147;148
  
(n=1055) 
Strong evidence of 
association 
1627;69;75;97;100;106;108;121;127;1
29;135;141;143;144;147;150
  
(n=483) 
11.46 (6.03 – 21.79) 
Significant 
association 
Strong evidence of 
association.  Those with less 
initial UL impairment are more 
likely to have better upper limb 
recovery in terms of 
impairment.   
Lower limb 
impairment (less 
vs. more 
impairment) 
374;147;150 (n=223) 274;147 (n=206) Limited evidence of 
association 
2147;150 (n=52) 
21.15 (4.29 – 104.16) 
Significant 
association 
Limited evidence of 
association.  Those with less 
LL impairment more likely to 
have better upper limb 
recovery in terms of 
impairment.   
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UL baseline 
functional 
measures (more 
vs. less function) 
1127 (n=9) 0 Limited evidence of 
no association 
1127 (n=9) 
12.60 (0.45 – 352.78) 
No significant 
association 
Limited evidence of no 
association between initial UL 
functional measures and upper 
limb recovery in terms of 
impairment.   
Hand grip 
asymmetry 
1141 (n=17) 0 Limited evidence of 
no association 
0 NA Limited evidence of no 
association between hand grip 
asymmetry and upper limb 
recovery in terms of 
impairment.  
Co-factors (associated with stroke severity) 
Side of stroke  
(left vs. right) 
1670;74;96;106;107;109;11
3;121;125;129;132;134;141;
143;144;146
 (n=916) 
0 Strong evidence of 
no association 
896;106;113;129;134;141;143;144 
(n=331) 
1.18 (0.73 – 1.90) 
No significant 
association 
Strong evidence of no 
association between side of 
stroke and upper limb recovery 
in terms of impairment.   
UL sensation  
(no deficit vs. 
deficit) 
957;70;109;113;121;132;13
9;141;148  
 (n=702) 
457;109;113;132  
(n=427) 
Inconclusive 
evidence 
2113;141 (n=171) 
2.02 (1.06 – 3.84) 
Significant 
association  
Inconclusive evidence.  
Suggestion that absence of 
sensory deficit is associated 
with better upper limb recovery 
in terms of impairment. 
Stroke location 674;111;134;136;141;150 
(n=396) 
174 (n=171)  Moderate evidence 
of no association 
Unable to pool data 
 
Unable to pool data Moderate evidence of no 
association between stroke 
location and upper limb 
recovery in terms of 
impairment.   
Cognition and 
perception (no 
deficit vs. deficit)*** 
570;74;109;113;139 
(n=550)  
274;109 (n=229) Inconclusive 
evidence 
1113  (n=149) 
1.53 (0.77 – 3.04) 
No significant 
association 
Inconclusive evidence relating 
to the association between 
cognition and perception and 
upper limb recovery in terms of 
impairment.   
Shoulder 
complications  
(absent vs. 
present)**** 
570;109;132;139;148 
(n=376) 
2109;139  (n=134) Inconclusive 
evidence 
0 NA Inconclusive evidence of 
association between shoulder 
complications and upper limb 
recovery in terms of 
impairment.  
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Handedness (right 
vs. left vs. 
ambidextrous) 
274;109 (n=229) 0 Limited evidence of 
no association 
0 NA Limited evidence of no 
association between 
handedness and upper limb 
recovery in terms of 
impairment. 
Visual disorders 
(absent vs. 
present) 
270;109 (n=154) 1109 (n=58) Inconclusive 
evidence 
0 NA Inconclusive evidence relating 
to association between visual 
disorders and upper limb 
recovery in terms of 
impairment.  
Speech disorders 
(absent vs. 
present)  
270;109  (n=154) 1109 (n=58) Inconclusive 
evidence   
0 NA Inconclusive evidence relating 
to association between speech 
disorders and upper limb 
recovery in terms of 
impairment.  
Length of stay 1132 (n=107) 0 Limited evidence of 
no association 
0 NA Limited evidence of no 
association between length of 
stay and upper limb recovery 
in terms of impairment.   
Mood  170 (n=96) 0 Limited evidence of 
no association 
0 NA Limited evidence of no 
association between mood and 
upper limb recovery in terms of 
impairment.  
No. of previous 
strokes 
1109 (n=58) 1109 (n=58) Limited evidence of 
association 
0 0 Limited evidence of 
association between number 
of previous strokes and upper 
limb recovery in terms of 
impairment.    
Duration for stroke 
to develop 
1109 (n=58) 1109 (n=58) Limited evidence of 
association 
0 NA Limited evidence of 
association between duration 
for stroke to develop and 
upper limb recovery in terms of 
impairment. 
Pain in arm  1109 (n=58) 1109 (n=58) Limited evidence of 
association 
0 NA Limited evidence of 
association between pain in 
arm and upper limb recovery in 
terms of impairment. 
Neurophysiological factors 
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Motor evoked 
potentials  
(present vs. 
absent)***** 
1869;96;103;104;106;107;1
10;112;115;116;118;120;129
;135;137;141;143;147
 
(n=632) 
1469;103;107;110;112;1
15-
117;120;129;135;137;143
;147
  (n=529) 
Strong evidence of 
association 
1369;96;104;106;116;118;120;129;13
5;137;141;143;147
 
 (n=370) 
12.40 (5.21 – 29.53) 
Significant 
association 
Strong evidence of 
association.  Those with 
present MEPs are more likely 
to have better upper limb 
recovery in terms of 
impairment.   
Somatosensory 
evoked potentials  
(present vs. 
absent) 
598;112;116;122;124;145  
(n=212) 
598;112;116;122;124;14
5 
 (n=212) 
Strong evidence of  
association  
1116 (n=29) 
6.66 (1.13 – 39.25) 
Significant 
association 
Strong evidence of 
association.  Those with 
present SSEPs are more likely 
to have better upper limb 
recovery in terms of 
impairment. 
Diffusion tensor 
tractography (DTT) 
(preserved 
corticospinal tract 
or not) 
3105;120;150 (n=125) 3105;120;150 
(n=125) 
Limited evidence of 
association 
2120;150 (n=70) 
35.46 (8.97 – 140.10) 
 Limited evidence of 
association.  Those with 
preserved corticospinal tract 
(determined by DTT) more 
likely to have better upper limb 
recovery in terms of 
impairment.   
Pre-morbid function 
Pre-stroke ability 1109 (n=58) 0 Limited evidence of 
no association   
0 NA Limited evidence of no 
association between pre-
stroke ability and upper limb 
recovery. 
Pre-stroke mental 
status 
1109 (n=58) 0 Limited evidence of 
no association   
0 NA Limited evidence of no 
association between pre-
stroke mental status and upper 
limb recovery.   
Footnotes:   
0 – no studies able to be included in statistical analysis 
NA – no conclusions could be drawn from statistical analysis as no studies were available for inclusion in meta-analysis 
Unable to pool data – due to differences in way data presented unable to sensibly combine in a meta-analyses 
 
* Prabhakaran 2008136 -  2 variables; subcortical lesion volume (significant) cortical lesion volume (non-significant).  Not included in any analysis.   
 
**Escuardo 1998110 reported a negative association between upper limb impairment at baseline and outcome.  Not included in analysis. 
** Katrak 199075 - 2 variables; Hand Movement Scale (HMS) (chosen for analysis) non-significant, significant association for shoulder shrug.   
** Katrak 1998121 - 3 variables; HMS, shoulder shrug and shoulder abduction.  HMS (chosen for analysis) and shoulder shrug significant association.  Shoulder abduction non-significant. 
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**Loubinoux 2003127 – 4 variables; MI, finger tapping test, dynamometer and MI (hand section).  MI (chosen for analysis) found to have a significant association.  Other three non-significant.   
**Paci 2007132 – 2 variables; Fugl-Meyer (upper limb section), Fugl-Meyer (ROM/pain score).  Fugl-Meyer (chosen for analysis) significant association.  Other variable non-significant association.   
**Smania 2007140 - 4 variables; active finger extension, shoulder shrug, shoulder abduction and HMS.  HMS (chosen for analysis), shoulder shrug and shoulder abduction no significant association 
reported.  Significant association reported for active finger extension. 
 
***De Weerdt 1987109 - 3 variables; Post stroke mental status, tactile hemi-inattention and stereognosis.  Post stroke mental status (chosen for analysis) and tactile hemi-inattention found to have a 
significant association.  Stereognosis found to have non-significant association.   
***Feys 200070 – 5 variables; Mini mental state examination, body image disturbance, locus of control scale, visual hemi-inattention and tactile hemi-inattention.  MMSE (chosen for use in analysis) 
found to have a non-significant association, 3 others non-significant.  Locus of control found to have a significant association.    
 
****Paci 2007132 – 2 variables; pain (chosen for analysis) not significantly associated, other predictor (subluxation) significantly associated. 
 
*****Rapisarda 1996137 - 2 variables; present/absent (chosen for use in analysis) significant; other variable (CMCT) variable non-significant.   
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Appendix C – Details of included studies 
Details of included trials for each intervention category as used in the review 
of interventions 
Table C-1 - Approaches to therapy (Bobath) 
Trials                                           
 
Participants
recruited; 
reported at 
outcome  
Interventions Comparison Outcome(s)  
Other review168 
Gelber 1995169 27; 19 Neurodevelopmental 
techniques (Bobath) 
Traditional 
functional 
retraining 
approach 
Box and Block 
Test (BBT) 
Nine Hole Peg 
Test (NHPT) 
Langhammer 
2000170 
61; 53 Bobath physiotherapy Motor 
relearning 
programme  
Motor Assessment 
Scale (MAS) (arm 
section) 
MAS (hand 
section) 
Logigian 1983171 
(male and 
female 
subgroups) 
42  Facilitation approach 
(Bobath) 
Traditional 
approach  
Manual Muscle 
Test (MMT) 
Platz 2005172 42  Bobath therapy 
(augmented Bobath 
therapy) 
Arm BASIS 
Training 
(augmented 
therapy time) 
Action Research 
Arm Test (ARAT) 
van Vliet 2005173 120; 85 Bobath physiotherapy Movement 
science based 
physiotherapy 
MAS (upper arm) 
MAS (hand 
movements) 
 
  
Table C-2 - Bilateral training  
Trials                                           
 
Participants
recruited; 
reported at 
outcome 
Interventions Comparison Outcome(s)  
Cochrane review174 
Cauraugh 
2002175 
20  Bilateral training 
+ EMG triggered 
stimulation 
Unilateral 
training +EMG 
triggered 
stimulation 
BBT – no 
poolable data 
available 
Cauraugh 
2008176 
16 Bilateral training 
+ EMG triggered 
stimulation 
Unilateral 
training +EMG 
triggered 
stimulation 
BBT 
Desrosiers 
2005177 
41; 33 Bilateral training Usual care BBT 
Purdue 
Pegboard Test 
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Lin 2009a178 40 Bilateral training Usual care Motor Activity 
Log (MAL) 
(amount of use 
(AOU)) 
Stroke Impact 
Scale (SIS) 
(hand function)  
Lin 2009b179 33 Bilateral training Usual care MAL (AOU) 
Luft 2004180 21 Bilateral training 
with Rhythmic 
Auditory Cueing 
Usual care Wolf Motor 
Arm Test  
Lum 2006181 14 Robot-bilateral 
training 
Robot-unilateral 
training 
Fugl-Meyer (F-
M) (UL 
proximal 
section) 
F-M (UL distal 
section) 
Morris 2008182 106; 97 Bilateral training Unilateral 
training 
ARAT 
NHPT 
Stoykov 
2009183 
24 Bilateral training Unilateral 
training 
MAS (upper 
arm function) 
MAS (hand 
movement) 
Summers 
2007184 
12 Bilateral training Unilateral 
training 
Modified MAS 
(upper arm 
function) 
Modified MAS 
(hand 
movement) 
 
Table C-3 - Constraint-induced movement training (CIMT)   
Trials                                           
 
Participants
recruited; 
reported at 
outcome 
Interventions Comparison Outcome(s) 
Cochrane review185 
Alberts 2004186 10 CIMT No treatment Wolf Motor 
Function Test 
(WMFT) – no 
poolable data 
available 
Atteya 2004187 4  Modified CIMT 
(mCIMT) 
Usual care  ARAT 
Boake 2007188 23; 20; 18 
(hand) 
mCIMT Usual care MAL  
Grooved 
Pegboard Test 
Dahl 2008189 30 CIMT Usual care WMFT 
SIS (hand 
function) 
Dromerick 
2000190 
23; 20 CIMT Usual care ARAT 
ARAT (pinch) 
Lin 2007191 34; 32 mCIMT Usual care MAL (AOU) 
Myint 2008192 48; 43; 39 
(hand) 
CIMT Usual care ARAT 
NHPT  
Page 2001193 4 mCIMT Usual care 
 
ARAT 
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Page 2002194 9 mCIMT Usual care ARAT - no 
poolable data 
available 
Page 2004195 11 mCIMT Usual care ARAT 
Page 2005196 10 mCIMT Usual care ARAT 
Page 2008197 25 mCIMT Usual care ARAT 
Ploughman 
2004198 
27; 23 Forced use 
therapy 
Usual care ARAT 
Chedoke 
McMaster 
Stroke 
Assessment 
(CMSA) (hand 
section) 
Taub 1993199 9 CIMT No treatment Arm Motor 
Activity Test 
Wittenberg 
2003200 
16 CIMT No treatment WMFT 
Wolf 2006201 222; 199 CIMT Usual care WMFT 
Wu 2007a202 30 mCIMT Usual care MAL (AOU) 
Wu 2007b203 47 mCIMT Usual care MAL (AOU) 
Wu 2007c204 26 mCIMT Usual care MAL (AOU) 
SIS (hand 
function) 
Additional 
trials 
Dromerick 
2009205 
 
36; 34 
 
CIMT 
 
Usual care 
 
ARAT 
Lin 2008206 22 CIMT Usual care MAL (AOU) 
Lin 2009178 40  Distributed form 
of CIT (dCIT) 
Usual care MAL (AOU) 
SIS (hand 
function) 
Lin 2010207 13 dCIMT Usual care MAL (AOU) 
                                              
Table C-4 - Electromyographic biofeedback (EMG-BFB)   
Trials                                           
 
Participants
recruited  
Interventions Comparison Outcome(s) 
Cochrane review208 
Armagan 
2003209 
27 Exercise 
programme + 
EMG-BFB 
Exercise 
programme + 
placebo EMG-
BFB 
Brunnstrom 
stage of hand 
recovery 
Basmajian 
1987210 
29 Physiotherapy + 
EMG-BFB 
Physiotherapy Upper 
Extremity 
Function Test 
(UEFT) 
Crow 1989211 40 Physiotherapy + 
EMG-BFB 
Physiotherapy ARAT 
Inglis 1984212 30 Physiotherapy + 
EMG-BFB 
Physiotherapy Brunnstrom 
stages of 
recovery 
 
248 
 
Table C-5 - Electrostimulation 
Trials                                           
 
Participants
recruited; 
reported at 
outcome 
Interventions Comparison Outcome(s) 
Cochrane review213 
Cauraugh 
2000214 
11 Electrostimulation No treatment BBT 
Cauraugh  
2002175 
15  Electrostimulation No treatment BBT 
Cauraugh 
2003215 
16 Electrostimulation No treatment BBT 
Chae 1998216 46; 28 Electrostimulation Placebo F-M 
Francisco 
1998217 
16; 9 Electrostimulation Usual care F-M 
Kimberley 
2004218 
16 Electrostimulation Placebo BBT 
Jebsen Hand 
Function Test 
(JHFT) 
Linn 1999219 40 Electrostimulation No treatment MAS 
Popovic 
2003220 
28 Electrostimulation No treatment UEFT 
Powell 
1999221 
60; 55 Electrostimulation No treatment ARAT 
NHPT 
Sonde 
1998222 
44 Electrostimulation No treatment F-M 
Additional 
trials 
Alon 2007223 
 
15 
 
Electrostimulation 
 
Task-specific 
practice 
 
BBT 
Alon 2008224 38; 26; 8 
(hand)  
Electrostimulation Task-specific 
practice 
BBT 
Jebsen-Taylor 
light object lift 
Chan 2009225 20 Electrostimulation Placebo Functional test 
of the 
hemiparetic 
upper 
extremity 
Grip power 
Gabr 2005226 12 Electrostimulation Home exercise 
programme 
ARAT – no 
poolable data 
available 
Hara 2006227 16; 14 Electrostimulation Usual care NHPT – no 
poolable data 
available 
Hara 2008228 22; 20 Electrostimulation Usual care NHPT – no 
poolable data 
available 
Hsu 2010229 66 Electrostimulation 
(high) 
Electrostimulation 
(low) 
Usual care ARAT 
ARAT pinch 
section 
Mangold 
2009230 
23 Electrostimulation Usual care CMSA (arm) 
CMSA (hand) 
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Ring 200541 22 Electrostimulation Usual care BBT  
JHFT  - no 
poolable data 
available for 
both outcomes 
Thrasher 
2008231 
21 Electrostimulation Usual care Chedoke 
McMaster 
Stages of 
Motor 
Recovery 
Weber 
2010232 
23 Electrostimulation Usual care ARAT 
 
Table C-6 – Hands-on therapy interventions 
Trials                                           
 
Participants 
recruited 
Interventions Comparison Outcome(s) 
Cochrane review233 
Carey 1980234  24 Manual 
stretching 
No intervention Joint Moving 
Tracking Test 
Mann 2005235 22 Passive 
extension 
exercises 
Other upper limb 
intervention 
ARAT 
Mikulecka 
2005236 
40 Soft tissue 
stretch, joint 
mobilisation and 
pressure to hand 
Usual care Jebsen Taylor 
Test 
 
Table C-7 - High-intensity therapy   
Trials Participants 
recruited; 
reported at 
outcome 
Interventions Comparison Outcome(s)  
Other review237 
Kwakkel 1999238 70; 63 Arm training Immobilisation of 
arm by inflatable 
air splint 
ARAT 
Lincoln 1999239 282 - Extra 
physiotherapy 
provided by 
assistant 
physiotherapist 
(APT) 
- Extra 
physiotherapy 
provided by 
qualified 
physiotherapist 
(QPT) 
Usual care 
(physiotherapy) 
Extended 
Motricity 
Index (MI) 
NHPT 
Rodgers 200351  123; 105 Enhanced upper 
limb therapy 
Usual care ARAT 
Sunderland 
1992 (mild and 
severe 
subgroups)240 
137; 121 Enhanced therapy Usual care ARAT  
NHPT 
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Table C-8 - Mental practice   
Trials                                           
 
Participants
recruited  
Interventions Comparison Outcome(s) 
Cochrane review241 
Muller 
2007242 
12 Mental practice  Motor practice  Jebsen hand 
function 
(stacking) 
(individual 
items) 
Page 
2001243 
13 Mental practice + 
physical practice 
of ADL tasks 
Control – physical 
practice of ADL or 
ambulation tasks 
+ listening to tape 
of stroke 
information 
ARAT 
Page 
2005244 
11 Mental practice + 
physical practice 
of ADL tasks 
Control – physical 
practice of ADL 
tasks + relaxation 
by audiotape 
ARAT 
Page 
2007245 
32 Mental practice + 
physical practice 
of ADL tasks  
Control – physical 
practice of ADL 
tasks + relaxation 
by audiotape 
ARAT 
Page 
2009246 
10 Mental practice + 
mCIMT  
mCIMT ARAT 
Riccio 
2010247 
36 Mental practice + 
conventional 
intervention 
Conventional 
intervention 
Arm Functional 
Test (Functional 
Ability Scale) 
 
Table C-9 - Mirror therapy   
Trials                                           
 
Participants 
recruited; 
reported at 
outcome 
Interventions Comparison Outcome(s) 
Other review248 
Altschuler 
1999249 
9 Parasagittal 
mirror 
Same protocol 
but with direct 
observation of 
affected arm 
ROM, speed and 
accuracy rated by 
2 senior 
neurologists  
Dohle 2009250 48; 36 Parasagittal 
mirror 
Same protocol 
but with direct 
observation of 
affected arm  
ARAT 
 
Rothgangel 
2004251 
16 Parasagittal 
mirror 
Same protocol 
but with direct 
observation of 
affected arm 
ARAT – no 
poolable data 
available 
Yavuzer 
2008252 
40 Parasagittal 
mirror 
Same protocol 
but with non-
reflective side 
of mirror 
Functional 
Independence 
Measure (FIM) 
(self-care) 
Brunnstrom stage 
(hand) 
251 
Additional 
trials 
Michielsen 
2011253 
 
40; 36 
 
Parasagittal 
mirror  
 
Same protocol 
but with direct 
observation of 
affected arm 
 
ARAT 
ABIL-hand 
 
Table C-10 - Repetitive task training   
Trials                                           
 
Participants 
recruited; 
reported at 
outcome 
Interventions Comparison Outcome(s) 
Cochrane review254 
Blennerhassett 
2004255 
30 Variety of 
activities 
Attention control MAS (arm) 
MAS (hand)  
Higgins 2006256 91 Functional 
tasks 
Lower extremity 
training 
BBT 
NHPT 
Kwakkel 1999238 70; 61 Functional 
exercises 
Immobilisation by 
splint 
ARAT 
Langhammer 
2000170 
61; 53 Motor 
relearning – 
functional task 
training 
Usual care MAS (arm) 
MAS (hand)  
Turton 1990257 22 Home-based 
exercises  
Usual care Southern 
Motor 
Assessment  
10 hole peg 
test 
Winstein 200462 43; 40 Task-specific 
functional 
training  
Usual care Functional test 
of the 
hemiparetic 
upper 
extremity 
van Vliet 2005173 120; 85 Movement 
science therapy 
– functional 
training 
Usual care Rivermead 
Motor 
Assessment 
(RMA) 
10 hole peg 
test 
Yen 2005258 30 Shaping 
training 
Usual care WMFT 
Additional trial 
Harris 2009259 
 
103  
 
Self-
administered 
homework 
based exercise 
program 
 
Control 
(education) 
 
ARAT 
Grip strength 
 
Table C-11 – Electromechanical/Robotic devices   
Trials                                           
 
Participants 
recruited; 
reported at 
outcome   
Interventions Comparison Outcome(s)  
Cochrane review260 
Amirabdollahian 
2007261 
31 Robot 
mediated 
therapy 
Sling suspension F-M – no 
poolable data 
available 
252 
Daly 2005262 13; 12 (hand) Robotic training Functional 
neuromuscular 
stimulation 
F-M 
AMAT 
wrist/hand 
Fazekas 2007263 30 Robot training Bobath therapy F-M 
 
Hesse 2005264 44; 43 (hand) Robotic training Functional 
electrical 
stimulation 
F-M  
F-M 
(wrist/hand) 
Kahn 2006265 19 Robot guided 
therapy 
Free-reaching 
therapy 
CMSA (arm) 
Lum 2002266 30; 27  Robot training  Physiotherapy + 5 
min robot training 
F-M 
F-M 
(wrist/hand) 
Lum 2006181 30; 16 (hand) Robot training 
(3 different 
groups 
collapsed into 
one robot 
group) 
Conventional 
therapy  
 
F-M 
F-M 
(wrist/hand) 
Masiero 2007267 35; 30 (hand) Robotic training Robot exposure F-M 
F-M 
(wrist/hand) 
Volpe 2000268 56 Robotic training Robot exposure F-M  
F-M 
(wrist/hand) – 
no poolable 
data available 
Volpe 2008269 21 Robotic therapy Intensive 
movement 
protocol 
F-M  
F-M 
(wrist/hand) 
Additional trials 
Burgar 2011270 
 
54  
 
Robotic therapy 
(low intensity) 
Robotic therapy 
(high intensity) 
 
Intensive 
conventional 
therapy 
 
F-M 
Conroy 2011271 62; 57  Robot assisted 
reaching 
(planar and 
vertical) (A) 
Robot assisted 
reaching 
(planar) (B) 
Intensive 
conventional 
therapy 
F-M 
SIS hand  
Housman 2009272  34; 31 Gravity-
supported, 
computer-
enhanced arm 
orthosis 
Tabletop 
exercises 
Rancho Los 
Amigos  
Grip strength 
Lo 2010273 53; 52  Robot-assisted 
therapy 
Usual care WMFT 
Masiero 2011274 21 Robotic therapy Conventional 
therapy 
Frenchay Arm 
Test 
F-M 
(wrist/hand) 
Rabadi 2008275 20  Robotic therapy Occupational 
therapy 
 
ARAT 
F-M 
(wrist/hand) 
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Table C-12 - Splinting   
Trials                                           
 
Participants
recruited; 
reported at 
outcome   
Interventions Comparison Outcome(s) 
Other Review276   
Lannin 2003277 28; 25 Static palmer 
resting mitt splint 
Usual care MAS (arm) 
MAS (hand) 
Poole 1990278 18 Inflatable splint Usual care F-M  
F-M 
(wrist/hand) 
Additional 
trial 
Lannin 2007279 
 
63; 62 
 
Neutral splint 
Extension splint 
 
Usual care 
 
MAS (items 6,7 
and 8) 
 
Table C-13 - Virtual reality training   
Trials                                      
 
Participants 
recruited; 
reported at 
outcome   
Interventions Comparison Outcome(s) 
Cochrane review280 
Crosbie 
2008281 
18 Virtual reality:  
reaching and 
grasping 
Bobath therapy ARAT 
Housman 
2009272 
34; 28 Virtual reality 
training 
Upper limb 
exercises 
F-M 
Grip strength 
Jang 2005282 10 Virtual reality:  
whole body 
No intervention BBT 
Piron 2007283 38 Virtual reality 
training 
Usual care F-M  
Piron 2009284 36 Virtual reality 
training 
Upper limb 
exercises 
F-M 
Piron 2010285 50; 47 Virtual reality 
training 
Upper limb 
exercises 
F-M 
Saposnik 
2010286 
22; 16 Virtual reality:  
Nintendo Wii 
Leisure activities Abbreviated 
WMFT 
Grip strength 
Sucar 2009287 22 Virtual reality 
training 
Upper limb 
exercises 
F-M 
Yavuzer 
2008288 
20 Virtual reality:  
Playstation 
eyetoy 
Watching 
playstation 
games 
Brunnstrom UE 
stages 
Brunnstrom 
hand stages 
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Appendix D – Characteristics of included studies (bilateral 
training) 
Table D-1 - Full characteristics of included studies for review of bilateral training 
Study Cauraugh 2002175 
Methods Randomised controlled trial.  Random assignment with restriction that 20 
participants were tested in 2 treatment groups.  Method of randomisation and 
allocation concealment not reported. 
Participants N=25 (only 20 relevant to this review), n=18 included in analysis; M/F:  21/4; 
Age:  63.7 years; Time since stroke:  39.1 mos; Type of stroke:  Not stated 
Inclusion criteria:  diagnosis of CVA and no more than two CVAs on same 
side of brain, upper limit of 80% motor recovery (EMG activation patterns 
compared with non-affected upper limb), lower limit of 10° voluntary wrist or 
finger extension against gravity, no other neurological deficits, no 
pacemaker, no use of drugs for spasticity, not enrolled in any other 
rehabilitation protocol. 
Interventions Group 1 (10 participants):  unilateral + EMG-triggered stimulation wrist/finger 
extension 
Group 2 (10 participants):  bilateral + EMG-triggered stimulation wrist/finger 
extension 
Each group completed 3 sets of 30 successful EMG-triggered neuromuscular 
stimulation trials (approximately 1 hour 30 mins); in total 6 hours of training (4 
days) were completed in 2 weeks.  Profession of individual(s) providing 
training unclear. 
Outcomes Primary outcome:  functional movement:  Box and Block Test (BBT) 
Secondary outcomes:  motor impairment – temporal outcomes:  reaction time 
for speed of information processing and rapid muscle onset (simple reaction 
time, premotor reaction time and chronometic motor reaction time) – 
premotor reaction time selected; strength outcomes:  EMG activity of 
wrist/fingers extensor muscles. 
Notes Control group (n=5) did not receive the neuromuscular electric stimulation or 
bilateral assistance for the wrist/fingers extensors therefore not included in 
any analyses. 
Unable to use presented data for BBT as no standard deviations presented.  
Means from graph were estimated and presented in results section.  Pre-
motor reaction time was chosen for inclusion as temporal outcomes as 
medians and SDs presented.  Medians imputed as mean values.  Two 
participants excluded from analyses due to extreme reaction times; it was 
unclear which groups these participants were in, therefore analysis for 
reaction time based on n=18 participants (1 participant removed from each 
group).  For muscle activity (strength) unable to use presented data within 
analysis as median root mean and square error presented with no SDs.  
Medians from graph were estimated and presented in results sections.  Data 
for this outcome based on 24 participants but unclear from which group the 
excluded participant was from. 
Study Cauraugh 2003289 
Methods Randomised controlled trial.  Participants randomly assigned to 1 of 2 
groups.  Method of randomisation and allocation concealment not reported. 
Participants N=20; M/F:  16/4; Age:  63.03 years; Time since stroke:  33.86 mos; Type of 
stroke:  Not stated 
Inclusion criteria:  absence of other neurological deficits, able to voluntarily 
extend wrist or fringes 10° against gravity, upper limit of 80% motor recovery 
(EMG activation patterns), diagnosis of CVA, sufficient voluntary control to 
activate the microprocessor, sufficient cognitive function to follow 
instructions. 
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Interventions Group 1 (10 participants):  unilateral + EMG-triggered stimulation wrist/finger 
extension 
Group 2 (10 participants):  bilateral + EMG-triggered stimulation wrist/finger 
extension 
Participants completed 3 sessions of 30 successful EMG triggered 
stimulation trials (approx. 90 minutes) with 5 minute break between sessions. 
Participants completed 360 trials across 12 sessions of training over 4 days.  
Profession of individual(s) providing training unclear. 
Outcomes Secondary outcomes:  motor impairment – strength outcomes:  EMG activity 
level of wrist and finger extensor muscles 
Notes Number of participants in each group not reported, an equal number in each 
group was assumed.  Data presented in paper as a graph – mean log10 and 
SE
.  
Means estimated from graph and SD calculated from estimated SE. 
Study Cauraugh 2005290 
Methods Randomised controlled trial.  Random assignment following a randomisation 
schedule.  No mention of allocation concealment.   
Participants N=21; M/F:  11/10; Age:  Unilateral 63.29±10.81 years, Bilateral 69.37±10.14 
years, Time since stroke:  Unilateral 3.57±2.42 years, Bilateral 4.73±3.52 
years, Type of stroke:  Not stated 
Inclusion criteria:  diagnosis of no more than 3 strokes, lower limit of 10° 
voluntary wrist/finger extension starting from 80°w rist and finger flexion, 
upper limit of 80% motor recovery, no other neurological deficits, not 
participating in another upper limb programme. 
Interventions Group 1 (10 participants):  unilateral + EMG-triggered stimulation wrist/finger 
extension 
Group 2 (11 participants):  bilateral + EMG-triggered stimulation wrist/finger 
extension 
Each group completed 4 days of 90 minutes training/week over 2 weeks.  
Profession of individual(s) providing training unclear. 
Outcomes Secondary outcomes:  motor impairment – temporal outcomes:  reaction time 
(ms), movement time (ms), deceleration time (ms), peak velocity (cm/s) and 
SD peak velocity (movement time selected).  All measured for sing aiming 
test and recorded by EMG.   
Notes Control group (n=5), no stroke history, not included in participant numbers or 
analysis.  Median values presented in paper, this imputed as mean values.  
Movement time data inverted for analysis (multiplied by -1).  
Study Cauraugh 2008176 
Methods Randomised controlled trial.  Randomly assigned to 1 of 2 treatment protocol 
orders.  Method of randomisation and allocation concealment not stated.   
Participants N=16, M/F:  10/6; Age:  Unilateral 66.6±12.35 years, Bilateral 65.04±12.47 
years, Time since stroke:  Unilateral 4.2±9.13 years, Bilateral 1.41±0.89 
years, Type of stroke:  Not stated 
Inclusion criteria:  diagnosis of no more than 3 strokes, lower limit of 10° 
voluntary wrist/finger extension starting from 80°w rist and finger flexion, 
upper limit of 80% motor recovery, no other neurological deficits, not 
participating in another upper limb programme. 
Interventions Group 1 (8 participants):  unilateral + EMG-triggered neuromuscular 
stimulation wrist/finger extension  
Group 2 (8 participants):  bilateral + EMG-triggered neuromuscular 
stimulation wrist/finger extension 
Both groups completed 5 consecutive upper limb protocols.  For the 
purposes of this review we compared the first treatment protocol from each 
group (as above).  Each training session involved 90 successful movement 
trials; completed in 4 days of 90 minutes training per day over 2 weeks. 
Consecutive treatment protocols were separated on average by 4 weeks of 
no rehabilitation.  Profession of individual(s) administering training unclear.   
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Outcomes Primary outcome:  functional movement:  (BBT) 
Secondary outcomes:  motor impairment – temporal outcomes:  motor 
reaction time and total reaction time - motor reaction time selected; strength 
outcomes:  maximal isometric contraction of wrist/fingers extensors.  No 
suitable data were available for strength outcome.  Outcomes were recorded 
at the end of each intervention protocol.   
Notes Data presented in paper in graph format - mean and SE for Box and Block 
Test.  Means estimated from graph and SD calculated from estimated SE.  
Two review authors independently estimated the values from the graphs, the 
average of the 2 estimates used in the analysis.  Motor reaction data also 
presented in graph format:  median and SE.  Median value estimated from 
graph imputed as mean and SD calculated from SE.  Motor reaction time 
score (m/s) inverted (multiplied by -1) for analysis.   
Study Chang 2006293 
Methods Randomised cross-over design.  Participants each performed 3 tasks in a 
randomly presented order.  Not designed or presented as a traditional RCT. 
Participants N=20; M/F:  17/3; Age:  56±10.54 years; Time since stroke:  404.7±565.06 
days, Type of stroke:  infarct 17, haemorrhagic 3 
Inclusion criteria:  CT or MRI imaging evidence of single-hemisphere stroke, 
arm reaching ability (Fugl-Meyer assessment > 30), no perceptual-cognitive 
dysfunction limiting comprehension of experimental task, no severe 
concurrent medical problems, no other neurological or orthopaedic 
conditions affecting arm/trunk movements. 
Interventions Each participant performed 3 movement tasks: (1) reaching forward with 
affected limb (unilateral); (2) reaching forward with both limbs simultaneously 
(bilateral); (3) reaching forward with both limbs simultaneously + load applied 
to non-affected upper limb (bilateral + load).   
Each movement condition performed for 5 trials with 5-minute rest between 
each condition.  Typical experimental session lasted approximately 40 
minutes.  There was no training period - movement and outcome 
measurement occurred simultaneously.  Profession of individual(s) providing 
training unclear. 
Outcomes Secondary outcomes:  motor impairment – temporal outcomes:  movement 
time, movement velocity, number of movement units and normalised jerk 
score of movement - movement time selected; spatial outcomes:  elbow 
flexion-extension range, shoulder flexion-extension range and trunk linear 
line value - elbow range selected. 
Notes Data not available for the first phase of this study, and therefore not included 
in any analyses.  The unilateral and bilateral conditions would have been a 
suitable comparison.   
Study Desrosiers 2005 
Methods Randomised controlled trial.  Randomly assigned by block randomisation 
scheme within each stratum (stratified on impairment level of hand and 
sensibility of the hand).  Randomisation completed in blocks of 4.  Allocation 
concealment completed through the use of sealed envelopes. 
Participants N=41, n=33 included in analysis; M/F:  19/22; Age:  Usual care 74.3±10.1 
years, Bilateral 72.2±10.8 years, Time since stroke:  Usual care 35.4±33.7 
days, Bilateral 34.2±34.4 days, Type of stroke:  infarct 40, haemorrhagic 1 
Inclusion criteria:  unilateral stroke > 10 days but < 2 months, cognitive 
functioning within normal limits, understanding of French or English, minimal 
upper extremity function (stage 2 for hand and stage 3 for arm on Chedoke-
McMaster Stroke Assessment), no severe body neglect or visual perception 
deficits. 
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Interventions Group 1 (21 participants): usual care - functional activities and exercises for 
the arm 
Group 2 (20 participants): bilateral training - package of interventions 
including bilateral and unilateral tasks 
Both groups received usual therapy interventions.  Both groups received 4 x 
45-minute sessions per week for 5 weeks, in total receiving between 15 and 
20 sessions.  Both interventions provided by same occupational therapy 
research assistant.  Note: the descriptions of interventions provided in the 
full-text paper are confusing; information given in the abstract has been 
central to the above classifications of the nature of the interventions.   
Outcomes Primary outcome: performance in activities of daily living: measure de 
l’independence fonctionelle (MIF - French translation of FIM) 
Primary outcome: functional movement - arm functional movement: BBT, 
TEMPA - BBT selected; hand functional outcome: Purdue Pegboard Test 
Secondary outcome: motor impairment - motor impairment scales: Fugl-
Meyer (upper limb section); temporal outcomes:  co-ordination (finger to 
nose, number of movements in 20 seconds); strength outcomes: grip 
strength (vigorimeter). 
AMPS also used as outcome measures but not relevant to this review 
Notes Control group received usual care; however this may have contained some 
bilateral tasks.  This could be a confounding factor.  Descriptions of 
interventions were unclear and definitions of symmetrical, synchronous and 
simultaneous were difficult to interpret.  Five drop-outs from Group 1 (lack of 
interest x2, early release, fatigue, death) and 3 drop-outs from Group 2 
(death, fracture and refusal). 
Study Dickstein 1993294 
Methods Randomised cross-over design.  Participants each performed 3 movements 
in a randomly presented order.  Not designed or presented as a traditional 
RCT. 
Participants N=25; M/F:  14/11; Age:  73±1.45 years; Time since stroke:  2.5±2.22 mos; 
Type of stroke:  infarct 24, head trauma 1 
Inclusion criteria:  absence of cognitive impairments, unimpaired hearing, 
absence of movement, disorders in unaffected upper extremity, ability to flex 
elbow on paretic side at least 30° from partial ext ension of 150°, not bilateral 
brain damage. 
Interventions Each participant performed 1 familiarisation set of unilateral movements with 
the unaffected arm, then performed 3 sets of movements presented in a 
random order (unilateral (unaffected), unilateral (affected) or bilateral).  Each 
set comprised 16 elbow flexion movements which were carried out in 
response to an auditory signal.  There was no training period - movement 
and outcome measurement occurred simultaneously.  Profession of 
individual(s) providing training unclear (assume physiotherapist). 
Outcomes Secondary outcomes:  motor impairment – temporal outcomes:  reaction and 
movement time (movement time selected).  
Notes Data not available for the first phase of this study, and therefore not included 
in any analyses.  The unilateral (affected) and bilateral conditions would have 
been a suitable comparison. 
Study Harris-Love 2005295 
Methods Randomised cross-over design.  Participants each performed 4 trials of 6 
reaching tasks in a block randomised order.  Not designed or presented as a 
traditional RCT. 
Participants N=32; M/F:  15/17; Age:  57±14 years; Time since stroke:  1.95 years; Type 
of stroke:  Ischemic  
Inclusion criteria:  at least 6 months post-stroke, at least 10° antigravity 
shoulder flexion and 20° of gravity minimised elbow  extension, able to 
produce at least 5 cm of forward translation of the hand on a table without 
leaning forward, no orthopaedic conditions and/or pain in paretic arm or 
shoulder. 
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Interventions Each participant performed 4 trials each of unilateral paretic, unilateral non-
paretic and bilateral reaching, then 4 trials of 6 reaching tasks (unilateral 
paretic, unilateral non-paretic, bilateral reaching and 3 bilateral reaching 
tasks involving different loads added to the non-paretic hand) completed at 
the fastest possible speed.  For all tasks participants were instructed to reach 
the target (box) as quickly as possible after a verbal go command and come 
to a complete stop.  There was no training period - movement and outcome 
measurement occurred simultaneously.  Profession of individual(s) providing 
training unclear (assume physiotherapist). 
Outcomes Secondary outcomes:  motor impairment – temporal outcomes:  movement 
time, peak velocity and peak acceleration -movement time selected.  
Notes Data not available for the first phase of this study, and therefore not included 
in any analyses.  The unilateral (paretic) and bilateral conditions would have 
been a suitable comparison.   
Study Kilbreath 2006296 
Methods Randomised cross-over design.  Participants each performed 3 tasks in 
randomly presented order.  Not designed or presented as a traditional RCT.   
Participants N=13; M/F:  8/5; Age:  67.9±8.3 years; Time since stroke:  36.1±18 mos; 
Type of stroke:  Not stated 
Inclusion criteria:  no significant musculotendinous or bony restrictions of 
upper limbs, no chronic disease independently causing significant disability 
or significant weakness of the upper limbs, sufficient strength in affected arm 
to move the arm forward at the shoulder and elbow and grasp with affected 
hand, score >= 1 on Frenchay upper limb test, comprehend simply 
instructions.  Note: it is unclear whether or not these were pre-stated 
inclusion criteria, or whether these criteria are descriptors of the participants 
who were eventually included. 
Interventions Each participant performed 2 bimanual and 1 unimanual tasks.  Each task 
involved participant reaching, grasping and transporting a tray with either 
affected arm (unimanual task), reaching for a large tray with both arms or 2 
small trays (bimanual tasks).  There was no training period - movement and 
outcome measurement occurred simultaneously.  Each task was performed 
5 times.  Profession of individual(s) providing training unclear (assume 
physiotherapist).   
Outcomes Secondary outcome: motor impairment – temporal outcomes: movement 
duration for hand to reach tray and for tray transport – movement time for 
hand to reach tray selected; spatial outcomes:  lateral deviation of the hands, 
synchrony of hand movements and relative phase angle - lateral deviation of 
the hand selected. 
Notes Study included another 13 participants with no stroke history; not included in 
participant numbers or analysis.  Data are not available for the first phase 
only of this study and it is therefore not included in any analyses.  The 
unilateral and bilateral conditions would have been a suitable comparison. 
Study Lin 2009a178 
Methods Randomised controlled trial using a stratified block allocation scheme.  
Computerised (block) randomisation, with per-stratification according to 
participating hospital.  Allocation concealment ensured by use of opaque, 
numbered envelopes (each hospital site had a pre-prepared set of envelopes 
with cards indicating allocation).   
Participants N=60; M/F:  34/26; Age:  Usual care 50.7±13.93 years, CIT 55.28±9.34, 
Bilateral 51.58±8.67 years; Time since stroke:  Usual care 21.9±20.51 mos, 
CIT 21.25±21.59 mos Bilateral 18.50±17.40 mos; Type of stroke:  Not stated 
Inclusion criteria:  > 6 months post CVA, > Stage III Brunnstrom stage for 
proximal and distal parts of upper limb, considerable non-use of the affected 
upper limb (Motor activity log, amount of use < 2.5), no serious cognitive 
deficits (  24 on MMSE), no excessive spasticity in any joints of upper limb 
(Modified Ashworth Scale 2), lack of participation in any experimental 
rehabilitation or drug study within past 6 months, no balance problems 
sufficient to compromise safety when wearing constraint mitt. 
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Interventions Group 1 (20 participants):  usual care – training for hand function, co-
ordination, balance and movements of the affected upper limb and 
compensatory practice with affected or both upper limbs 
Group 2 (20 participants):  other upper limb intervention - constraint-induced 
therapy: restriction of movement of the unaffected hand by placement in a 
mitt for 6 hours/day and intensive training of the affected upper limb in 
functional tasks; level of ability adapted based on patient ability and 
improvement during training 
Group 3 (20 participants): bilateral training - simultaneous movements of 
both affected and unaffected upper limb in functional tasks in symmetric or 
alternating patterns 
All groups completed therapy for 2 hours/day, 5 days per week for 3 weeks.  
All other interdisciplinary rehabilitation continued.  Occupational therapists 
undertook the training in each group. 
Outcomes Primary outcome: performance in activities of daily living: Functional 
Independence Measure 
Primary outcome: functional movement – arm functional movement:  Motor 
Activity Log amount of use and quality of movement scales - amount of use 
scale selected; hand functional outcome:   Stroke Impact Scale – hand 
function section 
Secondary outcome: performance in extended activities of daily living:  
Stroke Impact Scale (ADL/IADL section); motor impairment- motor 
impairment scales:  Fugl-Meyer scale. 
Notes Overall and sub-scores for the Functional Independence Measure and Fugl-
Meyer were presented.  Only the overall scores were used.    
Study Lin 2009b179 
Methods Randomised controlled trial.  Method of randomisation and allocation 
concealment not reported.   
Participants N=33; M/F:  19/14; Age:  Usual care 55.5±13.17 years, Bilateral 52.08±9.60 
years; Time since stroke:  Usual care 13.12±8.13 mos, Bilateral 
13.940±12.73 mos; Type of stroke:  Not stated 
Inclusion criteria:  clinical diagnosis of a first or recurrent unilateral stroke; 
ability to reach Brunnstrom stage III or above in the proximal and distal part 
of the arm; no serious cognitive deficits (MMSE ≥24); no excessive spasticity 
in the affected arm (Modified Ashworth Scale score ≤2 in any joint); no other 
neurologic, neuromuscular or orthopaedic disease; lack of participation in 
any experimental rehabilitation or drug studies. 
Interventions Group 1 (17 participants):  usual care –dose-matched standard occupational 
therapy that also focused on upper extremity training and included 
neurodevelopmental techniques, trunk-arm control, weight bearing by the 
affected arm, fine motor tasks practice and practice on compensatory 
strategies 
Group 2 (16 participants):  bilateral training – both upper extremities moving 
simultaneously in functional tasks with symmetric patterns 
Both groups received training for 2 hours per day, 5 days a week for 3 
weeks.  Occupational therapists provided the interventions.  
Outcomes Primary outcome: performance in activities of daily living: Functional 
independence measure 
Primary outcome: functional movement - Motor Activity Log amount of use 
and quality of movement scales - amount of use scale selected 
Secondary outcome: motor impairment - motor impairment scales: Fugl-
Meyer scale; temporal outcomes: movement time and percentage of 
movement time at which peak velocity occurs for unilateral and bilateral 
reaching task – movement time for unilateral task selected; spatial outcomes:  
normalised total distance   
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Notes Adjusted means (controlling for pre-treatment differences) and post-
treatment means were presented and used for all outcomes.  SDs were 
taken from the post-treatment columns.  Movement time and spatial outcome 
data inverted for analysis (multiplied by -1).  Sub-categories of the Functional 
Independence Measure presented.  Only total scores were used.   
Study Luft 2004180 
Methods Randomised controlled trial using a stratified block allocation scheme 
(variable block size, allocation 1:1).  Allocation concealment not reported.   
Participants N=21, M/F:  12/9; Age:  DMTE 59.6±10.5 years, BATRAC 63.3±15.3 years; 
Time since stroke:  DMTE median 45.5 (IQR 22.6-66.3) mos, BATRAC 75 
(IQR 37.9-84.5) mos; Type of stroke:  Not stated 
Inclusion criteria:  residual upper extremity spastic hemiparesis following 
single cortical or subcortical ischaemic stroke; ability to move affected limb 
(at least partial range movement against gravity); completed 3 to 6 months of 
rehabilitation therapy; adequate language and neurocognitive function to 
understand instructions; no multiple strokes, history of other neurological 
disease, chronic pain or emotional disorders. 
Interventions Group 1 (12 participants): usual care –Dose matched therapeutic exercises 
(DMTE) based on neurodevelopmental principals.  
Group 2 (9 participants):  bilateral training- bilateral training with auditory 
cueing (BATRAC).  This consisted of pushing and pulling bilaterally, either in 
synchrony or alternation, 2 independent handles sliding in the traverse plane.  
Training time consisted of hour-long therapy sessions (4 x 5-minute 
movement periods interspersed with 10-minute rest periods) 3 times per 
week for 6 weeks.  Profession of individual(s) providing training unclear 
(assume physiotherapist).  
Outcomes Primary outcome: functional movement – arm functional movement:  Wolf 
Motor Arm Test (time to complete 14 functional tasks with affected arm and 
hand),  University of Maryland Arm Questionnaire for stroke - WMAT 
selected 
Secondary outcome: motor impairment - motor impairment scales: Fugl-
Meyer Motor Performance Test (upper limb section); strength outcomes 
WMAT (strength) and dynamometry (elbow and shoulder strength) - WMAT 
strength selected   
fMRI and EMG variables also recorded – these were not relevant to this 
review.   
Notes Bilateral training group also received rhythmic auditory cueing, to guide the 
speed of the movements.  Discussion amongst review authors led to the 
conclusion that the rhythmic auditory cueing could be viewed as an adjunct 
or guide to the bilateral training and that therefore this study was relevant to 
this review (i.e. the rhythmic auditory cueing has not been considered as 
another intervention).  This study is a substudy of a larger study designed to 
investigate the effect of BATRAC.  SEM presented in paper, this was 
converted into SD units and entered into the analysis.  Change scores 
presented in paper and used in analysis.  WMFT (time) data inverted for 
analysis (multiplied by -1). 
Study Lum 2006181 
Methods Restricted randomised controlled trial.  Patients were stratified by initial Fugl-
Meyer score and side of stroke and randomly assigned to 1 of 4 groups.  
Following interim analysis the randomisation schedule was changed from 
providing the same number of participants to each group so that subsequent 
participants could only be allocated to 2 of the groups, therefore participants 
did not have an equal chance of entering 1 of the 4 groups.  The change in 
randomisation during the trial may have introduced bias.   
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Participants N=30 (only 14 relevant to this review); M/F:  7/7; Age:  Unilateral 69.8(SEM 
4) years, Bilateral 72.2(SEM 11.7) years; Time since stroke:  Unilateral 
10(SEM 1.9) wks, Bilateral 6.2 (SEM 1) wk; Type of stroke:  Not stated 
Inclusion criteria:  single CVA, 1 to 5 months post-stroke, no upper-limb joint 
pain or ROM limitation that would limit ability to complete training, no 
unstable cardiovascular, orthopaedic or neurological conditions, > 21 on 
MMSE 
Interventions Group 1 (9 participants): robot-unilateral training group, 12 reaching tasks 
progressing from easiest robotic-mode to most challenging mode 
Group 2 (5 participants): robot-bilateral training group, practiced same 12 
reaching tasks but in bilateral mode.  Rhythmic circular movements also 
performed.  
Training lasted 1 hour per session for 15 sessions over 4 weeks.  Training 
was supervised by an occupational therapist.  
Outcomes Primary outcome: performance in activities of daily living: Functional 
independence measure (self-care and transfer sections only) 
Secondary outcome: motor impairment - motor impairment scales: Fugl-
Meyer (proximal and distal upper limb sections), Motor Status Score 
(movement scale and synergy scale) and Modified Ashworth scale (proximal 
and distal cores) - Fugl-Meyer (proximal upper limb section); strength 
outcomes:  Motor power examination (several joints across proximal upper 
limb) 
Notes This study included assistive technology, however it compared a bilateral 
and unilateral group both receiving robotic assistance, therefore we decided 
that this was relevant to include as bilateral training versus unilateral training.  
Four groups were included in this trial: robot-unilateral, robot-bilateral, robot-
combined and control.  Only robot-unilateral and robot-bilateral relevant to 
this review.  Participants in the other 2 groups (16 participants) not included 
in any analysis.  Average gains data presented in paper and used in 
analysis.   SDs calculated from presented SE of the mean.  
Study Morris 2008182 
Methods Randomised controlled trial.  Randomly allocated using concealed web-
based randomisation.  Stratified according to side of hemiplegia, stroke 
classification and baseline ARAT. 
Participants N=106, n=97 included in analysis; M/F:  61/55; Age:  Unilateral 67.8±9.9 
years, Bilateral 67.9±13.1 years; Time since stroke:  Unilateral 23.2±5.7 
days, Bilateral 22.6±5.6 days; Type of stroke:  Reported as ischaemic 9, 
haemorrhagic 97 
Inclusion criteria:  acute unilateral stroke confirmed by CT; persistent upper 
limb impairment (< 6 on each upper limb sections of Motor Assessment 
Scale); ability to participate in 30-minute physiotherapy sessions; ability to sit 
unsupported for 1minute; no severe neglect, aphasia or cognitive impairment 
that would limit participation; no previous stroke resulting in residual 
disability; no premorbid arm impairment; no hemiplegic shoulder pain; ability 
to provide informed consent. 
Interventions Group 1 (50 participants): unilateral training  
Group 2 (56 participants): bilateral training 
Each group performed 4 tasks (moving dowelling peg, moving block, grasp 
empty glass and take to mouth and point to targets).   Intervention protocol 
was progressive and standardised. Systematic feedback was provided on 
performance.  Training lasted 20 minutes a session 5 days a week over 6 
weeks in addition to usual therapy.  As many trials as possible were 
completed in each session with a maximum of 30 trials of each task, per 
session.  Two senior stroke rehabilitation physiotherapists conducted the 
intervention.   
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Outcomes Primary outcome: performance in activities of daily living: Barthel Index 
Primary outcome functional movement – arm functional movement:  ARAT; 
hand functional movement:  NHPT 
Secondary outcome: motor impairment - motor impairment scales: 
Rivermead Motor Assessment (upper limb section). 
Hospital Anxiety and Depression Scale and Nottingham Health Profile also 
used as outcome measures but not relevant to this review.   
Notes End of intervention outcome assessment (6 weeks) used in analysis.  
Outcome measures also recorded after 18 weeks (97 participants).  At 6 
weeks: 4 drop-outs from Group 1 (died, moved away, requested withdrawal) 
and 5 drop-outs from Group 2 (died, moved away, requested withdrawal).  
Change and final outcome scores presented.  Outcome scores used in 
analysis. 
Study Mudie 2001291 
Methods Randomised controlled trial.  Randomly assigned to 1 of 2 groups.  Method 
of randomisation or allocation concealment not reported.   
Participants N=36; M/F:  26/10; Age:  Unilateral acute 77.9±9.2 years, Unilateral chronic 
65.7±13.1 years, Bilateral acute 71.98±5.8 years, Bilateral chronic 64.6±10.9 
years; Time since stroke:  Unilateral acute 1.8±0.6 mos, Unilateral chronic 
90±117 mos, Bilateral acute 1.9±1.1 mos, Bilateral chronic 34.2±37.2 mos; 
Type of stroke:  ischaemic 35 , after clipped aneurysm 1  
Inclusion criteria:  dense hemiplegia (less than or equal to 2 on Motor 
Assessment Scale items 6 and 7), able to understand instructions; produce a 
response with non-hemiplegic arm during bilateral trials, no other strokes or 
confounding co-morbidities. 
Interventions Group 1 (18 participants): unilateral training 
Group 2 (18 participants): bilateral training 
Each group completed 5 trials, including 5 repetitions of 5 seconds each (of 
isometric contractions for 2 tasks (shoulder abduction and wrist extension)).  
15 seconds rest between each of the 5 trials, and 5 minutes rest between the 
2 tasks. For Group 1, trials 1, 2, 3 and 5 were performed unilaterally and trial 
4 bilaterally.  For Group 2, trials 1, 3 and 5 were performed unilaterally and 
trials 2 and 4 bilaterally.  Therefore, data from trial 2 only was extracted for 
this review. There was no training period: movement and outcome 
measurement occurred simultaneously.  Profession of individual(s) providing 
training unclear (assume occupational therapist). 
Outcomes Secondary outcome: motor impairment –strength outcomes:  muscle activity 
(EMG) for shoulder abduction and wrist extension - wrist extension activity 
selected. 
Notes Results for acute and chronic patients presented separately, therefore 2 
subgroups of this trial are included in the relevant analysis. 
Study Platz 2001292 
Methods Randomised controlled trial.  Random allocation to 1 of 2 groups, with block 
randomisation according to side of stroke.  Details of allocation concealment 
not reported.   
Participants N=14; M/F:  9/5; Age: 55.9±11.6 years; Time since stroke:  Not stated; Type 
of stroke:  all ischaemic  
Inclusion criteria:  CT-proven stroke in middle cerebral artery territory, sub-
acute phase, clinically complete or almost complete recovery from 
hemiparesis, no cognitive impairment.  Note: it is unclear whether or not 
these were pre-stated inclusion criteria, or whether these criteria are 
descriptors of the included participants written following patient assessment. 
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Interventions Group 1 (7 participants): unilateral training 
Group 2 (7 participants): bilateral training 
Each group completed 3 training tasks (fast and accurate aiming 
movements, fast tapping movements with index finger, picking up and 
placing small wooden sticks).  Each participant completed training 
comprising of 10 practice blocks, each lasting 2.5 minutes.  Tasks were 
completed in a repetitive way and serial order.  Total training time was 
approximately 30minutes per session, performed on 5 consecutive 
weekdays.  Training was supervised by an occupational therapist. 
Outcomes Secondary outcome: motor impairment - temporal outcomes: total movement 
time (ms), MT/ first phase, MT/second phase, MT coefficient of variation 
(total movement time selected); spatial outcomes: spatial error (mm), spatial 
error/first phase (spatial error selected).  All outcomes assessed for aiming 
movements during single task and dual task.  Outcome data for single task 
aiming movement used for analysis. 
Notes Data extracted comprised least square means.  Standard deviation for 
outcomes not provided. SDs extracted from baseline data. 
Study Stoykov 2009183 
Methods Randomised controlled trial.  Stratified into 2 impairment levels based on 
Fugl-Meyer upper extremity scores (19 to 28 or 29 to 40).  Within each group 
of 12 participants a randomised computer-generated list provided group 
assignment.   
Participants N=24; M/F:  16/8; Age:  Unilateral 64.75±11.1 years, Bilateral 63.8±12.6 
years; Time since stroke:  Unilateral 10.2±10.1 years, Bilateral 9.5±5.4 years; 
Type of stroke:  all ischaemic  
Inclusion criteria:  Fugl-Meyer upper extremity score 19 to 40, >6 months 
post-stroke, cortical or subcortical lesion, ability to follow 2-step commands, 
18 to 80 years of age, no evidence of cerebellum or brainstem involvement, 
no evidence of field cut, no evidence of neglect, ability to give informed 
consent, no symptomatic cardiac failure or unstable angina, no uncontrolled 
hypertension, no significant orthopaedic or pain conditions in affected upper 
extremity, no severe obstructive pulmonary disease. 
Interventions Group 1 (12 participants): unilateral training 
Group 2 (12 participants): bilateral training 
Training consisted of 6 training tasks that incorporated both discrete 
movements (2 tasks) and rhythmic movements (4 tasks), paced by a 
metronome.  Initially most tasks completed for 20 repetitions, which was 
gradually increased to 40 repetitions. Therapeutic challenge was increased 
throughout the training period.  Three training sessions of 1 hour duration 
completed each week for 8 weeks.  Profession of individual(s) administering 
training not reported.   
Outcomes Primary outcome:  functional movement – arm functional movement:  Motor 
Assessment Scale upper arm and combined upper limb movements - upper 
arm function scores selected; hand functional movement:  Motor Assessment 
Scale hand movements and advanced hand movements - hand movement 
scores selected. 
Secondary outcome: motor impairment – motor impairment scales:  Motor 
Status Score (total score, shoulder/elbow scale and wrist/hand scale; total 
scale selected for use in analysis); strength outcomes:  muscle strength 
comparator dynamometer fro arm strength and Jamar dynamometer for grip 
strength (arm strength outcome selected for use in analysis).   
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Notes Data presented in paper in graph format - mean and SE for Motor 
Assessment Scale and Motor Status Score.  Means estimated from graph 
and SDs calculated from estimated SE.  Two review authors independently 
estimated the values from the graphs; the average of the 2 estimates was 
used in the analysis.  Unable to include strength outcome in analysis as 
separate results for the 2 groups (unilateral and bilateral) not presented.  A 
non-significant result between the groups reported in the paper on these 
measures and this indicated in the results section. 
Study Summers 2007184 
Methods Randomised controlled trial.  Randomly allocated to 1 of 2 groups.  Method 
of randomisation and allocation concealment not stated.  
Participants N=12, M/F:  5/7; Age:  Unilateral 60±14 years, Bilateral 63.16±16 years, 
Time since stroke:  Unilateral 4±3.1 years, Bilateral 6.3±5.2 years, Type of 
stroke:  Various 
Inclusion criteria:  first stoke at least 3 months prior to intervention, no 
multiple infarctions, most components of movement present in the affected 
extremity but impairment of function relative to unaffected side, intact 
cognitive functions, no other neurological disorders. 
Interventions Group 1 (6 participants): unilateral training 
Group 2 (6 participants): bilateral training 
Participants performed 50 training trials of a dowel placement task (lifting a 
wooden dowel from a table and placing it on a shelf) and 2 warm up reaching 
trials during each session.  Six sessions completed over a period of 6 days.  
Profession of individual(s) administering training not reported.   
Outcomes Primary outcome:  functional movement – arm functional movement:  
Modified Motor Assessment Scale upper arm function and combined upper 
limb movements - upper arm function scores selected; hand functional 
movement:  Modified Motor Assessment scale hand movements and 
advanced hand movements - hand movement scores selected. 
Secondary outcome: motor impairment – temporal outcomes:  movement 
time and velocity profile - movement time selected; spatial outcomes:  elbow 
angle and curvature of arm trajectories - elbow angle selected.  TMS 
recorded but not relevant to this review. 
Notes SD for bilateral group equals 0 for upper arm function on Modified Motor 
Assessment Scale, therefore effect size not estimable.  Imputed control 
group SD.  No SD presented for movement kinematics and therefore 
unsuitable for inclusion in statistical pooling.  Two participants excluded from 
movement time and elbow angle due to technical difficulties within the trial.   
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Appendix E – Characteristics of included studies (home-
based therapy programmes) 
Table E-1 - Full characteristics of included studies for review of home-based therapy 
programmes 
Study Duncan 1998336 
Methods RCT.  Participants randomly assigned to control or intervention group using a 
random list generated by group assignments. Randomisation completed in 
blocks of 10. Random list generated prior to the beginning of the study. Only 
a laboratory technician who had no input into participant selection or 
recruitment was aware of group assignment. 
Participants N=20 selected from local participating hospitals and Kansas City Stroke 
Registry.  M/F: Not reported; Age:  Usual care (67.8±7.2 years), Home 
therapy (67.3±9.6 years); Time since stroke: Usual care (56 days), Home 
therapy (66 days); Type of stroke: Ischaemic 18, Haemorrhage 2, Brain stem 
1;  Initial UL impairment: Usual care (F-M 36.4), Home therapy (F-M 38.1) 
Inclusion criteria:  30 to 90 days after stroke; minimal or moderately impaired 
sensorimotor function (Fugl-Meyer 40 to 90, Oprington Prognostic Scale 
score 2.0 to 5.2); ambulatory with supervision and/or assistive device; living 
at home; living within 50 miles of the University of Kansas Medical Center; no 
medical condition that interfered with outcome assessments or limited 
participation in submaximal exercise programme; MMSE > 18; and no 
receptive aphasia that interfered with ability to follow a 3-step command 
Interventions Group 1 (10 participants):  usual care. Usual care as prescribed by 
physicians. The therapy programmes received by the control group varied in 
intensity, frequency and duration. 
Group 2 (10 participants): home therapy programme. This involved an 
exercise programme designed to improve strength, balance and endurance 
and to encourage more use of the affected extremity.  The programme was a 
home-based exercise programme provided by a physical therapist.  Exercise 
sessions were divided into the following 4 blocks (preceded by a 10-minute 
warm-up session of stretching and flexibility exercises) (1) Assistive and 
resistive exercises using PNF patterns or theraband exercises to the major 
muscle groups of the upper and lower extremities (2) Balance exercises (3) 
Encouraged to use the affected upper extremity in functional activities (4) 
Progressive walking programme or progressive exercise on a bicycle 
ergometer.  The programme included 3 visits per week for 8 weeks, and the 
patients were instructed to continue the exercise programme for an 
additional 4 weeks. Each session lasted approximately 1.5 hours. 
Outcomes Primary outcome:  Performance in ADL:  Barthel Index (0 to 100) 
Primary outcome:  Functional movement:  Jebsen Test of Hand Function 
(dexterity measure). Data for this outcome could not be included in the data 
analysis as total scores and SD were not reported. 
Secondary outcome: Performance in extended ADL: Lawton Instrumental 
ADL 
Secondary outcome: Motor impairment:   Fugl-Meyer Upper Extremity Scale 
(0 to 66) 
Oprington Prognositc Scale, Fugl-Meyer Lower Extremity Scale (0 to 34), 
Medical Outcomes study- 36 Health Status Measurement, 10 metre walk, 6 
minute walk and Berg Balance Scale were also reported, but not relevant to 
this review. 
Outcome measures completed at the end of intervention period only.   
Notes SDs not included in the paper. However SDs were calculated from data 
gained from the study authors. Data gained from study authors was also 
used to enter mean values for Barthel Index. This data gained from personal 
communication with the author differs from those presented in the published 
paper. 
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Study Duncan 2003337 
Methods Prospective RCT.  Participants were randomly assigned to intervention or 
control group using a random-number generator with a block size of 6. 
Allocation concealment ensured through the use of sealed envelopes. 
Participants N=100 selected from Kansas City Stroke Registry.  M/F:56/44; Age:  Usual 
care (70.2±11.4 years), Home therapy (68.5±9.0 years), Drop-outs (74.6±9.8 
years)); Time since stroke: Usual care (73. 5±27.1 days), Home therapy 
(77.5±28.7 days), Drop-outs (84±27.2 days); Type of stroke: Ischaemic 90; 
Initial UL impairment: Usual care (F-M 43.3±11.9), Home therapy (F-M 
45.8±12.8), Drop-outs (F-M 50.6±7.4) 
Inclusion criteria:  stroke within 30 to 150 days; ability to ambulate 25 feet 
independently; mild to moderate stroke deficits (Fugl-Meyer Upper and 
Lower Extremity Scales 27 to 90, Orpington Prognositc Score 2 to 5.2, 
palpable wrist extension on involved side); MMSE ≥16; no serious cardiac 
conditions; not oxygen dependent; no severe weight-bearing pain; no other 
serious organ system disease; and life expectancy > 1 year 
Interventions Group 1 (50 participants):  usual care. Usual care as prescribed by 
physicians. Two-thirds were provided with an unsupervised exercise 
programme. Those who did receive therapy received an average of 8.7 ∓ 5.3 
physical therapy visits and 10.4 ∓ 7 occupational therapy visits. Physical and 
occupational therapy were received separately, as prescribed by participants' 
physicians. Duration of combined physical therapy and occupational therapy 
visits comparable to those in intervention group (approximately 90 minutes). 
There was much variation in the types of exercises received. 
Group 2 (50 participants): home therapy programme. This involved an 
exercise programme designed to improve strength, balance and endurance 
and to encourage more use of the affected extremity.  The programme was a 
home-based exercise programme provided by a physical therapist.  Exercise 
sessions were divided into the following 4 blocks (preceded by a 10-minute 
warm-up session of stretching and flexibility exercises) (1) Assistive and 
resistive exercises using PNF patterns or theraband exercises to the major 
muscle groups of the upper and lower extremities (2) Balance exercises (3) 
Encouraged to use the affected upper extremity in functional activities (4) 
Progressive walking programme or progressive exercise on a bicycle 
ergometer.  Physical and occupational therapists supervised the programme, 
at participants home and included 36 sessions of 90-minute duration over 12 
to 14 weeks. There were structured protocols for the exercise tasks, criteria 
for progression and guidelines for reintroducing therapy after intercurrent 
illness.  Each participant received an average of 33.4 ∓ 2.3 visits, and the 
average duration of a visit was 91 ∓ 4.5 minutes.  For both groups, treating 
therapists completed a treatment log to capture type of exercises and 
frequency and duration of therapy visits. 
Outcomes Primary outcome:  Performance in ADL:  Barthel Index (0 to 100).  Data for 
this outcome were extracted from the associated paper339 (n=93 post-
treatment, n=80 6 month follow-up). 
Primary outcome:  Functional movement:  Wolf Motor Function Test.  The 
data for this outcome were presented for patients above and below median 
at baseline.  It was assumed that 25 participants were in each group.   
Secondary outcome: Performance in extended ADL: Lawton Instrumental 
ADL.  Data for this outcome were extracted from the associated paper339 
Secondary outcome: Motor impairment:   Fugl-Meyer Upper Extremity Scale 
(0 to 66) and grip strength (Jamar dynamometer) 
Orpington Prognositc Scale, Fugl-Meyer Lower Extremity Scale (0 to 34), 
isometric strength testing for ankle dorsiflexion and knee extension, 10-metre 
walk test, 6 minute walk and Berg Balance Scale were also reported but are 
not relevant to this review.  The associated paper further reported Medical 
Outcomes Study short-form 36-item questionnaire (SF-36) and Stroke Impact 
Scale (SIS) which are also not relevant. 
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Notes Change scores only reported and therefore used in the analysis 
For performance in ADL and extended ADL outcomes,  data from another 
paper339 was used.  These data had been adjusted for age, pre-stroke 
physical function, stroke severity and baseline measurement of outcome and 
analysis was completed with multiple imputations; however data was entered 
not including drop-outs, therefore data only available for 93 participants. 
Follow-up data (6 months post-treatment) only available for 80 participants 
For other outcomes 8 drop-outs reported. 6 participants from intervention 
arm (significant renal insufficiency detected after randomisation, subclavian 
steal syndrome diagnosed after randomisation, 1 withdrew after 18 visits, 3 
experienced a second stroke) and 2 from usual care group (1 withdrew after 
randomisation, 1 did not return for 3-month assessment). ITT analysis was 
completed and therefore analysis based on 100 participants 
Wolf Motor Function Test time for completion was used in the analysis. The 
data was inverted for use in the analysis (multiplied x-1). To increase 
availability of included data presented SEs were converted into SDs (SD = 
SE√n). 
Study Piron 2008338 
Methods RCT.  Participants were randomly assigned using simple randomisation to 1 
of 2 treatment groups of 5 patients. Details of any allocation concealment 
were not reported. 
Participants N=10.  M/F: 5/5; Age:  VR 65±11 years, VR with telerehabilitation 53±15 
years; Time since stroke: VR 364±56 days, VR with telerehabilitation 280±56 
days; Type of stroke:  Ischaemic; Initial UL impairment:  (F-M) 50.3.   
Inclusion criteria:  mild to intermediate arm motor impairment; ischaemic 
stroke in the area of the middle cerebral artery; and no cognitive problems 
that could interfere with comprehension. 
Interventions Group 1 (5 participants):  virtual reality training with therapist. A 3D motion 
tracking system recorded participants' arm movements and a virtual 
environment created in which the participants' movements were represented. 
A sequence of virtual tasks was performed whilst participants watched their 
movement trajectory on screen compared with an ideal trajectory. The virtual 
reality system thus provided visual feedback, i.e. knowledge of performance 
and knowledge of results. Treatment occurred in hospital with a therapist 
present. 
Group 2 (5 participants): virtual reality with telerehabilitation at home. The 
same practice as group 1 was performed but via a computer in the 
participants’ homes, with a videoconferencing system and a remote link to 
the therapist in the hospital. 
Both groups received 1 hour of daily training for 1 month. Same physical 
therapist managed the rehabilitation sessions for both groups. 
Outcomes Secondary outcome: Motor impairment: Fugl-Meyer Upper Extremity Scale 
Multidimensional disease and treatment specific satisfaction questionnaire 
was also reported as an outcome but this was not relevant to this review. 
Outcome measures were completed at the end of the intervention period 
only. 
Notes No details given as to the training or experience of the therapist delivering 
the intervention. 
No SDs were included in the paper. In order to include this study in the meta-
analysis, we used the SD reported by Piron 2009, which included 
participants with similar levels of initial upper limb motor impairment. The 
largest SD reported by Piron 2009 (7.7) was used in order to be 
conservative. 
Study Piron 2009284 
Methods RCT.  Simple randomisation using sequentially numbered, opaque, sealed 
envelopes. Allocation to 1 of 2 treatment groups was performed by the 
therapist co-ordinator of the hospital who was not involved in the participants 
rehabilitation programme. 
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Participants N=36.  M/F: 21/15; Age:  Usual care 64.4±7.9 years, VR with 
telerehabilitation 66±7.9 years; Time since stroke: Usual care 333±11.9 days, 
VR with telerehabilitation 412±184.8 days; Type of stroke:  Ischaemic; Initial 
UL impairment:  Usual care (F-M) 47.3±4.5, VR with telerehabilitation 
48.4±7.2  
Inclusion criteria:  mild to intermediate arm motor impairment on Fugl-Meyer 
Upper Extremity Scale; single ischaemic stroke in the area of middle cerebral 
artery; no apraxia (< 62 points on the de Renzi Test); and no clinical 
evidence of cognitive impairment that could interfere with verbal 
comprehension, such as neglect and language disturbances (more than 40 
errors in the Token Test). 
Interventions Group 1 (18 participants):  conventional physiotherapy in the local health 
district. Participants performed specific exercises for the upper limb with a 
strategy of progressive complexity. First, they were requested to control 
isolated motions without postural control, then postural control was included, 
and finally complex motions with postural control were practiced. Examples 
of tasks were to touch different targets arranged in front, manipulate different 
objects, follow trajectories displayed on a plane and to recognise different 
arm positions 
Group 2 (18 participants): telerehabilitation system at home. This consisted 
of 2 dedicated personal computer-based workstations; 1 at the participant’s 
home; and 1 at the hospital. This generated a virtual environment in which 
participants executed motor tasks. This was combined with video-
conferencing which permitted the remote control of the participant’s video 
camera mobility in order to observe the participants movements during the 
rehabilitation tasks. The virtual reality system incorporated a 3D motion 
tracking system to record arm movements. 5 virtual tasks comprising simple 
arm movements were practised whilst participants watched their movement 
trajectory on screen compared to an ideal trajectory. Participants received 
verbal feedback from the therapist about the exactness of the movements 
Both groups received 1 hour of daily training, 5 days per week for 1 month. 
Outcomes Primary outcome: Functional movement: ABILHAND Scale 
Secondary outcome: Motor impairment scale: Fugl-Meyer Upper Extremity 
Subscore and Ashworth Scale. Fugl-Meyer selected for analysis. 
Outcome measures performed 1 month before treatment began, at baseline, 
immediately after 1 month treatment and at 1 month after treatment ceased 
(follow-up). 
Notes No details given as to the training or experience of the therapist delivering 
the intervention. 
 
 
269 
Appendix F – ArmeoSpring device 
 
 
 
 
 
 
 
Pictures taken from Hocoma website:  
http://www.hocoma.com/products/armeo/armeospring   2011 
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Appendix G - Consent form 
                                                    
 
 
CONSENT FORM  
Title of Project:   Arm intervention after stroke:  A feasibility study (AIAS) 
Name of Researcher:   Fiona Coupar                                                                                                                                      
Please initial box 
 
1.  I confirm that I have read and understand the information sheet dated 
     ……………… (version……) for the above study.  I have had the  
     opportunity to consider the information and ask questions.  
 
2.  I understand that my participation is voluntary and that I am free to  
     withdraw at any time without giving any reason, without my medical  
     care or legal rights being affected.   
 
3.  I understand that if I withdraw from the study that any data collected 
     may be used for analysis.  I give permission for this data to be used.   
 
4.  I understand that relevant sections of my medical notes and data  
     collected during the study may be looked at by researchers involved  
     in this study.  I give permission for these individuals to have access to  
     my records.   
 
5.  I understand that I will be asked to take part in an informal interview  
     about the treatment I receive.  I agree for this interview to be recorded. 
 
6.  I understand that the study treatments will not continue  
    after the study period but standard care will continue, as required. 
      
6.  I agree to participate in this study. 
 
7.  I agree for my G.P to be informed of my participation in this study. 
 
 
 
 
_________________             ________________           ________________________  
Name of Patient                     Date                                   Signature  
 
 
___________________         ________________          _________________________ 
Name of Person                     Date                                   Signature 
taking consent  
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Appendix H – Interview topic guide 
Introduction   
The aim of this part of the research is to find out your opinions about the 
therapy you received, targeted at your arm. 
To facilitate the process we would like to audio-tape our conversation today.   
Only researchers on the project will have access to the tapes and the tapes 
will be destroyed after the research is finished.  I will also be taking notes to 
help in the analysis process.  All interviews will be treated as confidential.  All 
information gained will be anonyomised and no identifiable data will be used.  
All information gained will be allocated a unique identification number.   
We have planned for the interview to last approximately 30 minutes.  During 
this time I will ask you a number of questions and seek your opinions about 
different aspects of the therapy you received.  I will be specifically looking for 
your opinions about the types of things that were done to improve your arm 
movement.  I am interested in hearing your opinions and feelings as you are 
the expert in the therapy you received.   
Background 
When did you have your stroke?     
How did the stroke affect you? 
Possible probe:  What did this mean for you? 
   How does this make you feel? 
In particular how was your arm affected?  
Possible probe:  What did this mean for you? 
   What affect(s) did this have? 
 
Therapy 
What therapy did you receive to improve you arm abilities? 
 Possible probe:  Tell me more about what this involved?   
What were your hopes for the intervention?   
How important was therapy targeted at your arm?   
 
Opinions of therapy   
Did you find the therapy you received acceptable? 
Possible probe:  Why was this? 
Were you satisfied with the therapy you received? 
Possible probe:  Why do you feel like this? 
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Did the therapy you received meet your expectations? 
Possible probe:  Why do you think that was?   
What did you like about the therapy? 
What did you not like about the therapy? 
Do you think it made a difference to your arm? 
Possible probe:  What makes you say that? 
How do you think the therapy for your arm could have been better? 
Would you recommend this therapy? 
 
End of interview 
Thank you for your time and participation.  Other closing comments/remarks.   
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Appendix I – Safety Checklist: End of intervention period 
Patient number:                                              Date:                                      
 
 
Safety outcomes/Adverse events 
 
(a) Arm pain scale (includes shoulder) 
 
In the last 2 weeks have you had any pain in your affected arm?    
 
Yes                  
 
No       
 
                                                                                                                                                                                                                                                                                                                                                       
How would you describe this pain (mark only one)?             
 
Excruciating (very severe)    
   
Severe  
   
Moderate  
  
Mild  
   
None    
 
If 0 (zero) is not pain at all and the number 10 (ten) means as painful as it could be, then 
how painful was it? (Please give a number between one and ten):    Number                
 
 
 (b) Borg Perceived Exertion scale (exertion of therapy) 
 
The 15-point scale is illustrated below as an example:  
6 would be the equivalent of sitting down doing nothing,  
9 would be walking gently, 13 a steady exercising pace and 19/20 the hardest 
exercise you have ever done.  
 
6 
7 - Very, very light                                               Number: 
8 
9 - Very light 
10 
11 - Fairly light 
12 
13 - Moderately hard 
14 
15 - Hard 
16 
17 - Very hard 
18 
19 - Very, very hard 
20 – Exhaust 
 
 
 
 
274 
(c) Subluxation (clinical report) No  Yes  
     
(d) Increased spasticity (clinical report) No  Yes  
     
(e) Skin breakdown on affected arm (observation) No  Yes  
     
(f) Adverse events (clinical report)     
                                                             
Chest infection No  Yes    
     
UTI No  Yes  
     
DVT/PTE No  Yes  
     
Falls No  Yes            
Number of falls:     
     
Recurrent stroke No  Yes  
 
 
Other (please specify)……………………………………………………………………… 
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Appendix J – Action Research Arm Test 
           Patient identifier 
 
Instructions 
There are four subtests: Grasp, Grip, Pinch and Gross Movement. If the participant passes 
the first task in each subset then they score top marks and move onto next subtest.  If a 
subject fails the first and the second tasks in a subtest, then they score 0 for that subtest and 
move onto the next.  The patient must be able to sit unaided to complete the test.  If not they 
score 0.   
 
Score:  0 = can perform no part of the test 1 = performs tasks partially 
 2 = completed test, but takes abnormally long time 3 = performs test normally 
 
Start with the least impaired arm first 
 
a) Grasp                                                                                                     R L 
1.  Pick up a 10 cm block (If score = 3 then total = 18 & go to Grip)     
    
2.  Pick up 2.5 cm block (If Grasp score = 0 so far then grasp     
total = 0 & go to Grip)    
    
3.  5 cm cube    
    
4.  7.5 cm cube    
    
5.  Ball (Cricket)    
    
6.  Stone     
                                                                                             
                                                                                                         Grasp total:     
    
b) Grip                                                                                                                             
1.  Pour water glass to glass (if score = 3 then total =12 & go to Pinch)                            
    
2.  2.25 cm tube (If grip score = 0 so far then Grip total = 0 & go to Pinch)    
    
3. 1 cm tube     
    
4. Washer over bolt     
    
                                                                                                            Grip total:    
    
c) Pinch     
1. 6 mm bearing 3rd finger & thumb (if score = 3, total = 18 & go to Gross)    
    
2. Marble index & thumb (If Pinch score = 0 then Pinch     
total = 0 & go to Gross)    
    
3. 6mm bearing 2nd finger and thumb    
    
4. 6mm bearing 1st finger and thumb    
    
5.  Marble 3rd finger and thumb     
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6. Marble 2nd finger and thumb     
    
                                                                                                          Pinch total:      
    
d) Gross     
1. Place hand behind head (If score = 3 then total = 9 & finish)    
    
2.  Place hand on top of head (If score = 0 then total = 0 & finish)    
    
3. Hand to mouth     
    
                                                                                                                       Gross total:      
    
                                                                                                                    ARAT total:    
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Appendix K – Fugl-Meyer Assessment 
 Patient Identifier  
1  Shoulder / elbow / forearm Score 
1.1 Reflex activity 
      1.1.1 Flexors (biceps and finger flexors) 0  2 
      1.1.2 Extensors (triceps) 0  2 
1.2  Flexor synergy – volitional movement within synergy 
       1.2.1 Shoulder retraction 0 1 2 
       1.2.2 Shoulder elevation 0 1 2 
       1.2.3 Shoulder abduction to 90º 0 1 2 
       1.2.4 Shoulder external rotation 0 1 2 
       1.2.5 Elbow flexion 0 1 2 
       1.2.6 Forearm supination 0 1 2 
1.3  Extensor synergy – volitional movement within synergy  
       1.3.1 Shoulder adduction/internal rotation 0 1 2 
       1.3.2 Elbow extension 0 1 2 
       1.3.3 Forearm pronation 0 1 2 
1.4  Volitional movement mixing the dynamic flexor and extensor 
        1.4.1 Hand on lumbar spine 0 1 2 
        1.4.2 Shoulder flexion 0º -90º 0 1 2 
        1.4.3 Forearm pronation/supination elbow at 90º 0 1 2 
1.5  Volitional movement are performed with little or no synergy dependence 
         1.5.1 Shoulder abduction 0 1 2 
         1.5.2 Shoulder flexion 90º-180º 0 1 2 
         1.5.3 Forearm pronation-supination elbow at 0º 0 1 2 
1.6  Normal reflex activity 0 1 2 
 
2  Wrist 
2.1 Wrist stability – elbow 90º 0 1 2 
2.2 Wrist flexion/extension – elbow 90 º 0 1 2 
2.3 Wrist stability – elbow 0º 0 1 2 
2.4 Wrist flexion/extension – elbow 0º 0 1 2 
2.5 Circumduction 0 1 2 
 
3  Hand 
3.1 Mass flexion – finger flexion 0 1 2 
3.2 Mass extension – finger extension 0 1 2 
3.3 Grasp A – distal finger grasp 0 1 2 
3.4 Grasp B – thumb adduction grasp - paper 0 1 2 
3.5 Grasp C – thumb to index finger grasp - opposition 0 1 2 
3.6 Grasp D – cylinder grasp 0 1 2 
3.7 Grasp E – spherical grasp- ball   0 1 2 
 
4.  Co-ordination/speed 
4.1 Tremor – finger to nose 0 1 2 
4.2 Dysmetria- finger to nose 0 1 2 
4.3 Speed – finger to nose 0 1 2 
                                                                                       
   Upper limb score  
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Appendix L  – Barthel Index 
Participant number:                                                       Date: 
Barthel Index 
If the participant indicates that they are not independent in any of these activities, ask "Who 
helps you with these tasks?", and note which person is the chief carer. 
 
 
 
 
FEEDING 
** Independent = Able to eat any normal food (not only soft food*). Food cooked and served 
by others (food provided in reach). But not cut up. Help = food cut up, patient feeds self*. 
Instruction: If the person is walking around and obviously sitting up by themselves, start at 2. 
 
Over the past two days 
have you (has he/she) 
- cutting up food ? 
Score = 2
>
YES
Score = 1
>
YES
Score = 0
had any help with: 
Score = 0 Score = 1
>
NO
∧
YES
NO
v
1. Can you (he/she) sit up enough
to feed yourself (himself/herself) ?
YES
v
>
NO
- spreading butter ? 
to any
Over the past two days
 (has he/she) 
had any help with 
putting food on your
fork or spoon ?(his/her)
have you
Over the past two days
have you  (has he/she) 
had any help with feeding 
yourself (himself/herself) ?
Score = 0
>
YES
to any
Over the past two days have you
 (has he/she) had any help with 
- feeding yourself (himself/herself) ?
- putting food on your (his/her)
fork or spoon ?
Over the past two days have you
 he/she) eaten all types of food (not 
only soft foods) without any help ?
(has
∧
YES
∧
NO
>
NO
NO
>
2.
 
 
 
 
DRESSING 
** Independent = Should be able to select and put on all clothes (including buttons, zips, laces 
etc), which  may be adapted. Half = help with buttons, zips etc (CHECK!), but can put on 
some garments alone* 
 
>
YES
Score = 1
Over the past two days have you
 (has he/she) 
own zips, buttons, or laces 
by yourself
her)
NO
v v
YES
Over the past 2 days have you
(has he/she) put on all your
>
NOdone up all your
Score = 0
clothes by yourself
(himself/herself) ? 
(his/
(himself/herself) ? 
In the past two days have you
chosen your 
completely by yourself
clothes before dressing
 (has he/she) 
(his/her) 
(himself/herself) ? 
Score = 2
Score = 1>
YES
>
NO
(his/her) 
 
  
 
 
GROOMING 
** Refers to preceding week. Refers to personal hygiene: doing teeth, fitting false teeth, 
doing hair, shaving, washing face. Implements* can be provided by helper 
 
Over the past week have you  Score = 1
Score = 0
(has he/she) had any help with:
- cleaning your (his/her)  teeth ?
- fitting your (his/her)  dentures ?
- doing your (his/her) hair ?
- washing your (his/her) own face ?
- (and for WOMEN ONLY)  putting on your (his/her)  own makeup ?
- (and for MEN ONLY) shaving ?
BE SURE TO ASK ALL PARAMETERS
>
NO to all
>
YES to any
 
  
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BATHING 
** Usually the most difficult activity. Must get in and out unsupervised, and wash self.  
Independent shower = "independent" if unsupervised/unaided*. 
 
YES
v
Score = 0 Score = 0 Score = 1
>
NO
NO
v
YES
v
Over the past two days
been helped when
(has he/she) 
the shower or bath ?
getting into and out of
have you 
>
NO
Did anyone 
(him/her) 
wash when
in the bath
help you 
to
or shower ?
Over the past two days has
(him/her), 
out of the shower or bath ?
safety while getting into and
anyone watched over you
to ensure your (his/her), 
YES
v
Score = 0
  
 
 
TOILET USE 
**Independent = Should be able to reach toilet/commode, undress sufficiently, clean self, dress and leave.  
With help = can wipe self, and do some other of above*. 
 
and putting on your
Score = 2
>
YES
Score = 1
>
NO
Score = 0
When going to the toilet 
has anyone helped you
(him/her) 
off the toilet ? 
to get on and
Score = 0
Has anyone helped you
 (him/her) 
(cleaning/wiping) yourself
(himself/herself) ?
does anyone help you
 (him/her) with removing
Score = 0
(his/her)
>
NO
clothes ?
∧
YES
NO
v
NO
v
Score = 1
>
YES
>
NO
NO
v
v
YES
>
YES
∧
YES
anyone help you (him/her)
with removing and putting on 
(his/her) clothes ?your
When going to the toilet does
When going to the toilet
with hygiene
yourself
with hygiene (cleaning/wiping)
(himself/herself) ?
Has anyone helped you  (him/her) 
anyone help you (him/her)
with removing and putting on 
(his/her) clothes ?your
When going to the toilet does
  
 
 
TRANSFER 
 ** Independent = From bed to chair and back.  
 Dependent = no sitting balance (unable to sit); two people to lift.  
 Major help = one strong/skilled, or two normal people. Can sit up.  
 Minor help (verbal or physical) = by one, untrained person, including supervision/ moral support. 
Instruction: If the person is walking around and obviously sitting up by themselves, start at 2. 
 
NO
v
Score = 1>1 strong/skilled or
2 untrained
people required
Score = 0 <
2 skilled
people
required
NO
v
Score = 3>
YES
Over the past two days when you've 
to chair or wheelchair and back again
(he's/she's) 
yourself 
have you (has he/she)
(himself/herself) ?
2.
have physically helped you move(him/her)
from bed to chair and back again ?
Who helped you ?
Over the past two days how many people 
1. Are you  (is he/ 
able to sit she) 
unaided in a chair?
YES
^
needed to move from bed
done this by 
Has anyone watched over you
(him/her) to ensure your
safety ?(his/her) >
NO
YES
v
Score = 2
1untrained
required
^
person
  
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STAIRS 
**Independent = Must carry any walking aid used (if used). If patient hasn’t walked up or down 
stairs because there are no stairs at home but usually does use them while shopping, etc, score as 
independent (use judgement). Needs help = verbal, physical, and carrying help 
Instruction: If you see the person walking up and down stairs, start at 2. 
 
Score = 0
When you go 
up and down one flight of 
assistance ?
(he/she goes) 
(i.e. watch) you
and/or provide any verbal
stairs does anyone supervise
When you  go 
up and down one flight of stairs
any physical support ?
(he/she goes) 
(him/her) does anyone give you
YES and needs
50% assistance≥
Score = 1
When you go up or down stairs(he/she goes) 
does anyone carry any walking aid for you
(him/her) 
Score = 2
>
YES
YESNO
v
Score = 1 Score = 0
YES
v
NO
v
YES and needs
< 50% assistance
NO
v
1. Over the past
two days have  
you  
down any stairs?  
walked up and
(has he/she)  
v
>
YES
NO
v
<
NO
v
<
<
NO
>
YES
? (e.g. a walking stick or frame)
When you  go 
up and down stairs does
(he/she goes) 
anyone carry any walking aid
for you (him/her) ? (e.g. a
walking stick or frame)
When you go 
up and down one flight of
any physical
(he/she goes) 
stairs does anyone give you 
(him/her)
2.
(him/her) 
support?
  
 
 
MOBILITY 
** Refers to mobility about house or ward, indoors.  
Independent = May use aid (stick, frame). If in a wheelchair, must negotiate doors/corners unaided.  
Help (physical/verbal) = by one, untrained person, including supervision/moral support. 
Instruction: If the person is walking around by themselves (at least 50 metres), start at 3. If the person 
is moving around by themselves in a wheelchair (at least 50 metres), start at 4. 
 
Score = 2
1 untrained
Score = 0
Score = 3
v
YES
YES
v
Was this 
with the aid of 
a wheelchair ? 
Over the past two days has anyone
 (him/her) 
corners and/or doorways) ?
(his/her)
to move about
Score = 0>
NO
v
Over the past two days has
 (him/her) 
to move about the house 
or ward either supervising 
anyone helped you
or physically assisting ?
NO
<
YES
<
1. Over the past 2 days,
(has he/she) 
moved around the
metres on the level ?
when needing to,
ward/house at least 50
have you
people have helped you (him/her)?
helped you
wheelchair (e.g. helped in negotiating
Score = 1
Score = 0
>
NO
2 untrained
or 1 strong/
skilled person v
>
NO
>
YES
the house/ward in your
Who helped you (him/her) ? 
2.
3.
4.
Over the past two days how many
  
 
 
BLADDER 
** Refers to preceding week. Occasional = less than once a day (max once per 24 hours).  
A catheterised patient who can manage the catheter alone is registered as continent. 
 
In the past week have you
been able to control(has he/she) 
 (his/her) bladder ?
Score = 2 Score = 1
How often do you
 (does he/she) have
accidents?
Score = 0
>
> 1 per day on
average over 
the past weekv
≤ 1 per day on
average over 
the past week
Do you (does he/she) ever need
a catheter to assist you
(him/her) in that matter?
Do you (does he/she) manage the
catheter yourself (himself/herself) ?
YES
v
NO
v
YES
<
NO
v
YES
^
NO
>
your
 
  
 
 
281 
 
 
 
BOWELS 
 ** Refers to preceding week.  
 If needs enema from nurse, then "incontinent". Occasional accident = once/week. 
 
Over the past 7 days
 (his/her) bowels ?
>
NO Score = 2
v
YES
>
≤ 1 during the entire week Score = 1
≥ 2 during the entire week Score = 0
(has he/she) have you >NO
How often have
 (has he/ 
control in the
past week?
you
> >
NO
v
YES
YES^
lost control of your
she) lost
Have you  (has he/she) 
been given an enema by 
someone else, e.g. a nurse? 
Have you  (has he/she) 
been given an enema by 
someone else, e.g. a nurse? 
 
  
 
 
282 
Reference List 
 
 1.  Hatano S. Experience from a multicenter stroke register:  a 
preliminary report. Bull World Health Organization 1976;54:541-53. 
 2.  Warlow C, Sudlow C, Dennis M, Wardlaw J, Sandercock P. Stroke. 
Lancet 2003;362:1211-24. 
 3.  Sudlow C, Warlow C. Comparable studies of the incidence of stroke 
and its pathological types - Results from an international 
collaboration. Stroke 1997;28:491-9. 
 4.  Feigin V, Lawes C, Bennett D, Anderson C. Stroke epidemiology: a 
review of population-based studies of incidence, prevalence, and 
case-fatality in the late 20th century. Lancet Neurol 2003;2:43-53. 
 5.  Warlow C, van Gijn J, Dennis M, Wardlaw J, Bamford J, Hankey G 
et al. Stroke; practical management. Oxford: Blackwell Publishing, 
2008. 
 6.  World Health Organization. The atlas of heart disease and stroke.  
www.who.int/cardiovascular.diseases/resources/atlas/en/.  Last 
accessed July 2008.     
 7.  Mant J, Wade C, Winner S. Health care needs assessment:  Stroke. 
In Stevens A, Raftery J, Mant J, Simpson S, eds. Health care needs 
assessment; the epidemiologically based needs assessment 
reviews, Oxford: Radcliffe Medical Press, 2004. 
 8.  Adamson J, Beswick A, Ebrahim S. Is stroke the most common 
cause of disability? J Stroke Cerebrovasc 2004;13:171-7. 
 9.  National Audit Office. Department of Health - Reducing brain 
damage:  Faster access to better stroke care (online). 2005.  
www.nao.org.uk/publications/0506/reducing_brain_damage.aspx.  
Last accessed July 2008.   
 10.  Wolfe C. The impact of stroke. Brit Med Bull 2000;56:275-86. 
 11.  Rothwell P. The high cost of not funding stroke research: a 
comparison with heart disease and cancer. Lancet 2001;357:1612-6. 
 12.  Bonita R. Epidemiology of Stroke. Lancet 1992;339:342-4. 
 13.  Scottish Executive. Coronary Heart Disease and Stroke Strategy for 
Scotland (online).  2002. 
www.scotland.gov.uk/publications/2002/10/15530.  Last accessed 
July 2008.  
 
283 
 14.  Department of Health. National Stroke Strategy (online).  2007.  
www.dh.gov.uk/en/Publicationsandstatistics/Publications/Publication
sPolicyAndGuidance/DH_081062.  Last accessed July 2008.   
 
 15.  Wolfe, C and Rudd, T. The burden of stroke of stroke white paper:  
Raising the awareness of the global toll of stroke related disability 
and death.  2007.  www.safestroke.org/resources/the-burden-of-
stroke-white-paper.aspx.  Last accessed July 2008.    
 
 16.  Department of Health. Stroke rehabilitation. Effective Health care 
1992;2:1-11. 
 17.  Langhorne P, Stott D, Robertson L, MacDonald J, Jones L, 
McAlpine C et al. Medical complications after stroke - Multicenter 
study. Stroke 2000;31:1223-9. 
 18.  Arganoff, A. Stroke motor impairment (online). 
http://emedicine.medscape.com/articles/324386-overview.  Last 
accessed July 2008.   
 
 19.  World Health Organization. International classification of functioning, 
disability and health (online).  2001.  
www.who.int/classification/icf/en/  Last accessed July 2008.   
 
 20.  Wade D, Langton Hewer R, Skilbeck C, David R. Stroke:  a critical 
approach to diagnosis, treatment and management. London: 
Chapman & Hall, 1985. 
 21.  Nakayama H, Jorgensen H, Raaschou H, Olsen T. Recovery of 
upper extremity function in stroke patients: the Copenhagen Stroke 
Study. Arch Phys Med Rehab 1994;75:394-8. 
 22.  Wade D. Measuring upper limb impairment and disability after 
stroke. Int Disabil Stud 1989;11:89-92. 
 23.  Fregni F, Pascual-Leone A. Hand motor recovery after stroke: 
Tuning the orchestra to improve hand motor function. Cog Behav 
Neurol 2006;19:21-33. 
 24.  Goulding R, Thompson D, Beech C. Caring for patients with 
hemiplegia in an arm following stroke. Br J Nurs 2004;13:534-9. 
 25.  Wyller T, Sveen U, Sodring K, Pettersen A, BautzHolter E. 
Subjective well-being one year after stroke. Clin Rehabil 
1997;11:139-45. 
 26.  Feys H, De Weerdt W, Selz B, Steck G, Spichiger R, Vereeck L et 
al. Effect of a therapeutic intervention for the hemiplegic upper limb 
in the acute phase after stroke - A single-blind, randomized, 
controlled multicenter trial. Stroke 1998;29:785-92. 
284 
 27.  Parker V, Wade D, Langton Hewer R. Loss of arm function after 
stroke: measurement, frequency, and recovery. Int Rehabil Med 
1986;8:69-73. 
 28.  Wardlaw J, Murray V, Berge E, del Zoppo G. Thrombolysis for acute 
ischaemic stroke. Cochrane Database Syst Rev 2009;4:CD000213. 
 29.  Scottish Intercollegiate Guidelines Network. Management of patients 
with stroke or TIA:  assessment, investigation, immediate 
management and secondary preventation:  a national clinical 
guideline (online).  2008.  
www.sign.ac.uk/guidelines/fulltext/108/index.html. Last accessed 
January 2012.   
 
 30.  Quaba O, Robertson C. Thrombolysis and its implications in the 
management of stroke in the accident and emergency department. 
Scot Med J 2002;47. 
 31.  O'Connor R, McGraw P, Edelsohn L. Thrombolytic therapy for acute 
ischemic stroke: Why the majority of patients remain ineligible for 
treatment. Ann Emerg Med 1999;33:9-14. 
 32.  Royal College of Physicians. National clinical guidelines for stroke 
(online).  2008.  www.rcplondon.ac.uk/resources/stroke-guidelines.  
Last accessed January 2012.   
 33.  Scottish Intercollegiate Guidelines Network. Management of patients 
with stroke:  Rehabilitation, prevention and management of 
  complications, and discharge planning (online).  2010.  
www.sign.ac.uk/guidelines/fulltext/118/index.html.  Last accessed 
January 2012.   
 34.  The European Stroke Organization (ESO) Guidelines for 
management of ischaemic stroke and transient ischaemic attack 
2008.  www.eso-stroke.org/pdf/ESO08-
Guidelines.original.english.pdf.  Last accessed February 2012.   
 
 35.  Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) 
care for stroke. Cochrane Database of Syst Rev 2012;4:CD000197.  
 36.  Langhorne P, Pollock A. What are the components of effective 
stroke unit care? Age Ageing 2002;31:365-71. 
 37.  Young J, Forster A. Rehabilitation after stroke. BMJ 2007;334:86-90. 
 38.  Wade D. Evidence relating to assessment in rehabilitation. Clin 
Rehabil 1998;12:183-6. 
 39.  Young J. Caring for older people - Rehabilitation and older people. 
BMJ 1996;313:677-81. 
285 
 40.  Bohannon R, Andrews A, Smith M. Rehabilitation Goals of Patients 
with Hemiplegia. Int J Rehabil Res 1988;11:181-3. 
 41.  Ring H, Rosenthal N. Controlled study of neuroprosthetic functional 
electrical stimulation in sub-acute post-stroke rehabilitation. J 
Rehabil Med 2005;37:32-6. 
 42.  Sackett D, Rosenberg W, Gray J, Haynes R, Richardson W. 
Evidence based medicine: What it is and what it isn't - It's about 
integrating individual clinical expertise and the best external 
evidence. BMJ 1996;312:71-2. 
 43.  Medical Research Council. A framework for development and 
evaluaion of RCTs for complex interventions to improve health. 
London: Medical Research Council, 2000. 
 44.  McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D. Randomised 
trials in surgery: problems and possible solutions. BMJ 
2002;324:1448-51. 
 45.  Pollock C, Freemantle N, Sheldon T, Song F, Mason J. 
Methodological difficulties in rehabilitation research. Clin Rehabil 
1993;7:63-72. 
 46.  Wolfe C, Rudd A, Tilling K. Trials of community rehabilitation need to 
be of adequate sample size. Stroke 1998;29:1737-8. 
 47.  Campbell N, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F 
et al. Designing and evaluating complex interventions to improve 
health care. BMJ 2007;334:455-9. 
 48.  Pomeroy V, Tallis R. Need to focus research in stroke rehabilitation. 
Lancet 2000;355:836-7. 
 49.  Day S, Altman D. Statistics Notes - Blinding in clinical trials and 
other studies. BMJ 2000;321:504. 
 50.  Schulz K, Chalmers I, Hayes R, Altman D. Evidence of bias:  
Dimensions of methodological quality associated with estimates of 
treatment effects in controlled trials. JAMA 1995;273:408-12. 
 51.  Rodgers H, Mackintosh J, Price C, Wood R, McNamee P, Fearon T 
et al. Does an early increased-intensity interdisciplinary upper limb 
therapy programme following acute stroke improve outcome? Clin 
Rehabil 2003;17:579-89. 
 52.  Legg L, Drummond AE, Langhorne P. Occupational Therapy for 
patients with problems of activities of daily living after stroke. 
Cochrane Database Syst Rev 2006;4:CD003585.  
 53.  van Peppen R, Kwakkel G, Wood-Dauphinee S, Hendriks H, Van 
der Wees P, Dekker J. The impact of physical therapy on functional 
286 
outcomes after stroke: what's the evidence? Clin Rehabil 
2004;18:833-62. 
 54.  Pomeroy V, Tallis R. Need to focus research in stroke rehabilitation. 
Lancet 2000;355:836-7. 
 55.  Scottish Executive. Allied Health Professions Research and 
Development Action Plan. Edinburgh: Scottish Executive (Astron), 
2004. 
 56.  Pomeroy V, Tallis R. Physical therapy to improve movement 
performance and functional ability poststroke.  Part 2.  A research 
direction. Rev Clin Gerontol 2000;10:381-7. 
 57.  Meldrum D, Pittock S, Hardiman O, Ni Dhuill C, O'Regan M. 
Recovery of the upper limb post ischaemic stroke and the predictive 
value of the Orpington Prognostic Score. Clin Rehabil 2004;18:694-
702. 
 58.  Campbell M, Fitzpatrick R, Haines A, Kinmonth A, Sandercock P, 
Spiegelhalter D et al. Framework for design and evaluation of 
complex interventions to improve health. BMJ 2000;321:694-6. 
 59.  Medical Research Council. Developing and evaluating complex 
interventions:  new guidance.  2008.  
www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC004871.  
Last accessed April 2012.   
 
 60.  Craig P, Dieppe P, MacIntyire S, Nazareth I, Petticrew M. 
Developing and evaluating complex interventions:  the new Medical 
Research Council guidance. BMJ 2008;337:979-83. 
 61.  Wyller T, Holmen J, Laake P, Laake K. Correlates of subjective well-
being in stroke patients. Stroke 1998;29:363-7. 
 62.  Winstein C, Rose D, Tan S, Lewthwaite R, Chui H, Azen S. A 
randomized controlled comparison of upper-extremity rehabilitation 
strategies in acute stroke: A pilot study of immediate and long-term 
outcomes. Arch Phys Med Rehab 2004;85:620-8. 
 63.  Putman K, De Wit L, Schoonacker M, Baert I, Beyens H, Brinkmann 
N et al. Effect of socioeconomic status on functional and motor 
recovery after stroke: a European multicentre study. J Neurol 
Neurosurg Psychiatry 2007;78:593-9. 
 64.  Wade D, Langton Hewer R, Wood V, Skilbeck C. The hemiplegic 
arm after stroke:  measurement and recovery. J Neurol Neurosurg 
Psychiatry 1983;46:521-4. 
 65.  Kwakkel G, Kollen B, van der GJ, Prevo A. Probability of regaining 
dexterity in the flaccid upper limb: impact of severity of paresis and 
time since onset in acute stroke. Stroke 2003;34:2181-6. 
287 
 66.  Van der Lee J, Snels I, Beckerman H, Lankhorst G, Wagenaar R, 
Bouter L. Exercise therapy for arm function in stroke patients:  a 
systematic review of randomized controlled trials. Clin Rehabil 
2001;15:20-31. 
 67.  Basmajian J, Gowland C. The Many Hidden Faces of Stroke - A Call 
for Action. Arch Phys Med Rehab 1987;68:319. 
 68.  Shelton F, Reding M. Effect of lesion location on upper limb motor 
recovery after stroke. Stroke 2001;32:107-12. 
 69.  Nascimbeni A, Gaffuri A, Imazio P. Motor evoked potentials: 
prognostic value in motor recovery after stroke. Funct Neurol 
2006;21:199-203. 
 70.  Feys H, De Weerdt W, Nuyens G, van de Winckel A, Selz B, 
Kiekens C. Predicting motor recovery of the upper limb after stroke 
rehabilitation: value of a clinical examination. Physiother Res Int 
2000;5:1-18. 
 71.  Altman D. Systematic reviews in health care - Systematic reviews of 
evaluations of prognostic variables. BMJ 2001;323:224-8. 
 72.  Dennis M. Predictions models in acute stroke - Potential uses and 
limitations. Stroke 2008;39:1665-6. 
 73.  Hendricks H, Zwarts M, Plat E, van Limbeek J. Systematic review for 
the early prediction of motor and functional outcome after stroke by 
using motor-evoked potentials. Arch Phys Med Rehab 
2002;83:1303-8. 
 74.  Shelton F, Volpe B, Reding M. Motor impairment as a predictor of 
functional recovery and guide to rehabilitation treatment after stroke. 
Neurorehabil Neural Repair 2001;15:229-37. 
 75.  Katrak P. Shoulder shrug--a prognostic sign for recovery of hand 
movement after stroke. Med J Australia 1990;152:297-301. 
 76.  Barreca S, Finlayson M, Gowland C, Basmajian J. Use of the 
Halstead Category Test as a cognitive predictor of functional 
recovery in the hemiplegic upper limb: a cross-validation study. Clin 
Neuropsyc 1999;13:171-81. 
 77.  Chen S-Y, Winstein C. A systematic review of voluntary arm 
recovery in hemiparetic stroke. J Neurol Phys Ther 2009;33:2-13. 
 78.  Stinear C. Prediction of recovery of motor function after stroke. 
Lancet Neurol 2010;9:1228-32. 
 79.  Egger M, Davey Smith G, Altman DG. Systematic reviews in health-
care:  Meta-analysis in context. London: BMJ, 2001. 
288 
 80.  Greenhalgh T. How to read a paper:  Papers that summarise other 
papers (systematic reviews and meta-analyses). BMJ 1997;372:672-
5. 
 81.  Stroup D, Berlin J, Morton S, Olkin I, Williamson G, Rennie D et al. 
Meta-analysis of observational studies in epidemiology - A proposal 
for reporting. JAMA 2000;283:2008-12. 
 82.  Mahoney F, Barthel D. Functional evaluation:  The Barthel Index. 
Maryland State Med J 1965;39:56-61. 
 83.  Bonita R, Beaglehole R. Modification of Rankin Scale:  Recovery of 
motor function after stroke. Stroke 1988;19:1497-500. 
 84.  Keith R, Granger C, Hamitlon B, herwin F. The Functional 
Independence Measure:  a new tool for rehabilitation. Adv Clin 
Rehabil 1987;1:6-18. 
 85.  Lyle R. A performance-test for assessment of upper limb function in 
physical rehabilitation treatment and research. Int J Rehabil Res 
1981;4:483-92. 
 86.  Carr J, Shepherd R. Investigation of a new Motor Assessment Scale 
for stroke patients. Phys Ther 1985;65:175-80. 
 87.  Mathiowetz V, Volland G, Kashman N, Weber K. Adult norms for the 
Box and Block Test of manual dexterity. Am J Occup Ther 
1985;39:386-91. 
 88.  Fugl-Meyer A, Jaasko L, Leyman I, Olsson S, Steglind S. The post-
stroke hemiplegic patient.  I. A method for evaluation of physical 
performance. Scand J Rehabil 1975;7:13-31. 
 89.  Jorgensen H, Nakayama H, Pedersen P, Kammersgaard L, Otto H, 
Tom R et al. Epidemiology of stroke-related disability: The 
Copenhagen Stroke Study. Clin Geriatr Med 1999;15:785-99. 
 90.  Sandercock P, Algra A, Anderson C, et al. Cochrane Stroke Group.  
About the Cochrane Colloboration (Cochrane Review Groups). The 
Cochrane Library 2009;2. 
 91.  Wells G, Shea B, O'Connell D, Peterson J, Welch V Losos M et al. 
The Newcastle-Ottawa Scale (NOS) for assessing the quality of 
nonrandomised studies in meta-analyses.  2008 
http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.  Last 
accessed January 2012.   
 92.  Belo J, Berger M, Reijman M, Koes B, Bierma-Zeinstra S. 
Prognostic factors of progression of osteoarthritis of the knee: A 
systematic review of observational studies. Arthrit Care Res 
2007;57:13-26. 
289 
 93.  Hayden J, Cote P, Bombardier C. Evaluation of the quality of 
prognosis studies in systematic reviews. Ann Intern Med 
2006;144:427-37. 
 94.  Scholten-Peeters G, Verhagen A, Bekkering G, van der Windt D, 
Barnsley L, Oostendorp R et al. Prognostic factors of whiplash-
associated disorders: A systematic review of prospective cohort 
studies. Pain 2003;104:303-22. 
 95.  Clarke M, Oxman Ae. Cochrane reviewers handbook version 4.2.0 
(Updated March 2003). Chichester: John Wiley & Sons, 2003. 
 96.  Alagona G, Delvaux V, Gerard P, De Pasqua V, Pennisi G, 
Delwaide P et al. Ipsilateral motor responses to focal transcranial 
magnetic stimulation in healthy subjects and acute-stroke patients. 
Stroke 2001;32:1304-9. 
 97.  Delaux V, Alagona G, Gerard P, De Pasqua V, Pennisi G, de 
Noordhout A. Post-stroke reorganization of hand motor area: a 1-
year prospective follow-up with focal transcranial magnetic 
stimulation. Clin Neurophysiol 2003;114:1217-25. 
 98.  Al-Rawi M, Hamdan F, Abdul-Muttalib A. Somatosensory evoked 
potentials as a predictor for functional recovery of the upper limb in 
patients with stroke. J Stroke Cerebrovasc 2009;18:262-8. 
 99.  Au-Yeung S, Hui-Chan C. Predicting recovery of dextrous hand 
function in acute stroke. Disabil Rehabil 2009;31:394-401. 
 100.  Beebe J, Lang C. Active range of motion predicts upper extremity 
function 3 months after stroke. Stroke 2009;40:1772-9. 
 101.  Binkofski F, Seitz R, Hacklander T, Pawelec D, Mau J, Freund H. 
Recovery of motor functions following hemiparetic stroke: a clinical 
and magnetic resonance-morphometric study. Cerebrovasc Dis 
2001;11:273-81. 
 102.  Canning C, Ada L, Adams R, O'Dwyer N. Loss of strength 
contributes more to physical disability after stroke than loss of 
dexterity. Clin Rehabil 2004;18:300-8. 
 103.  Catano A, Houa M, Caroyer J, Ducarne H, Noel P. Magnetic 
transcranial stimulation in non-haemorrhagic sylvian strokes: interest 
of facilitation for early functional prognosis. Electromyogr Motor C 
1995;97:349-54. 
 104.  Catano A, Houa M, Noel P. Magnetic transcranial stimulation: 
clinical interest of the silent period in acute and chronic stages of 
stroke. Electromyogr Motor C 1997;105:290-6. 
 105.  Cho S-H, KIm D, Kim D-S, Kim Y-H, Lee C-H, Jang S-H. Motor 
outcome according to the integrity of the corticospinal tract 
290 
determined by diffusion tensor tractography in the early stages of 
corona radiata infarct. Neurosci Lett 2007;426:123-7. 
 106.  Cruz MA, Tejada J, Diez TE. Motor hand recovery after stroke. 
Prognostic yield of early transcranial magnetic stimulation. 
Electromyogr Clin Neurophysiol 1999;39:405-10. 
 107.  Dachy B, Biltiau E, Bouillot E, Dan B, Deltenre P. Facilitation of 
motor evoked potentials in ischemic stroke patients: prognostic 
value and neurophysiologic correlations. Clin Neurophysiol 
2003;114:2370-5. 
 108.  De Souza L, Hewer R, Miller S. Assessment of recovery of arm 
control in hemiplegic stroke patients. 1. Arm function tests. Int 
Rehabil Med 1980;2:3-9. 
 109.  De Weerdt W, Lincoln N, Harrison M. Prediction of arm and hand 
function recovery in stroke patients. Int J Rehabil Res 1987;10:110-
2. 
 110.  Escudero J, Sancho J, Bautista D, Escudero M, Lopez-Trigo J. 
Prognostic value of motor evoked potential obtained by transcranial 
magnetic brain stimulation in motor function recovery in patients with 
acute ischemic stroke. Stroke 1998;29:1854-9. 
 111.  Feys H, Hetebrij J, Wilms G, Dom R, De Weerdt W. Predicting arm 
recovery following stroke: value of site of lesion. Acta Neurol Scand 
2000;102:371-7. 
 112.  Feys H, Van Hees J, Bruyninckx F, Mercelis R, De Weerdt W. Value 
of somatosensory and motor evoked potentials in predicting arm 
recovery after a stroke. J Neurol Neurosurg Psychiatry 2000;68:323-
31. 
 113.  Gowland C. Recovery of motor function following stroke profile and 
predictors. Physiother Can 1982;34:77-84. 
 114.  Hatakenaka M, Miyai I, Sakoda S, Yanagihara T. Proximal paresis of 
the upper extremity in patients with stroke. Neurology 2007;69:348-
55. 
 115.  Heald A, Bates D, Cartlidge N, French J, Miller S. Longitudinal study 
of central motor conduction time following stroke.  2.  Central motor 
conduction measured within 72 h after stroke as a predictor of 
functional outcome at 12 months. Brain 1993;116:1371-85. 
 116.  Hendricks H, Hageman G, van Limbeek J. Prediction of recovery 
from upper extremity paralysis after stroke by measuring evoked 
potentials. Scand J Rehabil Med 1997;29:155-9. 
 117.  Hendricks H, Pasman J, Mulder T, Notermans S, Schoonderwaldt H. 
Value of somatosensory evoked potentials for the prediction of 
291 
motor recovery of the upper extremity after cerebral infarction. J 
Rehabil Sci 1994;7:3-8. 
 118.  Hendricks H, Pasman J, van Limbeek J, Zwarts M. Motor evoked 
potentials in predicting recovery from upper extremity paralysis after 
acute stroke. Cerebrovasc Dis 2003;16:265-71. 
 119.  Higgins J, Mayo NE, Desrosiers J, Salbach NM, Ahmed S. Upper-
limb function and recovery in the acute phase poststroke. J Rehabil 
Res Dev 2005;42:65-76. 
 120.  Jang S, Ahn S, Sakong J, Byun W, Choi B, Chang C et al. 
Comparison of TMS and DTT for predicting motor outcome in 
intracerebral hemorrhage. J Neurol Sci 2010;290:107-11. 
 121.  Katrak P, Bowring G, Conroy P, Chilvers M, Poulos R, McNeil D. 
Predicting upper limb recovery after stroke: the place of early 
shoulder and hand movement. Arch Phys Med Rehab 1998;79:758-
61. 
 122.  Keren O, Ring H, Solzi P, Pratt H, Groswasser Z. Upper limb 
somatosensory evoked potentials as a predictor of rehabilitation 
progress in dominant hemisphere stroke patients. Stroke 
1993;24:1789-93. 
 123.  Keren O, Ring H, Pratt H, Groswasser Z. Dynamic changes in upper 
limb short latency somatosensory-evoked potentials following stroke 
in the dominant hemisphere. Clin Rehabil 1995;9:52-60. 
 124.  La Joie W, Reddy N, Melvin J. Somatosensory evoked potentials: 
their predictive value in right hemiplegia. Arch Phys Med Rehab 
1982;63:223-6. 
 125.  Lin K-C, Huang Y-H, Hsieh Y-W, Weu C-Y. Potential predictors of 
motor and functional outcomes after distributed constraint-induced 
therapy for patients with stroke. Neurorehab Neural Re 2009;23:336-
42. 
 126.  Loewen S, Anderson B. Predictors of stroke outcome using objective 
measurement scales. Stroke 1990;21:78-81. 
 127.  Loubinoux I, Carel C, Pariente J, Dechaumont S, Albucher J, 
Marque P et al. Correlation between cerebral reorganization and 
motor recovery after subcortical infarcts. Neuroimage. 2003;2166-
80. 
 128.  Meldrum D, Barrett A, O'Regan M, Pittock S, Moroney J, Hardiman 
O. Predicting upper limb recovery after ischemic stroke: role of the 
Orpington Prognostic Score. Physiother Ireland 2000;21:28-32. 
292 
 129.  Nagao S, Kawai N. Prediction of motor function by magnetic brain 
stimulation in patients with intracerebral hematoma. Neurol Med-Chir 
1992;32:268-74. 
 130.  Nijland R, van Wegen E, Harmeling-van der Wel B, Kwakkel G, 
Investigators EPOS. Presence of finger extension and shoulder 
abduction within 72 hours after stroke predicts functional recovery: 
early prediction of functional outcome after stroke: the EPOS cohort 
study. Stroke 2010;41:745-50. 
 131.  Olsen T. Arm and leg paresis as outcome predictors in stroke 
rehabilitation. Stroke 1990;21:247-51. 
 132.  Paci M, Nannetti L, Taiti P, Baccini M, Rinaldi L. Shoulder 
subluxation after stroke: relationships with pain and motor recovery. 
Physiother Res Int 2007;12:95-104. 
 133.  Park S, Wolf S, Blanton S, Winstein C, Nichols-Larsen D. The 
EXCITE trial: Predicting a clinically meaningful Motor Activity Log 
outcome. Neurorehab Neural Re 2008;22:486-93. 
 134.  Pennisi G, Rapisarda G, Bella R, Calabrese V, Maertens De 
Noordhout A, Delwaide P. Absence of response to early transcranial 
magnetic stimulation in ischemic stroke patients: prognostic value for 
hand motor recovery. Stroke 1999;30:2666-70. 
 135.  Pizzi A, Carrai R, Falsini C, Martini M, Verdesca S, Grippo A. 
Prognostic value of motor evoked potentials in motor function 
recovery of upper limb after stroke. J Rehabil Med 2009;41:654-60. 
 136.  Prabhakaran S, Zarahn E, Riley C, Speizer A, Chong J, Lazar R et 
al. Inter-individual variability in the capacity for motor recovery after 
ischemic stroke. Neurorehab Neural Re 2008;22:64-71. 
 137.  Rapisarda G, Bastings E, de Noordhout A, Pennisi G, Delwaide P. 
Can motor recovery in stroke patients be predicted by early 
transcranial magnetic stimulation? Stroke 1996;27:2191-6. 
 138.  Renner C, Bungert-Kahl P, Hummelsheim H. Change of strength 
and rate of rise of tension relate to functional arm recovery after 
stroke. Arch Phys Med Rehab 2009;90:1548-56. 
 139.  Roy C, Sands M, Hill L, Harrison A, Marshall S. The effect of 
shoulder pain on outcome of acute hemiplegia. Clin Rehabil 
1995;9:21-7. 
 140.  Smania N, Paolucci S, Tinazzi M, Borghero A, Manganotti P, Fiaschi 
A et al. Active finger extension - A simple movement predicting 
recovery of arm function in patients with acute stroke. Stroke 
2007;38:1088-90. 
293 
 141.  Stinear C, Barber P, Smale P, Coxon J, Fleming M, Byblow W. 
Functional potential in chronic stroke patients depends on 
corticospinal tract integrity. Brain 2007;130:170-80. 
 142.  Sunderland A, Tinson D, Bradley L, Hewer R. Arm function after 
stroke. An evaluation of grip strength as a measure of recovery and 
a prognostic indicator. J Neurol Neurosurg Psychiatry 1989;52:1267-
72. 
 143.  Trompetto C, Assini A, Buccolieri A, Marchese R, Abbruzzese G. 
Motor recovery following stroke: a transcranial magnetic stimulation 
study. Clin Neurophysiol 2000;111:1860-7. 
 144.  Turton A, Wroe S, Trepte N, Fraser C, Lemon R. Contralateral and 
ipsilateral EMC responses to transcranial magnetic stimulation 
during recovery of arm and hand function after stroke. Electromyogr 
Motor C 1996;101:316-28. 
 145.  Tzvetanov P, Rousseff R, Atanassova P. Prognostic value of median 
and tibial somatosensory evoked potentials in acute stroke. Neurosci 
Lett 2005;380:99-104. 
 146.  Tzvetanov P, Milanov I, Rousseff R, Christova P. Can SSEP results 
predict functional recovery of stroke patients within the "therapeutic 
window"? Electromyogr Clin Neurophysiol 2004;44:43-9. 
 147.  van Kuijk A, Pasman J, Hendricks H, Zwarts M, Geurts A. Predicting 
hand motor recovery in severe stroke: the role of motor evoked 
potentials in relation to early clinical assessment. Neurorehab Neural 
Re 2009;23:45-51. 
 148.  Wagner J, Lang C, Sahrmann S, Edwards D, Dromerick A. 
Sensorimotor impairments and reaching performance in subjects 
with poststroke hemiparesis during the first few months of recovery. 
Phys Ther 2007;87:751-65. 
 149.  Yagura H, Miyai I, Seike Y, Suzuki T, Yanagihara T. Benefit of 
inpatient multidisciplinary rehabilitation up to 1 year after stroke. 
Arch Phys Med Rehab 2003;84:1687-91. 
 150.  Yoshioka H, Horikoshi T, Aoki S, Hori M, Ishigame K, Uchida M et 
al. Diffusion tensor tractography predicts motor functional outcome 
in patients with spontaneous intracerebral hemorrhage. 
Neurosurgery 2008;62:97-103. 
 151.  Easterbrook P, Berlin J, Gorpalan R, Matthews D. Publication bias in 
clinical research. Lancet 1991;337:867-72. 
 152.  Deeks J, Higgins J, Altman D, (editors). Chapter 9:  Analysing data 
and undertaking meta-analyses. In Higgins JPT, Green S, eds. 
Cochrane Handbook for Systematic Reviews of Interventions 
294 
Version 5.1.0.  The Cochrane Collaboration, 2011.  www.cochrane-
handbook.org. Last accessed January 2012.   
 153.  COMET Initiative. www.comet-initiative.org/.  Last accessed April 
2012. 
 
 154.  Wade D. Measurement in neurological rehabilitaiton. Oxford: Oxford 
University Press, 1992. 
 155.  Ballinger C, Ashburn A, Low J, Roderick P. Unpacking the black box 
of therapy - a pilot study to describe occupational therapy and 
physiotherapy interventions for people with stroke. Clin Rehabil 
1999;13:301-9. 
 156.  De Wit L, Putman K, Lincoln N, Baert I, Berman P, Beyens H et al. 
Stroke rehabilitation in Europe - What do physiotherapists and 
occupational therapists actually do? Stroke 2006;37:1483-9. 
 157.  Cirstea C, Ptito A, Levin M. Feedback and cognition in arm motor 
skill reacquisition after stroke. Stroke 2006;37:1237-42. 
 158.  Barnes M, Dobkin B, Bogousslavsky J. Recovery after stroke. 
Cambridge: Cambridge University Press, 2005. 
 159.  Legg L, Langhorne P, Pollock A, Sellars C. A multidisciplinary 
research agenda for stroke rehabilitation. Br J Ther Rehabil 
2000;797:319-24. 
 160.  Sackett D, Strauss S, Richardson W. Evidence-based medicine:  
How to practice and teach EBM. Philadelphia: Churchill Livingstone, 
2000. 
 161.  Heller A, Wade D, Wood V, Sunderland A, Hewer R, Ward E. Arm 
function after stroke - Measurement and recovery over the first three 
months. J Neurol Neurosurg Psychiatry 1987;50:714-9. 
 162.  Kellor M, Frost J, Silberbe N, Iversen I, Cummings R. Norms for 
clinical use - Hand strength and dexterity. Am J Occup Ther 
1971;25:77-83. 
 163.  Demeurisse G, Demol O, Robaye E. Motor evaluation in vascular 
hemiplegia. Euro Neurol 1980;19:382-9. 
 164.  Higgins J, Altman D, Sterne J. Chapter 8:  Assessing risk of bias in 
included studies. In Higgins J, Green S, eds. Cochrane Handbook 
for Systematic Reviews of Interventions Version 5.1.0.  The 
Cochrane Collaboration, 2011.  www.cochrane-handbook.org. Last 
accessed January 2012.   
 165.  RevMan. The Nordic Cochrane Centre.  The Cochrane 
Collaboration.  Review Manager (RevMan).  5.0. Copenhagen: The 
Nordic Cochrane Centre, The Cochrane Collaboration, 2008. 
295 
 166.  Cohen J. Statistical power analysis for the behavioural sciences. 
USA: Lawerence Erlbaum Associates, 1988. 
 167.  Clinical Evidence. BMJ Publishing Group. 2009.  
http://clinicalevidence.bmj.com/ceweb/about/guide.jsp.  Last 
accessed April 2009.    
 
 168.  Luke C, Dodd K, Brock K. Outcomes of the Bobath concept on 
upper limb recovery following stroke. Clin Rehabil 2004;18:888-98. 
 169.  Gelber D, Josefczyk P, Herrman D, Good D, Verhulst S. 
Comparison of two therapy approaches in the rehabilitation of the 
pure motor hemiparetic stroke patient. J Neurol Rehabil 1995;9:191-
6. 
 170.  Langhammer B, Stanghelle J. Bobath or motor relearning 
programme? A comparison of two different approaches of 
physiotherapy in stroke rehabilitation: a randomized controlled study. 
Clin Rehabil 2000;14:361-9. 
 171.  Logigian M, Samuels M, Falconer J, Zagar R. Clinical exercise trial 
for stroke patients. Arch Phys Med Rehab 1983;64:364-7. 
 172.  Platz T, Eickhof C, van Kaick S, Engel U, Pinkowski C, Kalok S et al. 
Impairment-oriented training or Bobath therapy for severe arm 
paresis after stroke: a single-blind, multicentre randomized 
controlled trial. Clin Rehabil 2005;19:714-24. 
 173.  van Vliet P, Lincoln N, Foxall A. Comparison of bobath based and 
movement science based treatment for stroke: a randomised 
controlled trial. J Neurol Neurosurg Psychiatry 2005;76:503-8. 
 174.  Coupar F, Pollock A, van Wijck F, Morris J, Langhorne P. 
Simultaneous bilateral training for improving arm function after 
stroke. Cochrane Database Syst Rev 2010;4:CD006432. 
 175.  Cauraugh J, Kim S. Two coupled motor recovery protocols are 
better than one.  Electromyogram-triggered neuromuscular 
stimulation and bilateral movements. Stroke 2002;33:1589-94. 
 176.  Cauraugh J, Kim S, Summers J. Chronic stroke longitudinal motor 
improvements: cumulative learning evidence found in the upper 
extremity. Cerebrovasc Dis 2008;25:115-21. 
 177.  Desrosiers J, Bourbonnais D, Corriveau H, Gosselin S, Bravo G. 
Effectiveness of unilateral and symmetrical bilateral task training for 
arm during the subacute phase of stroke: a randomised controlled 
trial. Clin Rehabil 2005;19:581-93. 
 178.  Lin K-C, Chang Y-F, Wu C-Y, Chen Y-A. Effects of constraint-
induced therapy versus bilateral arm training on motor performance, 
296 
daily functions and quality of life in stroke survivors. Neurorehab 
Neural Re 2009;23:441-8. 
 179.  Lin K-C, Chen S-Y, Wu C-Y, Chen Y-A. The effects of bilateral arm 
training on motor control and functional performance in chronic 
stroke: a randomised controlled study. Neurorehab Neural Re 
2009;24:42-51. 
 180.  Luft A, McCombe-Waller S, Whitall J, Forrester L, Macko R, Sorkin 
JD et al. Repetitive bilateral arm training and motor cortex activation 
in chronic stroke. JAMA 2004;292:1853-61. 
 181.  Lum P, Burgar D, van der Loos M, Shor P, Majmundar M, Yap R. 
MIME robotic device for upper limb neurorehabilitation in subacute 
stroke subjects: a follow-up study. J Rehabil Res Dev 2006;43:631-
42. 
 182.  Morris J, van Wijck F, Joice S, Ogston S, Cole I, MacWalter A. 
Effectiveness of unilateral and symmetrical bilateral task training for 
arm during the subacute phase of stroke:  a randomised controlled 
trial. Clin Rehabil 2008;19:581-93. 
 183.  Stoykov M, Lewis G, Corcos D. Comparison of bilateral and 
unilateral training for upper extremity hemiparesis in stroke. 
Neurorehab Neural Re 2009;945-53. 
 184.  Summers J, Kagere F, Garry M, Hiraga C, Loftus A, Cauraugh J. 
Bilateral and unilateral movement training on upper limb function in 
chronic stroke patients: A TMS study. J Neurol Sci 2007;252:76-82. 
 185.  Sirtori V, Corbetta D, Moja L, Gatti R. Constraint-induced movement 
therapy for upper extremities in stroke patients. Cochrane Database 
Syst Rev 2009;4:CD004433. 
 186.  Alberts J, Butler A, Wolf S. The effects of constraint-induced therapy 
on precision grip: a preliminary study. Neurorehab Neural Re 
2004;18:250-8. 
 187.  Atteya A.. Effects of modified constraint induced movement therapy 
on upper limb function in subacute stroke patients. Neurosciences 
2004;9:24-9. 
 188.  Boake C, Noser E, Ro T, Baraniuk S, Gaber M, Johnson R et al. 
Constraint-induced movement therapy during early stroke 
rehabilitation. Neurorehab Neural Re 2007;21:14-24. 
 189.  Dahl A, Askim T, Stock R, Langorgen E, Lydersen S, Indredavik B. 
Short- and long-term outcome of constraint-induced movement 
therapy after stroke: a randomized controlled feasibility trial. Clin 
Rehabil 2008;22:436-47. 
297 
 190.  Dromerick A, Edwards D, Hahn M. Does the application of 
constraint-induced movement therapy during acute rehabilitation 
reduce arm impairment after ischemic stroke? Stroke 2000;31:2984-
8. 
 191.  Lin K, Wu C, Wei T, Lee C, Liu J. Effects of modified constraint-
induced movement therapy on reach-to-grasp movements and 
functional performance after chronic stroke: a randomized controlled 
study. Clin Rehabil 2007;21:1075-86. 
 192.  Myint J, Yuen G, Yu T, Kng C, Wong A, Chow K et al. A study of 
constraint-induced movement therapy in subacute stroke patients in 
Hong Kong. Clin Rehabil 2008;22:112-24. 
 193.  Page S, Sisto S, Levine P, Johnston M, Hughes M. Modified 
constraint induced therapy: A randomized feasibility and efficacy 
study. J Rehabil Res Dev 2001;38:583-90. 
 194.  Page S, Sisto S, Johnston M, Levine P. Modified constraint-induced 
therapy after subacute stroke: A preliminary study. Neurorehab 
Neural Re 2002;16:290-5. 
 195.  Page S, Sisto S, Levine P, McGarth R. Efficacy of modified 
constraint-induced movement therapy in chronic stroke: a single-
blinded randomized controlled trial. Arch Phys Med Rehab 
2004;85:14-8. 
 196.  Page S, Levine P, Leonard A. Modified constraint-induced therapy in 
acute stroke: A randomized controlled pilot study. Neurorehab 
Neural Re 2005;19:27-32. 
 197.  Page S, Levine P, Leonard A, Szaflarski J, Kissela B. Modified 
constraint-induced therapy in chronic stroke: Results of a single-
blinded randomized controlled trial. Phys Ther 2008;88:333-40. 
 198.  Ploughman M, Corbett D. Can forced-use therapy be clinically 
applied after stroke? An exploratory randomized controlled trial. Arch 
Phys Med Rehab 2004;85:1417-23. 
 199.  Taub E, Miller N, Novack T, Cook E, Fleming W, Nepomuceno C et 
al. Technique to improve chronic motor deficit after stroke. Arch 
Phys Med Rehab 1993;74:347-54. 
 200.  Wittenberg G, Chen R, Ishii K, Bushara K, Taub E, Gerber L et al. 
Constraint-induced therapy in stroke: Magnetic-stimulation motor 
maps and cerebral activation. Neurorehab Neural Re 2003;17:48-57. 
 201.  Wolf S, Winstein C, Miller J, Taub E, Uswatte G, Morris D et al. 
Effect of constraint-induced movement therapy on upper extremity 
function 3 to 9 months after stroke: the EXCITE randomized clinical 
trial. JAMA 2006;296:2095-104. 
298 
 202.  Wu C, Lin K, Chen H, Chen I, Hong W. Effects of modified 
constraint-induced movement therapy on movement kinematics and 
daily function in patients with stroke: A kinematic study of motor 
control mechanisms. Neurorehab Neural Re 2007;21:460-6. 
 203.  Wu C, Chen C, Tang, Lin K, Huang Y. Kinematic and clinical 
analyses of upper-extremity movements after constraint-induced 
movement therapy in patients with stroke: A randomized controlled 
trial. Arch Phys Med Rehab 2007;88:964-70. 
 204.  Wu C, Chen C, Tsai W, Lin K, Chou S. A randomized controlled trial 
of modified constraint-induced movement therapy for elderly stroke 
survivors: Changes in motor impairment, daily functioning, and 
quality of life. Arch Phys Med Rehab 2007;88:273-8. 
 205.  Dromerick A, Lang C, Birkenmeier R, Wagner J, Miller J, Videen T et 
al. Very early constraint-induced movement during Stroke 
Rehabilitation (VECTORS) A single-center RCT. Neurology 
2009;73:195-201. 
 206.  Lin K-C, Wu C-Y, Liu J-S. A randomized controlled trial of constraint-
induced movement therapy after stroke. Act Neur S 2008;101:61-4. 
 207.  Lin K-C, Chung H-Y, Wu C-Y, Liu H-L, Hsieh Y-W, Chen I-H et al. 
Constraint-induced therapy versus control intervention in patients 
with stroke:   A functional magnetic resonance imaging study. Am J 
Phys Med Rehab 2010;89:177-85. 
 208.  Woodford H, Price C. EMG biofeedback for the recovery of motor 
function after stroke. Cochrane Database Syst Rev 
2007;2:CD004585. 
 209.  Armagan O, Tascioglu F, Oner C. Electromyographic biofeedback in 
the treatment of the hemiplegic hand - A placebo-controlled study. 
Am J Phys Med Rehab 2003;82:856-61. 
 210.  Basmajian J, Gowland C, Finlayson M, Hall A, Swanson L, Stratford 
P et al. Stroke treatment: comparison of integrated behavioral-
physical therapy vs traditional physical therapy programs. Arch Phys 
Med Rehab 1987;68:267-72. 
 211.  Crow J, Lincoln N, Nouri F, de Weerdt W. The eff ectiveness of EMG 
biofeedback in the treatment of arm function after stroke. Int Disabil 
Stud 1989;11:155-60. 
 212.  Inglis J, Donald M, Monga T, Sproule M, Young M. 
Electromyographic Biofeedback and Physical Therapy of the 
Hemiplegic Upper Limb. Arch Phys Med Rehab 1984;65:755-9. 
 213.  Pomeroy V, King L, Pollock A, Baily-Hallam A, Langhorne P. 
Electrostimulation for promoting recovery of movement or functional 
ability after stroke. Cochrane Database Sys Rev 2006;2:CD003241. 
299 
 214.  Cauraugh J, Light K, Kim S, Thigpen M, Behrman A. Chronic motor 
dysfunction after stroke - Recovering wrist and finger extension by 
electromyography-triggered neuromuscular stimulation. Stroke 
2000;31:1360-4. 
 215.  Cauraugh J, Kim S. Chronic stroke motor recovery: duration of 
active neuromuscular stimulation. J Neurol Sci 2003;215:13-9. 
 216.  Chae J, Bethoux F, Bohinc T, Dobos L, Davis T, Friedl A. 
Neuromuscular stimulation for upper extremity motor and functional 
recovery in acute hemiplegia. Stroke 1998;29:975-9. 
 217.  Francisco G, Chae J, Chawla H, Kirshblum S, Zorowitz R, Lewis G 
et al. Electromyogram-triggered neuromuscular stimulation for 
improving the arm function of acute stroke survivors: A randomized 
pilot study. Arch Phys Med Rehab 1998;79:570-5. 
 218.  Kimberley T, Lewis S, Auerbach E, Dorsey L, Lojovich J, Carey J. 
Electrical stimulation driving functional improvements and cortical 
changes in subjects with stroke. Exp Brain Res 2004;154:450-60. 
 219.  Linn S, Granat M, Lees K. Prevention of shoulder subluxation after 
stroke with electrical stimulation. Stroke 1999;30:963-8. 
 220.  Popovic M, Popovic D, Sinkjaer T, Stefanovic A, Schwirtlich L. 
Clinical evaluation of Functional Electrical Therapy in acute 
hemiplegic subjects. J Rehabil Res Dev 2003;40:443-53. 
 221.  Powell J, Pandyan A, Granat M, Cameron M, Stott D. Electrical 
stimulation of wrist extensors in poststroke hemiplegia. Stroke 
1999;30:1384-9. 
 222.  Sonde L, Gip C, Fernaeus S, Nilsson C, Viitanen M. Stimulation with 
low frequency (1.7Hz) transcutaneous electric nerve stimulation 
(Low-TENS) increases motor function of the post-stroke paretic arm. 
Scand J Rehabil Med 1998;30:95-9. 
 223.  Alon G, Levitt A, McCarthy P. Functional electrical stimulation 
enhancement of upper extremity functional recovery during stroke 
rehabilitation: A pilot study. Neurorehab Neural Re 2007;21:207-15. 
 224.  Alon G, Levitt A, McCarthy P. Functional electrical stimulation (FES) 
may modify the poor prognosis of stroke survivors with severe motor 
loss of the upper extremity - A preliminary study. Am J Phys Med 
Rehab 2008;87:627-36. 
 225.  Chan M, Tong R, Chung K. Bilateral upper limb training with 
functional electric stimulation in patients with chronic stroke. 
Neurorehab Neural Re 2009;23:357-65. 
 226.  Gabr U, Levine P, Page S. Home-based electromyography-triggered 
stimulation in chronic stroke. Clin Rehabil 2005;19:737-45. 
300 
 227.  Hara Y, Ogawa S, Muraoka Y. Hybrid power-assisted functional 
electrical stimulation to improve hemiparetic upper-extremity 
function. Am J Phys Med Rehab 2006;85:977-85. 
 228.  Hara Y, Ogawa S, Tsujiuchi K, Muraoka Y. A home-based 
rehabilitation program for the hemiplegic upper extremity by power 
assisted functional electrical stimulation. Disabil Rehabil 
2008;30:296-304. 
 229.  Hsu S, Hu M, Wang Y, Yip P, Chiu J, Hsieh C. Dose-response 
relation between neuromuscular electrical stimulation and upper-
extremity function in patients with stroke. Stroke 2010;41:821-4. 
 230.  Mangold S, Schuster C, Keller T, Zimmermann-Schlatter A, Ettlin T. 
Motor training of upper extremity with functional electrical stimulation 
in early stroke rehabilitation. Neurorehab Neural Re 2009;23:184-90. 
 231.  Thrasher T, Zivanovic V, McIlroy W, Popovic M. Rehabilitation of 
reaching and grasping function in severe hemiplegic patients using 
functional electrical stimulation therapy. Neurorehab Neural Re 
2008;22:706-14. 
 232.  Weber D, Skidmore E, Niyonkuru C, Chang C-L, Huber L, Munin M. 
Cyclic functional electrical stimulation does not enhance gains in 
hand grasp function when used as an adjunct to onabotulinumtoxinA 
and task practice therapy:  A single-blind, randomized controlled 
pilot study. Arch Phys Med Rehab 2010;91:679-86. 
 233.  Winter J, Hunter S, Sim J, Crome P. Hands-on therapy interventions 
for upper limb motor dysfunction following stroke. Cochrane 
Database Syst Rev 2011;6:CD006609. 
 234.  Carey J. Manual stretch - effect on finger movement control and 
force control in stroke subjects with spastic extrinsic finger flexor 
muscles. Arch Phys Med Rehab 1990;71:888-94. 
 235.  Mann G, Burridge J, Malone L, Strike P. A pilot study to investigate 
the effects of electrical stimulation on recovery of hand function and 
sensation in subacute stroke patients. Neuromodulation 2005;8:193-
202. 
 236.  Mikulecka E, Petruskava L, Mayer M, Vlachova I. Differentiated 
manual treatment of the hand and forearm in early rehabilitation of 
stroke patients (a controlled study). Rehabilitacia 2005;42:52-61. 
 237.  Kwakkel G, van Peppen R, Wagenaar R, Dauphinee S, Richards C, 
Ashburn A et al. Effects of augmented exercise therapy time after 
stroke - a meta-analysis. Stroke 2004;35:2529-36. 
 238.  Kwakkel G, Wagenaar R, Twisk J, Lankhorst G, Koetsier J. Intensity 
of leg and arm training after primary middle-cerebral-artery stroke: a 
randomised trial. Lancet 1999;354:191-6. 
301 
 239.  Lincoln N, Parry R, Vass C. Randomized, controlled trial to evaluate 
increased intensity of physiotherapy treatment of arm function after 
stroke. Stroke 1999;30:573-9. 
 240.  Sunderland A, Tinson D, Bradley E, Fletcher D, Hewer R, Wade D. 
Enhanced physical therapy improves recovery of arm function after 
stroke - a randomized controlled trial. J Neurol Neurosurg Psychiatry 
1992;55:530-5. 
 241.  Barclay-Goddard R, Stevenson T, Poluha W, Thalman L. Mental 
practice for treating upper extremity deficits in individuals with 
hemiparesis after stroke. Cochrane Database Syst Rev 
2011;5:CD005950. 
 242.  Muller K, Butefisch C, Seitz R, Homberg V. Mental practice improves 
hand function after hemiparetic stroke. Restor Neurol Neuros 
2007;25:501-11. 
 243.  Page S, Levine P, Sisto S, Johnston M. A randomized efficacy and 
feasibility study of imagery in acute stroke. Clin Rehabil 
2001;15:233-40. 
 244.  Page S, Levine P, Leonard A. Effects of mental practice on affected 
limb use and function in chronic stroke. Arch Phys Med Rehab 
2005;86:399-402. 
 245.  Page S, Levine P, Leonard A. Mental practice in chronic stroke - 
results of a randomized, placebo-controlled trial. Stroke 
2007;38:1293-7. 
 246.  Page S, Levine P, Khoury J. Modified constraint-induced therapy 
combined with mental practice.  Thinking through better motor 
outcomes. Stroke 2009;40:551-4. 
 247.  Riccio I, Iolascon G, Barillari M, Gimigliano R, Gimigliano F. Mental 
practice is effective in upper limb recovery after stroke: a 
randomized single-blind cross-over study. Eur J Phys Rehab Med 
2010;46:19-25. 
 248.  Rothgangel A, Braun S, Beurskens A, Seitz R, Wade D. The clinical 
aspects of mirror therapy in rehabilitation: a systematic review of the 
literature. Int J Rehabil Res 2011;34:1-13. 
 249.  Altschuler E, Wisdom S, Stone L, Foster C, Galasko D, Llewellyn D 
et al. Rehabilitation of hemiparesis after stroke with a mirror. Lancet 
1999;353:2035-6. 
 250.  Dohle C, Pullen J, Nakaten A, Kust J, Rietz C, Karbe H. Mirror 
therapy promotes recovery from severe hemiparesis: a randomized 
controlled trial. Neurorehab Neural Re 2009;23:209-17. 
302 
 251.  Rothgangel A, Morton A, Van den Hout J, Beurskens A. Phantoms 
in the brain: mirror therapy in chronic stroke patients; a pilot study. 
Ned Tijdschr Fys. 2004;114:36-40. 
 252.  Yavuzer G, Selles R, Sezer N, Sutbeyaz S, Bussmann J, Koseoglu 
F et al. Mirror therapy improves hand function in subacute stroke: a 
randomized controlled trial. Arch Phys Med Rehab 2008;89:393-8. 
 253.  Michielsen M, Selles R, van der Geest J, Eckhardt M, Yavuzer G, 
Stam H et al. Motor recovery and cortical reorganization after mirror 
therapy in chronic stroke patients: a phase II randomized controlled 
trial. Neurorehab Neural Re 2011;25:223-33. 
 254.  French B, Thomas L, Leathley M, Sutton C, McAdam J, Forster A et 
al. Repetitive task training for improving functional ability after 
stroke. Cochrane Database Syst Rev 2007;4:CD006073. 
 255.  Blennerhassett J, Dite W. Additional task-related practice improves 
mobility and upper limb function early after stroke: A randomised 
controlled trial. Aust J Physiother 2004;50:219-24. 
 256.  Higgins J, Salbach N, Wood-Dauphinee S, Richards C, Cote R, 
Mayo N. The effect of a task-oriented intervention on arm function in 
people with stroke: a randomized controlled trial. Clin Rehabil 
2006;20:296-310. 
 257.  Turton A, Fraser C. The use of home therapy programmes for 
improving recovery of the upper limb following stroke. Br J Occup 
Ther 1990;53:457-62. 
 258.  Yen J, Wang R, Chen H, Hong C. Effectiveness of modified 
constraint-induced movement therapy on upper limb function in 
stroke subjects. Acta Neurol Taiwan 2005;14:16-20. 
 259.  Harris J, Eng J, Miller W, Dawson A. A self-administered graded 
repetitive arm supplementary program (GRASP) improves arm 
function during inpatient stroke rehabilitation: a multi-site 
randomized controlled trial. Stroke 2009;40:2123-8. 
 260.  Mehrholz J, Platz T, Kugler J, Pohl M. Electromechanical and robot-
assisted arm training for improving arm function and activities of 
daily living after stroke. Cochrane Database Syst Rev 
2008;4:CD006876. 
 261.  Amirabdollahian F, Loureiro R, Gradwell E, Collin C, Harwin W, 
Johnson G. Multivariate analysis of the Fugl-Meyer outcome 
measures assessing the effectiveness of GENTLE/S robot-mediated 
stroke therapy. J Neuroeng Rehabil 2007;4. 
 262.  Daly J, Hogan N, Perepezko E, Krebs H, Rogers J, Goyal K et al. 
Response to upper-limb robotics and functional neuromuscular 
stimulation following stroke. J Rehabil Res Dev 2005;42:723-36. 
303 
 263.  Fazekas G, Horvath M, Troznai T, Toth A. Robot-mediated upper 
limb physiotherapy for patients with spastic hemiparesis: a 
preliminary study. J Rehabil Med 2007;39:580-2. 
 264.  Hesse S, Werner C, Pohl M, Rueckriem S, Mehrholz J, Lingnau M. 
Computerized arm training improves the motor control of the 
severely affected arm after stroke - a single-blinded randomized trial 
in two centers. Stroke 2005;36:1960-6. 
 265.  Kahn L, Zygman M, Rymer W, Reinkensmeyer D. Robot-assisted 
reaching exercise promotes arm recovery in chronic hemiparetic 
stroke: a randomized controlled pilot study. Journal of Neuroeng and 
Rehabil 2006;3:12. 
 266.  Lum P, Burgar C, Shor P, Majmundar M, Van der Loos M. Robot-
assisted movement training compared with conventional therapy 
techniques for the rehabilitation of upper-limb motor function after 
stroke. Arch Phys Med Rehab 2002;83:952-9. 
 267.  Masiero S, Celia A, Rosati G, Armani M. Robotic-assisted 
rehabilitation of the upper limb after acute stroke. Arch Phys Med 
Rehab 2007;88:142-9. 
 268.  Volpe B, Krebs H, Hogan N, Edelstein L, Diels C, Aisen M. A novel 
approach to stroke rehabilitation - Robot-aided sensorimotor 
stimulation. Neurology 2000;54:1938-44. 
 269.  Volpe B, Lynch D, Rykman-Berland A, Ferraro M, Galgano M, 
Hogan N et al. Intensive sensorimotor arm training mediated by 
therapist or robot improves hemiparesis in patients with chronic 
stroke. Neurorehab Neural Re 2008;22:305-10. 
 270.  Burgar C, Lum P, Scremin A, Garber S, Van der Loos H, Kenney D 
et al. Robot-assisted upper-limb therapy in acute rehabilitation 
setting following stroke: Department of Veterans Affairs multisite 
clinical trial. J Rehab Res Dev 2011;48:445-58. 
 271.  Conroy S, Whitall J, Dipietro L, Jones-Lush L, Zhan M, Finley M et 
al. Effect of gravity on robot-assisted motor training after chronic 
stroke: a randomized trial. Arch Phys Med Rehab 2011;92:1754-61. 
 272.  Housman S, Scott K, Reinkensmeyer D. A randomized controlled 
trial of gravity-supported, computer-enhanced arm exercise for 
individuals with severe hemiparesis. Neurorehab Neural Re 
2009;23:505-14. 
 273.  Lo A, Guarino P, Richards L, Haselkorn J, Wittenberg G, Federman 
D et al. Robot-assisted therapy for long-term upper-limb impairment 
after stroke. New Engl J Med 2010;362:1772-83. 
 274.  Masiero S, Armani M, Rosati G. Upper-limb robot-assisted therapy 
in rehabilitation of acute stroke patients: focused review and results 
304 
of new randomized controlled trial. J Rehab Res Dev 2011;48:355-
66. 
 275.  Rabadi M, Galgano M, Lynch D, Akerman M, Lesser M, Volpe BT. A 
pilot study of activity-based therapy in the arm motor recovery post 
stroke: a randomized controlled trial. Clin Rehabil 2008;22:1071-82. 
 276.  Lannin N, Herbert R. Is hand splinting effective for adults following 
stroke? A systematic review and methodological critique of 
published research. Clin Rehabil 2003;17:807-16. 
 277.  Lannin N, Horsley S, Herbert R, McCuskey A, Cusiek A. Splinting 
the hand in the functional position after brain impairment: a 
randomized, controlled trial. Arch Phys Med Rehab 2003;84:297-
302. 
 278.  Poole J, Whitney S, Hangeland N, Baker C. The effectiveness of 
inflatable pressure splints on motor function in stroke patients. 
Occup Ther J Res 1990;10:360-6. 
 279.  Lannin N, Cusick A, McCluskey A, Herbert R. Effects of splinting on 
wrist contracture after stroke - a randomized controlled trial. Stroke 
2007;38:111-6. 
 280.  Laver K, George S, Thomas S, Deutsch J, Crotty M. Virtual reality 
for stroke rehabilitation. Cochrane Database Syst Rev 
2011;9:CD008349. 
 281.  Crosbie J. Virtual reality in the rehabilitation of the upper limb 
following stroke.  2008.  University of Ulster.  
 
 282.  Jang S, You S, Cho Y, Park C, Cho S, et al. Cortical reorganization 
and associated functional motor recovery after virtual reality in 
patients with chronic stroke: an experimenter-blind preliminary study. 
Arch Phys Med Rehab 2005;86:2218-23. 
 283.  Piron L, Tombolini P, Turolla A, Zucconi C, Agostini M, Dam M et al. 
Reinforced feedback in virtual environment facilitates the arm motor 
recovery in patients after a recent stroke. International Workshop of 
Virtual Reality 2007;121-3. 
 284.  Piron L, Turolla A, Agostini M, Zucconi C, Cortese F, Zampolini M et 
al. Exercises for paretic upper limb after stroke: a combined virtual-
reality and telemedicine approach. J Rehabil Med 2009;41:1016-20. 
 285.  Piron L, Turolla A, Agostini M, Zucconi C, Ventura L, Tonin P et al. 
Motor learning principles for rehabilitation: a pilot randomized 
controlled study in poststroke patients. Neurorehabilitation and 
Neural Repair 2010;24:501-8. 
 286.  Saposnik G, Teasell R, Mamdani M, Hall J, McIlroy W, Cheung D et 
al. Effectiveness of virtual reality using Wii gaming technology in 
305 
stroke rehabilitation: a pilot randomized clinical trial and proof of 
principle. Stroke 2010;41:1477-84. 
 287.  Sucar L, Leder R, Hernandez J, Sanchez I, Azcarate G. Clinical 
evaluation of a low-cost alternative for stroke rehabilitation. 
International Conference on Rehabilitation Robotics 2009;863-6. 
 288.  Yavuzer G, Senel A, Atay M, Stam HJ. "Playstation eyetoy games" 
improve upper extremity-related motor functioning in subacute 
stroke: a randomized controlled clinical trial. Eur J Phys Rehab Med 
2008;44:237-44. 
 289.  Cauraugh J, Kim S. Progress toward motor recovery with active 
neuromuscular stimulation: muscle activation pattern evidence after 
a stroke. J Neurol Sci 2003;207:25-9. 
 290.  Cauraugh J, Kim S, Duley A. Coupled bilateral movements and 
active neuromuscular stimulation: intralimb transfer evidence during 
bimanual aiming. Neurosci Lett 2005;382:39-44. 
 291.  Mudie M, Matyas T. Responses of the densely hemiplegic upper 
extremity to bilateral training. Neurorehab Neural Re 2001;15:129-
40. 
 292.  Platz T, Bock S, Prass K. Reduced skilfulness of arm motor 
behaviour among motor stroke patients with good clinical recovery: 
does it indicate reduced automaticity? Can it be improved by 
unilateral or bilateral training? A kinematic motion analysis study. 
Neuropsychologia 2001;39:687-98. 
 293.  Chang J, Tung W, Wu W, Su F. Effect of bilateral reaching on 
affected arm motor control in stroke - with and without loading on 
unaffected arm. Disabil Rehabil 2006;28:1507-16. 
 294.  Dickstein R, Hocherman S, Amdor G, Pillar T. Reaction and 
movement times in patients with hemiparesis for unilateral and 
bilateral elbow flexion. Phys Ther 1993;73:374-85. 
 295.  Harris-Love M, Waller S, Whitall J. Exploiting interlimb coupling to 
improve paretic arm reaching performance in people with chronic 
stroke. Arch Phys Med Rehab 2005;86:2131-7. 
 296.  Kilbreath S, Crosbie J, Canning C, Lee M. Inter-limb coordination in 
bimanual reach-to-grasp following stroke. Disabil Rehabil 
2006;28:1435-43. 
 297.  Fasoli S, Krebs H, Stein J, Frontera W, Hogan N. Effects of robotic 
therapy on motor impairment and recovery in chronic stroke. Arch 
Phys Med Rehab 2003;84:477-82. 
306 
 298.  Hao Z, Wang D, Zeng Y, Liu M. Repetitive transcranial magnetic 
stimulation for improving function after stroke (Protocol). Cochrane 
Database Syst Rev 2010;12:CD008862. 
 299.  Rabadi M, Rabadi F. Comparison of the action research arm test 
and the Fugl-Meyer assessment as measures of upper-extremity 
motor weakness after stroke. Archives of Physical Medicine and 
Rehabilitation 2006;87:962-6. 
 300.  Mudie M, Matyas T. Can simultaneous bilateral movement involve 
the undamaged hemisphere in reconstruction of neural networks 
damaged by stroke? Disabil Rehabil 2000;22:23-37. 
 301.  Kelso J, Southard D, Goodman D. Nature of Human Inter-Limb 
Coordination. Science 1979;203:1029-31. 
 302.  Swinnen S. Intermanual coordination: From behavioural principles to 
neural-network interactions. Nature Reviews Neuroscience 
2002;3:350-61. 
 303.  Stinear C, Barber P, Coxon J, Fleming M, Byblow W. Priming the 
motor system enhances the effects of upper limb therapy in chronic 
stroke. Brain 2008;131:1381-90. 
 304.  Cauraugh J, Summers J. Neural plasticity and bilateral movements: 
a rehabilitation approach for chronic stroke. Prog Neurobiol 
2005;75:309-20. 
 305.  Stewart K, Cauraugh J, Summers J. Bilateral movement training and 
stroke rehabilitation: a systematic review and meta-analysis. J 
Neurol Sci 2006;244:89-95. 
 306.  McCombe Waller S, Whitall J. Bilateral arm training: why and who 
benefits? Neurorehabilitation 2008;23:29-41. 
 307.  Higgins J. and Green S editors. Cochrane Handbook for Systematic 
Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 
2011. www.cochrane-handbook.org.  Last accessed January 2012. 
 
 308.  Whiting S, Lincoln N. An ADL assessment for stroke patients. Br J 
Occup Ther 1980;43:44-6. 
 309.  Wolf S, Catlin P, Ellis M, Archer A, Morgan B, Piacentino A. 
Assessing Wolf Motor function Test as outcome measure for 
research in patients after stroke. Stroke 2001;32:1635-9. 
 310.  Wilson D, Baker L, Craddock J. Functional test for the hemiparetic 
upper extremity. Am J Occup Ther 1984;38:159-64. 
 311.  Desrosiers J, Herbert R, Dutil E, Bravo G. Development and 
reliability of an upper extemity function test for the elderly:  the 
TEMPA. Can J Occup Ther 1993;60:9-16. 
307 
 312.  Barreca S, Stratford P, Lambert C, Masters L, Streiner D. Test-retest 
reliability, validity, and sensitivity of the Chedoke Arm and Hand 
Activity Inventory: a new measure of upper-limb function for 
survivors of stroke. Arch Phys Med Rehab 2005;86:1616-22. 
 313.  Sodring K, BautzHolter E, Ljunggren A, Wyller T. Description and 
validation of a test of motor function and activities in stroke patients - 
The Sodring Motor Evaluation of stroke patients. Scan J Rehabil 
Med 1995;27:211-7. 
 314.  Jebsen R, Taylor N, Trieschmann R, Howard LA. An objective and 
standardised test of hand function. Arch Phys Med Rehab 
1969;50:311-9. 
 315.  Tiffin J, Asher E. The Purdue Pegboard: norms and studies of 
reliability and validity. J Appl Psychol 1948;32:234-47. 
 316.  Nouri F, Lincoln N. An Extended Activities of Daily Living Index for 
stroke patients. Clinical Rehabilitation 1987;1:305. 
 317.  Rossier P, Wade D, Murphy M. An initial investigation of the 
reliability of the Rivermead Extended ADL index in patients 
presenting with neurological impairment. J Rehabil Med 2001;33:61-
70. 
 318.  Holbrook M, Skilbeck C. An activities index for use with stroke 
patients. Age Ageing 1983;12:166-70. 
 319.  Lincoln N, Leadbetter D. Assessment of motor function in stroke 
function. Physiotherapy 1979;65:48-51. 
 320.  Ashburn A. A physical assessment for stroke patients. 
Physiotherapy 1982;68:109-13. 
 321.  Ashworth B. Preliminary Trial of Carisoprodol in Multiple Sclerosis. 
Practitioner 1964;192:540-&. 
 322.  Bohannon R, Smith M. Interrater reliability of a modified Ashworth 
Scale of muscle spasticity. Phys Ther 1987;67:206-7. 
 323.  Medical Research Council. Aids to the investigation of peripheral 
nerve injuries. London: HMSO, 1975. 
 324.  Bohannon R, Andrews A. Interrater reliability of hand-held 
dynamometry. Phys Ther 1987;67:931-3. 
 325.  Mantel N, Haenszel W. Statistical aspects of the analysis of data 
from retrospective studies of disease. J Natl Cancer I 1959;22:719-
48. 
 326.  Dersimonian R, Laird N. Meta-analysis in clinical trials. Controlled 
Clin Trials 1986;7:177-88. 
308 
 327.  Deeks J, Altman D, Bradburn M. Statistical methods for examining 
heterogenity and combining results from several studies in meta-
analysis. Systematic Reviews in Health Care:  Meta-analysis in 
Context, London: BMJ Publication Group, 2001. 
 328.  Lewis G, Byblow W. Neurophysiological and behavioural 
adaptations to a bilateral training intervention in individuals following 
stroke. Clin Rehabil 2004;18:48-59. 
 329.  McCombe Waller S, Whitall J. Fine motor control in adults with and 
without chronic hemiparesis: baseline comparison to nondisabled 
adults and effects of bilateral arm training. Arch Phys Med Rehab 
2004;85:1076-83. 
 330.  Mudie H, Matays T. Upper extremity retraining following stroke:  
effects of bilateral practice. Neurorehab Neural Re 1996;10:184. 
 331.  Stinear J, Byblow W. Rhythmic bilateral movement training 
modulates corticomotor excitability and enhances upper limb 
motricity poststroke: a pilot study. J Clin Neurophysio 2004;21:124-
31. 
 332.  Whitall J, Waller S, Silver K, Macko RF. Repetitive bilateral arm 
training with rhythmic auditory cueing improves motor function in 
chronic hemiparetic stroke. Stroke 2000;31:2390-5. 
 333.  Early Supported Discharge Trialists. Services for reducing duration 
of hospital care for acute stroke patients. Cochrane Database Syst 
Rev 2005;2:CD000443. 
 334.  Outpatient Service Trialists. Therapy-based rehabilitation services 
for stroke patients at home. Cochrane Database Syst Rev 
2006;4:CD002925. 
 335.  Review Manager (RevMan). Version 5.1 Copenhagen.  The Nordic 
Cochrane Centre.  The Cochrane Collaboration.  2011.  
 
 336.  Duncan P, Richards L, Wallace D, Stoker-Yates J, Pohl P, Luchies 
C et al. A randomized, controlled pilot study of a home-based 
exercise program for individuals with mild and moderate stroke. 
Stroke 1998;29:2055-60. 
 337.  Duncan P, Studenski S, Richards L, Gollub S, Lai S, Reker D et al. 
Randomized clinical trial of therapeutic exercise in subacute stroke. 
Stroke 2003;34:2173-80. 
 338.  Piron L, Turolla A, Tonin P, Piccione F, Lain L, Dam M. Satisfaction 
with care in post-stroke patients undergoing a telerehabilitation 
programme at home. J Telemed Telecare 2008;14:257-60. 
 339.  Studenski S, Duncan P, Perera S, Reker D, Lai SM, Richards L. 
Daily functioning and quality of life in a randomized controlled trial of 
309 
therapeutic exercise for subacute stroke survivors. Stroke 
2005;36:1764-70. 
 340.  Baskett J, Broad J, Reekie G, Hocking C, Green G. Shared 
responsibility for ongoing rehabilitation: a new approach to home-
based therapy after stroke. Clin Rehabil 1999;13:23-33. 
 341.  Hocoma.  www.hocoma.com/en/products/armeo/armeo-spring.  Last 
accessed March 2012.   
 
 342.  Kwakkel G, Kollen B, Krebs H. Effects of robot-assisted therapy on 
upper limb recovery after stroke: a systematic review. Neurorehab 
Neural Re 2008;22:111-21. 
 343.  Borg G, Linderholm H. Exercise Performance and Perceived 
Exertion in Patients with Coronary Insufficiency, Arterial 
Hypertension and Vasoregulatory Asthenia. Acta Medica 
Scandinavica 1970;187:17-&. 
 344.  Gladstone D, Danells C, Black S. The Fugl-Meyer assessment of 
motor recovery after stroke: a critical review of its measurement 
properties. Neurorehab Neural Re 2002;16:232-40. 
 345.  Lang C, Wagner J, Dromerick A, Edwards D. Measurement of 
upper-extremity function early after stroke: properties of the action 
research arm test. Arch Phys Med Rehab 2006;87:1605-10. 
 346.  Wade D, Collin C. The Barthel ADL Index:  a standard measure of 
physical disability. Int Disabil Stud 1988;10:64-7. 
 347.  Wolfe C, Taub N, Woodrow E, Burney P. Assessment of Scales of 
Disability and Handicap for Stroke Patients. Stroke 1991;22:1242-4. 
 348.  Strauss A, Corbin J. Basics of qualitative research:  techniques and 
procedures for developing grounded theory. Newbury Park: Sage, 
1998. 
 349.  SPSS. SPSS version 19.  1-8-2010. Chicago, IL, USA, IBM.  
 
 350.  Elashoff, J. nQuery Advisor Version 7.0.  1-1-2007. Cork, Ireland, 
Statistical Solutions.  
 
 351.  van der Lee J, Wagenaar R, Lankhorst G, Vogelaar T, Deville W, 
Bouter L. Forced use of the upper extremity in chronic stroke 
patients - results from a single-blind randomized clinical trial. Stroke 
1999;30:2369-75. 
 352.  Dobkin B. Interpreting the randomized clinical trial of constraint-
induced movement therapy. Arch Neurol-Chicacgo 2007;64:336-8. 
 353.  van der Lee J, De Groot V, Beckerman H, Wagenaar R, Lankhorst 
G, Bouter L. The intra- and interrater reliability of the action research 
310 
arm test: a practical test of upper extremity function in patients with 
stroke. Arch Phys Med Rehab 2001;82:14-9. 
 354.  Lang C, Edwards D, Birkenmeier R, Dromerick A. Estimating 
minimal clinically important differences of upper-extremity measures 
early after stroke. Arch Phys Med Rehab 2008;89:1693-700. 
 
 
